id	sid	tid	token	lemma	pos
fnp-5116	1	1	pathological	pathological	ADJ
fnp-5116	1	2	perspectives	perspective	NOUN
fnp-5116	1	3	in	in	ADP
fnp-5116	1	4	pilocytic	pilocytic	ADJ
fnp-5116	1	5	astrocytomas	astrocytoma	NOUN
fnp-5116	1	6	:	:	PUNCT
fnp-5116	1	7	extent	extent	NOUN
fnp-5116	1	8	of	of	ADP
fnp-5116	1	9	resection	resection	NOUN
fnp-5116	1	10	as	as	ADP
fnp-5116	1	11	the	the	DET
fnp-5116	1	12	sole	sole	ADJ
fnp-5116	1	13	critical	critical	ADJ
fnp-5116	1	14	factor	factor	NOUN
fnp-5116	1	15	for	for	ADP
fnp-5116	1	16	recurrence	recurrence	NOUN
fnp-5116	1	17	-	-	PUNCT
fnp-5116	1	18	free	free	ADJ
fnp-5116	1	19	survival	survival	NOUN
fnp-5116	1	20	,	,	PUNCT
fnp-5116	1	21	and	and	CCONJ
fnp-5116	1	22	the	the	DET
fnp-5116	1	23	challenge	challenge	NOUN
fnp-5116	1	24	of	of	ADP
fnp-5116	1	25	evaluating	evaluate	VERB
fnp-5116	1	26	conclusions	conclusion	NOUN
fnp-5116	1	27	derived	derive	VERB
fnp-5116	1	28	from	from	ADP
fnp-5116	1	29	limited	limited	ADJ
fnp-5116	1	30	data	datum	NOUN
fnp-5116	1	31	feel	feel	VERB
fnp-5116	1	32	free	free	ADJ
fnp-5116	1	33	to	to	PART
fnp-5116	1	34	add	add	VERB
fnp-5116	1	35	comments	comment	NOUN
fnp-5116	1	36	by	by	ADP
fnp-5116	1	37	clicking	click	VERB
fnp-5116	1	38	these	these	DET
fnp-5116	1	39	icons	icon	NOUN
fnp-5116	1	40	on	on	ADP
fnp-5116	1	41	the	the	DET
fnp-5116	1	42	sidebar	sidebar	NOUN
fnp-5116	1	43	free	free	ADJ
fnp-5116	1	44	neuropathology	neuropathology	NOUN
fnp-5116	1	45	4:17	4:17	NUM
fnp-5116	1	46	(	(	PUNCT
fnp-5116	1	47	2023	2023	NUM
fnp-5116	1	48	)	)	PUNCT
fnp-5116	1	49	original	original	ADJ
fnp-5116	1	50	paper	paper	NOUN
fnp-5116	1	51	pathological	pathological	ADJ
fnp-5116	1	52	perspectives	perspective	NOUN
fnp-5116	1	53	in	in	ADP
fnp-5116	1	54	pilocytic	pilocytic	ADJ
fnp-5116	1	55	astrocytomas	astrocytoma	NOUN
fnp-5116	1	56	:	:	PUNCT
fnp-5116	1	57	extent	extent	NOUN
fnp-5116	1	58	of	of	ADP
fnp-5116	1	59	resection	resection	NOUN
fnp-5116	1	60	as	as	ADP
fnp-5116	1	61	the	the	DET
fnp-5116	1	62	sole	sole	ADJ
fnp-5116	1	63	critical	critical	ADJ
fnp-5116	1	64	factor	factor	NOUN
fnp-5116	1	65	for	for	ADP
fnp-5116	1	66	recurrence	recurrence	NOUN
fnp-5116	1	67	-	-	PUNCT
fnp-5116	1	68	free	free	ADJ
fnp-5116	1	69	survival	survival	NOUN
fnp-5116	1	70	,	,	PUNCT
fnp-5116	1	71	and	and	CCONJ
fnp-5116	1	72	the	the	DET
fnp-5116	1	73	challenge	challenge	NOUN
fnp-5116	1	74	of	of	ADP
fnp-5116	1	75	evaluating	evaluate	VERB
fnp-5116	1	76	conclusions	conclusion	NOUN
fnp-5116	1	77	derived	derive	VERB
fnp-5116	1	78	from	from	ADP
fnp-5116	1	79	limited	limited	ADJ
fnp-5116	1	80	data	datum	NOUN
fnp-5116	1	81	ibrahim	ibrahim	PROPN
fnp-5116	1	82	kulac1	kulac1	PROPN
fnp-5116	1	83	,	,	PUNCT
fnp-5116	1	84	irem	irem	PROPN
fnp-5116	1	85	yenidogan2	yenidogan2	PROPN
fnp-5116	1	86	,	,	PUNCT
fnp-5116	1	87	banu	banu	PROPN
fnp-5116	1	88	oflaz	oflaz	ADP
fnp-5116	1	89	sozmen2,3	sozmen2,3	PROPN
fnp-5116	1	90	,	,	PUNCT
fnp-5116	1	91	arzu	arzu	NOUN
fnp-5116	1	92	baygul4	baygul4	NOUN
fnp-5116	1	93	,	,	PUNCT
fnp-5116	1	94	soonmee	soonmee	PROPN
fnp-5116	1	95	cha5	cha5	ADJ
fnp-5116	1	96	,	,	PUNCT
fnp-5116	1	97	melike	melike	ADJ
fnp-5116	1	98	pekmezci6	pekmezci6	PROPN
fnp-5116	1	99	,	,	PUNCT
fnp-5116	1	100	tarik	tarik	PROPN
fnp-5116	1	101	tihan6	tihan6	PROPN
fnp-5116	1	102	department	department	PROPN
fnp-5116	1	103	of	of	ADP
fnp-5116	1	104	pathology	pathology	PROPN
fnp-5116	1	105	,	,	PUNCT
fnp-5116	1	106	koc	koc	PROPN
fnp-5116	1	107	university	university	PROPN
fnp-5116	1	108	school	school	NOUN
fnp-5116	1	109	of	of	ADP
fnp-5116	1	110	medicine	medicine	NOUN
fnp-5116	1	111	,	,	PUNCT
fnp-5116	1	112	istanbul	istanbul	PROPN
fnp-5116	1	113	,	,	PUNCT
fnp-5116	1	114	turkey	turkey	PROPN
fnp-5116	1	115	department	department	PROPN
fnp-5116	1	116	of	of	ADP
fnp-5116	1	117	pediatrics	pediatric	NOUN
fnp-5116	1	118	,	,	PUNCT
fnp-5116	1	119	koc	koc	PROPN
fnp-5116	1	120	university	university	PROPN
fnp-5116	1	121	school	school	NOUN
fnp-5116	1	122	of	of	ADP
fnp-5116	1	123	medicine	medicine	NOUN
fnp-5116	1	124	,	,	PUNCT
fnp-5116	1	125	istanbul	istanbul	PROPN
fnp-5116	1	126	,	,	PUNCT
fnp-5116	1	127	turkey	turkey	NOUN
fnp-5116	1	128	division	division	NOUN
fnp-5116	1	129	of	of	ADP
fnp-5116	1	130	pediatric	pediatric	ADJ
fnp-5116	1	131	hematology	hematology	NOUN
fnp-5116	1	132	and	and	CCONJ
fnp-5116	1	133	oncology	oncology	NOUN
fnp-5116	1	134	,	,	PUNCT
fnp-5116	1	135	koc	koc	PROPN
fnp-5116	1	136	university	university	PROPN
fnp-5116	1	137	school	school	NOUN
fnp-5116	1	138	of	of	ADP
fnp-5116	1	139	medicine	medicine	NOUN
fnp-5116	1	140	,	,	PUNCT
fnp-5116	1	141	istanbul	istanbul	PROPN
fnp-5116	1	142	,	,	PUNCT
fnp-5116	1	143	turkey	turkey	PROPN
fnp-5116	1	144	department	department	PROPN
fnp-5116	1	145	of	of	ADP
fnp-5116	1	146	biostatistics	biostatistics	PROPN
fnp-5116	1	147	,	,	PUNCT
fnp-5116	1	148	koc	koc	PROPN
fnp-5116	1	149	university	university	PROPN
fnp-5116	1	150	school	school	NOUN
fnp-5116	1	151	of	of	ADP
fnp-5116	1	152	medicine	medicine	NOUN
fnp-5116	1	153	,	,	PUNCT
fnp-5116	1	154	istanbul	istanbul	PROPN
fnp-5116	1	155	,	,	PUNCT
fnp-5116	1	156	turkey	turkey	PROPN
fnp-5116	1	157	department	department	PROPN
fnp-5116	1	158	of	of	ADP
fnp-5116	1	159	radiology	radiology	NOUN
fnp-5116	1	160	,	,	PUNCT
fnp-5116	1	161	university	university	PROPN
fnp-5116	1	162	of	of	ADP
fnp-5116	1	163	california	california	PROPN
fnp-5116	1	164	,	,	PUNCT
fnp-5116	1	165	san	san	PROPN
fnp-5116	1	166	francisco	francisco	PROPN
fnp-5116	1	167	,	,	PUNCT
fnp-5116	1	168	ca	ca	PROPN
fnp-5116	1	169	,	,	PUNCT
fnp-5116	1	170	usa	usa	PROPN
fnp-5116	1	171	department	department	PROPN
fnp-5116	1	172	of	of	ADP
fnp-5116	1	173	pathology	pathology	PROPN
fnp-5116	1	174	,	,	PUNCT
fnp-5116	1	175	university	university	PROPN
fnp-5116	1	176	of	of	ADP
fnp-5116	1	177	california	california	PROPN
fnp-5116	1	178	,	,	PUNCT
fnp-5116	1	179	san	san	PROPN
fnp-5116	1	180	francisco	francisco	PROPN
fnp-5116	1	181	,	,	PUNCT
fnp-5116	1	182	ca	ca	PROPN
fnp-5116	1	183	,	,	PUNCT
fnp-5116	1	184	usa	usa	PROPN
fnp-5116	1	185	corresponding	corresponding	PROPN
fnp-5116	1	186	author	author	NOUN
fnp-5116	1	187	:	:	PUNCT
fnp-5116	1	188	tarik	tarik	PROPN
fnp-5116	1	189	tihan	tihan	PROPN
fnp-5116	1	190	·	·	PUNCT
fnp-5116	1	191	department	department	NOUN
fnp-5116	1	192	of	of	ADP
fnp-5116	1	193	pathology	pathology	PROPN
fnp-5116	1	194	·	·	PUNCT
fnp-5116	1	195	division	division	NOUN
fnp-5116	1	196	of	of	ADP
fnp-5116	1	197	neuropathology	neuropathology	NOUN
fnp-5116	1	198	·	·	PUNCT
fnp-5116	1	199	university	university	PROPN
fnp-5116	1	200	of	of	ADP
fnp-5116	1	201	california	california	PROPN
fnp-5116	1	202	·	·	PUNCT
fnp-5116	1	203	san	san	PROPN
fnp-5116	1	204	francisco	francisco	PROPN
fnp-5116	1	205	·	·	PUNCT
fnp-5116	1	206	california	california	PROPN
fnp-5116	1	207	·	·	PUNCT
fnp-5116	1	208	usa	usa	PROPN
fnp-5116	1	209	tarik.tihan@ucsf.edu	tarik.tihan@ucsf.edu	PROPN
fnp-5116	1	210	submitted	submit	VERB
fnp-5116	1	211	:	:	PUNCT
fnp-5116	1	212	17	17	NUM
fnp-5116	1	213	september	september	PROPN
fnp-5116	1	214	2023	2023	NUM
fnp-5116	1	215	accepted	accept	VERB
fnp-5116	1	216	:	:	PUNCT
fnp-5116	1	217	09	09	NUM
fnp-5116	1	218	october	october	PROPN
fnp-5116	1	219	2023	2023	NUM
fnp-5116	1	220	copyedited	copyedit	VERB
fnp-5116	1	221	by	by	ADP
fnp-5116	1	222	:	:	PUNCT
fnp-5116	1	223	lauren	lauren	PROPN
fnp-5116	1	224	walker	walker	PROPN
fnp-5116	1	225	published	publish	VERB
fnp-5116	1	226	:	:	PUNCT
fnp-5116	1	227	20	20	NUM
fnp-5116	1	228	october	october	NOUN
fnp-5116	1	229	2023	2023	NUM
fnp-5116	1	230	https://doi.org/10.17879/freeneuropathology-2023-5116	https://doi.org/10.17879/freeneuropathology-2023-5116	NOUN
fnp-5116	1	231	keywords	keyword	NOUN
fnp-5116	1	232	:	:	PUNCT
fnp-5116	2	1	astrocytoma	astrocytoma	NOUN
fnp-5116	2	2	,	,	PUNCT
fnp-5116	2	3	entity	entity	NOUN
fnp-5116	2	4	,	,	PUNCT
fnp-5116	2	5	circumscribed	circumscribed	ADJ
fnp-5116	2	6	gliomas	glioma	NOUN
fnp-5116	2	7	,	,	PUNCT
fnp-5116	2	8	glioma	glioma	NOUN
fnp-5116	2	9	,	,	PUNCT
fnp-5116	2	10	juvenile	juvenile	ADJ
fnp-5116	2	11	pilocytic	pilocytic	ADJ
fnp-5116	2	12	astrocytoma	astrocytoma	NOUN
fnp-5116	2	13	,	,	PUNCT
fnp-5116	2	14	pilocytic	pilocytic	ADJ
fnp-5116	2	15	astrocytoma	astrocytoma	NOUN
fnp-5116	2	16	,	,	PUNCT
fnp-5116	2	17	piloid	piloid	ADJ
fnp-5116	2	18	,	,	PUNCT
fnp-5116	2	19	pilomyxoid	pilomyxoid	NOUN
fnp-5116	2	20	,	,	PUNCT
fnp-5116	2	21	tumor	tumor	NOUN
fnp-5116	2	22	type	type	NOUN
fnp-5116	2	23	abstract	abstract	ADJ
fnp-5116	2	24	introduction	introduction	NOUN
fnp-5116	2	25	:	:	PUNCT
fnp-5116	2	26	pilocytic	pilocytic	ADJ
fnp-5116	2	27	astrocytoma	astrocytoma	NOUN
fnp-5116	2	28	(	(	PUNCT
fnp-5116	2	29	pa	pa	PROPN
fnp-5116	2	30	)	)	PUNCT
fnp-5116	2	31	is	be	AUX
fnp-5116	2	32	one	one	NUM
fnp-5116	2	33	of	of	ADP
fnp-5116	2	34	the	the	DET
fnp-5116	2	35	most	most	ADV
fnp-5116	2	36	common	common	ADJ
fnp-5116	2	37	primary	primary	ADJ
fnp-5116	2	38	intracranial	intracranial	ADJ
fnp-5116	2	39	neoplasms	neoplasm	NOUN
fnp-5116	2	40	in	in	ADP
fnp-5116	2	41	childhood	childhood	NOUN
fnp-5116	2	42	with	with	ADP
fnp-5116	2	43	an	an	DET
fnp-5116	2	44	overall	overall	ADJ
fnp-5116	2	45	favorable	favorable	ADJ
fnp-5116	2	46	prognosis	prognosis	NOUN
fnp-5116	2	47	.	.	PUNCT
fnp-5116	3	1	despite	despite	SCONJ
fnp-5116	3	2	decades	decade	NOUN
fnp-5116	3	3	of	of	ADP
fnp-5116	3	4	experience	experience	NOUN
fnp-5116	3	5	,	,	PUNCT
fnp-5116	3	6	there	there	PRON
fnp-5116	3	7	are	be	VERB
fnp-5116	3	8	still	still	ADV
fnp-5116	3	9	diagnostic	diagnostic	ADJ
fnp-5116	3	10	and	and	CCONJ
fnp-5116	3	11	treatment	treatment	NOUN
fnp-5116	3	12	challenges	challenge	NOUN
fnp-5116	3	13	and	and	CCONJ
fnp-5116	3	14	unresolved	unresolved	ADJ
fnp-5116	3	15	issues	issue	NOUN
fnp-5116	3	16	regarding	regard	VERB
fnp-5116	3	17	risk	risk	NOUN
fnp-5116	3	18	factors	factor	NOUN
fnp-5116	3	19	associated	associate	VERB
fnp-5116	3	20	with	with	ADP
fnp-5116	3	21	recurrence	recurrence	NOUN
fnp-5116	3	22	,	,	PUNCT
fnp-5116	3	23	most	most	ADV
fnp-5116	3	24	often	often	ADV
fnp-5116	3	25	due	due	ADJ
fnp-5116	3	26	to	to	ADP
fnp-5116	3	27	conclusions	conclusion	NOUN
fnp-5116	3	28	of	of	ADP
fnp-5116	3	29	publications	publication	NOUN
fnp-5116	3	30	with	with	ADP
fnp-5116	3	31	limited	limited	ADJ
fnp-5116	3	32	data	datum	NOUN
fnp-5116	3	33	.	.	PUNCT
fnp-5116	4	1	we	we	PRON
fnp-5116	4	2	analyzed	analyze	VERB
fnp-5116	4	3	499	499	NUM
fnp-5116	4	4	patients	patient	NOUN
fnp-5116	4	5	with	with	ADP
fnp-5116	4	6	pa	pa	PROPN
fnp-5116	4	7	diagnosed	diagnose	VERB
fnp-5116	4	8	in	in	ADP
fnp-5116	4	9	a	a	DET
fnp-5116	4	10	single	single	ADJ
fnp-5116	4	11	institution	institution	NOUN
fnp-5116	4	12	over	over	ADP
fnp-5116	4	13	30	30	NUM
fnp-5116	4	14	years	year	NOUN
fnp-5116	4	15	in	in	ADP
fnp-5116	4	16	order	order	NOUN
fnp-5116	4	17	to	to	PART
fnp-5116	4	18	provide	provide	VERB
fnp-5116	4	19	answers	answer	NOUN
fnp-5116	4	20	to	to	ADP
fnp-5116	4	21	some	some	PRON
fnp-5116	4	22	of	of	ADP
fnp-5116	4	23	the	the	DET
fnp-5116	4	24	unresolved	unresolved	ADJ
fnp-5116	4	25	issues	issue	NOUN
fnp-5116	4	26	.	.	PUNCT
fnp-5116	5	1	materials	material	NOUN
fnp-5116	5	2	and	and	CCONJ
fnp-5116	5	3	methods	method	NOUN
fnp-5116	5	4	:	:	PUNCT
fnp-5116	5	5	we	we	PRON
fnp-5116	5	6	identified	identify	VERB
fnp-5116	5	7	pilocytic	pilocytic	ADJ
fnp-5116	5	8	astrocytomas	astrocytoma	NOUN
fnp-5116	5	9	diagnosed	diagnose	VERB
fnp-5116	5	10	at	at	ADP
fnp-5116	5	11	the	the	DET
fnp-5116	5	12	university	university	PROPN
fnp-5116	5	13	of	of	ADP
fnp-5116	5	14	california	california	PROPN
fnp-5116	5	15	,	,	PUNCT
fnp-5116	5	16	san	san	PROPN
fnp-5116	5	17	francisco	francisco	PROPN
fnp-5116	5	18	,	,	PUNCT
fnp-5116	5	19	between	between	ADP
fnp-5116	5	20	1989	1989	NUM
fnp-5116	5	21	and	and	CCONJ
fnp-5116	5	22	2019	2019	NUM
fnp-5116	5	23	,	,	PUNCT
fnp-5116	5	24	confirmed	confirm	VERB
fnp-5116	5	25	the	the	DET
fnp-5116	5	26	diagnoses	diagnosis	NOUN
fnp-5116	5	27	using	use	VERB
fnp-5116	5	28	the	the	DET
fnp-5116	5	29	who	who	PRON
fnp-5116	5	30	2021	2021	NUM
fnp-5116	5	31	essential	essential	ADJ
fnp-5116	5	32	and	and	CCONJ
fnp-5116	5	33	desirable	desirable	ADJ
fnp-5116	5	34	criteria	criterion	NOUN
fnp-5116	5	35	,	,	PUNCT
fnp-5116	5	36	and	and	CCONJ
fnp-5116	5	37	performed	perform	VERB
fnp-5116	5	38	a	a	DET
fnp-5116	5	39	retrospective	retrospective	ADJ
fnp-5116	5	40	review	review	NOUN
fnp-5116	5	41	of	of	ADP
fnp-5116	5	42	the	the	DET
fnp-5116	5	43	demographic	demographic	ADJ
fnp-5116	5	44	and	and	CCONJ
fnp-5116	5	45	clinical	clinical	ADJ
fnp-5116	5	46	features	feature	NOUN
fnp-5116	5	47	of	of	ADP
fnp-5116	5	48	the	the	DET
fnp-5116	5	49	patients	patient	NOUN
fnp-5116	5	50	and	and	CCONJ
fnp-5116	5	51	the	the	DET
fnp-5116	5	52	radiological	radiological	ADJ
fnp-5116	5	53	,	,	PUNCT
fnp-5116	5	54	pathologic	pathologic	ADJ
fnp-5116	5	55	and	and	CCONJ
fnp-5116	5	56	molecular	molecular	ADJ
fnp-5116	5	57	features	feature	NOUN
fnp-5116	5	58	of	of	ADP
fnp-5116	5	59	the	the	DET
fnp-5116	5	60	tumors	tumor	NOUN
fnp-5116	5	61	.	.	PUNCT
fnp-5116	6	1	results	result	NOUN
fnp-5116	6	2	:	:	PUNCT
fnp-5116	6	3	among	among	ADP
fnp-5116	6	4	the	the	DET
fnp-5116	6	5	patients	patient	NOUN
fnp-5116	6	6	identified	identify	VERB
fnp-5116	6	7	from	from	ADP
fnp-5116	6	8	pathology	pathology	NOUN
fnp-5116	6	9	archives	archive	NOUN
fnp-5116	6	10	,	,	PUNCT
fnp-5116	6	11	499	499	NUM
fnp-5116	6	12	cases	case	NOUN
fnp-5116	6	13	fulfilled	fulfil	VERB
fnp-5116	6	14	the	the	DET
fnp-5116	6	15	inclusion	inclusion	NOUN
fnp-5116	6	16	criteria	criterion	NOUN
fnp-5116	6	17	.	.	PUNCT
fnp-5116	7	1	median	median	ADJ
fnp-5116	7	2	age	age	NOUN
fnp-5116	7	3	at	at	ADP
fnp-5116	7	4	presentation	presentation	NOUN
fnp-5116	7	5	was	be	AUX
fnp-5116	7	6	12	12	NUM
fnp-5116	7	7	years	year	NOUN
fnp-5116	7	8	(	(	PUNCT
fnp-5116	7	9	range	range	NOUN
fnp-5116	7	10	3.5	3.5	NUM
fnp-5116	7	11	months	month	NOUN
fnp-5116	7	12	–	–	PUNCT
fnp-5116	7	13	73	73	NUM
fnp-5116	7	14	years	year	NOUN
fnp-5116	7	15	)	)	PUNCT
fnp-5116	7	16	and	and	CCONJ
fnp-5116	7	17	the	the	DET
fnp-5116	7	18	median	median	ADJ
fnp-5116	7	19	follow	follow	NOUN
fnp-5116	7	20	-	-	PUNCT
fnp-5116	7	21	up	up	NOUN
fnp-5116	7	22	was	be	AUX
fnp-5116	7	23	78.5	78.5	NUM
fnp-5116	7	24	months	month	NOUN
fnp-5116	7	25	.	.	PUNCT
fnp-5116	8	1	tumors	tumor	NOUN
fnp-5116	8	2	were	be	AUX
fnp-5116	8	3	predominantly	predominantly	ADV
fnp-5116	8	4	located	locate	VERB
fnp-5116	8	5	in	in	ADP
fnp-5116	8	6	the	the	DET
fnp-5116	8	7	posterior	posterior	ADJ
fnp-5116	8	8	fossa	fossa	NOUN
fnp-5116	8	9	(	(	PUNCT
fnp-5116	8	10	52.6	52.6	NUM
fnp-5116	8	11	%	%	NOUN
fnp-5116	8	12	)	)	PUNCT
fnp-5116	8	13	.	.	PUNCT
fnp-5116	9	1	there	there	PRON
fnp-5116	9	2	were	be	VERB
fnp-5116	9	3	six	six	NUM
fnp-5116	9	4	deaths	death	NOUN
fnp-5116	9	5	,	,	PUNCT
fnp-5116	9	6	but	but	CCONJ
fnp-5116	9	7	there	there	PRON
fnp-5116	9	8	were	be	VERB
fnp-5116	9	9	confounding	confound	VERB
fnp-5116	9	10	factors	factor	NOUN
fnp-5116	9	11	that	that	PRON
fnp-5116	9	12	prevented	prevent	VERB
fnp-5116	9	13	a	a	DET
fnp-5116	9	14	clear	clear	ADJ
fnp-5116	9	15	association	association	NOUN
fnp-5116	9	16	of	of	ADP
fnp-5116	9	17	death	death	NOUN
fnp-5116	9	18	to	to	ADP
fnp-5116	9	19	tumor	tumor	NOUN
fnp-5116	9	20	progression	progression	NOUN
fnp-5116	9	21	.	.	PUNCT
fnp-5116	10	1	extent	extent	NOUN
fnp-5116	10	2	of	of	ADP
fnp-5116	10	3	resection	resection	NOUN
fnp-5116	10	4	was	be	AUX
fnp-5116	10	5	the	the	DET
fnp-5116	10	6	only	only	ADJ
fnp-5116	10	7	significant	significant	ADJ
fnp-5116	10	8	factor	factor	NOUN
fnp-5116	10	9	for	for	ADP
fnp-5116	10	10	recurrence	recurrence	NOUN
fnp-5116	10	11	-	-	PUNCT
fnp-5116	10	12	free	free	ADJ
fnp-5116	10	13	survival	survival	NOUN
fnp-5116	10	14	.	.	PUNCT
fnp-5116	11	1	recurrence	recurrence	NOUN
fnp-5116	11	2	-	-	PUNCT
fnp-5116	11	3	free	free	ADJ
fnp-5116	11	4	survival	survival	NOUN
fnp-5116	11	5	time	time	NOUN
fnp-5116	11	6	was	be	AUX
fnp-5116	11	7	321.0	321.0	NUM
fnp-5116	11	8	months	month	NOUN
fnp-5116	11	9	for	for	ADP
fnp-5116	11	10	gross	gross	ADJ
fnp-5116	11	11	total	total	ADJ
fnp-5116	11	12	resection	resection	NOUN
fnp-5116	11	13	,	,	PUNCT
fnp-5116	11	14	compared	compare	VERB
fnp-5116	11	15	to	to	ADP
fnp-5116	11	16	160.9	160.9	NUM
fnp-5116	11	17	months	month	NOUN
fnp-5116	11	18	for	for	ADP
fnp-5116	11	19	subtotal	subtotal	ADJ
fnp-5116	11	20	resection	resection	NOUN
fnp-5116	11	21	(	(	PUNCT
fnp-5116	11	22	log	log	NOUN
fnp-5116	11	23	rank	rank	NOUN
fnp-5116	11	24	,	,	PUNCT
fnp-5116	11	25	p	p	X
fnp-5116	11	26	<	<	X
fnp-5116	11	27	0.001	0.001	NUM
fnp-5116	11	28	)	)	PUNCT
fnp-5116	11	29	.	.	PUNCT
fnp-5116	12	1	conclusion	conclusion	NOUN
fnp-5116	12	2	:	:	PUNCT
fnp-5116	12	3	multivariate	multivariate	NOUN
fnp-5116	12	4	analysis	analysis	NOUN
fnp-5116	12	5	was	be	AUX
fnp-5116	12	6	able	able	ADJ
fnp-5116	12	7	to	to	PART
fnp-5116	12	8	identify	identify	VERB
fnp-5116	12	9	extent	extent	NOUN
fnp-5116	12	10	of	of	ADP
fnp-5116	12	11	resection	resection	NOUN
fnp-5116	12	12	as	as	ADP
fnp-5116	12	13	the	the	DET
fnp-5116	12	14	only	only	ADJ
fnp-5116	12	15	significant	significant	ADJ
fnp-5116	12	16	variable	variable	NOUN
fnp-5116	12	17	to	to	PART
fnp-5116	12	18	influence	influence	VERB
fnp-5116	12	19	recurrence	recurrence	NOUN
fnp-5116	12	20	-	-	PUNCT
fnp-5116	12	21	free	free	ADJ
fnp-5116	12	22	survival	survival	NOUN
fnp-5116	12	23	.	.	PUNCT
fnp-5116	13	1	we	we	PRON
fnp-5116	13	2	did	do	AUX
fnp-5116	13	3	not	not	PART
fnp-5116	13	4	find	find	VERB
fnp-5116	13	5	a	a	DET
fnp-5116	13	6	statistically	statistically	ADV
fnp-5116	13	7	significant	significant	ADJ
fnp-5116	13	8	association	association	NOUN
fnp-5116	13	9	between	between	ADP
fnp-5116	13	10	age	age	NOUN
fnp-5116	13	11	,	,	PUNCT
fnp-5116	13	12	nf1	nf1	NOUN
fnp-5116	13	13	status	status	NOUN
fnp-5116	13	14	,	,	PUNCT
fnp-5116	13	15	tumor	tumor	NOUN
fnp-5116	13	16	location	location	NOUN
fnp-5116	13	17	,	,	PUNCT
fnp-5116	13	18	molecular	molecular	ADJ
fnp-5116	13	19	alterations	alteration	NOUN
fnp-5116	13	20	,	,	PUNCT
fnp-5116	13	21	and	and	CCONJ
fnp-5116	13	22	outcome	outcome	NOUN
fnp-5116	13	23	.	.	PUNCT
fnp-5116	14	1	smaller	small	ADJ
fnp-5116	14	2	series	series	NOUN
fnp-5116	14	3	with	with	ADP
fnp-5116	14	4	apparently	apparently	ADV
fnp-5116	14	5	significant	significant	ADJ
fnp-5116	14	6	results	result	NOUN
fnp-5116	14	7	may	may	AUX
fnp-5116	14	8	have	have	AUX
fnp-5116	14	9	suffered	suffer	VERB
fnp-5116	14	10	from	from	ADP
fnp-5116	14	11	limited	limited	ADJ
fnp-5116	14	12	sample	sample	NOUN
fnp-5116	14	13	size	size	NOUN
fnp-5116	14	14	,	,	PUNCT
fnp-5116	14	15	limited	limited	ADJ
fnp-5116	14	16	variables	variable	NOUN
fnp-5116	14	17	,	,	PUNCT
fnp-5116	14	18	acceptance	acceptance	NOUN
fnp-5116	14	19	of	of	ADP
fnp-5116	14	20	univariate	univariate	ADJ
fnp-5116	14	21	analysis	analysis	NOUN
fnp-5116	14	22	findings	finding	NOUN
fnp-5116	14	23	as	as	ADV
fnp-5116	14	24	well	well	ADV
fnp-5116	14	25	as	as	ADP
fnp-5116	14	26	a	a	DET
fnp-5116	14	27	larger	large	ADJ
fnp-5116	14	28	p	p	NOUN
fnp-5116	14	29	value	value	NOUN
fnp-5116	14	30	for	for	ADP
fnp-5116	14	31	biological	biological	ADJ
fnp-5116	14	32	significance	significance	NOUN
fnp-5116	14	33	.	.	PUNCT
fnp-5116	15	1	pa	pa	PROPN
fnp-5116	15	2	still	still	ADV
fnp-5116	15	3	remains	remain	VERB
fnp-5116	15	4	a	a	DET
fnp-5116	15	5	predominantly	predominantly	ADV
fnp-5116	15	6	surgical	surgical	ADJ
fnp-5116	15	7	disease	disease	NOUN
fnp-5116	15	8	and	and	CCONJ
fnp-5116	15	9	every	every	DET
fnp-5116	15	10	attempt	attempt	NOUN
fnp-5116	15	11	should	should	AUX
fnp-5116	15	12	be	be	AUX
fnp-5116	15	13	made	make	VERB
fnp-5116	15	14	to	to	PART
fnp-5116	15	15	achieve	achieve	VERB
fnp-5116	15	16	gross	gross	ADJ
fnp-5116	15	17	total	total	ADJ
fnp-5116	15	18	resection	resection	NOUN
fnp-5116	15	19	since	since	SCONJ
fnp-5116	15	20	this	this	PRON
fnp-5116	15	21	appears	appear	VERB
fnp-5116	15	22	to	to	PART
fnp-5116	15	23	be	be	AUX
fnp-5116	15	24	the	the	DET
fnp-5116	15	25	most	most	ADV
fnp-5116	15	26	reliable	reliable	ADJ
fnp-5116	15	27	predictor	predictor	NOUN
fnp-5116	15	28	of	of	ADP
fnp-5116	15	29	recurrence	recurrence	NOUN
fnp-5116	15	30	-	-	PUNCT
fnp-5116	15	31	free	free	ADJ
fnp-5116	15	32	survival	survival	NOUN
fnp-5116	15	33	.	.	PUNCT
fnp-5116	16	1	introduction	introduction	NOUN
fnp-5116	16	2	pilocytic	pilocytic	ADJ
fnp-5116	16	3	astrocytoma	astrocytoma	NOUN
fnp-5116	16	4	(	(	PUNCT
fnp-5116	16	5	pa	pa	PROPN
fnp-5116	16	6	)	)	PUNCT
fnp-5116	16	7	is	be	AUX
fnp-5116	16	8	a	a	DET
fnp-5116	16	9	circumscribed	circumscribed	ADJ
fnp-5116	16	10	astrocytoma	astrocytoma	NOUN
fnp-5116	16	11	with	with	ADP
fnp-5116	16	12	classic	classic	ADJ
fnp-5116	16	13	histologic	histologic	NOUN
fnp-5116	16	14	features	feature	NOUN
fnp-5116	16	15	such	such	ADJ
fnp-5116	16	16	as	as	ADP
fnp-5116	16	17	biphasic	biphasic	ADJ
fnp-5116	16	18	compact	compact	ADJ
fnp-5116	16	19	and	and	CCONJ
fnp-5116	16	20	loose	loose	ADJ
fnp-5116	16	21	growth	growth	NOUN
fnp-5116	16	22	patterns	pattern	NOUN
fnp-5116	16	23	,	,	PUNCT
fnp-5116	16	24	piloid	piloid	PROPN
fnp-5116	16	25	cytology	cytology	NOUN
fnp-5116	16	26	,	,	PUNCT
fnp-5116	16	27	and	and	CCONJ
fnp-5116	16	28	low	low	ADJ
fnp-5116	16	29	proliferative	proliferative	ADJ
fnp-5116	16	30	activity	activity	NOUN
fnp-5116	16	31	,	,	PUNCT
fnp-5116	16	32	with	with	ADP
fnp-5116	16	33	or	or	CCONJ
fnp-5116	16	34	without	without	ADP
fnp-5116	16	35	rosenthal	rosenthal	NOUN
fnp-5116	16	36	fibers	fiber	NOUN
fnp-5116	16	37	and/or	and/or	CCONJ
fnp-5116	16	38	eosinophilic	eosinophilic	ADJ
fnp-5116	16	39	granular	granular	ADJ
fnp-5116	16	40	bodies	body	NOUN
fnp-5116	16	41	[	[	X
fnp-5116	16	42	1	1	NUM
fnp-5116	16	43	]	]	PUNCT
fnp-5116	16	44	.	.	PUNCT
fnp-5116	17	1	the	the	DET
fnp-5116	17	2	essential	essential	ADJ
fnp-5116	17	3	criteria	criterion	NOUN
fnp-5116	17	4	adopted	adopt	VERB
fnp-5116	17	5	by	by	ADP
fnp-5116	17	6	the	the	DET
fnp-5116	17	7	world	world	PROPN
fnp-5116	17	8	health	health	PROPN
fnp-5116	17	9	organization	organization	NOUN
fnp-5116	17	10	(	(	PUNCT
fnp-5116	17	11	who	who	PRON
fnp-5116	17	12	)	)	PUNCT
fnp-5116	17	13	2021	2021	NUM
fnp-5116	17	14	also	also	ADV
fnp-5116	17	15	defines	define	VERB
fnp-5116	17	16	pa	pa	PROPN
fnp-5116	17	17	as	as	ADP
fnp-5116	17	18	a	a	DET
fnp-5116	17	19	“	"	PUNCT
fnp-5116	17	20	piloid	piloid	ADJ
fnp-5116	17	21	astrocytic	astrocytic	ADJ
fnp-5116	17	22	neoplasm	neoplasm	NOUN
fnp-5116	17	23	with	with	ADP
fnp-5116	17	24	a	a	DET
fnp-5116	17	25	solitary	solitary	ADJ
fnp-5116	17	26	mapk	mapk	NOUN
fnp-5116	17	27	pathway	pathway	NOUN
fnp-5116	17	28	alteration	alteration	NOUN
fnp-5116	17	29	,	,	PUNCT
fnp-5116	17	30	such	such	ADJ
fnp-5116	17	31	as	as	ADP
fnp-5116	17	32	kiaa1549::braf	kiaa1549::braf	NOUN
fnp-5116	17	33	fusion	fusion	NOUN
fnp-5116	17	34	”	"	PUNCT
fnp-5116	17	35	[	[	X
fnp-5116	17	36	2	2	NUM
fnp-5116	17	37	]	]	PUNCT
fnp-5116	17	38	.	.	PUNCT
fnp-5116	18	1	over	over	ADP
fnp-5116	18	2	the	the	DET
fnp-5116	18	3	last	last	ADJ
fnp-5116	18	4	century	century	NOUN
fnp-5116	18	5	,	,	PUNCT
fnp-5116	18	6	beginning	begin	VERB
fnp-5116	18	7	with	with	ADP
fnp-5116	18	8	the	the	DET
fnp-5116	18	9	first	first	ADJ
fnp-5116	18	10	use	use	NOUN
fnp-5116	18	11	of	of	ADP
fnp-5116	18	12	the	the	DET
fnp-5116	18	13	word	word	NOUN
fnp-5116	18	14	“	"	PUNCT
fnp-5116	18	15	pilocytic	pilocytic	ADJ
fnp-5116	18	16	”	"	PUNCT
fnp-5116	18	17	[	[	X
fnp-5116	18	18	3	3	X
fnp-5116	18	19	]	]	PUNCT
fnp-5116	18	20	who	who	PRON
fnp-5116	18	21	classification	classification	NOUN
fnp-5116	18	22	schemes	scheme	NOUN
fnp-5116	18	23	defined	define	VERB
fnp-5116	18	24	pa	pa	PROPN
fnp-5116	18	25	as	as	ADP
fnp-5116	18	26	a	a	DET
fnp-5116	18	27	clinically	clinically	ADV
fnp-5116	18	28	,	,	PUNCT
fnp-5116	18	29	radiologically	radiologically	ADV
fnp-5116	18	30	,	,	PUNCT
fnp-5116	18	31	pathologically	pathologically	ADV
fnp-5116	18	32	,	,	PUNCT
fnp-5116	18	33	and	and	CCONJ
fnp-5116	18	34	most	most	ADV
fnp-5116	18	35	recently	recently	ADV
fnp-5116	18	36	,	,	PUNCT
fnp-5116	18	37	a	a	DET
fnp-5116	18	38	molecularly	molecularly	ADV
fnp-5116	18	39	distinct	distinct	ADJ
fnp-5116	18	40	entity	entity	NOUN
fnp-5116	18	41	.	.	PUNCT
fnp-5116	19	1	typical	typical	ADJ
fnp-5116	19	2	radiological	radiological	ADJ
fnp-5116	19	3	and	and	CCONJ
fnp-5116	19	4	histological	histological	ADJ
fnp-5116	19	5	features	feature	NOUN
fnp-5116	19	6	are	be	AUX
fnp-5116	19	7	presented	present	VERB
fnp-5116	19	8	in	in	ADP
fnp-5116	19	9	figure	figure	NOUN
fnp-5116	19	10	1	1	NUM
fnp-5116	19	11	.	.	PUNCT
fnp-5116	20	1	figure	figure	NOUN
fnp-5116	20	2	1	1	NUM
fnp-5116	20	3	.	.	PUNCT
fnp-5116	21	1	a	a	DET
fnp-5116	21	2	cystic	cystic	ADJ
fnp-5116	21	3	tumor	tumor	NOUN
fnp-5116	21	4	with	with	ADP
fnp-5116	21	5	mural	mural	ADJ
fnp-5116	21	6	nodule	nodule	NOUN
fnp-5116	21	7	in	in	ADP
fnp-5116	21	8	posterior	posterior	ADJ
fnp-5116	21	9	fossa	fossa	NOUN
fnp-5116	21	10	on	on	ADP
fnp-5116	21	11	axial	axial	ADJ
fnp-5116	21	12	t1	t1	NOUN
fnp-5116	21	13	post	post	NOUN
fnp-5116	21	14	-	-	ADJ
fnp-5116	21	15	contrast	contrast	ADJ
fnp-5116	21	16	(	(	PUNCT
fnp-5116	21	17	a	a	NOUN
fnp-5116	21	18	)	)	PUNCT
fnp-5116	21	19	and	and	CCONJ
fnp-5116	21	20	t2	t2	PROPN
fnp-5116	21	21	(	(	PUNCT
fnp-5116	21	22	b	b	NOUN
fnp-5116	21	23	)	)	PUNCT
fnp-5116	21	24	weighted	weight	VERB
fnp-5116	21	25	mri	mri	NOUN
fnp-5116	21	26	images	image	NOUN
fnp-5116	21	27	.	.	PUNCT
fnp-5116	22	1	an	an	DET
fnp-5116	22	2	intraoperative	intraoperative	ADJ
fnp-5116	22	3	smear	smear	NOUN
fnp-5116	22	4	slide	slide	NOUN
fnp-5116	22	5	of	of	ADP
fnp-5116	22	6	a	a	DET
fnp-5116	22	7	pa	pa	NOUN
fnp-5116	22	8	case	case	NOUN
fnp-5116	22	9	with	with	ADP
fnp-5116	22	10	plenty	plenty	NOUN
fnp-5116	22	11	of	of	ADP
fnp-5116	22	12	piloid	piloid	ADJ
fnp-5116	22	13	cells	cell	NOUN
fnp-5116	22	14	distributed	distribute	VERB
fnp-5116	22	15	on	on	ADP
fnp-5116	22	16	a	a	DET
fnp-5116	22	17	glial	glial	ADJ
fnp-5116	22	18	background	background	NOUN
fnp-5116	22	19	(	(	PUNCT
fnp-5116	22	20	c	c	NOUN
fnp-5116	22	21	)	)	PUNCT
fnp-5116	22	22	.	.	PUNCT
fnp-5116	23	1	hematoxylin	hematoxylin	PROPN
fnp-5116	23	2	&	&	CCONJ
fnp-5116	23	3	eosin	eosin	PROPN
fnp-5116	23	4	image	image	NOUN
fnp-5116	23	5	of	of	ADP
fnp-5116	23	6	a	a	DET
fnp-5116	23	7	demonstrative	demonstrative	ADJ
fnp-5116	23	8	pa	pa	PROPN
fnp-5116	23	9	case	case	NOUN
fnp-5116	23	10	with	with	ADP
fnp-5116	23	11	an	an	DET
fnp-5116	23	12	overall	overall	ADJ
fnp-5116	23	13	fibrillary	fibrillary	ADJ
fnp-5116	23	14	appearance	appearance	NOUN
fnp-5116	23	15	(	(	PUNCT
fnp-5116	23	16	d	d	NOUN
fnp-5116	23	17	)	)	PUNCT
fnp-5116	23	18	,	,	PUNCT
fnp-5116	23	19	closer	close	ADJ
fnp-5116	23	20	view	view	NOUN
fnp-5116	23	21	with	with	ADP
fnp-5116	23	22	plenty	plenty	NOUN
fnp-5116	23	23	of	of	ADP
fnp-5116	23	24	rosenthal	rosenthal	NOUN
fnp-5116	23	25	fibers	fiber	NOUN
fnp-5116	23	26	,	,	PUNCT
fnp-5116	23	27	classical	classical	ADJ
fnp-5116	23	28	finding	finding	NOUN
fnp-5116	23	29	in	in	ADP
fnp-5116	23	30	pas	pas	PROPN
fnp-5116	23	31	(	(	PUNCT
fnp-5116	23	32	e	e	NOUN
fnp-5116	23	33	)	)	PUNCT
fnp-5116	23	34	.	.	PUNCT
fnp-5116	24	1	myxoid	myxoid	ADJ
fnp-5116	24	2	,	,	PUNCT
fnp-5116	24	3	loose	loose	ADJ
fnp-5116	24	4	areas	area	NOUN
fnp-5116	24	5	are	be	AUX
fnp-5116	24	6	another	another	DET
fnp-5116	24	7	common	common	ADJ
fnp-5116	24	8	finding	finding	NOUN
fnp-5116	24	9	in	in	ADP
fnp-5116	24	10	pa	pa	PROPN
fnp-5116	24	11	(	(	PUNCT
fnp-5116	24	12	f	f	PROPN
fnp-5116	24	13	)	)	PUNCT
fnp-5116	24	14	.	.	PUNCT
fnp-5116	25	1	linear	linear	PROPN
fnp-5116	25	2	glomeruloid	glomeruloid	ADJ
fnp-5116	25	3	vascular	vascular	ADJ
fnp-5116	25	4	structures	structure	NOUN
fnp-5116	25	5	are	be	AUX
fnp-5116	25	6	commonly	commonly	ADV
fnp-5116	25	7	observed	observe	VERB
fnp-5116	25	8	(	(	PUNCT
fnp-5116	25	9	g	g	NOUN
fnp-5116	25	10	)	)	PUNCT
fnp-5116	25	11	along	along	ADP
fnp-5116	25	12	with	with	ADP
fnp-5116	25	13	hyalinized	hyalinized	ADJ
fnp-5116	25	14	,	,	PUNCT
fnp-5116	25	15	thick	thick	ADJ
fnp-5116	25	16	vessels	vessel	NOUN
fnp-5116	25	17	(	(	PUNCT
fnp-5116	25	18	h	h	NOUN
fnp-5116	25	19	)	)	PUNCT
fnp-5116	25	20	.	.	PUNCT
fnp-5116	26	1	pa	pa	PROPN
fnp-5116	26	2	can	can	AUX
fnp-5116	26	3	be	be	AUX
fnp-5116	26	4	observed	observe	VERB
fnp-5116	26	5	at	at	ADP
fnp-5116	26	6	any	any	DET
fnp-5116	26	7	age	age	NOUN
fnp-5116	26	8	with	with	ADP
fnp-5116	26	9	a	a	DET
fnp-5116	26	10	reported	report	VERB
fnp-5116	26	11	incidence	incidence	NOUN
fnp-5116	26	12	rate	rate	NOUN
fnp-5116	26	13	of	of	ADP
fnp-5116	26	14	approximately	approximately	ADV
fnp-5116	26	15	0.84	0.84	NUM
fnp-5116	26	16	per	per	ADP
fnp-5116	26	17	100,000	100,000	NUM
fnp-5116	26	18	[	[	SYM
fnp-5116	26	19	4	4	NUM
fnp-5116	26	20	-	-	SYM
fnp-5116	26	21	6	6	NUM
fnp-5116	26	22	]	]	PUNCT
fnp-5116	26	23	,	,	PUNCT
fnp-5116	26	24	and	and	CCONJ
fnp-5116	26	25	has	have	VERB
fnp-5116	26	26	a	a	DET
fnp-5116	26	27	favorable	favorable	ADJ
fnp-5116	26	28	outcome	outcome	NOUN
fnp-5116	26	29	[	[	X
fnp-5116	26	30	5	5	NUM
fnp-5116	26	31	]	]	PUNCT
fnp-5116	26	32	.	.	PUNCT
fnp-5116	27	1	despite	despite	SCONJ
fnp-5116	27	2	being	be	AUX
fnp-5116	27	3	the	the	DET
fnp-5116	27	4	most	most	ADV
fnp-5116	27	5	common	common	ADJ
fnp-5116	27	6	glioma	glioma	NOUN
fnp-5116	27	7	among	among	ADP
fnp-5116	27	8	the	the	DET
fnp-5116	27	9	pediatric	pediatric	ADJ
fnp-5116	27	10	population	population	NOUN
fnp-5116	27	11	,	,	PUNCT
fnp-5116	27	12	overall	overall	ADJ
fnp-5116	27	13	rarity	rarity	NOUN
fnp-5116	27	14	of	of	ADP
fnp-5116	27	15	this	this	DET
fnp-5116	27	16	neoplasm	neoplasm	NOUN
fnp-5116	27	17	makes	make	VERB
fnp-5116	27	18	it	it	PRON
fnp-5116	27	19	an	an	DET
fnp-5116	27	20	orphan	orphan	NOUN
fnp-5116	27	21	disease	disease	NOUN
fnp-5116	27	22	as	as	ADV
fnp-5116	27	23	well	well	ADV
fnp-5116	27	24	as	as	ADP
fnp-5116	27	25	a	a	DET
fnp-5116	27	26	“	"	PUNCT
fnp-5116	27	27	chronic	chronic	ADJ
fnp-5116	27	28	disease	disease	NOUN
fnp-5116	27	29	”	"	PUNCT
fnp-5116	27	30	affecting	affect	VERB
fnp-5116	27	31	patients	patient	NOUN
fnp-5116	27	32	and	and	CCONJ
fnp-5116	27	33	families	family	NOUN
fnp-5116	27	34	for	for	ADP
fnp-5116	27	35	many	many	ADJ
fnp-5116	27	36	years	year	NOUN
fnp-5116	27	37	,	,	PUNCT
fnp-5116	27	38	creating	create	VERB
fnp-5116	27	39	challenges	challenge	NOUN
fnp-5116	27	40	in	in	ADP
fnp-5116	27	41	its	its	PRON
fnp-5116	27	42	management	management	NOUN
fnp-5116	27	43	[	[	X
fnp-5116	27	44	7	7	NUM
fnp-5116	27	45	-	-	SYM
fnp-5116	27	46	11	11	NUM
fnp-5116	27	47	]	]	PUNCT
fnp-5116	27	48	.	.	PUNCT
fnp-5116	28	1	coding	code	VERB
fnp-5116	28	2	of	of	ADP
fnp-5116	28	3	pas	pas	PROPN
fnp-5116	28	4	in	in	ADP
fnp-5116	28	5	tumor	tumor	NOUN
fnp-5116	28	6	registries	registry	NOUN
fnp-5116	28	7	has	have	AUX
fnp-5116	28	8	been	be	AUX
fnp-5116	28	9	problematic	problematic	ADJ
fnp-5116	28	10	in	in	ADP
fnp-5116	28	11	recent	recent	ADJ
fnp-5116	28	12	years	year	NOUN
fnp-5116	28	13	due	due	ADP
fnp-5116	28	14	to	to	ADP
fnp-5116	28	15	their	their	PRON
fnp-5116	28	16	designation	designation	NOUN
fnp-5116	28	17	as	as	ADP
fnp-5116	28	18	“	"	PUNCT
fnp-5116	28	19	malignant	malignant	ADJ
fnp-5116	28	20	”	"	PUNCT
fnp-5116	28	21	in	in	ADP
fnp-5116	28	22	some	some	DET
fnp-5116	28	23	countries	country	NOUN
fnp-5116	28	24	.	.	PUNCT
fnp-5116	29	1	this	this	DET
fnp-5116	29	2	change	change	NOUN
fnp-5116	29	3	was	be	AUX
fnp-5116	29	4	made	make	VERB
fnp-5116	29	5	in	in	ADP
fnp-5116	29	6	order	order	NOUN
fnp-5116	29	7	to	to	PART
fnp-5116	29	8	capture	capture	VERB
fnp-5116	29	9	these	these	DET
fnp-5116	29	10	tumors	tumor	NOUN
fnp-5116	29	11	in	in	ADP
fnp-5116	29	12	cancer	cancer	NOUN
fnp-5116	29	13	registries	registry	NOUN
fnp-5116	29	14	[	[	X
fnp-5116	29	15	12	12	NUM
fnp-5116	29	16	]	]	PUNCT
fnp-5116	29	17	.	.	PUNCT
fnp-5116	30	1	consequently	consequently	ADV
fnp-5116	30	2	,	,	PUNCT
fnp-5116	30	3	incidence	incidence	NOUN
fnp-5116	30	4	of	of	ADP
fnp-5116	30	5	benign	benign	ADJ
fnp-5116	30	6	or	or	CCONJ
fnp-5116	30	7	malignant	malignant	ADJ
fnp-5116	30	8	pediatric	pediatric	ADJ
fnp-5116	30	9	brain	brain	NOUN
fnp-5116	30	10	tumors	tumor	NOUN
fnp-5116	30	11	show	show	VERB
fnp-5116	30	12	significant	significant	ADJ
fnp-5116	30	13	variations	variation	NOUN
fnp-5116	30	14	over	over	ADP
fnp-5116	30	15	time	time	NOUN
fnp-5116	30	16	in	in	ADP
fnp-5116	30	17	epidemiological	epidemiological	ADJ
fnp-5116	30	18	analyses	analysis	NOUN
fnp-5116	30	19	[	[	X
fnp-5116	30	20	13	13	NUM
fnp-5116	30	21	]	]	PUNCT
fnp-5116	30	22	.	.	PUNCT
fnp-5116	31	1	we	we	PRON
fnp-5116	31	2	are	be	AUX
fnp-5116	31	3	not	not	PART
fnp-5116	31	4	sure	sure	ADJ
fnp-5116	31	5	whether	whether	SCONJ
fnp-5116	31	6	designating	designate	VERB
fnp-5116	31	7	pas	pa	NOUN
fnp-5116	31	8	as	as	ADP
fnp-5116	31	9	“	"	PUNCT
fnp-5116	31	10	malignant	malignant	ADJ
fnp-5116	31	11	”	"	PUNCT
fnp-5116	31	12	in	in	ADP
fnp-5116	31	13	order	order	NOUN
fnp-5116	31	14	to	to	PART
fnp-5116	31	15	capture	capture	VERB
fnp-5116	31	16	them	they	PRON
fnp-5116	31	17	in	in	ADP
fnp-5116	31	18	registries	registry	NOUN
fnp-5116	31	19	is	be	AUX
fnp-5116	31	20	a	a	DET
fnp-5116	31	21	good	good	ADJ
fnp-5116	31	22	idea	idea	NOUN
fnp-5116	31	23	,	,	PUNCT
fnp-5116	31	24	or	or	CCONJ
fnp-5116	31	25	whether	whether	SCONJ
fnp-5116	31	26	this	this	DET
fnp-5116	31	27	practice	practice	NOUN
fnp-5116	31	28	should	should	AUX
fnp-5116	31	29	be	be	AUX
fnp-5116	31	30	abandoned	abandon	VERB
fnp-5116	31	31	to	to	PART
fnp-5116	31	32	bring	bring	VERB
fnp-5116	31	33	more	more	ADJ
fnp-5116	31	34	clarity	clarity	NOUN
fnp-5116	31	35	and	and	CCONJ
fnp-5116	31	36	uniformity	uniformity	NOUN
fnp-5116	31	37	to	to	ADP
fnp-5116	31	38	the	the	DET
fnp-5116	31	39	issue	issue	NOUN
fnp-5116	31	40	worldwide	worldwide	ADV
fnp-5116	31	41	,	,	PUNCT
fnp-5116	31	42	but	but	CCONJ
fnp-5116	31	43	risk	risk	NOUN
fnp-5116	31	44	losing	lose	VERB
fnp-5116	31	45	their	their	PRON
fnp-5116	31	46	identification	identification	NOUN
fnp-5116	31	47	in	in	ADP
fnp-5116	31	48	cancer	cancer	NOUN
fnp-5116	31	49	statistics	statistic	NOUN
fnp-5116	31	50	.	.	PUNCT
fnp-5116	32	1	pa	pa	PROPN
fnp-5116	32	2	is	be	AUX
fnp-5116	32	3	most	most	ADV
fnp-5116	32	4	commonly	commonly	ADV
fnp-5116	32	5	located	locate	VERB
fnp-5116	32	6	in	in	ADP
fnp-5116	32	7	the	the	DET
fnp-5116	32	8	posterior	posterior	ADJ
fnp-5116	32	9	fossa	fossa	NOUN
fnp-5116	32	10	,	,	PUNCT
fnp-5116	32	11	specifically	specifically	ADV
fnp-5116	32	12	in	in	ADP
fnp-5116	32	13	cerebellar	cerebellar	ADJ
fnp-5116	32	14	hemispheres	hemisphere	NOUN
fnp-5116	32	15	.	.	PUNCT
fnp-5116	33	1	other	other	ADJ
fnp-5116	33	2	common	common	ADJ
fnp-5116	33	3	locations	location	NOUN
fnp-5116	33	4	include	include	VERB
fnp-5116	33	5	hypothalamic	hypothalamic	ADJ
fnp-5116	33	6	/	/	SYM
fnp-5116	33	7	chiasmatic	chiasmatic	ADJ
fnp-5116	33	8	region	region	NOUN
fnp-5116	33	9	and	and	CCONJ
fnp-5116	33	10	the	the	DET
fnp-5116	33	11	optic	optic	NOUN
fnp-5116	33	12	nerve	nerve	NOUN
fnp-5116	33	13	,	,	PUNCT
fnp-5116	33	14	the	the	DET
fnp-5116	33	15	latter	latter	ADJ
fnp-5116	33	16	being	be	AUX
fnp-5116	33	17	particularly	particularly	ADV
fnp-5116	33	18	common	common	ADJ
fnp-5116	33	19	in	in	ADP
fnp-5116	33	20	the	the	DET
fnp-5116	33	21	setting	setting	NOUN
fnp-5116	33	22	of	of	ADP
fnp-5116	33	23	neurofibromatosis	neurofibromatosis	NOUN
fnp-5116	33	24	1	1	NUM
fnp-5116	33	25	syndrome	syndrome	NOUN
fnp-5116	33	26	[	[	X
fnp-5116	33	27	14	14	NUM
fnp-5116	33	28	]	]	SYM
fnp-5116	33	29	.	.	PUNCT
fnp-5116	34	1	thalamic	thalamic	ADJ
fnp-5116	34	2	,	,	PUNCT
fnp-5116	34	3	cerebral	cerebral	ADJ
fnp-5116	34	4	,	,	PUNCT
fnp-5116	34	5	and	and	CCONJ
fnp-5116	34	6	spinal	spinal	ADJ
fnp-5116	34	7	tumors	tumor	NOUN
fnp-5116	34	8	are	be	AUX
fnp-5116	34	9	distinctly	distinctly	ADV
fnp-5116	34	10	less	less	ADV
fnp-5116	34	11	common	common	ADJ
fnp-5116	34	12	[	[	X
fnp-5116	34	13	5	5	NUM
fnp-5116	34	14	]	]	PUNCT
fnp-5116	34	15	.	.	PUNCT
fnp-5116	35	1	some	some	DET
fnp-5116	35	2	authors	author	NOUN
fnp-5116	35	3	suggested	suggest	VERB
fnp-5116	35	4	that	that	SCONJ
fnp-5116	35	5	there	there	PRON
fnp-5116	35	6	were	be	VERB
fnp-5116	35	7	prognostic	prognostic	ADJ
fnp-5116	35	8	differences	difference	NOUN
fnp-5116	35	9	among	among	ADP
fnp-5116	35	10	pas	pas	NOUN
fnp-5116	35	11	in	in	ADP
fnp-5116	35	12	different	different	ADJ
fnp-5116	35	13	locations	location	NOUN
fnp-5116	35	14	that	that	PRON
fnp-5116	35	15	could	could	AUX
fnp-5116	35	16	not	not	PART
fnp-5116	35	17	be	be	AUX
fnp-5116	35	18	explained	explain	VERB
fnp-5116	35	19	simply	simply	ADV
fnp-5116	35	20	by	by	ADP
fnp-5116	35	21	differences	difference	NOUN
fnp-5116	35	22	in	in	ADP
fnp-5116	35	23	clinical	clinical	ADJ
fnp-5116	35	24	variables	variable	NOUN
fnp-5116	36	1	[	[	X
fnp-5116	36	2	15	15	NUM
fnp-5116	36	3	-	-	SYM
fnp-5116	36	4	17	17	NUM
fnp-5116	36	5	]	]	PUNCT
fnp-5116	36	6	.	.	PUNCT
fnp-5116	37	1	it	it	PRON
fnp-5116	37	2	is	be	AUX
fnp-5116	37	3	not	not	PART
fnp-5116	37	4	clear	clear	ADJ
fnp-5116	37	5	whether	whether	SCONJ
fnp-5116	37	6	different	different	ADJ
fnp-5116	37	7	locations	location	NOUN
fnp-5116	37	8	are	be	AUX
fnp-5116	37	9	associated	associate	VERB
fnp-5116	37	10	with	with	ADP
fnp-5116	37	11	different	different	ADJ
fnp-5116	37	12	outcomes	outcome	NOUN
fnp-5116	37	13	beyond	beyond	ADP
fnp-5116	37	14	access	access	NOUN
fnp-5116	37	15	to	to	ADP
fnp-5116	37	16	gross	gross	ADJ
fnp-5116	37	17	total	total	ADJ
fnp-5116	37	18	resection	resection	NOUN
fnp-5116	37	19	,	,	PUNCT
fnp-5116	37	20	and	and	CCONJ
fnp-5116	37	21	whether	whether	SCONJ
fnp-5116	37	22	tumor	tumor	NOUN
fnp-5116	37	23	location	location	NOUN
fnp-5116	37	24	is	be	AUX
fnp-5116	37	25	associated	associate	VERB
fnp-5116	37	26	with	with	ADP
fnp-5116	37	27	different	different	ADJ
fnp-5116	37	28	driver	driver	NOUN
fnp-5116	37	29	mutations	mutation	NOUN
fnp-5116	37	30	and	and	CCONJ
fnp-5116	37	31	treatment	treatment	NOUN
fnp-5116	37	32	response	response	NOUN
fnp-5116	37	33	.	.	PUNCT
fnp-5116	38	1	in	in	ADP
fnp-5116	38	2	addition	addition	NOUN
fnp-5116	38	3	to	to	ADP
fnp-5116	38	4	location	location	NOUN
fnp-5116	38	5	,	,	PUNCT
fnp-5116	38	6	some	some	DET
fnp-5116	38	7	studies	study	NOUN
fnp-5116	38	8	suggest	suggest	VERB
fnp-5116	38	9	that	that	SCONJ
fnp-5116	38	10	age	age	NOUN
fnp-5116	38	11	is	be	AUX
fnp-5116	38	12	important	important	ADJ
fnp-5116	38	13	determinant	determinant	ADJ
fnp-5116	38	14	of	of	ADP
fnp-5116	38	15	outcome	outcome	NOUN
fnp-5116	38	16	,	,	PUNCT
fnp-5116	38	17	and	and	CCONJ
fnp-5116	38	18	adult	adult	NOUN
fnp-5116	38	19	and	and	CCONJ
fnp-5116	38	20	pediatric	pediatric	ADJ
fnp-5116	38	21	pas	pas	NOUN
fnp-5116	38	22	do	do	AUX
fnp-5116	38	23	not	not	PART
fnp-5116	38	24	have	have	VERB
fnp-5116	38	25	similar	similar	ADJ
fnp-5116	38	26	prognoses	prognosis	NOUN
fnp-5116	38	27	[	[	X
fnp-5116	38	28	18	18	NUM
fnp-5116	38	29	-	-	SYM
fnp-5116	38	30	21	21	NUM
fnp-5116	38	31	]	]	PUNCT
fnp-5116	38	32	.	.	PUNCT
fnp-5116	39	1	pas	pas	PROPN
fnp-5116	39	2	can	can	AUX
fnp-5116	39	3	have	have	VERB
fnp-5116	39	4	diverse	diverse	ADJ
fnp-5116	39	5	morphological	morphological	ADJ
fnp-5116	39	6	features	feature	NOUN
fnp-5116	39	7	,	,	PUNCT
fnp-5116	39	8	some	some	PRON
fnp-5116	39	9	of	of	ADP
fnp-5116	39	10	which	which	PRON
fnp-5116	39	11	may	may	AUX
fnp-5116	39	12	result	result	VERB
fnp-5116	39	13	in	in	ADP
fnp-5116	39	14	misclassification	misclassification	NOUN
fnp-5116	39	15	of	of	ADP
fnp-5116	39	16	some	some	DET
fnp-5116	39	17	tumors	tumor	NOUN
fnp-5116	39	18	as	as	ADP
fnp-5116	39	19	diffuse	diffuse	NOUN
fnp-5116	39	20	gliomas	glioma	NOUN
fnp-5116	39	21	.	.	PUNCT
fnp-5116	40	1	some	some	DET
fnp-5116	40	2	pas	pas	NOUN
fnp-5116	40	3	with	with	ADP
fnp-5116	40	4	the	the	DET
fnp-5116	40	5	so	so	ADV
fnp-5116	40	6	-	-	PUNCT
fnp-5116	40	7	called	call	VERB
fnp-5116	40	8	“	"	PUNCT
fnp-5116	40	9	diffuse	diffuse	ADJ
fnp-5116	40	10	pilocytic	pilocytic	ADJ
fnp-5116	40	11	pattern	pattern	NOUN
fnp-5116	40	12	”	"	PUNCT
fnp-5116	40	13	may	may	AUX
fnp-5116	40	14	be	be	AUX
fnp-5116	40	15	easily	easily	ADV
fnp-5116	40	16	misdiagnosed	misdiagnose	VERB
fnp-5116	40	17	as	as	ADP
fnp-5116	40	18	diffuse	diffuse	ADJ
fnp-5116	40	19	gliomas	glioma	NOUN
fnp-5116	40	20	[	[	X
fnp-5116	40	21	22	22	NUM
fnp-5116	40	22	]	]	PUNCT
fnp-5116	40	23	.	.	PUNCT
fnp-5116	41	1	conversely	conversely	ADV
fnp-5116	41	2	,	,	PUNCT
fnp-5116	41	3	other	other	ADJ
fnp-5116	41	4	entities	entity	NOUN
fnp-5116	41	5	may	may	AUX
fnp-5116	41	6	also	also	ADV
fnp-5116	41	7	be	be	AUX
fnp-5116	41	8	misclassified	misclassifie	VERB
fnp-5116	41	9	as	as	ADP
fnp-5116	41	10	pa	pa	PROPN
fnp-5116	41	11	and	and	CCONJ
fnp-5116	41	12	some	some	DET
fnp-5116	41	13	high	high	ADJ
fnp-5116	41	14	-	-	PUNCT
fnp-5116	41	15	grade	grade	NOUN
fnp-5116	41	16	tumors	tumor	NOUN
fnp-5116	41	17	with	with	ADP
fnp-5116	41	18	remote	remote	ADJ
fnp-5116	41	19	resemblance	resemblance	NOUN
fnp-5116	41	20	to	to	ADP
fnp-5116	41	21	pa	pa	PROPN
fnp-5116	41	22	may	may	AUX
fnp-5116	41	23	be	be	AUX
fnp-5116	41	24	erroneously	erroneously	ADV
fnp-5116	41	25	classified	classify	VERB
fnp-5116	41	26	as	as	ADP
fnp-5116	41	27	tumors	tumor	NOUN
fnp-5116	41	28	with	with	ADP
fnp-5116	41	29	piloid	piloid	PROPN
fnp-5116	41	30	features	feature	NOUN
fnp-5116	41	31	or	or	CCONJ
fnp-5116	41	32	simply	simply	ADV
fnp-5116	41	33	anaplastic	anaplastic	ADJ
fnp-5116	41	34	pa	pa	PROPN
fnp-5116	42	1	[	[	X
fnp-5116	42	2	23	23	NUM
fnp-5116	42	3	]	]	PUNCT
fnp-5116	42	4	.	.	PUNCT
fnp-5116	43	1	high	high	ADJ
fnp-5116	43	2	-	-	PUNCT
fnp-5116	43	3	grade	grade	NOUN
fnp-5116	43	4	histological	histological	ADJ
fnp-5116	43	5	features	feature	NOUN
fnp-5116	43	6	in	in	ADP
fnp-5116	43	7	otherwise	otherwise	ADV
fnp-5116	43	8	typical	typical	ADJ
fnp-5116	43	9	pas	pas	NOUN
fnp-5116	43	10	are	be	AUX
fnp-5116	43	11	also	also	ADV
fnp-5116	43	12	problematic	problematic	ADJ
fnp-5116	43	13	and	and	CCONJ
fnp-5116	43	14	the	the	DET
fnp-5116	43	15	current	current	NOUN
fnp-5116	43	16	who	who	PRON
fnp-5116	43	17	classification	classification	NOUN
fnp-5116	43	18	scheme	scheme	NOUN
fnp-5116	43	19	did	do	AUX
fnp-5116	43	20	not	not	PART
fnp-5116	43	21	find	find	VERB
fnp-5116	43	22	sufficient	sufficient	ADJ
fnp-5116	43	23	evidence	evidence	NOUN
fnp-5116	43	24	to	to	PART
fnp-5116	43	25	define	define	VERB
fnp-5116	43	26	an	an	DET
fnp-5116	43	27	anaplastic	anaplastic	ADJ
fnp-5116	43	28	subtype	subtype	NOUN
fnp-5116	43	29	[	[	X
fnp-5116	43	30	24	24	NUM
fnp-5116	43	31	]	]	PUNCT
fnp-5116	43	32	.	.	PUNCT
fnp-5116	44	1	however	however	ADV
fnp-5116	44	2	,	,	PUNCT
fnp-5116	44	3	there	there	PRON
fnp-5116	44	4	is	be	VERB
fnp-5116	44	5	clear	clear	ADJ
fnp-5116	44	6	evidence	evidence	NOUN
fnp-5116	44	7	that	that	SCONJ
fnp-5116	44	8	rare	rare	ADJ
fnp-5116	44	9	pas	pa	NOUN
fnp-5116	44	10	behave	behave	VERB
fnp-5116	44	11	aggressively	aggressively	ADV
fnp-5116	44	12	and	and	CCONJ
fnp-5116	44	13	some	some	PRON
fnp-5116	44	14	of	of	ADP
fnp-5116	44	15	these	these	DET
fnp-5116	44	16	tumors	tumor	NOUN
fnp-5116	44	17	may	may	AUX
fnp-5116	44	18	be	be	AUX
fnp-5116	44	19	justifiably	justifiably	ADV
fnp-5116	44	20	designated	designate	VERB
fnp-5116	44	21	as	as	ADP
fnp-5116	44	22	high	high	ADJ
fnp-5116	44	23	-	-	PUNCT
fnp-5116	44	24	grade	grade	NOUN
fnp-5116	44	25	gliomas	glioma	NOUN
fnp-5116	44	26	[	[	X
fnp-5116	44	27	25	25	NUM
fnp-5116	44	28	]	]	PUNCT
fnp-5116	44	29	.	.	PUNCT
fnp-5116	45	1	on	on	ADP
fnp-5116	45	2	the	the	DET
fnp-5116	45	3	other	other	ADJ
fnp-5116	45	4	hand	hand	NOUN
fnp-5116	45	5	,	,	PUNCT
fnp-5116	45	6	some	some	DET
fnp-5116	45	7	worrisome	worrisome	ADJ
fnp-5116	45	8	histological	histological	ADJ
fnp-5116	45	9	features	feature	NOUN
fnp-5116	45	10	in	in	ADP
fnp-5116	45	11	pa	pa	PROPN
fnp-5116	45	12	have	have	AUX
fnp-5116	45	13	not	not	PART
fnp-5116	45	14	been	be	AUX
fnp-5116	45	15	associated	associate	VERB
fnp-5116	45	16	with	with	ADP
fnp-5116	45	17	adverse	adverse	ADJ
fnp-5116	45	18	prognosis	prognosis	NOUN
fnp-5116	45	19	[	[	X
fnp-5116	45	20	26	26	NUM
fnp-5116	45	21	-	-	SYM
fnp-5116	45	22	28	28	NUM
fnp-5116	45	23	]	]	PUNCT
fnp-5116	45	24	.	.	PUNCT
fnp-5116	46	1	additional	additional	ADJ
fnp-5116	46	2	studies	study	NOUN
fnp-5116	46	3	and	and	CCONJ
fnp-5116	46	4	observations	observation	NOUN
fnp-5116	46	5	are	be	AUX
fnp-5116	46	6	needed	need	VERB
fnp-5116	46	7	to	to	PART
fnp-5116	46	8	validate	validate	VERB
fnp-5116	46	9	a	a	DET
fnp-5116	46	10	high	high	ADJ
fnp-5116	46	11	-	-	PUNCT
fnp-5116	46	12	grade	grade	NOUN
fnp-5116	46	13	subtype	subtype	NOUN
fnp-5116	46	14	of	of	ADP
fnp-5116	46	15	pa	pa	PROPN
fnp-5116	46	16	and	and	CCONJ
fnp-5116	46	17	its	its	PRON
fnp-5116	46	18	definition	definition	NOUN
fnp-5116	46	19	.	.	PUNCT
fnp-5116	47	1	currently	currently	ADV
fnp-5116	47	2	,	,	PUNCT
fnp-5116	47	3	the	the	DET
fnp-5116	47	4	only	only	ADJ
fnp-5116	47	5	recognized	recognize	VERB
fnp-5116	47	6	subtype	subtype	NOUN
fnp-5116	47	7	of	of	ADP
fnp-5116	47	8	pa	pa	PROPN
fnp-5116	47	9	is	be	AUX
fnp-5116	47	10	the	the	DET
fnp-5116	47	11	pilomyxoid	pilomyxoid	NOUN
fnp-5116	47	12	astrocytoma	astrocytoma	NOUN
fnp-5116	47	13	(	(	PUNCT
fnp-5116	47	14	pma	pma	PROPN
fnp-5116	47	15	)	)	PUNCT
fnp-5116	47	16	,	,	PUNCT
fnp-5116	47	17	that	that	PRON
fnp-5116	47	18	appears	appear	VERB
fnp-5116	47	19	to	to	PART
fnp-5116	47	20	be	be	AUX
fnp-5116	47	21	more	more	ADV
fnp-5116	47	22	aggressive	aggressive	ADJ
fnp-5116	47	23	compared	compare	VERB
fnp-5116	47	24	to	to	ADP
fnp-5116	47	25	typical	typical	ADJ
fnp-5116	47	26	pas	pas	NOUN
fnp-5116	47	27	[	[	X
fnp-5116	47	28	29	29	NUM
fnp-5116	47	29	]	]	PUNCT
fnp-5116	47	30	.	.	PUNCT
fnp-5116	48	1	however	however	ADV
fnp-5116	48	2	,	,	PUNCT
fnp-5116	48	3	in	in	ADP
fnp-5116	48	4	the	the	DET
fnp-5116	48	5	recent	recent	ADJ
fnp-5116	48	6	editions	edition	NOUN
fnp-5116	48	7	of	of	ADP
fnp-5116	48	8	the	the	PRON
fnp-5116	48	9	who	who	PRON
fnp-5116	48	10	classification	classification	NOUN
fnp-5116	48	11	of	of	ADP
fnp-5116	48	12	central	central	ADJ
fnp-5116	48	13	nervous	nervous	ADJ
fnp-5116	48	14	system	system	NOUN
fnp-5116	48	15	(	(	PUNCT
fnp-5116	48	16	cns	cns	NOUN
fnp-5116	48	17	)	)	PUNCT
fnp-5116	48	18	tumors	tumor	NOUN
fnp-5116	48	19	,	,	PUNCT
fnp-5116	48	20	the	the	DET
fnp-5116	48	21	working	work	VERB
fnp-5116	48	22	groups	group	NOUN
fnp-5116	48	23	decided	decide	VERB
fnp-5116	48	24	that	that	SCONJ
fnp-5116	48	25	the	the	DET
fnp-5116	48	26	data	datum	NOUN
fnp-5116	48	27	for	for	ADP
fnp-5116	48	28	recognizing	recognize	VERB
fnp-5116	48	29	this	this	DET
fnp-5116	48	30	subtype	subtype	NOUN
fnp-5116	48	31	as	as	ADP
fnp-5116	48	32	more	more	ADV
fnp-5116	48	33	aggressive	aggressive	ADJ
fnp-5116	48	34	were	be	AUX
fnp-5116	48	35	not	not	PART
fnp-5116	48	36	sufficient	sufficient	ADJ
fnp-5116	48	37	to	to	PART
fnp-5116	48	38	designate	designate	VERB
fnp-5116	48	39	a	a	DET
fnp-5116	48	40	specific	specific	ADJ
fnp-5116	48	41	who	who	PRON
fnp-5116	48	42	grade	grade	NOUN
fnp-5116	48	43	for	for	ADP
fnp-5116	48	44	pma	pma	NOUN
fnp-5116	48	45	[	[	X
fnp-5116	48	46	15	15	NUM
fnp-5116	48	47	,	,	PUNCT
fnp-5116	48	48	29	29	NUM
fnp-5116	48	49	,	,	PUNCT
fnp-5116	48	50	30	30	NUM
fnp-5116	48	51	]	]	PUNCT
fnp-5116	48	52	.	.	PUNCT
fnp-5116	49	1	further	further	ADJ
fnp-5116	49	2	studies	study	NOUN
fnp-5116	49	3	are	be	AUX
fnp-5116	49	4	needed	need	VERB
fnp-5116	49	5	for	for	SCONJ
fnp-5116	49	6	the	the	DET
fnp-5116	49	7	pilomyxoid	pilomyxoid	NOUN
fnp-5116	49	8	tumors	tumor	NOUN
fnp-5116	49	9	to	to	PART
fnp-5116	49	10	allow	allow	VERB
fnp-5116	49	11	their	their	PRON
fnp-5116	49	12	grading	grading	NOUN
fnp-5116	49	13	and	and	CCONJ
fnp-5116	49	14	prognostication	prognostication	NOUN
fnp-5116	49	15	.	.	PUNCT
fnp-5116	50	1	recent	recent	ADJ
fnp-5116	50	2	genomic	genomic	ADJ
fnp-5116	50	3	studies	study	NOUN
fnp-5116	50	4	outline	outline	VERB
fnp-5116	50	5	the	the	DET
fnp-5116	50	6	molecular	molecular	ADJ
fnp-5116	50	7	landscape	landscape	NOUN
fnp-5116	50	8	of	of	ADP
fnp-5116	50	9	pas	pas	NOUN
fnp-5116	50	10	as	as	ADP
fnp-5116	50	11	tumors	tumor	NOUN
fnp-5116	50	12	with	with	ADP
fnp-5116	50	13	a	a	DET
fnp-5116	50	14	very	very	ADV
fnp-5116	50	15	stable	stable	ADJ
fnp-5116	50	16	genome	genome	NOUN
fnp-5116	50	17	,	,	PUNCT
fnp-5116	50	18	carrying	carry	VERB
fnp-5116	50	19	less	less	ADJ
fnp-5116	50	20	than	than	ADP
fnp-5116	50	21	0.1	0.1	NUM
fnp-5116	50	22	mutations	mutation	NOUN
fnp-5116	50	23	per	per	ADP
fnp-5116	50	24	megabase	megabase	NOUN
fnp-5116	50	25	[	[	X
fnp-5116	50	26	31	31	NUM
fnp-5116	50	27	,	,	PUNCT
fnp-5116	50	28	32	32	NUM
fnp-5116	50	29	]	]	PUNCT
fnp-5116	50	30	.	.	PUNCT
fnp-5116	51	1	mitogen	mitogen	PROPN
fnp-5116	51	2	activated	activate	VERB
fnp-5116	51	3	protein	protein	NOUN
fnp-5116	51	4	kinase	kinase	NOUN
fnp-5116	51	5	(	(	PUNCT
fnp-5116	51	6	mapk	mapk	NOUN
fnp-5116	51	7	)	)	PUNCT
fnp-5116	51	8	pathway	pathway	NOUN
fnp-5116	51	9	is	be	AUX
fnp-5116	51	10	the	the	DET
fnp-5116	51	11	most	most	ADV
fnp-5116	51	12	commonly	commonly	ADV
fnp-5116	51	13	affected	affect	VERB
fnp-5116	51	14	pathway	pathway	NOUN
fnp-5116	51	15	in	in	ADP
fnp-5116	51	16	pas	pas	PROPN
fnp-5116	51	17	.	.	PUNCT
fnp-5116	52	1	the	the	DET
fnp-5116	52	2	most	most	ADV
fnp-5116	52	3	common	common	ADJ
fnp-5116	52	4	genetic	genetic	ADJ
fnp-5116	52	5	alteration	alteration	NOUN
fnp-5116	52	6	is	be	AUX
fnp-5116	52	7	the	the	DET
fnp-5116	52	8	braf	braf	NOUN
fnp-5116	52	9	internal	internal	ADJ
fnp-5116	52	10	tandem	tandem	NOUN
fnp-5116	52	11	duplication	duplication	NOUN
fnp-5116	52	12	resulting	result	VERB
fnp-5116	52	13	with	with	ADP
fnp-5116	52	14	a	a	DET
fnp-5116	52	15	fusion	fusion	NOUN
fnp-5116	52	16	of	of	ADP
fnp-5116	52	17	a	a	DET
fnp-5116	52	18	neighboring	neighboring	NOUN
fnp-5116	52	19	gene	gene	NOUN
fnp-5116	52	20	,	,	PUNCT
fnp-5116	52	21	kiaa1549	kiaa1549	PROPN
fnp-5116	52	22	.	.	PUNCT
fnp-5116	53	1	other	other	ADJ
fnp-5116	53	2	alterations	alteration	NOUN
fnp-5116	53	3	of	of	ADP
fnp-5116	53	4	the	the	DET
fnp-5116	53	5	mapk	mapk	NOUN
fnp-5116	53	6	pathway	pathway	NOUN
fnp-5116	53	7	,	,	PUNCT
fnp-5116	53	8	such	such	ADJ
fnp-5116	53	9	as	as	ADP
fnp-5116	53	10	other	other	ADJ
fnp-5116	53	11	braf	braf	NOUN
fnp-5116	53	12	fusions	fusion	NOUN
fnp-5116	53	13	,	,	PUNCT
fnp-5116	53	14	mutations	mutation	NOUN
fnp-5116	53	15	in	in	ADP
fnp-5116	53	16	braf	braf	NOUN
fnp-5116	53	17	,	,	PUNCT
fnp-5116	53	18	ras	ras	PROPN
fnp-5116	53	19	or	or	CCONJ
fnp-5116	53	20	nf1	nf1	NOUN
fnp-5116	53	21	were	be	AUX
fnp-5116	53	22	also	also	ADV
fnp-5116	53	23	reported	report	VERB
fnp-5116	53	24	[	[	X
fnp-5116	53	25	2	2	NUM
fnp-5116	53	26	,	,	PUNCT
fnp-5116	53	27	33	33	NUM
fnp-5116	53	28	-	-	SYM
fnp-5116	53	29	39	39	NUM
fnp-5116	53	30	]	]	PUNCT
fnp-5116	53	31	.	.	PUNCT
fnp-5116	54	1	while	while	SCONJ
fnp-5116	54	2	the	the	DET
fnp-5116	54	3	type	type	NOUN
fnp-5116	54	4	of	of	ADP
fnp-5116	54	5	mapk	mapk	NOUN
fnp-5116	54	6	alterations	alteration	NOUN
fnp-5116	54	7	has	have	AUX
fnp-5116	54	8	not	not	PART
fnp-5116	54	9	been	be	AUX
fnp-5116	54	10	associated	associate	VERB
fnp-5116	54	11	with	with	ADP
fnp-5116	54	12	different	different	ADJ
fnp-5116	54	13	outcomes	outcome	NOUN
fnp-5116	54	14	,	,	PUNCT
fnp-5116	54	15	it	it	PRON
fnp-5116	54	16	is	be	AUX
fnp-5116	54	17	not	not	PART
fnp-5116	54	18	clear	clear	ADJ
fnp-5116	54	19	whether	whether	SCONJ
fnp-5116	54	20	the	the	DET
fnp-5116	54	21	cumulative	cumulative	ADJ
fnp-5116	54	22	effect	effect	NOUN
fnp-5116	54	23	of	of	ADP
fnp-5116	54	24	multiple	multiple	ADJ
fnp-5116	54	25	genetic	genetic	ADJ
fnp-5116	54	26	alterations	alteration	NOUN
fnp-5116	54	27	may	may	AUX
fnp-5116	54	28	lead	lead	VERB
fnp-5116	54	29	to	to	ADP
fnp-5116	54	30	a	a	DET
fnp-5116	54	31	more	more	ADV
fnp-5116	54	32	aggressive	aggressive	ADJ
fnp-5116	54	33	behavior	behavior	NOUN
fnp-5116	54	34	in	in	ADP
fnp-5116	54	35	pas	pas	PROPN
fnp-5116	54	36	.	.	PUNCT
fnp-5116	55	1	some	some	DET
fnp-5116	55	2	studies	study	NOUN
fnp-5116	55	3	implicated	implicate	VERB
fnp-5116	55	4	molecular	molecular	ADJ
fnp-5116	55	5	alterations	alteration	NOUN
fnp-5116	55	6	such	such	ADJ
fnp-5116	55	7	as	as	ADP
fnp-5116	55	8	loss	loss	NOUN
fnp-5116	55	9	of	of	ADP
fnp-5116	55	10	cdkn2a	cdkn2a	PROPN
fnp-5116	55	11	,	,	PUNCT
fnp-5116	55	12	gain	gain	NOUN
fnp-5116	55	13	of	of	ADP
fnp-5116	55	14	chromosome	chromosome	NOUN
fnp-5116	55	15	7	7	NUM
fnp-5116	55	16	and	and	CCONJ
fnp-5116	55	17	loss	loss	NOUN
fnp-5116	55	18	of	of	ADP
fnp-5116	55	19	chromosome	chromosome	NOUN
fnp-5116	55	20	17q	17q	NOUN
fnp-5116	55	21	as	as	ADP
fnp-5116	55	22	being	be	AUX
fnp-5116	55	23	associated	associate	VERB
fnp-5116	55	24	with	with	ADP
fnp-5116	55	25	worse	bad	ADJ
fnp-5116	55	26	outcome	outcome	NOUN
fnp-5116	55	27	,	,	PUNCT
fnp-5116	55	28	but	but	CCONJ
fnp-5116	55	29	none	none	NOUN
fnp-5116	55	30	of	of	ADP
fnp-5116	55	31	these	these	DET
fnp-5116	55	32	studies	study	NOUN
fnp-5116	55	33	were	be	AUX
fnp-5116	55	34	validated	validate	VERB
fnp-5116	55	35	in	in	ADP
fnp-5116	55	36	large	large	ADJ
fnp-5116	55	37	series	series	NOUN
fnp-5116	55	38	,	,	PUNCT
fnp-5116	55	39	prospective	prospective	ADJ
fnp-5116	55	40	trials	trial	NOUN
fnp-5116	55	41	or	or	CCONJ
fnp-5116	55	42	by	by	ADP
fnp-5116	55	43	more	more	ADJ
fnp-5116	55	44	than	than	ADP
fnp-5116	55	45	one	one	NUM
fnp-5116	55	46	group	group	NOUN
fnp-5116	55	47	[	[	X
fnp-5116	55	48	25	25	NUM
fnp-5116	55	49	,	,	PUNCT
fnp-5116	55	50	40	40	NUM
fnp-5116	55	51	]	]	PUNCT
fnp-5116	55	52	.	.	PUNCT
fnp-5116	56	1	several	several	ADJ
fnp-5116	56	2	clinical	clinical	ADJ
fnp-5116	56	3	and	and	CCONJ
fnp-5116	56	4	biological	biological	ADJ
fnp-5116	56	5	markers	marker	NOUN
fnp-5116	56	6	reportedly	reportedly	ADV
fnp-5116	56	7	influence	influence	VERB
fnp-5116	56	8	prognosis	prognosis	NOUN
fnp-5116	56	9	in	in	ADP
fnp-5116	56	10	patients	patient	NOUN
fnp-5116	56	11	with	with	ADP
fnp-5116	56	12	pa	pa	PROPN
fnp-5116	56	13	,	,	PUNCT
fnp-5116	56	14	but	but	CCONJ
fnp-5116	56	15	these	these	DET
fnp-5116	56	16	parameters	parameter	NOUN
fnp-5116	56	17	,	,	PUNCT
fnp-5116	56	18	with	with	ADP
fnp-5116	56	19	the	the	DET
fnp-5116	56	20	exception	exception	NOUN
fnp-5116	56	21	of	of	ADP
fnp-5116	56	22	extent	extent	NOUN
fnp-5116	56	23	of	of	ADP
fnp-5116	56	24	resection	resection	NOUN
fnp-5116	56	25	,	,	PUNCT
fnp-5116	56	26	have	have	AUX
fnp-5116	56	27	not	not	PART
fnp-5116	56	28	been	be	AUX
fnp-5116	56	29	consistently	consistently	ADV
fnp-5116	56	30	found	find	VERB
fnp-5116	56	31	as	as	ADP
fnp-5116	56	32	independent	independent	ADJ
fnp-5116	56	33	variables	variable	NOUN
fnp-5116	56	34	[	[	X
fnp-5116	56	35	26	26	NUM
fnp-5116	56	36	-	-	SYM
fnp-5116	56	37	28	28	NUM
fnp-5116	56	38	,	,	PUNCT
fnp-5116	56	39	41	41	NUM
fnp-5116	56	40	]	]	PUNCT
fnp-5116	56	41	.	.	PUNCT
fnp-5116	57	1	we	we	PRON
fnp-5116	57	2	also	also	ADV
fnp-5116	57	3	suggested	suggest	VERB
fnp-5116	57	4	that	that	SCONJ
fnp-5116	57	5	access	access	NOUN
fnp-5116	57	6	to	to	ADP
fnp-5116	57	7	healthcare	healthcare	NOUN
fnp-5116	57	8	is	be	AUX
fnp-5116	57	9	a	a	DET
fnp-5116	57	10	key	key	ADJ
fnp-5116	57	11	factor	factor	NOUN
fnp-5116	57	12	in	in	ADP
fnp-5116	57	13	the	the	DET
fnp-5116	57	14	outcome	outcome	NOUN
fnp-5116	57	15	of	of	ADP
fnp-5116	57	16	patients	patient	NOUN
fnp-5116	57	17	with	with	ADP
fnp-5116	57	18	pa	pa	PROPN
fnp-5116	57	19	,	,	PUNCT
fnp-5116	57	20	most	most	ADV
fnp-5116	57	21	likely	likely	ADV
fnp-5116	57	22	unrelated	unrelated	ADJ
fnp-5116	57	23	to	to	ADP
fnp-5116	57	24	tumor	tumor	NOUN
fnp-5116	57	25	biology	biology	NOUN
fnp-5116	57	26	[	[	X
fnp-5116	57	27	42	42	NUM
fnp-5116	57	28	]	]	PUNCT
fnp-5116	57	29	.	.	PUNCT
fnp-5116	58	1	in	in	ADP
fnp-5116	58	2	this	this	DET
fnp-5116	58	3	retrospective	retrospective	ADJ
fnp-5116	58	4	study	study	NOUN
fnp-5116	58	5	,	,	PUNCT
fnp-5116	58	6	we	we	PRON
fnp-5116	58	7	report	report	VERB
fnp-5116	58	8	our	our	PRON
fnp-5116	58	9	experience	experience	NOUN
fnp-5116	58	10	with	with	ADP
fnp-5116	58	11	499	499	NUM
fnp-5116	58	12	pas	pas	NOUN
fnp-5116	58	13	diagnosed	diagnose	VERB
fnp-5116	58	14	and	and	CCONJ
fnp-5116	58	15	treated	treat	VERB
fnp-5116	58	16	in	in	ADP
fnp-5116	58	17	a	a	DET
fnp-5116	58	18	single	single	ADJ
fnp-5116	58	19	institution	institution	NOUN
fnp-5116	58	20	over	over	ADP
fnp-5116	58	21	the	the	DET
fnp-5116	58	22	last	last	ADJ
fnp-5116	58	23	three	three	NUM
fnp-5116	58	24	decades	decade	NOUN
fnp-5116	58	25	in	in	ADP
fnp-5116	58	26	order	order	NOUN
fnp-5116	58	27	to	to	PART
fnp-5116	58	28	bring	bring	VERB
fnp-5116	58	29	clarity	clarity	NOUN
fnp-5116	58	30	to	to	ADP
fnp-5116	58	31	some	some	PRON
fnp-5116	58	32	of	of	ADP
fnp-5116	58	33	the	the	DET
fnp-5116	58	34	uncertainties	uncertainty	NOUN
fnp-5116	58	35	mentioned	mention	VERB
fnp-5116	58	36	above	above	ADV
fnp-5116	58	37	,	,	PUNCT
fnp-5116	58	38	and	and	CCONJ
fnp-5116	58	39	to	to	PART
fnp-5116	58	40	further	far	ADV
fnp-5116	58	41	demonstrate	demonstrate	VERB
fnp-5116	58	42	the	the	DET
fnp-5116	58	43	need	need	NOUN
fnp-5116	58	44	for	for	ADP
fnp-5116	58	45	collaborative	collaborative	ADJ
fnp-5116	58	46	studies	study	NOUN
fnp-5116	58	47	and	and	CCONJ
fnp-5116	58	48	larger	large	ADJ
fnp-5116	58	49	series	series	NOUN
fnp-5116	58	50	to	to	PART
fnp-5116	58	51	better	well	ADV
fnp-5116	58	52	understand	understand	VERB
fnp-5116	58	53	factors	factor	NOUN
fnp-5116	58	54	associated	associate	VERB
fnp-5116	58	55	with	with	ADP
fnp-5116	58	56	outcome	outcome	NOUN
fnp-5116	58	57	.	.	PUNCT
fnp-5116	59	1	material	material	NOUN
fnp-5116	59	2	and	and	CCONJ
fnp-5116	59	3	methods	method	NOUN
fnp-5116	59	4	patient	patient	ADJ
fnp-5116	59	5	selection	selection	NOUN
fnp-5116	59	6	all	all	DET
fnp-5116	59	7	patients	patient	NOUN
fnp-5116	59	8	diagnosed	diagnose	VERB
fnp-5116	59	9	as	as	ADP
fnp-5116	59	10	pa	pa	PROPN
fnp-5116	59	11	or	or	CCONJ
fnp-5116	59	12	pma	pma	NOUN
fnp-5116	59	13	between	between	ADP
fnp-5116	59	14	1989	1989	NUM
fnp-5116	59	15	and	and	CCONJ
fnp-5116	59	16	2019	2019	NUM
fnp-5116	59	17	,	,	PUNCT
fnp-5116	59	18	were	be	AUX
fnp-5116	59	19	retrieved	retrieve	VERB
fnp-5116	59	20	from	from	ADP
fnp-5116	59	21	the	the	DET
fnp-5116	59	22	pathology	pathology	NOUN
fnp-5116	59	23	archives	archive	NOUN
fnp-5116	59	24	of	of	ADP
fnp-5116	59	25	the	the	DET
fnp-5116	59	26	department	department	NOUN
fnp-5116	59	27	of	of	ADP
fnp-5116	59	28	pathology	pathology	PROPN
fnp-5116	59	29	.	.	PUNCT
fnp-5116	60	1	the	the	DET
fnp-5116	60	2	inclusion	inclusion	NOUN
fnp-5116	60	3	criteria	criterion	NOUN
fnp-5116	60	4	were	be	AUX
fnp-5116	60	5	as	as	SCONJ
fnp-5116	60	6	follows	follow	VERB
fnp-5116	60	7	:	:	PUNCT
fnp-5116	60	8	1all	1all	NUM
fnp-5116	60	9	patients	patient	NOUN
fnp-5116	60	10	diagnosed	diagnose	VERB
fnp-5116	60	11	and/or	and/or	CCONJ
fnp-5116	60	12	treated	treat	VERB
fnp-5116	60	13	at	at	ADP
fnp-5116	60	14	our	our	PRON
fnp-5116	60	15	institution	institution	NOUN
fnp-5116	60	16	between	between	ADP
fnp-5116	60	17	1989	1989	NUM
fnp-5116	60	18	and	and	CCONJ
fnp-5116	60	19	2019	2019	NUM
fnp-5116	60	20	,	,	PUNCT
fnp-5116	60	21	and	and	CCONJ
fnp-5116	60	22	2sufficient	2sufficient	NUM
fnp-5116	60	23	clinical	clinical	ADJ
fnp-5116	60	24	information	information	NOUN
fnp-5116	60	25	to	to	PART
fnp-5116	60	26	include	include	VERB
fnp-5116	60	27	into	into	ADP
fnp-5116	60	28	the	the	DET
fnp-5116	60	29	database	database	NOUN
fnp-5116	60	30	,	,	PUNCT
fnp-5116	60	31	and	and	CCONJ
fnp-5116	60	32	3sufficient	3sufficient	NUM
fnp-5116	60	33	pathology	pathology	NOUN
fnp-5116	60	34	material	material	NOUN
fnp-5116	60	35	available	available	ADJ
fnp-5116	60	36	for	for	ADP
fnp-5116	60	37	review	review	NOUN
fnp-5116	60	38	and	and	CCONJ
fnp-5116	60	39	diagnosis	diagnosis	NOUN
fnp-5116	60	40	,	,	PUNCT
fnp-5116	60	41	and	and	CCONJ
fnp-5116	60	42	4the	4the	NUM
fnp-5116	60	43	diagnosis	diagnosis	NOUN
fnp-5116	60	44	of	of	ADP
fnp-5116	60	45	pa	pa	PROPN
fnp-5116	60	46	or	or	CCONJ
fnp-5116	60	47	pma	pma	NOUN
fnp-5116	60	48	upon	upon	SCONJ
fnp-5116	60	49	review	review	NOUN
fnp-5116	60	50	of	of	ADP
fnp-5116	60	51	the	the	DET
fnp-5116	60	52	available	available	ADJ
fnp-5116	60	53	material	material	NOUN
fnp-5116	60	54	.	.	PUNCT
fnp-5116	61	1	the	the	DET
fnp-5116	61	2	database	database	NOUN
fnp-5116	61	3	search	search	NOUN
fnp-5116	61	4	included	include	VERB
fnp-5116	61	5	a	a	DET
fnp-5116	61	6	series	series	NOUN
fnp-5116	61	7	of	of	ADP
fnp-5116	61	8	keywords	keyword	NOUN
fnp-5116	61	9	for	for	ADP
fnp-5116	61	10	final	final	ADJ
fnp-5116	61	11	diagnoses	diagnosis	NOUN
fnp-5116	61	12	,	,	PUNCT
fnp-5116	61	13	and	and	CCONJ
fnp-5116	61	14	the	the	DET
fnp-5116	61	15	search	search	NOUN
fnp-5116	61	16	was	be	AUX
fnp-5116	61	17	conducted	conduct	VERB
fnp-5116	61	18	at	at	ADP
fnp-5116	61	19	two	two	NUM
fnp-5116	61	20	separate	separate	ADJ
fnp-5116	61	21	occasions	occasion	NOUN
fnp-5116	61	22	,	,	PUNCT
fnp-5116	61	23	which	which	PRON
fnp-5116	61	24	yielded	yield	VERB
fnp-5116	61	25	nearly	nearly	ADV
fnp-5116	61	26	identical	identical	ADJ
fnp-5116	61	27	results	result	NOUN
fnp-5116	61	28	with	with	ADP
fnp-5116	61	29	a	a	DET
fnp-5116	61	30	rare	rare	ADJ
fnp-5116	61	31	exception	exception	NOUN
fnp-5116	61	32	due	due	ADP
fnp-5116	61	33	to	to	PART
fnp-5116	61	34	delay	delay	VERB
fnp-5116	61	35	in	in	ADP
fnp-5116	61	36	the	the	DET
fnp-5116	61	37	database	database	NOUN
fnp-5116	61	38	registry	registry	NOUN
fnp-5116	61	39	.	.	PUNCT
fnp-5116	62	1	clinical	clinical	ADJ
fnp-5116	62	2	and	and	CCONJ
fnp-5116	62	3	radiological	radiological	ADJ
fnp-5116	62	4	information	information	NOUN
fnp-5116	62	5	were	be	AUX
fnp-5116	62	6	obtained	obtain	VERB
fnp-5116	62	7	from	from	ADP
fnp-5116	62	8	the	the	DET
fnp-5116	62	9	hospital	hospital	NOUN
fnp-5116	62	10	electronic	electronic	ADJ
fnp-5116	62	11	information	information	NOUN
fnp-5116	62	12	systems	system	NOUN
fnp-5116	62	13	or	or	CCONJ
fnp-5116	62	14	from	from	ADP
fnp-5116	62	15	the	the	DET
fnp-5116	62	16	patient	patient	ADJ
fnp-5116	62	17	charts	chart	NOUN
fnp-5116	62	18	for	for	ADP
fnp-5116	62	19	older	old	ADJ
fnp-5116	62	20	cases	case	NOUN
fnp-5116	62	21	.	.	PUNCT
fnp-5116	63	1	all	all	DET
fnp-5116	63	2	relevant	relevant	ADJ
fnp-5116	63	3	clinical	clinical	ADJ
fnp-5116	63	4	information	information	NOUN
fnp-5116	63	5	necessary	necessary	ADJ
fnp-5116	63	6	for	for	SCONJ
fnp-5116	63	7	the	the	DET
fnp-5116	63	8	purposes	purpose	NOUN
fnp-5116	63	9	of	of	ADP
fnp-5116	63	10	our	our	PRON
fnp-5116	63	11	analyses	analysis	NOUN
fnp-5116	63	12	were	be	AUX
fnp-5116	63	13	collected	collect	VERB
fnp-5116	63	14	in	in	ADP
fnp-5116	63	15	an	an	DET
fnp-5116	63	16	anonymized	anonymize	VERB
fnp-5116	63	17	fashion	fashion	NOUN
fnp-5116	63	18	and	and	CCONJ
fnp-5116	63	19	a	a	DET
fnp-5116	63	20	research	research	NOUN
fnp-5116	63	21	database	database	NOUN
fnp-5116	63	22	was	be	AUX
fnp-5116	63	23	created	create	VERB
fnp-5116	63	24	.	.	PUNCT
fnp-5116	64	1	radiological	radiological	ADJ
fnp-5116	64	2	reports	report	NOUN
fnp-5116	64	3	were	be	AUX
fnp-5116	64	4	also	also	ADV
fnp-5116	64	5	reviewed	review	VERB
fnp-5116	64	6	to	to	PART
fnp-5116	64	7	ensure	ensure	VERB
fnp-5116	64	8	that	that	SCONJ
fnp-5116	64	9	radiological	radiological	ADJ
fnp-5116	64	10	impression	impression	NOUN
fnp-5116	64	11	was	be	AUX
fnp-5116	64	12	consistent	consistent	ADJ
fnp-5116	64	13	with	with	ADP
fnp-5116	64	14	pa	pa	PROPN
fnp-5116	64	15	.	.	PROPN
fnp-5116	64	16	extent	extent	NOUN
fnp-5116	64	17	of	of	ADP
fnp-5116	64	18	resection	resection	NOUN
fnp-5116	64	19	was	be	AUX
fnp-5116	64	20	obtained	obtain	VERB
fnp-5116	64	21	from	from	ADP
fnp-5116	64	22	the	the	DET
fnp-5116	64	23	operative	operative	ADJ
fnp-5116	64	24	reports	report	NOUN
fnp-5116	64	25	and	and	CCONJ
fnp-5116	64	26	was	be	AUX
fnp-5116	64	27	reported	report	VERB
fnp-5116	64	28	as	as	ADP
fnp-5116	64	29	either	either	CCONJ
fnp-5116	64	30	gross	gross	ADJ
fnp-5116	64	31	total	total	ADJ
fnp-5116	64	32	resection	resection	NOUN
fnp-5116	64	33	(	(	PUNCT
fnp-5116	64	34	gtr	gtr	NOUN
fnp-5116	64	35	)	)	PUNCT
fnp-5116	64	36	or	or	CCONJ
fnp-5116	64	37	subtotal	subtotal	ADJ
fnp-5116	64	38	resection	resection	NOUN
fnp-5116	64	39	(	(	PUNCT
fnp-5116	64	40	str	str	NOUN
fnp-5116	64	41	)	)	PUNCT
fnp-5116	64	42	.	.	PUNCT
fnp-5116	65	1	any	any	DET
fnp-5116	65	2	level	level	NOUN
fnp-5116	65	3	of	of	ADP
fnp-5116	65	4	resection	resection	NOUN
fnp-5116	65	5	less	less	ADJ
fnp-5116	65	6	than	than	ADP
fnp-5116	65	7	gtr	gtr	NOUN
fnp-5116	65	8	was	be	AUX
fnp-5116	65	9	considered	consider	VERB
fnp-5116	65	10	str	str	NOUN
fnp-5116	65	11	.	.	PUNCT
fnp-5116	66	1	recurrence	recurrence	NOUN
fnp-5116	66	2	was	be	AUX
fnp-5116	66	3	defined	define	VERB
fnp-5116	66	4	as	as	ADP
fnp-5116	66	5	worsening	worsen	VERB
fnp-5116	66	6	of	of	ADP
fnp-5116	66	7	clinical	clinical	ADJ
fnp-5116	66	8	symptoms	symptom	NOUN
fnp-5116	66	9	attributed	attribute	VERB
fnp-5116	66	10	to	to	ADP
fnp-5116	66	11	tumor	tumor	NOUN
fnp-5116	66	12	growth	growth	NOUN
fnp-5116	66	13	.	.	PUNCT
fnp-5116	67	1	recurrence	recurrence	NOUN
fnp-5116	67	2	-	-	PUNCT
fnp-5116	67	3	free	free	ADJ
fnp-5116	67	4	survival	survival	NOUN
fnp-5116	67	5	(	(	PUNCT
fnp-5116	67	6	rfs	rfs	PROPN
fnp-5116	67	7	)	)	PUNCT
fnp-5116	67	8	was	be	AUX
fnp-5116	67	9	calculated	calculate	VERB
fnp-5116	67	10	between	between	ADP
fnp-5116	67	11	the	the	DET
fnp-5116	67	12	date	date	NOUN
fnp-5116	67	13	of	of	ADP
fnp-5116	67	14	the	the	DET
fnp-5116	67	15	initial	initial	ADJ
fnp-5116	67	16	surgery	surgery	NOUN
fnp-5116	67	17	and	and	CCONJ
fnp-5116	67	18	the	the	DET
fnp-5116	67	19	first	first	ADJ
fnp-5116	67	20	record	record	NOUN
fnp-5116	67	21	of	of	ADP
fnp-5116	67	22	clinical	clinical	ADJ
fnp-5116	67	23	worsening	worsening	NOUN
fnp-5116	67	24	in	in	ADP
fnp-5116	67	25	the	the	DET
fnp-5116	67	26	chart	chart	NOUN
fnp-5116	67	27	.	.	PUNCT
fnp-5116	68	1	overall	overall	ADJ
fnp-5116	68	2	survival	survival	NOUN
fnp-5116	68	3	was	be	AUX
fnp-5116	68	4	calculated	calculate	VERB
fnp-5116	68	5	as	as	ADP
fnp-5116	68	6	the	the	DET
fnp-5116	68	7	time	time	NOUN
fnp-5116	68	8	between	between	ADP
fnp-5116	68	9	the	the	DET
fnp-5116	68	10	initial	initial	ADJ
fnp-5116	68	11	surgery	surgery	NOUN
fnp-5116	68	12	and	and	CCONJ
fnp-5116	68	13	death	death	NOUN
fnp-5116	68	14	due	due	ADP
fnp-5116	68	15	to	to	ADP
fnp-5116	68	16	tumor	tumor	NOUN
fnp-5116	68	17	,	,	PUNCT
fnp-5116	68	18	and	and	CCONJ
fnp-5116	68	19	all	all	DET
fnp-5116	68	20	others	other	NOUN
fnp-5116	68	21	were	be	AUX
fnp-5116	68	22	censored	censor	VERB
fnp-5116	68	23	.	.	PUNCT
fnp-5116	69	1	the	the	DET
fnp-5116	69	2	cut	cut	NOUN
fnp-5116	69	3	-	-	PUNCT
fnp-5116	69	4	off	off	NOUN
fnp-5116	69	5	for	for	ADP
fnp-5116	69	6	the	the	DET
fnp-5116	69	7	follow	follow	VERB
fnp-5116	69	8	-	-	PUNCT
fnp-5116	69	9	up	up	ADP
fnp-5116	69	10	time	time	NOUN
fnp-5116	69	11	was	be	AUX
fnp-5116	69	12	january	january	PROPN
fnp-5116	69	13	2022	2022	NUM
fnp-5116	69	14	.	.	PUNCT
fnp-5116	70	1	patients	patient	NOUN
fnp-5116	70	2	who	who	PRON
fnp-5116	70	3	could	could	AUX
fnp-5116	70	4	not	not	PART
fnp-5116	70	5	be	be	AUX
fnp-5116	70	6	identified	identify	VERB
fnp-5116	70	7	in	in	ADP
fnp-5116	70	8	the	the	DET
fnp-5116	70	9	system	system	NOUN
fnp-5116	70	10	by	by	ADP
fnp-5116	70	11	that	that	DET
fnp-5116	70	12	date	date	NOUN
fnp-5116	70	13	were	be	AUX
fnp-5116	70	14	considered	consider	VERB
fnp-5116	70	15	lost	lose	VERB
fnp-5116	70	16	to	to	PART
fnp-5116	70	17	follow	follow	VERB
fnp-5116	70	18	-	-	PUNCT
fnp-5116	70	19	up	up	NOUN
fnp-5116	70	20	.	.	PUNCT
fnp-5116	71	1	this	this	DET
fnp-5116	71	2	study	study	NOUN
fnp-5116	71	3	was	be	AUX
fnp-5116	71	4	approved	approve	VERB
fnp-5116	71	5	by	by	ADP
fnp-5116	71	6	the	the	DET
fnp-5116	71	7	university	university	PROPN
fnp-5116	71	8	of	of	ADP
fnp-5116	71	9	california	california	PROPN
fnp-5116	71	10	san	san	PROPN
fnp-5116	71	11	francisco	francisco	PROPN
fnp-5116	71	12	institutional	institutional	PROPN
fnp-5116	71	13	review	review	PROPN
fnp-5116	71	14	board	board	NOUN
fnp-5116	71	15	(	(	PUNCT
fnp-5116	71	16	irb	irb	VERB
fnp-5116	71	17	approval	approval	NOUN
fnp-5116	72	1	no	no	INTJ
fnp-5116	72	2	.	.	PUNCT
fnp-5116	73	1	chr	chr	PROPN
fnp-5116	73	2	10	10	NUM
fnp-5116	73	3	-	-	SYM
fnp-5116	73	4	01252	01252	NUM
fnp-5116	73	5	)	)	PUNCT
fnp-5116	73	6	.	.	PUNCT
fnp-5116	74	1	pathological	pathological	ADJ
fnp-5116	74	2	evaluation	evaluation	NOUN
fnp-5116	74	3	all	all	PRON
fnp-5116	74	4	available	available	ADJ
fnp-5116	74	5	pathology	pathology	NOUN
fnp-5116	74	6	material	material	NOUN
fnp-5116	74	7	from	from	ADP
fnp-5116	74	8	all	all	DET
fnp-5116	74	9	cases	case	NOUN
fnp-5116	74	10	were	be	AUX
fnp-5116	74	11	reviewed	review	VERB
fnp-5116	74	12	by	by	ADP
fnp-5116	74	13	two	two	NUM
fnp-5116	74	14	of	of	ADP
fnp-5116	74	15	the	the	DET
fnp-5116	74	16	authors	author	NOUN
fnp-5116	74	17	(	(	PUNCT
fnp-5116	74	18	ik	ik	PROPN
fnp-5116	74	19	,	,	PUNCT
fnp-5116	74	20	tt	tt	PROPN
fnp-5116	74	21	)	)	PUNCT
fnp-5116	74	22	and	and	CCONJ
fnp-5116	74	23	one	one	NUM
fnp-5116	74	24	of	of	ADP
fnp-5116	74	25	the	the	DET
fnp-5116	74	26	authors	author	NOUN
fnp-5116	74	27	(	(	PUNCT
fnp-5116	74	28	mp	mp	PROPN
fnp-5116	74	29	)	)	PUNCT
fnp-5116	74	30	contributed	contribute	VERB
fnp-5116	74	31	to	to	ADP
fnp-5116	74	32	the	the	DET
fnp-5116	74	33	pathological	pathological	ADJ
fnp-5116	74	34	review	review	NOUN
fnp-5116	74	35	process	process	NOUN
fnp-5116	74	36	for	for	ADP
fnp-5116	74	37	the	the	DET
fnp-5116	74	38	recent	recent	ADJ
fnp-5116	74	39	cases	case	NOUN
fnp-5116	74	40	during	during	ADP
fnp-5116	74	41	the	the	DET
fnp-5116	74	42	last	last	ADJ
fnp-5116	74	43	decade	decade	NOUN
fnp-5116	74	44	.	.	PUNCT
fnp-5116	75	1	pa	pa	PROPN
fnp-5116	75	2	and	and	CCONJ
fnp-5116	75	3	pma	pma	PROPN
fnp-5116	75	4	diagnoses	diagnosis	NOUN
fnp-5116	75	5	were	be	AUX
fnp-5116	75	6	based	base	VERB
fnp-5116	75	7	on	on	ADP
fnp-5116	75	8	the	the	DET
fnp-5116	75	9	essential	essential	ADJ
fnp-5116	75	10	and	and	CCONJ
fnp-5116	75	11	desirable	desirable	ADJ
fnp-5116	75	12	criteria	criterion	NOUN
fnp-5116	75	13	proposed	propose	VERB
fnp-5116	75	14	by	by	ADP
fnp-5116	75	15	the	the	DET
fnp-5116	75	16	who	who	PRON
fnp-5116	75	17	2021	2021	NUM
fnp-5116	75	18	classification	classification	NOUN
fnp-5116	75	19	scheme	scheme	NOUN
fnp-5116	75	20	.	.	PUNCT
fnp-5116	76	1	pertinent	pertinent	ADJ
fnp-5116	76	2	histopathological	histopathological	ADJ
fnp-5116	76	3	features	feature	NOUN
fnp-5116	76	4	were	be	AUX
fnp-5116	76	5	recorded	record	VERB
fnp-5116	76	6	.	.	PUNCT
fnp-5116	77	1	immunohistochemical	immunohistochemical	ADJ
fnp-5116	77	2	studies	study	NOUN
fnp-5116	77	3	were	be	AUX
fnp-5116	77	4	performed	perform	VERB
fnp-5116	77	5	as	as	ADP
fnp-5116	77	6	a	a	DET
fnp-5116	77	7	part	part	NOUN
fnp-5116	77	8	of	of	ADP
fnp-5116	77	9	the	the	DET
fnp-5116	77	10	routine	routine	ADJ
fnp-5116	77	11	work	work	NOUN
fnp-5116	77	12	-	-	PUNCT
fnp-5116	77	13	up	up	NOUN
fnp-5116	77	14	of	of	ADP
fnp-5116	77	15	cases	case	NOUN
fnp-5116	77	16	to	to	PART
fnp-5116	77	17	establish	establish	VERB
fnp-5116	77	18	diagnosis	diagnosis	NOUN
fnp-5116	77	19	and	and	CCONJ
fnp-5116	77	20	further	far	ADV
fnp-5116	77	21	characterize	characterize	VERB
fnp-5116	77	22	the	the	DET
fnp-5116	77	23	histological	histological	ADJ
fnp-5116	77	24	features	feature	NOUN
fnp-5116	77	25	.	.	PUNCT
fnp-5116	78	1	braf	braf	NOUN
fnp-5116	78	2	v600	v600	PROPN
fnp-5116	78	3	mutation	mutation	NOUN
fnp-5116	78	4	analysis	analysis	NOUN
fnp-5116	78	5	by	by	ADP
fnp-5116	78	6	real	real	ADJ
fnp-5116	78	7	time	time	NOUN
fnp-5116	78	8	pcr	pcr	PROPN
fnp-5116	78	9	a	a	DET
fnp-5116	78	10	total	total	NOUN
fnp-5116	78	11	of	of	ADP
fnp-5116	78	12	222	222	NUM
fnp-5116	78	13	patient	patient	NOUN
fnp-5116	78	14	samples	sample	NOUN
fnp-5116	78	15	were	be	AUX
fnp-5116	78	16	submitted	submit	VERB
fnp-5116	78	17	to	to	ADP
fnp-5116	78	18	braf	braf	NOUN
fnp-5116	78	19	v600e	v600e	VERB
fnp-5116	78	20	mutational	mutational	ADJ
fnp-5116	78	21	analysis	analysis	NOUN
fnp-5116	78	22	by	by	ADP
fnp-5116	78	23	real	real	ADJ
fnp-5116	78	24	time	time	NOUN
fnp-5116	78	25	pcr	pcr	PROPN
fnp-5116	78	26	as	as	ADP
fnp-5116	78	27	a	a	DET
fnp-5116	78	28	part	part	NOUN
fnp-5116	78	29	of	of	ADP
fnp-5116	78	30	their	their	PRON
fnp-5116	78	31	routine	routine	ADJ
fnp-5116	78	32	diagnosis	diagnosis	NOUN
fnp-5116	78	33	.	.	PUNCT
fnp-5116	79	1	real	real	ADJ
fnp-5116	79	2	time	time	NOUN
fnp-5116	79	3	pcr	pcr	PROPN
fnp-5116	79	4	was	be	AUX
fnp-5116	79	5	performed	perform	VERB
fnp-5116	79	6	according	accord	VERB
fnp-5116	79	7	to	to	ADP
fnp-5116	79	8	published	publish	VERB
fnp-5116	79	9	methodology	methodology	NOUN
fnp-5116	79	10	at	at	ADP
fnp-5116	79	11	the	the	DET
fnp-5116	79	12	clinical	clinical	ADJ
fnp-5116	79	13	cancer	cancer	NOUN
fnp-5116	79	14	genomics	genomic	NOUN
fnp-5116	79	15	laboratory	laboratory	NOUN
fnp-5116	79	16	that	that	PRON
fnp-5116	79	17	operates	operate	VERB
fnp-5116	79	18	under	under	ADP
fnp-5116	79	19	a	a	DET
fnp-5116	79	20	clia	clia	PROPN
fnp-5116	79	21	license	license	NOUN
fnp-5116	79	22	.	.	PUNCT
fnp-5116	80	1	appropriate	appropriate	ADJ
fnp-5116	80	2	controls	control	NOUN
fnp-5116	80	3	and	and	CCONJ
fnp-5116	80	4	quality	quality	NOUN
fnp-5116	80	5	assurance	assurance	NOUN
fnp-5116	80	6	parameters	parameter	NOUN
fnp-5116	80	7	have	have	AUX
fnp-5116	80	8	been	be	AUX
fnp-5116	80	9	established	establish	VERB
fnp-5116	80	10	at	at	ADP
fnp-5116	80	11	this	this	DET
fnp-5116	80	12	laboratory	laboratory	NOUN
fnp-5116	80	13	(	(	PUNCT
fnp-5116	80	14	https://genomics.ucsf.edu/content/braf-mutation-testing-including-v600e	https://genomics.ucsf.edu/content/braf-mutation-testing-including-v600e	NOUN
fnp-5116	80	15	)	)	PUNCT
fnp-5116	80	16	.	.	PUNCT
fnp-5116	81	1	braf	braf	NOUN
fnp-5116	81	2	duplication	duplication	NOUN
fnp-5116	81	3	/	/	SYM
fnp-5116	81	4	kiaa1549::braf	kiaa1549::braf	NOUN
fnp-5116	81	5	fusion	fusion	NOUN
fnp-5116	81	6	analysis	analysis	NOUN
fnp-5116	81	7	in	in	ADP
fnp-5116	81	8	limited	limited	ADJ
fnp-5116	81	9	number	number	NOUN
fnp-5116	81	10	of	of	ADP
fnp-5116	81	11	cases	case	NOUN
fnp-5116	81	12	,	,	PUNCT
fnp-5116	81	13	braf	braf	NOUN
fnp-5116	81	14	duplication	duplication	NOUN
fnp-5116	81	15	only	only	ADV
fnp-5116	81	16	was	be	AUX
fnp-5116	81	17	investigated	investigate	VERB
fnp-5116	81	18	via	via	ADP
fnp-5116	81	19	fluorescence	fluorescence	NOUN
fnp-5116	81	20	in	in	ADP
fnp-5116	81	21	-	-	PUNCT
fnp-5116	81	22	situ	situ	NOUN
fnp-5116	81	23	hybridization	hybridization	NOUN
fnp-5116	81	24	(	(	PUNCT
fnp-5116	81	25	fish	fish	NOUN
fnp-5116	81	26	)	)	PUNCT
fnp-5116	81	27	as	as	SCONJ
fnp-5116	81	28	previously	previously	ADV
fnp-5116	81	29	described	describe	VERB
fnp-5116	81	30	as	as	ADP
fnp-5116	81	31	a	a	DET
fnp-5116	81	32	part	part	NOUN
fnp-5116	81	33	of	of	ADP
fnp-5116	81	34	the	the	DET
fnp-5116	81	35	patients	patient	NOUN
fnp-5116	81	36	’	'	PUNCT
fnp-5116	81	37	routine	routine	ADJ
fnp-5116	81	38	diagnostic	diagnostic	ADJ
fnp-5116	81	39	work	work	NOUN
fnp-5116	81	40	-	-	PUNCT
fnp-5116	81	41	up	up	NOUN
fnp-5116	81	42	at	at	ADP
fnp-5116	81	43	the	the	DET
fnp-5116	81	44	clinical	clinical	ADJ
fnp-5116	81	45	cancer	cancer	NOUN
fnp-5116	81	46	genomics	genomics	NOUN
fnp-5116	81	47	laboratory	laboratory	NOUN
fnp-5116	81	48	(	(	PUNCT
fnp-5116	81	49	https://genomics.ucsf.edu/content/braf-rearrangement-fish	https://genomics.ucsf.edu/content/braf-rearrangement-fish	PROPN
fnp-5116	81	50	)	)	PUNCT
fnp-5116	81	51	.	.	PUNCT
fnp-5116	82	1	analysis	analysis	NOUN
fnp-5116	82	2	of	of	ADP
fnp-5116	82	3	molecular	molecular	ADJ
fnp-5116	82	4	alterations	alteration	NOUN
fnp-5116	82	5	and	and	CCONJ
fnp-5116	82	6	copy	copy	VERB
fnp-5116	82	7	number	number	NOUN
fnp-5116	82	8	variations	variation	NOUN
fnp-5116	82	9	(	(	PUNCT
fnp-5116	82	10	cnv	cnv	NOUN
fnp-5116	82	11	)	)	PUNCT
fnp-5116	82	12	capture	capture	NOUN
fnp-5116	82	13	-	-	PUNCT
fnp-5116	82	14	based	base	VERB
fnp-5116	82	15	next	next	ADJ
fnp-5116	82	16	-	-	PUNCT
fnp-5116	82	17	generation	generation	NOUN
fnp-5116	82	18	dna	dna	NOUN
fnp-5116	82	19	sequencing	sequencing	NOUN
fnp-5116	82	20	(	(	PUNCT
fnp-5116	82	21	ngs	ng	NOUN
fnp-5116	82	22	)	)	PUNCT
fnp-5116	82	23	was	be	AUX
fnp-5116	82	24	performed	perform	VERB
fnp-5116	82	25	at	at	ADP
fnp-5116	82	26	the	the	DET
fnp-5116	82	27	ucsf	ucsf	PROPN
fnp-5116	82	28	clinical	clinical	ADJ
fnp-5116	82	29	cancer	cancer	NOUN
fnp-5116	82	30	genomics	genomic	NOUN
fnp-5116	82	31	laboratory	laboratory	NOUN
fnp-5116	82	32	(	(	PUNCT
fnp-5116	82	33	also	also	ADV
fnp-5116	82	34	referred	refer	VERB
fnp-5116	82	35	as	as	SCONJ
fnp-5116	82	36	ucsf500	ucsf500	PROPN
fnp-5116	82	37	ngs	ng	NOUN
fnp-5116	82	38	assay	assay	VERB
fnp-5116	82	39	)	)	PUNCT
fnp-5116	82	40	in	in	ADP
fnp-5116	82	41	106	106	NUM
fnp-5116	82	42	patients	patient	NOUN
fnp-5116	82	43	as	as	ADP
fnp-5116	82	44	a	a	DET
fnp-5116	82	45	part	part	NOUN
fnp-5116	82	46	of	of	ADP
fnp-5116	82	47	their	their	PRON
fnp-5116	82	48	routine	routine	ADJ
fnp-5116	82	49	diagnostic	diagnostic	ADJ
fnp-5116	82	50	work	work	NOUN
fnp-5116	82	51	-	-	PUNCT
fnp-5116	82	52	up	up	NOUN
fnp-5116	82	53	according	accord	VERB
fnp-5116	82	54	to	to	ADP
fnp-5116	82	55	protocols	protocol	NOUN
fnp-5116	82	56	described	describe	VERB
fnp-5116	82	57	previously	previously	ADV
fnp-5116	82	58	[	[	X
fnp-5116	82	59	43	43	NUM
fnp-5116	82	60	]	]	PUNCT
fnp-5116	82	61	.	.	PUNCT
fnp-5116	83	1	further	further	ADJ
fnp-5116	83	2	information	information	NOUN
fnp-5116	83	3	on	on	ADP
fnp-5116	83	4	the	the	DET
fnp-5116	83	5	specifics	specific	NOUN
fnp-5116	83	6	of	of	ADP
fnp-5116	83	7	the	the	DET
fnp-5116	83	8	ucsf500	ucsf500	PROPN
fnp-5116	83	9	ngs	ng	NOUN
fnp-5116	83	10	platform	platform	NOUN
fnp-5116	83	11	is	be	AUX
fnp-5116	83	12	available	available	ADJ
fnp-5116	83	13	at	at	ADP
fnp-5116	83	14	the	the	DET
fnp-5116	83	15	ccgl	ccgl	ADJ
fnp-5116	83	16	website	website	NOUN
fnp-5116	83	17	(	(	PUNCT
fnp-5116	83	18	https://genomics.ucsf.edu/content/ucsf-500-cancer-gene-panel-test-ucsf500-uc500	https://genomics.ucsf.edu/content/ucsf-500-cancer-gene-panel-test-ucsf500-uc500	NUM
fnp-5116	83	19	)	)	PUNCT
fnp-5116	83	20	.	.	PUNCT
fnp-5116	84	1	statistical	statistical	ADJ
fnp-5116	84	2	analysis	analysis	NOUN
fnp-5116	84	3	statistical	statistical	ADJ
fnp-5116	84	4	analysis	analysis	NOUN
fnp-5116	84	5	was	be	AUX
fnp-5116	84	6	performed	perform	VERB
fnp-5116	84	7	using	use	VERB
fnp-5116	84	8	the	the	DET
fnp-5116	84	9	ibm	ibm	PROPN
fnp-5116	84	10	spss	spss	PROPN
fnp-5116	84	11	statistics	statistic	NOUN
fnp-5116	84	12	for	for	ADP
fnp-5116	84	13	windows	window	NOUN
fnp-5116	84	14	(	(	PUNCT
fnp-5116	84	15	ibm	ibm	PROPN
fnp-5116	84	16	corp	corp	PROPN
fnp-5116	84	17	.	.	PROPN
fnp-5116	84	18	,	,	PUNCT
fnp-5116	84	19	version	version	NOUN
fnp-5116	84	20	28.0	28.0	NUM
fnp-5116	84	21	,	,	PUNCT
fnp-5116	84	22	released	release	VERB
fnp-5116	84	23	2021	2021	NUM
fnp-5116	84	24	,	,	PUNCT
fnp-5116	84	25	armonk	armonk	PROPN
fnp-5116	84	26	,	,	PUNCT
fnp-5116	84	27	ny	ny	PROPN
fnp-5116	84	28	:	:	PROPN
fnp-5116	84	29	ibm	ibm	PROPN
fnp-5116	84	30	corp	corp	PROPN
fnp-5116	84	31	)	)	PUNCT
fnp-5116	84	32	.	.	PUNCT
fnp-5116	85	1	the	the	DET
fnp-5116	85	2	normality	normality	NOUN
fnp-5116	85	3	of	of	ADP
fnp-5116	85	4	continuous	continuous	ADJ
fnp-5116	85	5	variables	variable	NOUN
fnp-5116	85	6	was	be	AUX
fnp-5116	85	7	investigated	investigate	VERB
fnp-5116	85	8	by	by	ADP
fnp-5116	85	9	shapiro	shapiro	PROPN
fnp-5116	85	10	-	-	PUNCT
fnp-5116	85	11	wilk	wilk	NOUN
fnp-5116	85	12	’s	’s	PART
fnp-5116	85	13	test	test	NOUN
fnp-5116	85	14	.	.	PUNCT
fnp-5116	86	1	descriptive	descriptive	ADJ
fnp-5116	86	2	statistics	statistic	NOUN
fnp-5116	86	3	were	be	AUX
fnp-5116	86	4	presented	present	VERB
fnp-5116	86	5	using	use	VERB
fnp-5116	86	6	mean	mean	ADJ
fnp-5116	86	7	,	,	PUNCT
fnp-5116	86	8	standard	standard	ADJ
fnp-5116	86	9	deviation	deviation	NOUN
fnp-5116	86	10	,	,	PUNCT
fnp-5116	86	11	median	median	NOUN
fnp-5116	86	12	and	and	CCONJ
fnp-5116	86	13	interquartile	interquartile	ADJ
fnp-5116	86	14	range	range	NOUN
fnp-5116	86	15	.	.	PUNCT
fnp-5116	87	1	categorical	categorical	ADJ
fnp-5116	87	2	variables	variable	NOUN
fnp-5116	87	3	were	be	AUX
fnp-5116	87	4	expressed	express	VERB
fnp-5116	87	5	by	by	ADP
fnp-5116	87	6	using	use	VERB
fnp-5116	87	7	frequencies	frequency	NOUN
fnp-5116	87	8	(	(	PUNCT
fnp-5116	87	9	n	n	CCONJ
fnp-5116	87	10	)	)	PUNCT
fnp-5116	87	11	and	and	CCONJ
fnp-5116	87	12	percentages	percentage	NOUN
fnp-5116	87	13	(	(	PUNCT
fnp-5116	87	14	%	%	INTJ
fnp-5116	87	15	)	)	PUNCT
fnp-5116	87	16	.	.	PUNCT
fnp-5116	88	1	to	to	PART
fnp-5116	88	2	compare	compare	VERB
fnp-5116	88	3	categorical	categorical	ADJ
fnp-5116	88	4	variables	variable	NOUN
fnp-5116	88	5	chi	chi	ADJ
fnp-5116	88	6	-	-	PUNCT
fnp-5116	88	7	square	square	ADJ
fnp-5116	88	8	test	test	NOUN
fnp-5116	88	9	(	(	PUNCT
fnp-5116	88	10	or	or	CCONJ
fnp-5116	88	11	fisher	fisher	PROPN
fnp-5116	88	12	exact	exact	ADJ
fnp-5116	88	13	test	test	NOUN
fnp-5116	88	14	/	/	SYM
fnp-5116	88	15	yates	yates	PROPN
fnp-5116	88	16	continuity	continuity	NOUN
fnp-5116	88	17	correction	correction	NOUN
fnp-5116	88	18	as	as	ADP
fnp-5116	88	19	appropriate	appropriate	ADJ
fnp-5116	88	20	)	)	PUNCT
fnp-5116	88	21	was	be	AUX
fnp-5116	88	22	used	use	VERB
fnp-5116	88	23	.	.	PUNCT
fnp-5116	89	1	the	the	DET
fnp-5116	89	2	recurrence	recurrence	NOUN
fnp-5116	89	3	-	-	PUNCT
fnp-5116	89	4	free	free	ADJ
fnp-5116	89	5	survival	survival	NOUN
fnp-5116	89	6	was	be	AUX
fnp-5116	89	7	evaluated	evaluate	VERB
fnp-5116	89	8	by	by	ADP
fnp-5116	89	9	kaplan	kaplan	PROPN
fnp-5116	89	10	-	-	PUNCT
fnp-5116	89	11	meier	meier	PROPN
fnp-5116	89	12	method	method	NOUN
fnp-5116	89	13	and	and	CCONJ
fnp-5116	89	14	the	the	DET
fnp-5116	89	15	median	median	PROPN
fnp-5116	89	16	survival	survival	NOUN
fnp-5116	89	17	times	time	NOUN
fnp-5116	89	18	were	be	AUX
fnp-5116	89	19	compared	compare	VERB
fnp-5116	89	20	by	by	ADP
fnp-5116	89	21	log	log	PROPN
fnp-5116	89	22	rank	rank	PROPN
fnp-5116	89	23	test	test	NOUN
fnp-5116	89	24	.	.	PUNCT
fnp-5116	90	1	the	the	DET
fnp-5116	90	2	associations	association	NOUN
fnp-5116	90	3	between	between	ADP
fnp-5116	90	4	clinicopathologic	clinicopathologic	ADJ
fnp-5116	90	5	features	feature	NOUN
fnp-5116	90	6	and	and	CCONJ
fnp-5116	90	7	the	the	DET
fnp-5116	90	8	recurrence	recurrence	NOUN
fnp-5116	90	9	free	free	ADJ
fnp-5116	90	10	survival	survival	NOUN
fnp-5116	90	11	were	be	AUX
fnp-5116	90	12	evaluated	evaluate	VERB
fnp-5116	90	13	by	by	ADP
fnp-5116	90	14	cox	cox	PROPN
fnp-5116	90	15	regression	regression	PROPN
fnp-5116	90	16	model	model	NOUN
fnp-5116	90	17	.	.	PUNCT
fnp-5116	91	1	the	the	DET
fnp-5116	91	2	cut	cut	NOUN
fnp-5116	91	3	off	off	ADP
fnp-5116	91	4	for	for	ADP
fnp-5116	91	5	statistical	statistical	ADJ
fnp-5116	91	6	significance	significance	NOUN
fnp-5116	91	7	was	be	AUX
fnp-5116	91	8	set	set	VERB
fnp-5116	91	9	as	as	ADP
fnp-5116	91	10	p<0.001	p<0.001	PROPN
fnp-5116	91	11	.	.	PUNCT
fnp-5116	92	1	results	result	VERB
fnp-5116	92	2	demographic	demographic	ADJ
fnp-5116	92	3	and	and	CCONJ
fnp-5116	92	4	clinical	clinical	ADJ
fnp-5116	92	5	features	feature	NOUN
fnp-5116	92	6	among	among	ADP
fnp-5116	92	7	a	a	DET
fnp-5116	92	8	total	total	NOUN
fnp-5116	92	9	of	of	ADP
fnp-5116	92	10	528	528	NUM
fnp-5116	92	11	patients	patient	NOUN
fnp-5116	92	12	identified	identify	VERB
fnp-5116	92	13	from	from	ADP
fnp-5116	92	14	the	the	DET
fnp-5116	92	15	database	database	NOUN
fnp-5116	92	16	with	with	ADP
fnp-5116	92	17	the	the	DET
fnp-5116	92	18	diagnosis	diagnosis	NOUN
fnp-5116	92	19	of	of	ADP
fnp-5116	92	20	pa	pa	PROPN
fnp-5116	92	21	or	or	CCONJ
fnp-5116	92	22	pma	pma	NOUN
fnp-5116	92	23	between	between	ADP
fnp-5116	92	24	1989	1989	NUM
fnp-5116	92	25	-	-	SYM
fnp-5116	92	26	2019	2019	NUM
fnp-5116	92	27	,	,	PUNCT
fnp-5116	92	28	499	499	NUM
fnp-5116	92	29	patients	patient	NOUN
fnp-5116	92	30	fulfilled	fulfil	VERB
fnp-5116	92	31	the	the	DET
fnp-5116	92	32	inclusion	inclusion	NOUN
fnp-5116	92	33	criteria	criterion	NOUN
fnp-5116	92	34	and	and	CCONJ
fnp-5116	92	35	were	be	AUX
fnp-5116	92	36	included	include	VERB
fnp-5116	92	37	in	in	ADP
fnp-5116	92	38	this	this	DET
fnp-5116	92	39	study	study	NOUN
fnp-5116	92	40	.	.	PUNCT
fnp-5116	93	1	mean	mean	VERB
fnp-5116	93	2	age	age	NOUN
fnp-5116	93	3	at	at	ADP
fnp-5116	93	4	the	the	DET
fnp-5116	93	5	diagnosis	diagnosis	NOUN
fnp-5116	93	6	was	be	AUX
fnp-5116	93	7	15.5	15.5	NUM
fnp-5116	93	8	years	year	NOUN
fnp-5116	93	9	(	(	PUNCT
fnp-5116	93	10	range	range	NOUN
fnp-5116	93	11	:	:	PUNCT
fnp-5116	93	12	3.4	3.4	NUM
fnp-5116	93	13	months-72	months-72	NOUN
fnp-5116	93	14	years	year	NOUN
fnp-5116	93	15	)	)	PUNCT
fnp-5116	93	16	and	and	CCONJ
fnp-5116	93	17	the	the	DET
fnp-5116	93	18	median	median	ADJ
fnp-5116	93	19	age	age	NOUN
fnp-5116	93	20	was	be	AUX
fnp-5116	93	21	12	12	NUM
fnp-5116	93	22	years	year	NOUN
fnp-5116	93	23	.	.	PUNCT
fnp-5116	94	1	there	there	PRON
fnp-5116	94	2	were	be	VERB
fnp-5116	94	3	276	276	NUM
fnp-5116	94	4	females	female	NOUN
fnp-5116	94	5	(	(	PUNCT
fnp-5116	94	6	55.3	55.3	NUM
fnp-5116	94	7	%	%	NOUN
fnp-5116	94	8	)	)	PUNCT
fnp-5116	94	9	and	and	CCONJ
fnp-5116	94	10	223	223	NUM
fnp-5116	94	11	males	male	NOUN
fnp-5116	94	12	(	(	PUNCT
fnp-5116	94	13	44.7	44.7	NUM
fnp-5116	94	14	%	%	NOUN
fnp-5116	94	15	)	)	PUNCT
fnp-5116	94	16	.	.	PUNCT
fnp-5116	95	1	the	the	DET
fnp-5116	95	2	patients	patient	NOUN
fnp-5116	95	3	were	be	AUX
fnp-5116	95	4	grouped	group	VERB
fnp-5116	95	5	into	into	ADP
fnp-5116	95	6	three	three	NUM
fnp-5116	95	7	age	age	NOUN
fnp-5116	95	8	categories	category	NOUN
fnp-5116	95	9	;	;	PUNCT
fnp-5116	95	10	286	286	NUM
fnp-5116	95	11	patients	patient	NOUN
fnp-5116	95	12	were	be	AUX
fnp-5116	95	13	<	<	X
fnp-5116	95	14	14	14	NUM
fnp-5116	95	15	years	year	NOUN
fnp-5116	95	16	old	old	ADJ
fnp-5116	95	17	,	,	PUNCT
fnp-5116	95	18	77	77	NUM
fnp-5116	95	19	patients	patient	NOUN
fnp-5116	95	20	were	be	AUX
fnp-5116	95	21	between	between	ADP
fnp-5116	95	22	14	14	NUM
fnp-5116	95	23	-	-	SYM
fnp-5116	95	24	21	21	NUM
fnp-5116	95	25	years	year	NOUN
fnp-5116	95	26	old	old	ADJ
fnp-5116	95	27	,	,	PUNCT
fnp-5116	95	28	and	and	CCONJ
fnp-5116	95	29	136	136	NUM
fnp-5116	95	30	cases	case	NOUN
fnp-5116	95	31	were	be	AUX
fnp-5116	95	32	>	>	X
fnp-5116	95	33	21	21	NUM
fnp-5116	95	34	years	year	NOUN
fnp-5116	95	35	old	old	ADJ
fnp-5116	95	36	.	.	PUNCT
fnp-5116	96	1	the	the	DET
fnp-5116	96	2	median	median	ADJ
fnp-5116	96	3	follow	follow	NOUN
fnp-5116	96	4	-	-	PUNCT
fnp-5116	96	5	up	up	NOUN
fnp-5116	96	6	was	be	AUX
fnp-5116	96	7	78.5	78.5	NUM
fnp-5116	96	8	months	month	NOUN
fnp-5116	96	9	(	(	PUNCT
fnp-5116	96	10	1	1	NUM
fnp-5116	96	11	–	–	SYM
fnp-5116	96	12	580	580	NUM
fnp-5116	96	13	months	month	NOUN
fnp-5116	96	14	)	)	PUNCT
fnp-5116	96	15	and	and	CCONJ
fnp-5116	96	16	47	47	NUM
fnp-5116	96	17	(	(	PUNCT
fnp-5116	96	18	9.4	9.4	NUM
fnp-5116	96	19	%	%	NOUN
fnp-5116	96	20	)	)	PUNCT
fnp-5116	96	21	patients	patient	NOUN
fnp-5116	96	22	had	have	VERB
fnp-5116	96	23	a	a	DET
fnp-5116	96	24	follow	follow	VERB
fnp-5116	96	25	-	-	PUNCT
fnp-5116	96	26	up	up	NOUN
fnp-5116	96	27	period	period	NOUN
fnp-5116	96	28	less	less	ADJ
fnp-5116	96	29	than	than	ADP
fnp-5116	96	30	12	12	NUM
fnp-5116	96	31	months	month	NOUN
fnp-5116	96	32	.	.	PUNCT
fnp-5116	97	1	in	in	ADP
fnp-5116	97	2	addition	addition	NOUN
fnp-5116	97	3	,	,	PUNCT
fnp-5116	97	4	178	178	NUM
fnp-5116	97	5	patients	patient	NOUN
fnp-5116	97	6	had	have	VERB
fnp-5116	97	7	>	>	SYM
fnp-5116	97	8	5	5	NUM
fnp-5116	97	9	years	year	NOUN
fnp-5116	97	10	and	and	CCONJ
fnp-5116	97	11	114	114	NUM
fnp-5116	97	12	patients	patient	NOUN
fnp-5116	97	13	had	have	VERB
fnp-5116	97	14	>	>	PROPN
fnp-5116	97	15	10	10	NUM
fnp-5116	97	16	years	year	NOUN
fnp-5116	97	17	of	of	ADP
fnp-5116	97	18	follow	follow	NOUN
fnp-5116	97	19	-	-	PUNCT
fnp-5116	97	20	up	up	NOUN
fnp-5116	97	21	.	.	PUNCT
fnp-5116	98	1	non	non	ADJ
fnp-5116	98	2	-	-	ADJ
fnp-5116	98	3	surgical	surgical	ADJ
fnp-5116	98	4	treatment	treatment	NOUN
fnp-5116	98	5	data	datum	NOUN
fnp-5116	98	6	were	be	AUX
fnp-5116	98	7	available	available	ADJ
fnp-5116	98	8	on	on	ADP
fnp-5116	98	9	approximately	approximately	ADV
fnp-5116	98	10	half	half	NOUN
fnp-5116	98	11	(	(	PUNCT
fnp-5116	98	12	n=298	n=298	PROPN
fnp-5116	98	13	)	)	PUNCT
fnp-5116	98	14	of	of	ADP
fnp-5116	98	15	the	the	DET
fnp-5116	98	16	cases	case	NOUN
fnp-5116	98	17	and	and	CCONJ
fnp-5116	98	18	among	among	ADP
fnp-5116	98	19	them	they	PRON
fnp-5116	98	20	,	,	PUNCT
fnp-5116	98	21	82	82	NUM
fnp-5116	98	22	patients	patient	NOUN
fnp-5116	98	23	have	have	AUX
fnp-5116	98	24	received	receive	VERB
fnp-5116	98	25	chemotherapy	chemotherapy	NOUN
fnp-5116	98	26	and	and	CCONJ
fnp-5116	98	27	63	63	NUM
fnp-5116	98	28	have	have	AUX
fnp-5116	98	29	received	receive	VERB
fnp-5116	98	30	radiotherapy	radiotherapy	NOUN
fnp-5116	98	31	.	.	PUNCT
fnp-5116	99	1	six	six	NUM
fnp-5116	99	2	patients	patient	NOUN
fnp-5116	99	3	died	die	VERB
fnp-5116	99	4	during	during	ADP
fnp-5116	99	5	the	the	DET
fnp-5116	99	6	follow	follow	NOUN
fnp-5116	99	7	-	-	PUNCT
fnp-5116	99	8	up	up	NOUN
fnp-5116	99	9	period	period	NOUN
fnp-5116	99	10	,	,	PUNCT
fnp-5116	99	11	but	but	CCONJ
fnp-5116	99	12	detailed	detailed	ADJ
fnp-5116	99	13	analysis	analysis	NOUN
fnp-5116	99	14	of	of	ADP
fnp-5116	99	15	their	their	PRON
fnp-5116	99	16	disease	disease	NOUN
fnp-5116	99	17	course	course	NOUN
fnp-5116	99	18	could	could	AUX
fnp-5116	99	19	not	not	PART
fnp-5116	99	20	directly	directly	ADV
fnp-5116	99	21	establish	establish	VERB
fnp-5116	99	22	cause	cause	NOUN
fnp-5116	99	23	of	of	ADP
fnp-5116	99	24	death	death	NOUN
fnp-5116	99	25	as	as	ADP
fnp-5116	99	26	being	be	AUX
fnp-5116	99	27	due	due	ADJ
fnp-5116	99	28	to	to	ADP
fnp-5116	99	29	tumor	tumor	NOUN
fnp-5116	99	30	.	.	PUNCT
fnp-5116	100	1	all	all	DET
fnp-5116	100	2	six	six	NUM
fnp-5116	100	3	patients	patient	NOUN
fnp-5116	100	4	initially	initially	ADV
fnp-5116	100	5	underwent	undergo	VERB
fnp-5116	100	6	subtotal	subtotal	ADJ
fnp-5116	100	7	resections	resection	NOUN
fnp-5116	100	8	,	,	PUNCT
fnp-5116	100	9	received	receive	VERB
fnp-5116	100	10	radiotherapy	radiotherapy	NOUN
fnp-5116	100	11	and	and	CCONJ
fnp-5116	100	12	multiple	multiple	ADJ
fnp-5116	100	13	chemotherapy	chemotherapy	NOUN
fnp-5116	100	14	regimens	regimen	NOUN
fnp-5116	100	15	,	,	PUNCT
fnp-5116	100	16	and	and	CCONJ
fnp-5116	100	17	had	have	VERB
fnp-5116	100	18	significant	significant	ADJ
fnp-5116	100	19	comorbidities	comorbiditie	NOUN
fnp-5116	100	20	(	(	PUNCT
fnp-5116	100	21	see	see	VERB
fnp-5116	100	22	table	table	NOUN
fnp-5116	100	23	1	1	NUM
fnp-5116	100	24	)	)	PUNCT
fnp-5116	100	25	.	.	PUNCT
fnp-5116	101	1	in	in	ADP
fnp-5116	101	2	most	most	ADJ
fnp-5116	101	3	cases	case	NOUN
fnp-5116	101	4	,	,	PUNCT
fnp-5116	101	5	there	there	PRON
fnp-5116	101	6	was	be	VERB
fnp-5116	101	7	no	no	DET
fnp-5116	101	8	clear	clear	ADJ
fnp-5116	101	9	tumor	tumor	NOUN
fnp-5116	101	10	growth	growth	NOUN
fnp-5116	101	11	,	,	PUNCT
fnp-5116	101	12	and	and	CCONJ
fnp-5116	101	13	the	the	DET
fnp-5116	101	14	disease	disease	NOUN
fnp-5116	101	15	course	course	NOUN
fnp-5116	101	16	was	be	AUX
fnp-5116	101	17	complicated	complicate	VERB
fnp-5116	101	18	by	by	ADP
fnp-5116	101	19	additional	additional	ADJ
fnp-5116	101	20	factors	factor	NOUN
fnp-5116	101	21	.	.	PUNCT
fnp-5116	102	1	table	table	NOUN
fnp-5116	102	2	1	1	NUM
fnp-5116	102	3	.	.	PUNCT
fnp-5116	103	1	clinical	clinical	ADJ
fnp-5116	103	2	details	detail	NOUN
fnp-5116	103	3	of	of	ADP
fnp-5116	103	4	deceased	deceased	ADJ
fnp-5116	103	5	patients	patient	NOUN
fnp-5116	103	6	i	i	NOUN
fnp-5116	103	7	d	d	PROPN
fnp-5116	103	8	patient	patient	NOUN
fnp-5116	103	9	age	age	NOUN
fnp-5116	103	10	at	at	ADP
fnp-5116	103	11	sx	sx	PROPN
fnp-5116	103	12	location	location	NOUN
fnp-5116	103	13	treatment	treatment	NOUN
fnp-5116	103	14	comorbidities	comorbiditie	NOUN
fnp-5116	103	15	molecular	molecular	ADJ
fnp-5116	103	16	findings	finding	NOUN
fnp-5116	103	17	os	os	NOUN
fnp-5116	103	18	case	case	NOUN
fnp-5116	103	19	#	#	NOUN
fnp-5116	103	20	29	29	NUM
fnp-5116	103	21	5	5	NUM
fnp-5116	103	22	years	year	NOUN
fnp-5116	103	23	cerebral	cerebral	ADJ
fnp-5116	103	24	4	4	NUM
fnp-5116	103	25	surgeries	surgery	NOUN
fnp-5116	103	26	wbrt	wbrt	NOUN
fnp-5116	103	27	multiple	multiple	ADJ
fnp-5116	103	28	 	 	SPACE
fnp-5116	103	29	chemotherapies	chemotherapy	NOUN
fnp-5116	103	30	hemiparesis	hemiparesis	NOUN
fnp-5116	103	31	.	.	PUNCT
fnp-5116	104	1	seizures	seizure	NOUN
fnp-5116	104	2	.	.	PUNCT
fnp-5116	105	1	panhypopituitarism	panhypopituitarism	NOUN
fnp-5116	105	2	radiation	radiation	NOUN
fnp-5116	105	3	-	-	PUNCT
fnp-5116	105	4	associated	associate	VERB
fnp-5116	105	5	necrosis	necrosis	NOUN
fnp-5116	105	6	*	*	SYM
fnp-5116	105	7	.	.	PUNCT
fnp-5116	106	1	stable	stable	ADJ
fnp-5116	106	2	tumor	tumor	NOUN
fnp-5116	106	3	in	in	ADP
fnp-5116	106	4	last	last	ADJ
fnp-5116	106	5	neuroimaging	neuroimaging	NOUN
fnp-5116	106	6	study	study	NOUN
fnp-5116	106	7	n	n	CCONJ
fnp-5116	106	8	/	/	SYM
fnp-5116	106	9	a	a	DET
fnp-5116	106	10	24	24	NUM
fnp-5116	106	11	 	 	SPACE
fnp-5116	106	12	yr	yr	NOUN
fnp-5116	106	13	case	case	NOUN
fnp-5116	106	14	#	#	NOUN
fnp-5116	106	15	49	49	NUM
fnp-5116	106	16	1.3	1.3	NUM
fnp-5116	106	17	years	year	NOUN
fnp-5116	106	18	hypothalamic/	hypothalamic/	NUM
fnp-5116	106	19	chiasmatic	chiasmatic	ADJ
fnp-5116	106	20	2	2	NUM
fnp-5116	106	21	surgeries	surgery	NOUN
fnp-5116	106	22	multiple	multiple	ADJ
fnp-5116	106	23	 	 	SPACE
fnp-5116	106	24	chemotherapies	chemotherapy	NOUN
fnp-5116	106	25	external	external	ADJ
fnp-5116	106	26	beam	beam	NOUN
fnp-5116	106	27	radiation	radiation	NOUN
fnp-5116	106	28	11	11	NUM
fnp-5116	106	29	surgical	surgical	ADJ
fnp-5116	106	30	procedures	procedure	NOUN
fnp-5116	106	31	radiation	radiation	NOUN
fnp-5116	106	32	-	-	PUNCT
fnp-5116	106	33	associated	associate	VERB
fnp-5116	106	34	necrosis	necrosis	NOUN
fnp-5116	106	35	*	*	SYM
fnp-5116	106	36	.	.	PUNCT
fnp-5116	107	1	seizures	seizure	NOUN
fnp-5116	107	2	.	.	PUNCT
fnp-5116	108	1	hydrocephalus	hydrocephalus	X
fnp-5116	108	2	.	.	PUNCT
fnp-5116	109	1	secondary	secondary	ADJ
fnp-5116	109	2	infection	infection	NOUN
fnp-5116	109	3	-	-	PUNCT
fnp-5116	109	4	sepsis	sepsis	NOUN
fnp-5116	109	5	.	.	PUNCT
fnp-5116	110	1	n	n	CCONJ
fnp-5116	110	2	/	/	SYM
fnp-5116	110	3	a	a	DET
fnp-5116	110	4	11	11	NUM
fnp-5116	110	5	 	 	SPACE
fnp-5116	110	6	mo	mo	NOUN
fnp-5116	110	7	case	case	NOUN
fnp-5116	110	8	#	#	NOUN
fnp-5116	110	9	86	86	NUM
fnp-5116	110	10	49	49	NUM
fnp-5116	110	11	years	year	NOUN
fnp-5116	110	12	posterior	posterior	ADJ
fnp-5116	110	13	fossa	fossa	ADJ
fnp-5116	110	14	2	2	NUM
fnp-5116	110	15	surgeries	surgery	NOUN
fnp-5116	110	16	external	external	ADJ
fnp-5116	110	17	beam	beam	NOUN
fnp-5116	110	18	radiation	radiation	NOUN
fnp-5116	110	19	multiple	multiple	ADJ
fnp-5116	110	20	 	 	SPACE
fnp-5116	110	21	chemotherapies	chemotherapy	NOUN
fnp-5116	110	22	radiation	radiation	NOUN
fnp-5116	110	23	-	-	PUNCT
fnp-5116	110	24	associated	associate	VERB
fnp-5116	110	25	necrosis	necrosis	NOUN
fnp-5116	110	26	*	*	X
fnp-5116	110	27	.	.	PUNCT
fnp-5116	111	1	hemiparesis	hemiparesis	NOUN
fnp-5116	111	2	hydrocephalus	hydrocephalus	X
fnp-5116	111	3	.	.	PUNCT
fnp-5116	112	1	siadh	siadh	NOUN
fnp-5116	112	2	.	.	PUNCT
fnp-5116	113	1	stable	stable	ADJ
fnp-5116	113	2	tumor	tumor	NOUN
fnp-5116	113	3	in	in	ADP
fnp-5116	113	4	last	last	ADJ
fnp-5116	113	5	neuroimaging	neuroimaging	NOUN
fnp-5116	113	6	study	study	NOUN
fnp-5116	113	7	n	n	CCONJ
fnp-5116	113	8	/	/	SYM
fnp-5116	113	9	a	a	DET
fnp-5116	113	10	2	2	NUM
fnp-5116	113	11	 	 	SPACE
fnp-5116	113	12	yr	yr	NOUN
fnp-5116	113	13	case	case	NOUN
fnp-5116	113	14	#	#	SYM
fnp-5116	113	15	177	177	NUM
fnp-5116	113	16	39	39	NUM
fnp-5116	113	17	years	year	NOUN
fnp-5116	113	18	spinal	spinal	ADJ
fnp-5116	113	19	cord	cord	NOUN
fnp-5116	113	20	2	2	NUM
fnp-5116	113	21	surgeries	surgery	NOUN
fnp-5116	113	22	radiation	radiation	NOUN
fnp-5116	113	23	treatment	treatment	NOUN
fnp-5116	113	24	multiple	multiple	ADJ
fnp-5116	113	25	 	 	SPACE
fnp-5116	113	26	chemotherapies	chemotherapy	NOUN
fnp-5116	113	27	radiation	radiation	NOUN
fnp-5116	113	28	associated	associate	VERB
fnp-5116	113	29	necrosis	necrosis	NOUN
fnp-5116	113	30	*	*	X
fnp-5116	113	31	.	.	PUNCT
fnp-5116	114	1	paraplegia	paraplegia	ADJ
fnp-5116	114	2	neurogenic	neurogenic	ADJ
fnp-5116	114	3	bladder	bladder	NOUN
fnp-5116	114	4	,	,	PUNCT
fnp-5116	114	5	recurrent	recurrent	ADJ
fnp-5116	114	6	uti	uti	PROPN
fnp-5116	114	7	.	.	PUNCT
fnp-5116	115	1	papillary	papillary	ADJ
fnp-5116	115	2	urothelial	urothelial	ADJ
fnp-5116	115	3	carcinoma	carcinoma	NOUN
fnp-5116	115	4	.	.	PUNCT
fnp-5116	116	1	stable	stable	ADJ
fnp-5116	116	2	tumor	tumor	NOUN
fnp-5116	116	3	in	in	ADP
fnp-5116	116	4	last	last	ADJ
fnp-5116	116	5	neuroimaging	neuroimage	VERB
fnp-5116	116	6	study	study	NOUN
fnp-5116	116	7	.	.	PUNCT
fnp-5116	117	1	n	n	CCONJ
fnp-5116	117	2	/	/	SYM
fnp-5116	117	3	a	a	DET
fnp-5116	117	4	14	14	NUM
fnp-5116	117	5	 	 	SPACE
fnp-5116	117	6	yr	yr	NOUN
fnp-5116	117	7	case	case	NOUN
fnp-5116	117	8	#	#	NOUN
fnp-5116	117	9	249	249	NUM
fnp-5116	117	10	4	4	NUM
fnp-5116	117	11	years	year	NOUN
fnp-5116	117	12	hypothalamic/	hypothalamic/	NUM
fnp-5116	117	13	chiasmatic	chiasmatic	ADJ
fnp-5116	117	14	2	2	NUM
fnp-5116	117	15	surgeries	surgery	NOUN
fnp-5116	117	16	radiation	radiation	NOUN
fnp-5116	117	17	treatment	treatment	NOUN
fnp-5116	117	18	multiple	multiple	ADJ
fnp-5116	117	19	 	 	SPACE
fnp-5116	117	20	chemotherapies	chemotherapy	NOUN
fnp-5116	117	21	multiple	multiple	ADJ
fnp-5116	117	22	vp	vp	X
fnp-5116	117	23	shunting	shunt	VERB
fnp-5116	117	24	hydrocephalus	hydrocephalus	X
fnp-5116	117	25	.	.	PUNCT
fnp-5116	118	1	radiation	radiation	NOUN
fnp-5116	118	2	-	-	PUNCT
fnp-5116	118	3	associated	associate	VERB
fnp-5116	118	4	necrosis	necrosis	NOUN
fnp-5116	118	5	*	*	SYM
fnp-5116	118	6	.	.	PUNCT
fnp-5116	118	7	seizures	seizure	NOUN
fnp-5116	118	8	.	.	PUNCT
fnp-5116	119	1	cerebral	cerebral	ADJ
fnp-5116	119	2	infarction	infarction	NOUN
fnp-5116	119	3	.	.	PUNCT
fnp-5116	120	1	siadh	siadh	NOUN
fnp-5116	120	2	.	.	PUNCT
fnp-5116	121	1	dysphagia	dysphagia	NOUN
fnp-5116	121	2	and	and	CCONJ
fnp-5116	121	3	aspiration	aspiration	NOUN
fnp-5116	121	4	pneumonia	pneumonia	NOUN
fnp-5116	121	5	braf::kiaa1549	braf::kiaa1549	PROPN
fnp-5116	121	6	11	11	NUM
fnp-5116	121	7	 	 	SPACE
fnp-5116	121	8	yr	yr	NOUN
fnp-5116	121	9	case	case	NOUN
fnp-5116	121	10	#	#	SYM
fnp-5116	121	11	454	454	NUM
fnp-5116	121	12	35	35	NUM
fnp-5116	121	13	years	year	NOUN
fnp-5116	121	14	posterior	posterior	ADJ
fnp-5116	121	15	fossa	fossa	VERB
fnp-5116	121	16	3	3	NUM
fnp-5116	121	17	surgeries	surgery	NOUN
fnp-5116	121	18	radiation	radiation	NOUN
fnp-5116	121	19	treatments	treatment	NOUN
fnp-5116	121	20	(	(	PUNCT
fnp-5116	121	21	3	3	X
fnp-5116	121	22	)	)	PUNCT
fnp-5116	121	23	multiple	multiple	ADJ
fnp-5116	121	24	 	 	SPACE
fnp-5116	121	25	chemotherapies	chemotherapy	NOUN
fnp-5116	121	26	multiple	multiple	ADJ
fnp-5116	121	27	shunt	shunt	NOUN
fnp-5116	121	28	revisions	revision	NOUN
fnp-5116	121	29	neurofibromatosis	neurofibromatosis	NOUN
fnp-5116	121	30	1	1	NUM
fnp-5116	121	31	.	.	PUNCT
fnp-5116	121	32	aspiration	aspiration	NOUN
fnp-5116	121	33	pneumonia	pneumonia	NOUN
fnp-5116	121	34	multiple	multiple	ADJ
fnp-5116	121	35	neurofibromas	neurofibroma	NOUN
fnp-5116	121	36	.	.	PUNCT
fnp-5116	122	1	radiation	radiation	NOUN
fnp-5116	122	2	-	-	PUNCT
fnp-5116	122	3	associated	associate	VERB
fnp-5116	122	4	necrosis	necrosis	NOUN
fnp-5116	122	5	*	*	SYM
fnp-5116	122	6	,	,	PUNCT
fnp-5116	122	7	cerebellum	cerebellum	ADJ
fnp-5116	122	8	.	.	PUNCT
fnp-5116	123	1	multiple	multiple	ADJ
fnp-5116	123	2	flair	flair	ADJ
fnp-5116	123	3	abnormalities	abnormality	NOUN
fnp-5116	123	4	in	in	ADP
fnp-5116	123	5	the	the	DET
fnp-5116	123	6	cerebral	cerebral	ADJ
fnp-5116	123	7	hemispheres	hemisphere	NOUN
fnp-5116	123	8	.	.	PUNCT
fnp-5116	124	1	no	no	DET
fnp-5116	124	2	tumor	tumor	NOUN
fnp-5116	124	3	growth	growth	NOUN
fnp-5116	124	4	reported	report	VERB
fnp-5116	124	5	following	follow	VERB
fnp-5116	124	6	third	third	ADJ
fnp-5116	124	7	surgery	surgery	NOUN
fnp-5116	124	8	on	on	ADP
fnp-5116	124	9	radioimaging	radioimage	VERB
fnp-5116	124	10	nf1	nf1	NOUN
fnp-5116	124	11	loss	loss	NOUN
fnp-5116	124	12	somatic/	somatic/	NUM
fnp-5116	124	13	germline	germline	NOUN
fnp-5116	124	14	cdkn2a	cdkn2a	VERB
fnp-5116	124	15	homozygous	homozygous	ADJ
fnp-5116	124	16	deletion	deletion	NOUN
fnp-5116	124	17	in	in	ADP
fnp-5116	124	18	recurrent	recurrent	ADJ
fnp-5116	124	19	tumor	tumor	NOUN
fnp-5116	124	20	6	6	NUM
fnp-5116	124	21	 	 	SPACE
fnp-5116	124	22	yr	yr	NOUN
fnp-5116	124	23	•	•	NOUN
fnp-5116	124	24	radiation	radiation	NOUN
fnp-5116	124	25	-	-	PUNCT
fnp-5116	124	26	associated	associate	VERB
fnp-5116	124	27	necrosis	necrosis	NOUN
fnp-5116	124	28	was	be	AUX
fnp-5116	124	29	confirmed	confirm	VERB
fnp-5116	124	30	on	on	ADP
fnp-5116	124	31	radioimaging	radioimage	VERB
fnp-5116	124	32	as	as	ADV
fnp-5116	124	33	well	well	ADV
fnp-5116	124	34	as	as	ADP
fnp-5116	124	35	pathological	pathological	ADJ
fnp-5116	124	36	studies	study	NOUN
fnp-5116	124	37	of	of	ADP
fnp-5116	124	38	the	the	DET
fnp-5116	124	39	recurrent	recurrent	ADJ
fnp-5116	124	40	tumors	tumor	NOUN
fnp-5116	124	41	•	•	NUM
fnp-5116	124	42	wbrtwhole	wbrtwhole	NOUN
fnp-5116	124	43	brain	brain	NOUN
fnp-5116	124	44	radiation	radiation	NOUN
fnp-5116	124	45	;	;	PUNCT
fnp-5116	124	46	vp	vp	X
fnp-5116	124	47	:	:	PUNCT
fnp-5116	124	48	ventriculoperitoneal	ventriculoperitoneal	NOUN
fnp-5116	124	49	;	;	PUNCT
fnp-5116	124	50	siadh	siadh	NOUN
fnp-5116	124	51	:	:	PUNCT
fnp-5116	124	52	syndrome	syndrome	NOUN
fnp-5116	124	53	of	of	ADP
fnp-5116	124	54	inappropriate	inappropriate	ADJ
fnp-5116	124	55	adh	adh	NOUN
fnp-5116	124	56	secretion	secretion	NOUN
fnp-5116	124	57	;	;	PUNCT
fnp-5116	124	58	uti	uti	PROPN
fnp-5116	124	59	:	:	PUNCT
fnp-5116	124	60	urinary	urinary	ADJ
fnp-5116	124	61	tract	tract	NOUN
fnp-5116	124	62	infection	infection	NOUN
fnp-5116	124	63	;	;	PUNCT
fnp-5116	124	64	os	os	ADJ
fnp-5116	124	65	:	:	PUNCT
fnp-5116	124	66	overall	overall	ADJ
fnp-5116	124	67	survival	survival	NOUN
fnp-5116	124	68	.	.	PUNCT
fnp-5116	125	1	tumor	tumor	NOUN
fnp-5116	125	2	recurrence	recurrence	NOUN
fnp-5116	125	3	information	information	NOUN
fnp-5116	125	4	was	be	AUX
fnp-5116	125	5	available	available	ADJ
fnp-5116	125	6	for	for	ADP
fnp-5116	125	7	321	321	NUM
fnp-5116	125	8	patients	patient	NOUN
fnp-5116	125	9	,	,	PUNCT
fnp-5116	125	10	of	of	ADP
fnp-5116	125	11	which	which	PRON
fnp-5116	125	12	109	109	NUM
fnp-5116	125	13	suffered	suffer	VERB
fnp-5116	125	14	at	at	ADP
fnp-5116	125	15	least	least	ADV
fnp-5116	125	16	one	one	NUM
fnp-5116	125	17	recurrence	recurrence	NOUN
fnp-5116	125	18	(	(	PUNCT
fnp-5116	125	19	34	34	NUM
fnp-5116	125	20	%	%	NOUN
fnp-5116	125	21	,	,	PUNCT
fnp-5116	125	22	109	109	NUM
fnp-5116	125	23	of	of	ADP
fnp-5116	125	24	321	321	NUM
fnp-5116	125	25	cases	case	NOUN
fnp-5116	125	26	)	)	PUNCT
fnp-5116	125	27	.	.	PUNCT
fnp-5116	126	1	major	major	ADJ
fnp-5116	126	2	demographic	demographic	ADJ
fnp-5116	126	3	and	and	CCONJ
fnp-5116	126	4	clinical	clinical	ADJ
fnp-5116	126	5	features	feature	NOUN
fnp-5116	126	6	are	be	AUX
fnp-5116	126	7	presented	present	VERB
fnp-5116	126	8	in	in	ADP
fnp-5116	126	9	table	table	NOUN
fnp-5116	126	10	2	2	NUM
fnp-5116	126	11	.	.	PUNCT
fnp-5116	126	12	tumor	tumor	NOUN
fnp-5116	126	13	localization	localization	NOUN
fnp-5116	126	14	among	among	ADP
fnp-5116	126	15	the	the	DET
fnp-5116	126	16	cases	case	NOUN
fnp-5116	126	17	where	where	SCONJ
fnp-5116	126	18	the	the	DET
fnp-5116	126	19	localization	localization	NOUN
fnp-5116	126	20	information	information	NOUN
fnp-5116	126	21	was	be	AUX
fnp-5116	126	22	available	available	ADJ
fnp-5116	126	23	(	(	PUNCT
fnp-5116	126	24	n=494	n=494	NUM
fnp-5116	126	25	)	)	PUNCT
fnp-5116	126	26	,	,	PUNCT
fnp-5116	126	27	259	259	NUM
fnp-5116	126	28	(	(	PUNCT
fnp-5116	126	29	52.6	52.6	NUM
fnp-5116	126	30	%	%	NOUN
fnp-5116	126	31	)	)	PUNCT
fnp-5116	126	32	were	be	AUX
fnp-5116	126	33	in	in	ADP
fnp-5116	126	34	the	the	DET
fnp-5116	126	35	posterior	posterior	ADJ
fnp-5116	126	36	fossa	fossa	NOUN
fnp-5116	126	37	,	,	PUNCT
fnp-5116	126	38	208	208	NUM
fnp-5116	126	39	(	(	PUNCT
fnp-5116	126	40	42.3	42.3	NUM
fnp-5116	126	41	%	%	NOUN
fnp-5116	126	42	)	)	PUNCT
fnp-5116	126	43	were	be	AUX
fnp-5116	126	44	supratentorial	supratentorial	ADJ
fnp-5116	126	45	(	(	PUNCT
fnp-5116	126	46	includes	include	VERB
fnp-5116	126	47	hemispheric	hemispheric	ADJ
fnp-5116	126	48	,	,	PUNCT
fnp-5116	126	49	hypothalamic	hypothalamic	ADJ
fnp-5116	126	50	/	/	SYM
fnp-5116	126	51	chiasmatic	chiasmatic	ADJ
fnp-5116	126	52	,	,	PUNCT
fnp-5116	126	53	intraventricular	intraventricular	ADJ
fnp-5116	126	54	and	and	CCONJ
fnp-5116	126	55	optic	optic	ADJ
fnp-5116	126	56	nerve	nerve	NOUN
fnp-5116	126	57	tumors	tumor	NOUN
fnp-5116	126	58	)	)	PUNCT
fnp-5116	126	59	,	,	PUNCT
fnp-5116	126	60	and	and	CCONJ
fnp-5116	126	61	25	25	NUM
fnp-5116	126	62	(	(	PUNCT
fnp-5116	126	63	5.1	5.1	NUM
fnp-5116	126	64	%	%	NOUN
fnp-5116	126	65	)	)	PUNCT
fnp-5116	126	66	were	be	AUX
fnp-5116	126	67	in	in	ADP
fnp-5116	126	68	the	the	DET
fnp-5116	126	69	spinal	spinal	ADJ
fnp-5116	126	70	cord	cord	NOUN
fnp-5116	126	71	.	.	PUNCT
fnp-5116	127	1	two	two	NUM
fnp-5116	127	2	patients	patient	NOUN
fnp-5116	127	3	had	have	VERB
fnp-5116	127	4	multifocal	multifocal	ADJ
fnp-5116	127	5	tumors	tumor	NOUN
fnp-5116	127	6	at	at	ADP
fnp-5116	127	7	diagnosis	diagnosis	NOUN
fnp-5116	127	8	,	,	PUNCT
fnp-5116	127	9	and	and	CCONJ
fnp-5116	127	10	the	the	DET
fnp-5116	127	11	exact	exact	ADJ
fnp-5116	127	12	information	information	NOUN
fnp-5116	127	13	on	on	ADP
fnp-5116	127	14	location	location	NOUN
fnp-5116	127	15	was	be	AUX
fnp-5116	127	16	not	not	PART
fnp-5116	127	17	available	available	ADJ
fnp-5116	127	18	for	for	ADP
fnp-5116	127	19	5	5	NUM
fnp-5116	127	20	patients	patient	NOUN
fnp-5116	127	21	.	.	PUNCT
fnp-5116	128	1	table	table	NOUN
fnp-5116	128	2	2	2	NUM
fnp-5116	128	3	.	.	X
fnp-5116	128	4	major	major	ADJ
fnp-5116	128	5	demographic	demographic	ADJ
fnp-5116	128	6	and	and	CCONJ
fnp-5116	128	7	clinical	clinical	ADJ
fnp-5116	128	8	features	feature	NOUN
fnp-5116	128	9	of	of	ADP
fnp-5116	128	10	patients	patient	NOUN
fnp-5116	128	11	variable	variable	ADJ
fnp-5116	128	12	groups	group	NOUN
fnp-5116	128	13	n	n	PRON
fnp-5116	128	14	%	%	NOUN
fnp-5116	128	15	age	age	NOUN
fnp-5116	128	16	n:499	n:499	PROPN
fnp-5116	128	17	0	0	NUM
fnp-5116	128	18	-	-	SYM
fnp-5116	128	19	14	14	NUM
fnp-5116	128	20	14	14	NUM
fnp-5116	128	21	-	-	SYM
fnp-5116	128	22	21	21	NUM
fnp-5116	128	23	>	>	SYM
fnp-5116	128	24	21	21	NUM
fnp-5116	128	25	286	286	NUM
fnp-5116	128	26	77	77	NUM
fnp-5116	128	27	136	136	NUM
fnp-5116	128	28	57.3	57.3	NUM
fnp-5116	128	29	%	%	NOUN
fnp-5116	128	30	15.4	15.4	NUM
fnp-5116	128	31	%	%	NOUN
fnp-5116	128	32	27.3	27.3	NUM
fnp-5116	128	33	%	%	NOUN
fnp-5116	128	34	sex	sex	NOUN
fnp-5116	128	35	n:499	n:499	NOUN
fnp-5116	128	36	male	male	ADJ
fnp-5116	128	37	female	female	ADJ
fnp-5116	128	38	276	276	NUM
fnp-5116	128	39	223	223	NUM
fnp-5116	128	40	55.3	55.3	NUM
fnp-5116	128	41	%	%	NOUN
fnp-5116	128	42	44.7	44.7	NUM
fnp-5116	128	43	%	%	NOUN
fnp-5116	128	44	extent	extent	NOUN
fnp-5116	128	45	of	of	ADP
fnp-5116	128	46	resection	resection	NOUN
fnp-5116	128	47	n:499	n:499	PROPN
fnp-5116	128	48	str	str	PROPN
fnp-5116	128	49	gtr	gtr	NOUN
fnp-5116	128	50	unknown	unknown	ADJ
fnp-5116	128	51	235	235	NUM
fnp-5116	128	52	169	169	NUM
fnp-5116	128	53	95	95	NUM
fnp-5116	128	54	47.1	47.1	NUM
fnp-5116	128	55	%	%	NOUN
fnp-5116	128	56	33.9	33.9	NUM
fnp-5116	128	57	%	%	NOUN
fnp-5116	128	58	19.0	19.0	NUM
fnp-5116	128	59	%	%	NOUN
fnp-5116	128	60	tumor	tumor	NOUN
fnp-5116	128	61	localization	localization	NOUN
fnp-5116	128	62	n:499	n:499	PROPN
fnp-5116	128	63	infratentorial	infratentorial	VERB
fnp-5116	128	64	supratentorial	supratentorial	ADJ
fnp-5116	128	65	spinal	spinal	NOUN
fnp-5116	128	66	multifocal	multifocal	ADJ
fnp-5116	128	67	unknown	unknown	ADJ
fnp-5116	128	68	259	259	NUM
fnp-5116	128	69	208	208	NUM
fnp-5116	128	70	25	25	NUM
fnp-5116	128	71	2	2	NUM
fnp-5116	128	72	5	5	NUM
fnp-5116	128	73	51.9	51.9	NUM
fnp-5116	128	74	%	%	NOUN
fnp-5116	128	75	41.6	41.6	NUM
fnp-5116	128	76	%	%	NOUN
fnp-5116	128	77	05.0	05.0	NUM
fnp-5116	128	78	%	%	NOUN
fnp-5116	128	79	0.5	0.5	NUM
fnp-5116	128	80	%	%	NOUN
fnp-5116	128	81	01.0	01.0	NUM
fnp-5116	128	82	%	%	NOUN
fnp-5116	128	83	treatment	treatment	NOUN
fnp-5116	128	84	n:499	n:499	PROPN
fnp-5116	128	85	chemotherapy	chemotherapy	NOUN
fnp-5116	128	86	   	   	SPACE
fnp-5116	129	1	yes	yes	INTJ
fnp-5116	129	2	   	   	SPACE
fnp-5116	129	3	no	no	DET
fnp-5116	129	4	   	   	SPACE
fnp-5116	129	5	unknown	unknown	ADJ
fnp-5116	129	6	radiotherapy	radiotherapy	NOUN
fnp-5116	129	7	   	   	SPACE
fnp-5116	129	8	yes	yes	INTJ
fnp-5116	129	9	   	   	SPACE
fnp-5116	129	10	no	no	DET
fnp-5116	129	11	   	   	SPACE
fnp-5116	129	12	unknown	unknown	ADJ
fnp-5116	129	13	82	82	NUM
fnp-5116	129	14	216	216	NUM
fnp-5116	129	15	201	201	NUM
fnp-5116	129	16	63	63	NUM
fnp-5116	129	17	235	235	NUM
fnp-5116	129	18	201	201	NUM
fnp-5116	129	19	16.4	16.4	NUM
fnp-5116	129	20	%	%	NOUN
fnp-5116	129	21	43.3	43.3	NUM
fnp-5116	129	22	%	%	NOUN
fnp-5116	129	23	40.3	40.3	NUM
fnp-5116	129	24	%	%	NOUN
fnp-5116	129	25	12.6	12.6	NUM
fnp-5116	129	26	%	%	NOUN
fnp-5116	129	27	47.1	47.1	NUM
fnp-5116	129	28	%	%	NOUN
fnp-5116	129	29	40.3	40.3	NUM
fnp-5116	129	30	%	%	NOUN
fnp-5116	129	31	outcome	outcome	NOUN
fnp-5116	129	32	n:499	n:499	NOUN
fnp-5116	129	33	no	no	DET
fnp-5116	129	34	evidence	evidence	NOUN
fnp-5116	129	35	of	of	ADP
fnp-5116	129	36	disease	disease	NOUN
fnp-5116	129	37	alive	alive	ADJ
fnp-5116	129	38	with	with	ADP
fnp-5116	129	39	disease	disease	NOUN
fnp-5116	129	40	lost	lose	VERB
fnp-5116	129	41	,	,	PUNCT
fnp-5116	129	42	to	to	PART
fnp-5116	129	43	follow	follow	VERB
fnp-5116	129	44	up	up	ADP
fnp-5116	129	45	died	die	VERB
fnp-5116	129	46	of	of	ADP
fnp-5116	129	47	other	other	ADJ
fnp-5116	129	48	causes	cause	VERB
fnp-5116	129	49	80	80	NUM
fnp-5116	129	50	62	62	NUM
fnp-5116	129	51	351	351	NUM
fnp-5116	129	52	6	6	NUM
fnp-5116	129	53	16.0	16.0	NUM
fnp-5116	129	54	%	%	NOUN
fnp-5116	129	55	12.4	12.4	NUM
fnp-5116	129	56	%	%	NOUN
fnp-5116	129	57	70.3	70.3	NUM
fnp-5116	129	58	%	%	NOUN
fnp-5116	129	59	01.2	01.2	NUM
fnp-5116	129	60	%	%	NOUN
fnp-5116	129	61	recurrence	recurrence	NOUN
fnp-5116	129	62	n:499	n:499	PROPN
fnp-5116	130	1	yes	yes	INTJ
fnp-5116	130	2	no	no	DET
fnp-5116	130	3	unknown	unknown	ADJ
fnp-5116	130	4	109	109	NUM
fnp-5116	130	5	212	212	NUM
fnp-5116	130	6	178	178	NUM
fnp-5116	130	7	21.8	21.8	NUM
fnp-5116	130	8	%	%	NOUN
fnp-5116	130	9	42.5	42.5	NUM
fnp-5116	130	10	%	%	NOUN
fnp-5116	130	11	35.7	35.7	NUM
fnp-5116	130	12	%	%	NOUN
fnp-5116	130	13	second	second	ADJ
fnp-5116	130	14	recurrence	recurrence	NOUN
fnp-5116	130	15	n:109	n:109	VERB
fnp-5116	130	16	yes	yes	INTJ
fnp-5116	131	1	no	no	DET
fnp-5116	131	2	unknown	unknown	ADJ
fnp-5116	131	3	20	20	NUM
fnp-5116	131	4	58	58	NUM
fnp-5116	131	5	31	31	NUM
fnp-5116	131	6	18.3	18.3	NUM
fnp-5116	131	7	%	%	NOUN
fnp-5116	131	8	53.2	53.2	NUM
fnp-5116	131	9	%	%	NOUN
fnp-5116	131	10	28.5	28.5	NUM
fnp-5116	131	11	%	%	NOUN
fnp-5116	131	12	n	n	CCONJ
fnp-5116	131	13	:	:	PUNCT
fnp-5116	131	14	total	total	ADJ
fnp-5116	131	15	number	number	NOUN
fnp-5116	131	16	of	of	ADP
fnp-5116	131	17	patients	patient	NOUN
fnp-5116	131	18	;	;	PUNCT
fnp-5116	131	19	str	str	NUM
fnp-5116	131	20	:	:	PUNCT
fnp-5116	131	21	subtotal	subtotal	ADJ
fnp-5116	131	22	resection	resection	NOUN
fnp-5116	131	23	;	;	PUNCT
fnp-5116	131	24	gtr	gtr	NOUN
fnp-5116	131	25	:	:	PUNCT
fnp-5116	131	26	gross	gross	ADJ
fnp-5116	131	27	total	total	ADJ
fnp-5116	131	28	resection	resection	NOUN
fnp-5116	131	29	.	.	PUNCT
fnp-5116	132	1	second	second	ADJ
fnp-5116	132	2	recurrence	recurrence	NOUN
fnp-5116	132	3	is	be	AUX
fnp-5116	132	4	reported	report	VERB
fnp-5116	132	5	for	for	ADP
fnp-5116	132	6	109	109	NUM
fnp-5116	132	7	patients	patient	NOUN
fnp-5116	132	8	who	who	PRON
fnp-5116	132	9	had	have	AUX
fnp-5116	132	10	documented	document	VERB
fnp-5116	132	11	recurrences	recurrence	NOUN
fnp-5116	132	12	.	.	PUNCT
fnp-5116	133	1	among	among	ADP
fnp-5116	133	2	208	208	NUM
fnp-5116	133	3	supratentorial	supratentorial	ADJ
fnp-5116	133	4	tumors	tumor	NOUN
fnp-5116	133	5	,	,	PUNCT
fnp-5116	133	6	108	108	NUM
fnp-5116	133	7	(	(	PUNCT
fnp-5116	133	8	51.9	51.9	NUM
fnp-5116	133	9	%	%	NOUN
fnp-5116	133	10	)	)	PUNCT
fnp-5116	133	11	were	be	AUX
fnp-5116	133	12	in	in	ADP
fnp-5116	133	13	the	the	DET
fnp-5116	133	14	cerebral	cerebral	ADJ
fnp-5116	133	15	hemispheres	hemisphere	NOUN
fnp-5116	133	16	,	,	PUNCT
fnp-5116	133	17	79	79	NUM
fnp-5116	133	18	(	(	PUNCT
fnp-5116	133	19	38	38	NUM
fnp-5116	133	20	%	%	NOUN
fnp-5116	133	21	)	)	PUNCT
fnp-5116	133	22	were	be	AUX
fnp-5116	133	23	in	in	ADP
fnp-5116	133	24	the	the	DET
fnp-5116	133	25	hypothalamic	hypothalamic	ADJ
fnp-5116	133	26	/	/	SYM
fnp-5116	133	27	chiasmatic	chiasmatic	ADJ
fnp-5116	133	28	region	region	NOUN
fnp-5116	133	29	,	,	PUNCT
fnp-5116	133	30	6	6	NUM
fnp-5116	133	31	(	(	PUNCT
fnp-5116	133	32	2.9	2.9	NUM
fnp-5116	133	33	%	%	NOUN
fnp-5116	133	34	)	)	PUNCT
fnp-5116	133	35	were	be	AUX
fnp-5116	133	36	intraventricular	intraventricular	ADJ
fnp-5116	133	37	,	,	PUNCT
fnp-5116	133	38	and	and	CCONJ
fnp-5116	133	39	15	15	NUM
fnp-5116	133	40	(	(	PUNCT
fnp-5116	133	41	7.2	7.2	NUM
fnp-5116	133	42	%	%	NOUN
fnp-5116	133	43	)	)	PUNCT
fnp-5116	133	44	were	be	AUX
fnp-5116	133	45	involving	involve	VERB
fnp-5116	133	46	the	the	DET
fnp-5116	133	47	optic	optic	ADJ
fnp-5116	133	48	nerve	nerve	NOUN
fnp-5116	133	49	.	.	PUNCT
fnp-5116	134	1	while	while	SCONJ
fnp-5116	134	2	there	there	PRON
fnp-5116	134	3	was	be	VERB
fnp-5116	134	4	a	a	DET
fnp-5116	134	5	suggestion	suggestion	NOUN
fnp-5116	134	6	that	that	SCONJ
fnp-5116	134	7	posterior	posterior	ADJ
fnp-5116	134	8	fossa	fossa	ADJ
fnp-5116	134	9	tumors	tumor	NOUN
fnp-5116	134	10	were	be	AUX
fnp-5116	134	11	less	less	ADV
fnp-5116	134	12	likely	likely	ADJ
fnp-5116	134	13	to	to	PART
fnp-5116	134	14	recur	recur	VERB
fnp-5116	134	15	compared	compare	VERB
fnp-5116	134	16	with	with	ADP
fnp-5116	134	17	hypothalamic	hypothalamic	ADJ
fnp-5116	134	18	/	/	SYM
fnp-5116	134	19	chiasmatic	chiasmatic	ADJ
fnp-5116	134	20	tumors	tumor	NOUN
fnp-5116	134	21	,	,	PUNCT
fnp-5116	134	22	there	there	PRON
fnp-5116	134	23	was	be	VERB
fnp-5116	134	24	no	no	DET
fnp-5116	134	25	statistical	statistical	ADJ
fnp-5116	134	26	significance	significance	NOUN
fnp-5116	134	27	(	(	PUNCT
fnp-5116	134	28	p=0.043	p=0.043	NOUN
fnp-5116	134	29	)	)	PUNCT
fnp-5116	134	30	partly	partly	ADV
fnp-5116	134	31	due	due	ADJ
fnp-5116	134	32	to	to	ADP
fnp-5116	134	33	the	the	DET
fnp-5116	134	34	small	small	ADJ
fnp-5116	134	35	number	number	NOUN
fnp-5116	134	36	of	of	ADP
fnp-5116	134	37	cases	case	NOUN
fnp-5116	134	38	for	for	ADP
fnp-5116	134	39	each	each	DET
fnp-5116	134	40	location	location	NOUN
fnp-5116	134	41	category	category	NOUN
fnp-5116	134	42	when	when	SCONJ
fnp-5116	134	43	controlled	control	VERB
fnp-5116	134	44	for	for	ADP
fnp-5116	134	45	other	other	ADJ
fnp-5116	134	46	variables	variable	NOUN
fnp-5116	134	47	.	.	PUNCT
fnp-5116	135	1	even	even	ADV
fnp-5116	135	2	after	after	ADP
fnp-5116	135	3	regrouping	regroup	VERB
fnp-5116	135	4	cases	case	NOUN
fnp-5116	135	5	into	into	ADP
fnp-5116	135	6	“	"	PUNCT
fnp-5116	135	7	hypothalamo	hypothalamo	NOUN
fnp-5116	135	8	-	-	PUNCT
fnp-5116	135	9	suprachiasmatic+brainstem	suprachiasmatic+brainstem	NOUN
fnp-5116	135	10	"	"	PUNCT
fnp-5116	135	11	and	and	CCONJ
fnp-5116	135	12	"	"	PUNCT
fnp-5116	135	13	other	other	ADJ
fnp-5116	135	14	locations	location	NOUN
fnp-5116	135	15	"	"	PUNCT
fnp-5116	135	16	,	,	PUNCT
fnp-5116	135	17	we	we	PRON
fnp-5116	135	18	did	do	AUX
fnp-5116	135	19	not	not	PART
fnp-5116	135	20	find	find	VERB
fnp-5116	135	21	statistically	statistically	ADV
fnp-5116	135	22	significant	significant	ADJ
fnp-5116	135	23	correlation	correlation	NOUN
fnp-5116	135	24	with	with	ADP
fnp-5116	135	25	recurrence	recurrence	NOUN
fnp-5116	135	26	rates	rate	NOUN
fnp-5116	135	27	(	(	PUNCT
fnp-5116	135	28	p=0.004	p=0.004	NOUN
fnp-5116	135	29	)	)	PUNCT
fnp-5116	135	30	,	,	PUNCT
fnp-5116	135	31	or	or	CCONJ
fnp-5116	135	32	with	with	ADP
fnp-5116	135	33	rfs	rfs	PROPN
fnp-5116	135	34	.	.	PROPN
fnp-5116	135	35	location	location	NOUN
fnp-5116	135	36	was	be	AUX
fnp-5116	135	37	not	not	PART
fnp-5116	135	38	found	find	VERB
fnp-5116	135	39	to	to	PART
fnp-5116	135	40	be	be	AUX
fnp-5116	135	41	significant	significant	ADJ
fnp-5116	135	42	on	on	ADP
fnp-5116	135	43	multivariate	multivariate	NOUN
fnp-5116	135	44	analysis	analysis	NOUN
fnp-5116	135	45	,	,	PUNCT
fnp-5116	135	46	suggesting	suggest	VERB
fnp-5116	135	47	that	that	SCONJ
fnp-5116	135	48	it	it	PRON
fnp-5116	135	49	is	be	AUX
fnp-5116	135	50	a	a	DET
fnp-5116	135	51	dependent	dependent	ADJ
fnp-5116	135	52	variable	variable	NOUN
fnp-5116	135	53	.	.	PUNCT
fnp-5116	136	1	hypothalamic	hypothalamic	ADJ
fnp-5116	136	2	/	/	SYM
fnp-5116	136	3	midline	midline	NOUN
fnp-5116	136	4	tumors	tumor	NOUN
fnp-5116	136	5	are	be	AUX
fnp-5116	136	6	difficult	difficult	ADJ
fnp-5116	136	7	to	to	PART
fnp-5116	136	8	reach	reach	VERB
fnp-5116	136	9	and	and	CCONJ
fnp-5116	136	10	harder	hard	ADJ
fnp-5116	136	11	to	to	PART
fnp-5116	136	12	remove	remove	VERB
fnp-5116	136	13	completely	completely	ADV
fnp-5116	136	14	or	or	CCONJ
fnp-5116	136	15	there	there	PRON
fnp-5116	136	16	may	may	AUX
fnp-5116	136	17	be	be	AUX
fnp-5116	136	18	additional	additional	ADJ
fnp-5116	136	19	confounding	confound	VERB
fnp-5116	136	20	factors	factor	NOUN
fnp-5116	136	21	and	and	CCONJ
fnp-5116	136	22	our	our	PRON
fnp-5116	136	23	dataset	dataset	NOUN
fnp-5116	136	24	may	may	AUX
fnp-5116	136	25	not	not	PART
fnp-5116	136	26	be	be	AUX
fnp-5116	136	27	large	large	ADJ
fnp-5116	136	28	enough	enough	ADV
fnp-5116	136	29	to	to	PART
fnp-5116	136	30	tease	tease	VERB
fnp-5116	136	31	out	out	ADP
fnp-5116	136	32	these	these	DET
fnp-5116	136	33	specific	specific	ADJ
fnp-5116	136	34	factors	factor	NOUN
fnp-5116	136	35	,	,	PUNCT
fnp-5116	136	36	so	so	SCONJ
fnp-5116	136	37	that	that	SCONJ
fnp-5116	136	38	a	a	DET
fnp-5116	136	39	significance	significance	NOUN
fnp-5116	136	40	may	may	AUX
fnp-5116	136	41	be	be	AUX
fnp-5116	136	42	observed	observe	VERB
fnp-5116	136	43	in	in	ADP
fnp-5116	136	44	larger	large	ADJ
fnp-5116	136	45	studies	study	NOUN
fnp-5116	136	46	with	with	ADP
fnp-5116	136	47	longer	long	ADJ
fnp-5116	136	48	follow	follow	VERB
fnp-5116	136	49	-	-	PUNCT
fnp-5116	136	50	up	up	NOUN
fnp-5116	136	51	.	.	PUNCT
fnp-5116	137	1	there	there	PRON
fnp-5116	137	2	was	be	VERB
fnp-5116	137	3	no	no	DET
fnp-5116	137	4	statistically	statistically	ADV
fnp-5116	137	5	significant	significant	ADJ
fnp-5116	137	6	difference	difference	NOUN
fnp-5116	137	7	in	in	ADP
fnp-5116	137	8	rfs	rfs	PROPN
fnp-5116	137	9	between	between	ADP
fnp-5116	137	10	infratentorial	infratentorial	ADJ
fnp-5116	137	11	and	and	CCONJ
fnp-5116	137	12	supratentorial	supratentorial	ADJ
fnp-5116	137	13	tumors	tumor	NOUN
fnp-5116	137	14	,	,	PUNCT
fnp-5116	137	15	with	with	ADP
fnp-5116	137	16	supratentorial	supratentorial	ADJ
fnp-5116	137	17	tumors	tumor	NOUN
fnp-5116	137	18	having	have	VERB
fnp-5116	137	19	a	a	DET
fnp-5116	137	20	minimally	minimally	ADV
fnp-5116	137	21	higher	high	ADJ
fnp-5116	137	22	recurrence	recurrence	NOUN
fnp-5116	137	23	rate	rate	NOUN
fnp-5116	137	24	on	on	ADP
fnp-5116	137	25	univariate	univariate	ADJ
fnp-5116	137	26	analysis	analysis	NOUN
fnp-5116	137	27	that	that	PRON
fnp-5116	137	28	disappeared	disappear	VERB
fnp-5116	137	29	on	on	ADP
fnp-5116	137	30	multivariate	multivariate	NOUN
fnp-5116	137	31	analysis	analysis	NOUN
fnp-5116	137	32	.	.	PUNCT
fnp-5116	138	1	histological	histological	ADJ
fnp-5116	138	2	and	and	CCONJ
fnp-5116	138	3	molecular	molecular	ADJ
fnp-5116	138	4	/	/	SYM
fnp-5116	138	5	genetic	genetic	ADJ
fnp-5116	138	6	features	feature	NOUN
fnp-5116	138	7	we	we	PRON
fnp-5116	138	8	identified	identify	VERB
fnp-5116	138	9	6	6	NUM
fnp-5116	138	10	patients	patient	NOUN
fnp-5116	138	11	with	with	ADP
fnp-5116	138	12	pma	pma	NOUN
fnp-5116	138	13	,	,	PUNCT
fnp-5116	138	14	and	and	CCONJ
fnp-5116	138	15	6	6	NUM
fnp-5116	138	16	other	other	ADJ
fnp-5116	138	17	cases	case	NOUN
fnp-5116	138	18	with	with	ADP
fnp-5116	138	19	histological	histological	ADJ
fnp-5116	138	20	evidence	evidence	NOUN
fnp-5116	138	21	of	of	ADP
fnp-5116	138	22	anaplasia	anaplasia	NOUN
fnp-5116	138	23	on	on	ADP
fnp-5116	138	24	pathological	pathological	ADJ
fnp-5116	138	25	evaluation	evaluation	NOUN
fnp-5116	138	26	.	.	PUNCT
fnp-5116	139	1	the	the	DET
fnp-5116	139	2	remaining	remain	VERB
fnp-5116	139	3	487	487	NUM
fnp-5116	139	4	demonstrated	demonstrate	VERB
fnp-5116	139	5	histological	histological	ADJ
fnp-5116	139	6	features	feature	NOUN
fnp-5116	139	7	diagnostic	diagnostic	ADJ
fnp-5116	139	8	of	of	ADP
fnp-5116	139	9	pa	pa	PROPN
fnp-5116	139	10	,	,	PUNCT
fnp-5116	139	11	occasionally	occasionally	ADV
fnp-5116	139	12	aided	aid	VERB
fnp-5116	139	13	by	by	ADP
fnp-5116	139	14	immunohistochemical	immunohistochemical	ADJ
fnp-5116	139	15	evaluation	evaluation	NOUN
fnp-5116	139	16	.	.	PUNCT
fnp-5116	140	1	it	it	PRON
fnp-5116	140	2	was	be	AUX
fnp-5116	140	3	not	not	PART
fnp-5116	140	4	possible	possible	ADJ
fnp-5116	140	5	to	to	PART
fnp-5116	140	6	make	make	VERB
fnp-5116	140	7	a	a	DET
fnp-5116	140	8	statistical	statistical	ADJ
fnp-5116	140	9	analysis	analysis	NOUN
fnp-5116	140	10	due	due	ADJ
fnp-5116	140	11	to	to	ADP
fnp-5116	140	12	limited	limited	ADJ
fnp-5116	140	13	numbers	number	NOUN
fnp-5116	140	14	of	of	ADP
fnp-5116	140	15	cases	case	NOUN
fnp-5116	140	16	with	with	ADP
fnp-5116	140	17	unusual	unusual	ADJ
fnp-5116	140	18	histological	histological	ADJ
fnp-5116	140	19	features	feature	NOUN
fnp-5116	140	20	.	.	PUNCT
fnp-5116	141	1	likewise	likewise	ADV
fnp-5116	141	2	,	,	PUNCT
fnp-5116	141	3	a	a	DET
fnp-5116	141	4	meaningful	meaningful	ADJ
fnp-5116	141	5	analysis	analysis	NOUN
fnp-5116	141	6	of	of	ADP
fnp-5116	141	7	rfs	rfs	PROPN
fnp-5116	141	8	for	for	ADP
fnp-5116	141	9	pma	pma	NOUN
fnp-5116	141	10	and	and	CCONJ
fnp-5116	141	11	tumors	tumor	NOUN
fnp-5116	141	12	with	with	ADP
fnp-5116	141	13	anaplastic	anaplastic	ADJ
fnp-5116	141	14	histology	histology	NOUN
fnp-5116	141	15	could	could	AUX
fnp-5116	141	16	not	not	PART
fnp-5116	141	17	be	be	AUX
fnp-5116	141	18	made	make	VERB
fnp-5116	141	19	.	.	PUNCT
fnp-5116	142	1	salient	salient	NOUN
fnp-5116	142	2	features	feature	NOUN
fnp-5116	142	3	of	of	ADP
fnp-5116	142	4	pmas	pma	NOUN
fnp-5116	142	5	and	and	CCONJ
fnp-5116	142	6	tumors	tumor	NOUN
fnp-5116	142	7	with	with	ADP
fnp-5116	142	8	anaplastic	anaplastic	ADJ
fnp-5116	142	9	histology	histology	NOUN
fnp-5116	142	10	are	be	AUX
fnp-5116	142	11	presented	present	VERB
fnp-5116	142	12	on	on	ADP
fnp-5116	142	13	tables	table	NOUN
fnp-5116	142	14	3	3	NUM
fnp-5116	142	15	and	and	CCONJ
fnp-5116	142	16	4	4	NUM
fnp-5116	142	17	,	,	PUNCT
fnp-5116	142	18	respectively	respectively	ADV
fnp-5116	142	19	.	.	PUNCT
fnp-5116	143	1	histological	histological	ADJ
fnp-5116	143	2	features	feature	NOUN
fnp-5116	143	3	were	be	AUX
fnp-5116	143	4	critical	critical	ADJ
fnp-5116	143	5	for	for	ADP
fnp-5116	143	6	the	the	DET
fnp-5116	143	7	recognition	recognition	NOUN
fnp-5116	143	8	of	of	ADP
fnp-5116	143	9	pa	pa	PROPN
fnp-5116	143	10	,	,	PUNCT
fnp-5116	143	11	but	but	CCONJ
fnp-5116	143	12	their	their	PRON
fnp-5116	143	13	analysis	analysis	NOUN
fnp-5116	143	14	did	do	AUX
fnp-5116	143	15	not	not	PART
fnp-5116	143	16	reveal	reveal	VERB
fnp-5116	143	17	statistically	statistically	ADV
fnp-5116	143	18	meaningful	meaningful	ADJ
fnp-5116	143	19	associations	association	NOUN
fnp-5116	143	20	(	(	PUNCT
fnp-5116	143	21	data	datum	NOUN
fnp-5116	143	22	not	not	PART
fnp-5116	143	23	shown	show	VERB
fnp-5116	143	24	)	)	PUNCT
fnp-5116	143	25	.	.	PUNCT
fnp-5116	144	1	table	table	NOUN
fnp-5116	145	1	3	3	NUM
fnp-5116	145	2	.	.	PUNCT
fnp-5116	146	1	clinical	clinical	ADJ
fnp-5116	146	2	and	and	CCONJ
fnp-5116	146	3	pathological	pathological	ADJ
fnp-5116	146	4	features	feature	NOUN
fnp-5116	146	5	of	of	ADP
fnp-5116	146	6	patients	patient	NOUN
fnp-5116	146	7	with	with	ADP
fnp-5116	146	8	tumors	tumor	NOUN
fnp-5116	146	9	showing	show	VERB
fnp-5116	146	10	anaplastic	anaplastic	ADJ
fnp-5116	146	11	histology	histology	NOUN
fnp-5116	146	12	  	  	SPACE
fnp-5116	146	13	age	age	NOUN
fnp-5116	146	14	/	/	SYM
fnp-5116	146	15	sex	sex	NOUN
fnp-5116	146	16	localization	localization	NOUN
fnp-5116	146	17	surgery	surgery	NOUN
fnp-5116	146	18	type	type	NOUN
fnp-5116	146	19	diagnosis	diagnosis	NOUN
fnp-5116	146	20	mutational	mutational	ADJ
fnp-5116	146	21	profile	profile	NOUN
fnp-5116	146	22	initial	initial	ADJ
fnp-5116	146	23	pathology/	pathology/	NUM
fnp-5116	146	24	history	history	NOUN
fnp-5116	147	1	chr	chr	PROPN
fnp-5116	147	2	loss	loss	PROPN
fnp-5116	147	3	chr	chr	PROPN
fnp-5116	147	4	gains	gain	VERB
fnp-5116	147	5	recurrence/	recurrence/	NUM
fnp-5116	147	6	time	time	NOUN
fnp-5116	147	7	to	to	ADP
fnp-5116	147	8	rec	rec	X
fnp-5116	147	9	(	(	PUNCT
fnp-5116	147	10	months	month	NOUN
fnp-5116	147	11	)	)	PUNCT
fnp-5116	147	12	case	case	NOUN
fnp-5116	147	13	#	#	NOUN
fnp-5116	147	14	226	226	NUM
fnp-5116	147	15	42	42	NUM
fnp-5116	147	16	/	/	SYM
fnp-5116	147	17	f	f	PROPN
fnp-5116	147	18	hemispheric	hemispheric	ADJ
fnp-5116	147	19	gross	gross	ADJ
fnp-5116	147	20	total	total	ADJ
fnp-5116	147	21	resection	resection	NOUN
fnp-5116	147	22	pilocytic	pilocytic	ADJ
fnp-5116	147	23	astrocytoma	astrocytoma	NOUN
fnp-5116	147	24	with	with	ADP
fnp-5116	147	25	anaplastic	anaplastic	ADJ
fnp-5116	147	26	features	feature	NOUN
fnp-5116	147	27	braf::kiaa1549	braf::kiaa1549	PROPN
fnp-5116	147	28	fusion	fusion	NOUN
fnp-5116	147	29	,	,	PUNCT
fnp-5116	147	30	cdkn2a	cdkn2a	PROPN
fnp-5116	147	31	loss	loss	NOUN
fnp-5116	147	32	,	,	PUNCT
fnp-5116	147	33	atrx	atrx	NOUN
fnp-5116	147	34	and	and	CCONJ
fnp-5116	147	35	nf1	nf1	NOUN
fnp-5116	147	36	mutations	mutation	NOUN
fnp-5116	147	37	history	history	NOUN
fnp-5116	147	38	of	of	ADP
fnp-5116	147	39	pa	pa	PROPN
fnp-5116	147	40	,	,	PUNCT
fnp-5116	147	41	grade	grade	NOUN
fnp-5116	147	42	1	1	NUM
fnp-5116	147	43	(	(	PUNCT
fnp-5116	147	44	12	12	NUM
fnp-5116	147	45	years	year	NOUN
fnp-5116	147	46	ago	ago	ADV
fnp-5116	147	47	)	)	PUNCT
fnp-5116	147	48	2q	2q	NUM
fnp-5116	147	49	,	,	PUNCT
fnp-5116	147	50	8p	8p	NUM
fnp-5116	147	51	,	,	PUNCT
fnp-5116	147	52	9q	9q	NUM
fnp-5116	147	53	,	,	PUNCT
fnp-5116	147	54	10p	10p	NUM
fnp-5116	147	55	,	,	PUNCT
fnp-5116	147	56	11p	11p	NUM
fnp-5116	147	57	,	,	PUNCT
fnp-5116	147	58	14q	14q	X
fnp-5116	147	59	2p	2p	NOUN
fnp-5116	147	60	,	,	PUNCT
fnp-5116	147	61	3q	3q	NUM
fnp-5116	147	62	,	,	PUNCT
fnp-5116	147	63	7q	7q	NOUN
fnp-5116	147	64	yes	yes	INTJ
fnp-5116	147	65	/	/	SYM
fnp-5116	147	66	146	146	NUM
fnp-5116	147	67	case	case	NOUN
fnp-5116	147	68	#	#	NOUN
fnp-5116	147	69	384	384	NUM
fnp-5116	147	70	46	46	NUM
fnp-5116	147	71	/	/	SYM
fnp-5116	147	72	m	m	VERB
fnp-5116	147	73	posterior	posterior	ADJ
fnp-5116	147	74	fossa	fossa	ADJ
fnp-5116	147	75	subtotal	subtotal	ADJ
fnp-5116	147	76	resection	resection	NOUN
fnp-5116	147	77	pilocytic	pilocytic	ADJ
fnp-5116	147	78	astrocytoma	astrocytoma	NOUN
fnp-5116	147	79	with	with	ADP
fnp-5116	147	80	anaplastic	anaplastic	ADJ
fnp-5116	147	81	features	feature	NOUN
fnp-5116	147	82	fgfr1	fgfr1	PROPN
fnp-5116	147	83	,	,	PUNCT
fnp-5116	147	84	ptpn11	ptpn11	NOUN
fnp-5116	147	85	 	 	SPACE
fnp-5116	147	86	mutations	mutation	NOUN
fnp-5116	147	87	,	,	PUNCT
fnp-5116	147	88	cdkn2a	cdkn2a	PROPN
fnp-5116	147	89	/	/	SYM
fnp-5116	147	90	b	b	NOUN
fnp-5116	147	91	 	 	SPACE
fnp-5116	147	92	loss	loss	NOUN
fnp-5116	147	93	,	,	PUNCT
fnp-5116	147	94	atrx	atrx	NOUN
fnp-5116	147	95	 	 	SPACE
fnp-5116	147	96	mutation	mutation	NOUN
fnp-5116	147	97	,	,	PUNCT
fnp-5116	147	98	pik3r1	pik3r1	NOUN
fnp-5116	147	99	 	 	SPACE
fnp-5116	147	100	mutation	mutation	NOUN
fnp-5116	147	101	history	history	NOUN
fnp-5116	147	102	of	of	ADP
fnp-5116	147	103	a	a	DET
fnp-5116	147	104	posterior	posterior	ADJ
fnp-5116	147	105	fossa	fossa	ADJ
fnp-5116	147	106	tumor	tumor	NOUN
fnp-5116	147	107	at	at	ADP
fnp-5116	147	108	childhood	childhood	NOUN
fnp-5116	147	109	with	with	ADP
fnp-5116	147	110	unknown	unknown	ADJ
fnp-5116	147	111	histology	histology	NOUN
fnp-5116	147	112	2q	2q	NOUN
fnp-5116	147	113	,	,	PUNCT
fnp-5116	147	114	8p	8p	NUM
fnp-5116	147	115	,	,	PUNCT
fnp-5116	147	116	9p	9p	NUM
fnp-5116	147	117	,	,	PUNCT
fnp-5116	147	118	10q	10q	NOUN
fnp-5116	147	119	,	,	PUNCT
fnp-5116	147	120	13q	13q	NUM
fnp-5116	147	121	,	,	PUNCT
fnp-5116	147	122	22q	22q	NOUN
fnp-5116	147	123	8q	8q	VERB
fnp-5116	147	124	yes	yes	INTJ
fnp-5116	147	125	/	/	SYM
fnp-5116	147	126	6	6	NUM
fnp-5116	147	127	case	case	NOUN
fnp-5116	147	128	#	#	NOUN
fnp-5116	147	129	454	454	NUM
fnp-5116	147	130	35	35	NUM
fnp-5116	147	131	/	/	SYM
fnp-5116	147	132	f	f	PROPN
fnp-5116	147	133	posterior	posterior	ADJ
fnp-5116	147	134	fossa	fossa	ADJ
fnp-5116	147	135	subtotal	subtotal	ADJ
fnp-5116	147	136	resection	resection	NOUN
fnp-5116	147	137	pilocytic	pilocytic	ADJ
fnp-5116	147	138	astrocytoma	astrocytoma	NOUN
fnp-5116	147	139	with	with	ADP
fnp-5116	147	140	anaplastic	anaplastic	ADJ
fnp-5116	147	141	features	feature	NOUN
fnp-5116	147	142	nf1	nf1	NOUN
fnp-5116	147	143	and	and	CCONJ
fnp-5116	147	144	chek2	chek2	NOUN
fnp-5116	147	145	mutations	mutation	NOUN
fnp-5116	147	146	,	,	PUNCT
fnp-5116	147	147	cdkn2a	cdkn2a	PROPN
fnp-5116	147	148	/	/	SYM
fnp-5116	147	149	b	b	NOUN
fnp-5116	147	150	 	 	SPACE
fnp-5116	147	151	loss	loss	NOUN
fnp-5116	147	152	(	(	PUNCT
fnp-5116	147	153	in	in	ADP
fnp-5116	147	154	recurrent	recurrent	ADJ
fnp-5116	147	155	tumor	tumor	NOUN
fnp-5116	147	156	)	)	PUNCT
fnp-5116	147	157	history	history	NOUN
fnp-5116	147	158	of	of	ADP
fnp-5116	147	159	pa	pa	PROPN
fnp-5116	147	160	,	,	PUNCT
fnp-5116	147	161	grade	grade	NOUN
fnp-5116	147	162	1	1	NUM
fnp-5116	147	163	(	(	PUNCT
fnp-5116	147	164	4	4	NUM
fnp-5116	147	165	years	year	NOUN
fnp-5116	147	166	ago	ago	ADV
fnp-5116	147	167	)	)	PUNCT
fnp-5116	147	168	1	1	NUM
fnp-5116	147	169	,	,	PUNCT
fnp-5116	147	170	4p	4p	NUM
fnp-5116	147	171	,	,	PUNCT
fnp-5116	147	172	5q	5q	NUM
fnp-5116	147	173	,	,	PUNCT
fnp-5116	147	174	9p	9p	NUM
fnp-5116	147	175	,	,	PUNCT
fnp-5116	147	176	10q	10q	NOUN
fnp-5116	147	177	,	,	PUNCT
fnp-5116	147	178	13q	13q	NUM
fnp-5116	147	179	,	,	PUNCT
fnp-5116	147	180	16p	16p	NOUN
fnp-5116	147	181	2p	2p	NUM
fnp-5116	147	182	,	,	PUNCT
fnp-5116	147	183	4p	4p	NUM
fnp-5116	147	184	,	,	PUNCT
fnp-5116	147	185	12q	12q	NOUN
fnp-5116	147	186	,	,	PUNCT
fnp-5116	147	187	22q	22q	NOUN
fnp-5116	147	188	yes	yes	INTJ
fnp-5116	147	189	/	/	SYM
fnp-5116	147	190	35	35	NUM
fnp-5116	147	191	case	case	NOUN
fnp-5116	147	192	#	#	NOUN
fnp-5116	147	193	362	362	NUM
fnp-5116	147	194	27	27	NUM
fnp-5116	147	195	/	/	SYM
fnp-5116	147	196	f	f	PROPN
fnp-5116	147	197	posterior	posterior	ADJ
fnp-5116	147	198	fossa	fossa	ADJ
fnp-5116	147	199	subtotal	subtotal	ADJ
fnp-5116	147	200	resection	resection	NOUN
fnp-5116	147	201	pilocytic	pilocytic	ADJ
fnp-5116	147	202	astrocytoma	astrocytoma	NOUN
fnp-5116	147	203	with	with	ADP
fnp-5116	147	204	anaplastic	anaplastic	ADJ
fnp-5116	147	205	features	feature	NOUN
fnp-5116	147	206	germline	germline	VERB
fnp-5116	147	207	nf1	nf1	NOUN
fnp-5116	147	208	 	 	SPACE
fnp-5116	147	209	mutation	mutation	NOUN
fnp-5116	147	210	,	,	PUNCT
fnp-5116	147	211	atrx	atrx	NOUN
fnp-5116	147	212	 	 	SPACE
fnp-5116	147	213	mutation	mutation	NOUN
fnp-5116	147	214	,	,	PUNCT
fnp-5116	147	215	cdkn2a	cdkn2a	PROPN
fnp-5116	147	216	/	/	SYM
fnp-5116	147	217	b	b	NOUN
fnp-5116	147	218	 	 	SPACE
fnp-5116	147	219	loss	loss	NOUN
fnp-5116	147	220	history	history	NOUN
fnp-5116	147	221	of	of	ADP
fnp-5116	147	222	pa	pa	PROPN
fnp-5116	147	223	,	,	PUNCT
fnp-5116	147	224	grade	grade	NOUN
fnp-5116	147	225	1	1	NUM
fnp-5116	147	226	(	(	PUNCT
fnp-5116	147	227	22	22	NUM
fnp-5116	147	228	years	year	NOUN
fnp-5116	147	229	ago	ago	ADV
fnp-5116	147	230	)	)	PUNCT
fnp-5116	147	231	none	none	NOUN
fnp-5116	147	232	none	none	NOUN
fnp-5116	147	233	lost	lose	VERB
fnp-5116	147	234	fu	fu	NOUN
fnp-5116	147	235	/	/	PUNCT
fnp-5116	147	236	no	no	DET
fnp-5116	147	237	 	 	SPACE
fnp-5116	147	238	information	information	NOUN
fnp-5116	147	239	case	case	NOUN
fnp-5116	147	240	#	#	NOUN
fnp-5116	147	241	488	488	NUM
fnp-5116	147	242	54	54	NUM
fnp-5116	147	243	/	/	SYM
fnp-5116	147	244	m	m	VERB
fnp-5116	147	245	posterior	posterior	ADJ
fnp-5116	147	246	fossa	fossa	ADJ
fnp-5116	147	247	subtotal	subtotal	ADJ
fnp-5116	147	248	resection	resection	NOUN
fnp-5116	147	249	pilocytic	pilocytic	ADJ
fnp-5116	147	250	astrocytoma	astrocytoma	NOUN
fnp-5116	147	251	with	with	ADP
fnp-5116	147	252	anaplastic	anaplastic	ADJ
fnp-5116	147	253	features	feature	NOUN
fnp-5116	147	254	cdk4	cdk4	VERB
fnp-5116	147	255	and	and	CCONJ
fnp-5116	147	256	gab2	gab2	NOUN
fnp-5116	147	257	amplification	amplification	NOUN
fnp-5116	147	258	,	,	PUNCT
fnp-5116	147	259	tp53	tp53	PROPN
fnp-5116	147	260	 	 	SPACE
fnp-5116	147	261	mutation	mutation	NOUN
fnp-5116	147	262	history	history	NOUN
fnp-5116	147	263	of	of	ADP
fnp-5116	147	264	a	a	DET
fnp-5116	147	265	posterior	posterior	ADJ
fnp-5116	147	266	fossa	fossa	ADJ
fnp-5116	147	267	tumor	tumor	NOUN
fnp-5116	147	268	with	with	ADP
fnp-5116	147	269	unknown	unknown	ADJ
fnp-5116	147	270	histology	histology	NOUN
fnp-5116	147	271	5q	5q	NOUN
fnp-5116	147	272	,	,	PUNCT
fnp-5116	147	273	10q	10q	NOUN
fnp-5116	147	274	,	,	PUNCT
fnp-5116	147	275	18p	18p	NOUN
fnp-5116	147	276	,	,	PUNCT
fnp-5116	147	277	20p	20p	NOUN
fnp-5116	147	278	4	4	NUM
fnp-5116	147	279	,	,	PUNCT
fnp-5116	147	280	8p	8p	NUM
fnp-5116	147	281	,	,	PUNCT
fnp-5116	147	282	8q	8q	NUM
fnp-5116	147	283	,	,	PUNCT
fnp-5116	147	284	9q	9q	NUM
fnp-5116	147	285	,	,	PUNCT
fnp-5116	147	286	12p	12p	NOUN
fnp-5116	147	287	,	,	PUNCT
fnp-5116	147	288	16	16	NUM
fnp-5116	147	289	,	,	PUNCT
fnp-5116	147	290	17q	17q	NUM
fnp-5116	147	291	,	,	PUNCT
fnp-5116	147	292	18q	18q	NOUN
fnp-5116	147	293	,	,	PUNCT
fnp-5116	147	294	21q	21q	NOUN
fnp-5116	147	295	lost	lose	VERB
fnp-5116	147	296	fu	fu	NOUN
fnp-5116	147	297	/	/	PUNCT
fnp-5116	147	298	no	no	DET
fnp-5116	147	299	 	 	SPACE
fnp-5116	147	300	information	information	NOUN
fnp-5116	147	301	case	case	NOUN
fnp-5116	147	302	#	#	NOUN
fnp-5116	147	303	347	347	NUM
fnp-5116	147	304	73	73	NUM
fnp-5116	147	305	/	/	SYM
fnp-5116	147	306	m	m	VERB
fnp-5116	147	307	hemispheric	hemispheric	ADJ
fnp-5116	147	308	subtotal	subtotal	ADJ
fnp-5116	147	309	resection	resection	NOUN
fnp-5116	147	310	pilocytic	pilocytic	ADJ
fnp-5116	147	311	astrocytoma	astrocytoma	NOUN
fnp-5116	147	312	with	with	ADP
fnp-5116	147	313	anaplastic	anaplastic	ADJ
fnp-5116	147	314	features	feature	NOUN
fnp-5116	147	315	n	n	CCONJ
fnp-5116	147	316	/	/	SYM
fnp-5116	147	317	a	a	DET
fnp-5116	147	318	concurrent	concurrent	ADJ
fnp-5116	147	319	pa	pa	PROPN
fnp-5116	147	320	morphology	morphology	NOUN
fnp-5116	147	321	.	.	PUNCT
fnp-5116	148	1	history	history	NOUN
fnp-5116	148	2	of	of	ADP
fnp-5116	148	3	unknown	unknown	ADJ
fnp-5116	148	4	brain	brain	NOUN
fnp-5116	148	5	tumor	tumor	NOUN
fnp-5116	148	6	.	.	PUNCT
fnp-5116	148	7	    	    	SPACE
fnp-5116	148	8	lost	lose	VERB
fnp-5116	148	9	fu	fu	NOUN
fnp-5116	148	10	/	/	PUNCT
fnp-5116	148	11	no	no	DET
fnp-5116	148	12	 	 	SPACE
fnp-5116	148	13	information	information	NOUN
fnp-5116	148	14	table	table	NOUN
fnp-5116	148	15	4	4	NUM
fnp-5116	148	16	.	.	PUNCT
fnp-5116	149	1	clinical	clinical	ADJ
fnp-5116	149	2	and	and	CCONJ
fnp-5116	149	3	pathological	pathological	ADJ
fnp-5116	149	4	features	feature	NOUN
fnp-5116	149	5	of	of	ADP
fnp-5116	149	6	patients	patient	NOUN
fnp-5116	149	7	with	with	ADP
fnp-5116	149	8	pilomyxoid	pilomyxoid	NOUN
fnp-5116	149	9	astrocytoma	astrocytoma	NOUN
fnp-5116	149	10	  	  	SPACE
fnp-5116	149	11	age	age	NOUN
fnp-5116	149	12	/	/	SYM
fnp-5116	149	13	sex	sex	NOUN
fnp-5116	149	14	localization	localization	NOUN
fnp-5116	149	15	surgery	surgery	NOUN
fnp-5116	149	16	type	type	NOUN
fnp-5116	149	17	mutational	mutational	ADJ
fnp-5116	149	18	profile	profile	NOUN
fnp-5116	149	19	chr	chr	PROPN
fnp-5116	149	20	loss	loss	PROPN
fnp-5116	149	21	chr	chr	PROPN
fnp-5116	149	22	gains	gain	VERB
fnp-5116	149	23	recurrence/	recurrence/	NUM
fnp-5116	149	24	time	time	NOUN
fnp-5116	149	25	to	to	ADP
fnp-5116	149	26	rec	rec	X
fnp-5116	149	27	(	(	PUNCT
fnp-5116	149	28	months	month	NOUN
fnp-5116	149	29	)	)	PUNCT
fnp-5116	149	30	case	case	NOUN
fnp-5116	149	31	#	#	NOUN
fnp-5116	149	32	237	237	NUM
fnp-5116	149	33	1.5	1.5	NUM
fnp-5116	149	34	/	/	SYM
fnp-5116	149	35	m	m	VERB
fnp-5116	149	36	hypothalamic	hypothalamic	ADJ
fnp-5116	149	37	-	-	PUNCT
fnp-5116	149	38	suprachiasmatic	suprachiasmatic	ADJ
fnp-5116	149	39	subtotal	subtotal	ADJ
fnp-5116	149	40	resection	resection	NOUN
fnp-5116	149	41	braf::kiaa1549	braf::kiaa1549	PROPN
fnp-5116	149	42	fusion	fusion	NOUN
fnp-5116	149	43	none	none	NOUN
fnp-5116	149	44	none	none	NOUN
fnp-5116	150	1	yes	yes	INTJ
fnp-5116	150	2	/	/	SYM
fnp-5116	150	3	77	77	NUM
fnp-5116	150	4	case	case	NOUN
fnp-5116	150	5	#	#	NOUN
fnp-5116	150	6	315	315	NUM
fnp-5116	150	7	<	<	SYM
fnp-5116	150	8	1	1	NUM
fnp-5116	150	9	/	/	SYM
fnp-5116	150	10	f	f	PROPN
fnp-5116	150	11	hypothalamic	hypothalamic	ADJ
fnp-5116	150	12	-	-	PUNCT
fnp-5116	150	13	suprachiasmatic	suprachiasmatic	ADJ
fnp-5116	150	14	no	no	DET
fnp-5116	150	15	information	information	NOUN
fnp-5116	150	16	braf::kiaa1549	braf::kiaa1549	NOUN
fnp-5116	150	17	fusion	fusion	NOUN
fnp-5116	150	18	none	none	NOUN
fnp-5116	150	19	none	none	NOUN
fnp-5116	150	20	no	no	DET
fnp-5116	150	21	case	case	NOUN
fnp-5116	150	22	#	#	NOUN
fnp-5116	150	23	345	345	NUM
fnp-5116	150	24	6	6	NUM
fnp-5116	150	25	/	/	SYM
fnp-5116	150	26	f	f	PROPN
fnp-5116	150	27	hypothalamic	hypothalamic	ADJ
fnp-5116	150	28	-	-	PUNCT
fnp-5116	150	29	suprachiasmatic	suprachiasmatic	ADJ
fnp-5116	150	30	subtotal	subtotal	ADJ
fnp-5116	150	31	resection	resection	NOUN
fnp-5116	150	32	kras	kras	PROPN
fnp-5116	150	33	p.q61l	p.q61l	PROPN
fnp-5116	150	34	none	none	NOUN
fnp-5116	150	35	none	none	NOUN
fnp-5116	150	36	lost	lose	VERB
fnp-5116	150	37	fu	fu	NOUN
fnp-5116	150	38	/	/	PUNCT
fnp-5116	150	39	no	no	DET
fnp-5116	150	40	information	information	NOUN
fnp-5116	150	41	case	case	NOUN
fnp-5116	150	42	#	#	NOUN
fnp-5116	150	43	366	366	NUM
fnp-5116	150	44	9.1	9.1	NUM
fnp-5116	150	45	/	/	SYM
fnp-5116	150	46	f	f	PROPN
fnp-5116	150	47	posterior	posterior	ADJ
fnp-5116	150	48	fossa	fossa	ADJ
fnp-5116	150	49	gross	gross	ADJ
fnp-5116	150	50	total	total	ADJ
fnp-5116	150	51	resection	resection	NOUN
fnp-5116	150	52	braf::kiaa1549	braf::kiaa1549	PROPN
fnp-5116	150	53	fusion	fusion	NOUN
fnp-5116	150	54	none	none	NOUN
fnp-5116	150	55	11	11	NUM
fnp-5116	150	56	lost	lose	VERB
fnp-5116	150	57	fu	fu	NOUN
fnp-5116	150	58	/	/	PUNCT
fnp-5116	150	59	no	no	DET
fnp-5116	150	60	information	information	NOUN
fnp-5116	150	61	case	case	NOUN
fnp-5116	150	62	#	#	NOUN
fnp-5116	150	63	379	379	NUM
fnp-5116	150	64	8.3	8.3	NUM
fnp-5116	150	65	/	/	SYM
fnp-5116	150	66	f	f	PROPN
fnp-5116	150	67	multifocal	multifocal	ADJ
fnp-5116	150	68	subtotal	subtotal	ADJ
fnp-5116	150	69	resection	resection	NOUN
fnp-5116	150	70	braf	braf	NOUN
fnp-5116	151	1	p.599dup	p.599dup	VERB
fnp-5116	151	2	none	none	NOUN
fnp-5116	151	3	5	5	NUM
fnp-5116	151	4	,	,	PUNCT
fnp-5116	151	5	6	6	NUM
fnp-5116	151	6	,	,	PUNCT
fnp-5116	151	7	7	7	NUM
fnp-5116	151	8	,	,	PUNCT
fnp-5116	151	9	8	8	NUM
fnp-5116	151	10	,	,	PUNCT
fnp-5116	151	11	11	11	NUM
fnp-5116	151	12	,	,	PUNCT
fnp-5116	151	13	12	12	NUM
fnp-5116	151	14	,	,	PUNCT
fnp-5116	151	15	14	14	NUM
fnp-5116	151	16	,	,	PUNCT
fnp-5116	151	17	16	16	NUM
fnp-5116	151	18	,	,	PUNCT
fnp-5116	151	19	18	18	NUM
fnp-5116	151	20	,	,	PUNCT
fnp-5116	151	21	20	20	NUM
fnp-5116	151	22	yes	yes	NOUN
fnp-5116	151	23	/	/	SYM
fnp-5116	151	24	1	1	NUM
fnp-5116	151	25	case	case	NOUN
fnp-5116	151	26	#	#	NOUN
fnp-5116	151	27	382	382	NUM
fnp-5116	151	28	8.5	8.5	NUM
fnp-5116	151	29	/	/	SYM
fnp-5116	151	30	f	f	PROPN
fnp-5116	151	31	hypothalamic	hypothalamic	ADJ
fnp-5116	151	32	-	-	PUNCT
fnp-5116	151	33	suprachiasmatic	suprachiasmatic	ADJ
fnp-5116	151	34	subtotal	subtotal	ADJ
fnp-5116	151	35	resection	resection	NOUN
fnp-5116	151	36	fgfr1	fgfr1	NOUN
fnp-5116	151	37	and	and	CCONJ
fnp-5116	151	38	ptpn11	ptpn11	NOUN
fnp-5116	151	39	mutations	mutation	NOUN
fnp-5116	151	40	none	none	NOUN
fnp-5116	151	41	8	8	NUM
fnp-5116	151	42	,	,	PUNCT
fnp-5116	151	43	12	12	NUM
fnp-5116	151	44	no	no	INTJ
fnp-5116	151	45	because	because	SCONJ
fnp-5116	151	46	of	of	ADP
fnp-5116	151	47	the	the	DET
fnp-5116	151	48	retrospective	retrospective	ADJ
fnp-5116	151	49	nature	nature	NOUN
fnp-5116	151	50	of	of	ADP
fnp-5116	151	51	this	this	DET
fnp-5116	151	52	study	study	NOUN
fnp-5116	151	53	and	and	CCONJ
fnp-5116	151	54	due	due	ADP
fnp-5116	151	55	to	to	ADP
fnp-5116	151	56	the	the	DET
fnp-5116	151	57	long	long	ADJ
fnp-5116	151	58	period	period	NOUN
fnp-5116	151	59	of	of	ADP
fnp-5116	151	60	study	study	NOUN
fnp-5116	151	61	,	,	PUNCT
fnp-5116	151	62	the	the	DET
fnp-5116	151	63	type	type	NOUN
fnp-5116	151	64	of	of	ADP
fnp-5116	151	65	molecular	molecular	ADJ
fnp-5116	151	66	testing	testing	NOUN
fnp-5116	151	67	significantly	significantly	ADV
fnp-5116	151	68	varied	varied	ADJ
fnp-5116	151	69	within	within	ADP
fnp-5116	151	70	the	the	DET
fnp-5116	151	71	group	group	NOUN
fnp-5116	151	72	.	.	PUNCT
fnp-5116	152	1	tumors	tumor	NOUN
fnp-5116	152	2	from	from	ADP
fnp-5116	152	3	earlier	early	ADJ
fnp-5116	152	4	years	year	NOUN
fnp-5116	152	5	were	be	AUX
fnp-5116	152	6	tested	test	VERB
fnp-5116	152	7	either	either	ADV
fnp-5116	152	8	with	with	ADP
fnp-5116	152	9	sanger	sanger	PROPN
fnp-5116	152	10	sequencing	sequence	VERB
fnp-5116	152	11	for	for	ADP
fnp-5116	152	12	braf	braf	NOUN
fnp-5116	152	13	mutations	mutation	NOUN
fnp-5116	152	14	or	or	CCONJ
fnp-5116	152	15	with	with	ADP
fnp-5116	152	16	fish	fish	NOUN
fnp-5116	152	17	for	for	ADP
fnp-5116	152	18	braf	braf	NOUN
fnp-5116	152	19	duplication	duplication	NOUN
fnp-5116	152	20	(	(	PUNCT
fnp-5116	152	21	n=191	n=191	NOUN
fnp-5116	152	22	)	)	PUNCT
fnp-5116	152	23	.	.	PUNCT
fnp-5116	153	1	in	in	ADP
fnp-5116	153	2	addition	addition	NOUN
fnp-5116	153	3	,	,	PUNCT
fnp-5116	153	4	106	106	NUM
fnp-5116	153	5	more	more	ADJ
fnp-5116	153	6	recent	recent	ADJ
fnp-5116	153	7	cases	case	NOUN
fnp-5116	153	8	were	be	AUX
fnp-5116	153	9	analyzed	analyze	VERB
fnp-5116	153	10	with	with	ADP
fnp-5116	153	11	a	a	DET
fnp-5116	153	12	ucsf	ucsf	ADJ
fnp-5116	153	13	500	500	NUM
fnp-5116	153	14	ngs	ng	NOUN
fnp-5116	153	15	platform	platform	NOUN
fnp-5116	153	16	.	.	PUNCT
fnp-5116	154	1	twenty	twenty	NUM
fnp-5116	154	2	-	-	PUNCT
fnp-5116	154	3	four	four	NUM
fnp-5116	154	4	of	of	ADP
fnp-5116	154	5	the	the	DET
fnp-5116	154	6	cases	case	NOUN
fnp-5116	154	7	had	have	AUX
fnp-5116	154	8	confirmed	confirm	VERB
fnp-5116	154	9	germline	germline	NOUN
fnp-5116	154	10	nf1	nf1	NOUN
fnp-5116	154	11	mutation	mutation	NOUN
fnp-5116	154	12	(	(	PUNCT
fnp-5116	154	13	while	while	SCONJ
fnp-5116	154	14	nf1	nf1	NOUN
fnp-5116	154	15	mutations	mutation	NOUN
fnp-5116	154	16	were	be	AUX
fnp-5116	154	17	detected	detect	VERB
fnp-5116	154	18	in	in	ADP
fnp-5116	154	19	5	5	NUM
fnp-5116	154	20	additional	additional	ADJ
fnp-5116	154	21	tumors	tumor	NOUN
fnp-5116	154	22	,	,	PUNCT
fnp-5116	154	23	the	the	DET
fnp-5116	154	24	ucsf500	ucsf500	PROPN
fnp-5116	154	25	ngs	ng	NOUN
fnp-5116	154	26	platform	platform	NOUN
fnp-5116	154	27	was	be	AUX
fnp-5116	154	28	conducted	conduct	VERB
fnp-5116	154	29	solely	solely	ADV
fnp-5116	154	30	on	on	ADP
fnp-5116	154	31	tumor	tumor	NOUN
fnp-5116	154	32	tissue	tissue	NOUN
fnp-5116	154	33	in	in	ADP
fnp-5116	154	34	these	these	DET
fnp-5116	154	35	cases	case	NOUN
fnp-5116	154	36	,	,	PUNCT
fnp-5116	154	37	making	make	VERB
fnp-5116	154	38	it	it	PRON
fnp-5116	154	39	impossible	impossible	ADJ
fnp-5116	154	40	to	to	PART
fnp-5116	154	41	determine	determine	VERB
fnp-5116	154	42	whether	whether	SCONJ
fnp-5116	154	43	these	these	DET
fnp-5116	154	44	mutations	mutation	NOUN
fnp-5116	154	45	were	be	AUX
fnp-5116	154	46	germline	germline	NOUN
fnp-5116	154	47	or	or	CCONJ
fnp-5116	154	48	somatic	somatic	ADJ
fnp-5116	154	49	.	.	PUNCT
fnp-5116	154	50	)	)	PUNCT
fnp-5116	155	1	one	one	NUM
fnp-5116	155	2	of	of	ADP
fnp-5116	155	3	the	the	DET
fnp-5116	155	4	tumors	tumor	NOUN
fnp-5116	155	5	harbored	harbor	VERB
fnp-5116	155	6	both	both	CCONJ
fnp-5116	155	7	fgfr1	fgfr1	NOUN
fnp-5116	155	8	and	and	CCONJ
fnp-5116	155	9	nf1	nf1	NOUN
fnp-5116	155	10	mutations	mutation	NOUN
fnp-5116	155	11	.	.	PUNCT
fnp-5116	156	1	the	the	DET
fnp-5116	156	2	distribution	distribution	NOUN
fnp-5116	156	3	of	of	ADP
fnp-5116	156	4	mutations	mutation	NOUN
fnp-5116	156	5	is	be	AUX
fnp-5116	156	6	displayed	display	VERB
fnp-5116	156	7	in	in	ADP
fnp-5116	156	8	table	table	NOUN
fnp-5116	156	9	5	5	NUM
fnp-5116	156	10	.	.	PUNCT
fnp-5116	156	11	table	table	NOUN
fnp-5116	156	12	5	5	NUM
fnp-5116	156	13	.	.	PUNCT
fnp-5116	157	1	mutations	mutation	NOUN
fnp-5116	157	2	in	in	ADP
fnp-5116	157	3	199	199	NUM
fnp-5116	157	4	pilocytic	pilocytic	ADJ
fnp-5116	157	5	astrocytomas	astrocytomas	ADJ
fnp-5116	157	6	mutation	mutation	NOUN
fnp-5116	157	7	type	type	NOUN
fnp-5116	157	8	n	n	CCONJ
fnp-5116	157	9	(	(	PUNCT
fnp-5116	157	10	%	%	NOUN
fnp-5116	157	11	)	)	PUNCT
fnp-5116	157	12	braf	braf	NOUN
fnp-5116	157	13	fusion	fusion	NOUN
fnp-5116	157	14	/	/	SYM
fnp-5116	157	15	duplication	duplication	NOUN
fnp-5116	157	16	114	114	NUM
fnp-5116	157	17	(	(	PUNCT
fnp-5116	157	18	57.3	57.3	NUM
fnp-5116	157	19	%	%	NOUN
fnp-5116	157	20	)	)	PUNCT
fnp-5116	157	21	braf	braf	NOUN
fnp-5116	157	22	v600	v600	PROPN
fnp-5116	157	23	mutations	mutation	NOUN
fnp-5116	157	24	36	36	NUM
fnp-5116	157	25	(	(	PUNCT
fnp-5116	157	26	18.1	18.1	NUM
fnp-5116	157	27	%	%	NOUN
fnp-5116	157	28	)	)	PUNCT
fnp-5116	157	29	nf1	nf1	NOUN
fnp-5116	157	30	alterations	alteration	NOUN
fnp-5116	157	31	(	(	PUNCT
fnp-5116	157	32	germline	germline	NOUN
fnp-5116	157	33	+	+	CCONJ
fnp-5116	157	34	somatic	somatic	ADJ
fnp-5116	157	35	)	)	PUNCT
fnp-5116	157	36	29	29	NUM
fnp-5116	157	37	(	(	PUNCT
fnp-5116	157	38	14.6	14.6	NUM
fnp-5116	157	39	%	%	NOUN
fnp-5116	157	40	)	)	PUNCT
fnp-5116	158	1	fgfr1	fgfr1	NOUN
fnp-5116	158	2	alterations	alteration	NOUN
fnp-5116	158	3	8	8	NUM
fnp-5116	158	4	(	(	PUNCT
fnp-5116	158	5	4	4	NUM
fnp-5116	158	6	%	%	NOUN
fnp-5116	158	7	)	)	PUNCT
fnp-5116	158	8	raf1	raf1	ADJ
fnp-5116	158	9	alterations	alteration	NOUN
fnp-5116	158	10	3	3	NUM
fnp-5116	158	11	(	(	PUNCT
fnp-5116	158	12	1.5	1.5	NUM
fnp-5116	158	13	%	%	NOUN
fnp-5116	158	14	)	)	PUNCT
fnp-5116	158	15	kras	kras	PROPN
fnp-5116	158	16	alterations	alteration	NOUN
fnp-5116	158	17	2	2	NUM
fnp-5116	158	18	(	(	PUNCT
fnp-5116	158	19	1	1	NUM
fnp-5116	158	20	%	%	NOUN
fnp-5116	158	21	)	)	PUNCT
fnp-5116	158	22	sos1	sos1	PROPN
fnp-5116	158	23	mutation	mutation	NOUN
fnp-5116	158	24	1	1	NUM
fnp-5116	158	25	(	(	PUNCT
fnp-5116	158	26	%	%	NOUN
fnp-5116	158	27	0.5	0.5	NUM
fnp-5116	158	28	)	)	PUNCT
fnp-5116	158	29	cdk4	cdk4	NOUN
fnp-5116	158	30	&	&	CCONJ
fnp-5116	158	31	gab2	gab2	PROPN
fnp-5116	158	32	amplification	amplification	NOUN
fnp-5116	158	33	1	1	NUM
fnp-5116	158	34	(	(	PUNCT
fnp-5116	158	35	%	%	NOUN
fnp-5116	158	36	0.5	0.5	NUM
fnp-5116	158	37	)	)	PUNCT
fnp-5116	158	38	fgfr1	fgfr1	NOUN
fnp-5116	159	1	+	+	CCONJ
fnp-5116	159	2	nf1	nf1	NOUN
fnp-5116	159	3	alterations	alteration	NOUN
fnp-5116	159	4	1	1	NUM
fnp-5116	159	5	(	(	PUNCT
fnp-5116	159	6	%	%	NOUN
fnp-5116	159	7	0.5	0.5	NUM
fnp-5116	159	8	)	)	PUNCT
fnp-5116	159	9	no	no	DET
fnp-5116	159	10	alterations	alteration	NOUN
fnp-5116	159	11	identified	identify	VERB
fnp-5116	159	12	4	4	NUM
fnp-5116	159	13	(	(	PUNCT
fnp-5116	159	14	2	2	NUM
fnp-5116	159	15	%	%	NOUN
fnp-5116	159	16	)	)	PUNCT
fnp-5116	159	17	total	total	NOUN
fnp-5116	159	18	199	199	NUM
fnp-5116	159	19	(	(	PUNCT
fnp-5116	159	20	100	100	NUM
fnp-5116	159	21	%	%	NOUN
fnp-5116	159	22	)	)	PUNCT
fnp-5116	159	23	among	among	ADP
fnp-5116	159	24	199	199	NUM
fnp-5116	159	25	cases	case	NOUN
fnp-5116	159	26	that	that	PRON
fnp-5116	159	27	had	have	VERB
fnp-5116	159	28	molecular	molecular	ADJ
fnp-5116	159	29	analysis	analysis	NOUN
fnp-5116	159	30	performed	perform	VERB
fnp-5116	159	31	,	,	PUNCT
fnp-5116	159	32	the	the	DET
fnp-5116	159	33	majority	majority	NOUN
fnp-5116	159	34	(	(	PUNCT
fnp-5116	159	35	n=150	n=150	PROPN
fnp-5116	159	36	,	,	PUNCT
fnp-5116	159	37	75.4	75.4	NUM
fnp-5116	159	38	%	%	NOUN
fnp-5116	159	39	)	)	PUNCT
fnp-5116	159	40	had	have	VERB
fnp-5116	159	41	alterations	alteration	NOUN
fnp-5116	159	42	in	in	ADP
fnp-5116	159	43	braf	braf	NOUN
fnp-5116	159	44	gene	gene	NOUN
fnp-5116	159	45	(	(	PUNCT
fnp-5116	159	46	either	either	CCONJ
fnp-5116	159	47	p.v600	p.v600	NOUN
fnp-5116	159	48	mutations	mutation	NOUN
fnp-5116	159	49	,	,	PUNCT
fnp-5116	159	50	internal	internal	ADJ
fnp-5116	159	51	tandem	tandem	NOUN
fnp-5116	159	52	duplication	duplication	NOUN
fnp-5116	159	53	and	and	CCONJ
fnp-5116	159	54	or	or	CCONJ
fnp-5116	159	55	kiaa1549::braf	kiaa1549::braf	NOUN
fnp-5116	159	56	fusion	fusion	NOUN
fnp-5116	159	57	)	)	PUNCT
fnp-5116	159	58	;	;	PUNCT
fnp-5116	159	59	and	and	CCONJ
fnp-5116	159	60	the	the	DET
fnp-5116	159	61	majority	majority	NOUN
fnp-5116	159	62	of	of	ADP
fnp-5116	159	63	the	the	DET
fnp-5116	159	64	rest	rest	NOUN
fnp-5116	159	65	had	have	VERB
fnp-5116	159	66	alterations	alteration	NOUN
fnp-5116	159	67	in	in	ADP
fnp-5116	159	68	other	other	ADJ
fnp-5116	159	69	components	component	NOUN
fnp-5116	159	70	of	of	ADP
fnp-5116	159	71	mapk	mapk	NOUN
fnp-5116	159	72	pathway	pathway	NOUN
fnp-5116	159	73	.	.	PUNCT
fnp-5116	160	1	because	because	SCONJ
fnp-5116	160	2	of	of	ADP
fnp-5116	160	3	the	the	DET
fnp-5116	160	4	small	small	ADJ
fnp-5116	160	5	number	number	NOUN
fnp-5116	160	6	of	of	ADP
fnp-5116	160	7	tumors	tumor	NOUN
fnp-5116	160	8	in	in	ADP
fnp-5116	160	9	other	other	ADJ
fnp-5116	160	10	groups	group	NOUN
fnp-5116	160	11	,	,	PUNCT
fnp-5116	160	12	it	it	PRON
fnp-5116	160	13	was	be	AUX
fnp-5116	160	14	not	not	PART
fnp-5116	160	15	possible	possible	ADJ
fnp-5116	160	16	to	to	PART
fnp-5116	160	17	make	make	VERB
fnp-5116	160	18	a	a	DET
fnp-5116	160	19	statistical	statistical	ADJ
fnp-5116	160	20	analysis	analysis	NOUN
fnp-5116	160	21	between	between	ADP
fnp-5116	160	22	the	the	DET
fnp-5116	160	23	type	type	NOUN
fnp-5116	160	24	of	of	ADP
fnp-5116	160	25	mutation	mutation	NOUN
fnp-5116	160	26	and	and	CCONJ
fnp-5116	160	27	rfs	rf	NOUN
fnp-5116	160	28	.	.	PUNCT
fnp-5116	161	1	we	we	PRON
fnp-5116	161	2	analyzed	analyze	VERB
fnp-5116	161	3	whether	whether	SCONJ
fnp-5116	161	4	tumors	tumor	NOUN
fnp-5116	161	5	with	with	ADP
fnp-5116	161	6	distinct	distinct	ADJ
fnp-5116	161	7	genetic	genetic	ADJ
fnp-5116	161	8	alterations	alteration	NOUN
fnp-5116	161	9	cluster	cluster	NOUN
fnp-5116	161	10	in	in	ADP
fnp-5116	161	11	particular	particular	ADJ
fnp-5116	161	12	locations	location	NOUN
fnp-5116	161	13	.	.	PUNCT
fnp-5116	162	1	as	as	SCONJ
fnp-5116	162	2	anticipated	anticipate	VERB
fnp-5116	162	3	,	,	PUNCT
fnp-5116	162	4	braf	braf	NOUN
fnp-5116	162	5	alterations	alteration	NOUN
fnp-5116	162	6	were	be	AUX
fnp-5116	162	7	the	the	DET
fnp-5116	162	8	most	most	ADV
fnp-5116	162	9	frequent	frequent	ADJ
fnp-5116	162	10	type	type	NOUN
fnp-5116	162	11	of	of	ADP
fnp-5116	162	12	mutations	mutation	NOUN
fnp-5116	162	13	in	in	ADP
fnp-5116	162	14	all	all	DET
fnp-5116	162	15	locations	location	NOUN
fnp-5116	162	16	.	.	PUNCT
fnp-5116	163	1	however	however	ADV
fnp-5116	163	2	,	,	PUNCT
fnp-5116	163	3	braf	braf	NOUN
fnp-5116	163	4	alterations	alteration	NOUN
fnp-5116	163	5	were	be	AUX
fnp-5116	163	6	more	more	ADV
fnp-5116	163	7	frequent	frequent	ADJ
fnp-5116	163	8	in	in	ADP
fnp-5116	163	9	posterior	posterior	ADJ
fnp-5116	163	10	fossa	fossa	ADJ
fnp-5116	163	11	tumors	tumor	NOUN
fnp-5116	163	12	(	(	PUNCT
fnp-5116	163	13	81	81	NUM
fnp-5116	163	14	%	%	NOUN
fnp-5116	163	15	)	)	PUNCT
fnp-5116	163	16	in	in	ADP
fnp-5116	163	17	comparison	comparison	NOUN
fnp-5116	163	18	to	to	ADP
fnp-5116	163	19	supratentorial	supratentorial	ADJ
fnp-5116	163	20	tumors	tumor	NOUN
fnp-5116	163	21	(	(	PUNCT
fnp-5116	163	22	69.4	69.4	NUM
fnp-5116	163	23	%	%	NOUN
fnp-5116	163	24	;	;	PUNCT
fnp-5116	163	25	p<0.001	p<0.001	PROPN
fnp-5116	163	26	)	)	PUNCT
fnp-5116	163	27	.	.	PUNCT
fnp-5116	164	1	notably	notably	ADV
fnp-5116	164	2	,	,	PUNCT
fnp-5116	164	3	fgfr1	fgfr1	PROPN
fnp-5116	164	4	mutations	mutation	NOUN
fnp-5116	164	5	were	be	AUX
fnp-5116	164	6	primarily	primarily	ADV
fnp-5116	164	7	observed	observe	VERB
fnp-5116	164	8	in	in	ADP
fnp-5116	164	9	supratentorial	supratentorial	ADJ
fnp-5116	164	10	tumors	tumor	NOUN
fnp-5116	164	11	,	,	PUNCT
fnp-5116	164	12	with	with	ADP
fnp-5116	164	13	seven	seven	NUM
fnp-5116	164	14	out	out	ADP
fnp-5116	164	15	of	of	ADP
fnp-5116	164	16	eight	eight	NUM
fnp-5116	164	17	cases	case	NOUN
fnp-5116	164	18	located	locate	VERB
fnp-5116	164	19	in	in	ADP
fnp-5116	164	20	the	the	DET
fnp-5116	164	21	hemispheric	hemispheric	ADJ
fnp-5116	164	22	,	,	PUNCT
fnp-5116	164	23	hypothalamic	hypothalamic	ADJ
fnp-5116	164	24	-	-	PUNCT
fnp-5116	164	25	suprachiasmatic	suprachiasmatic	ADJ
fnp-5116	164	26	,	,	PUNCT
fnp-5116	164	27	or	or	CCONJ
fnp-5116	164	28	intraventricular	intraventricular	ADJ
fnp-5116	164	29	regions	region	NOUN
fnp-5116	164	30	.	.	PUNCT
fnp-5116	165	1	although	although	SCONJ
fnp-5116	165	2	the	the	DET
fnp-5116	165	3	number	number	NOUN
fnp-5116	165	4	of	of	ADP
fnp-5116	165	5	cases	case	NOUN
fnp-5116	165	6	was	be	AUX
fnp-5116	165	7	limited	limit	VERB
fnp-5116	165	8	,	,	PUNCT
fnp-5116	165	9	all	all	DET
fnp-5116	165	10	seven	seven	NUM
fnp-5116	165	11	cases	case	NOUN
fnp-5116	165	12	with	with	ADP
fnp-5116	165	13	mutations	mutation	NOUN
fnp-5116	165	14	in	in	ADP
fnp-5116	165	15	other	other	ADJ
fnp-5116	165	16	components	component	NOUN
fnp-5116	165	17	of	of	ADP
fnp-5116	165	18	the	the	DET
fnp-5116	165	19	mapk	mapk	NOUN
fnp-5116	165	20	pathway	pathway	NOUN
fnp-5116	165	21	(	(	PUNCT
fnp-5116	165	22	kras	kras	PROPN
fnp-5116	165	23	,	,	PUNCT
fnp-5116	165	24	raf1	raf1	PROPN
fnp-5116	165	25	,	,	PUNCT
fnp-5116	165	26	sos1	sos1	PROPN
fnp-5116	165	27	)	)	PUNCT
fnp-5116	165	28	were	be	AUX
fnp-5116	165	29	supratentorial	supratentorial	ADJ
fnp-5116	165	30	.	.	PUNCT
fnp-5116	166	1	table	table	NOUN
fnp-5116	166	2	6	6	NUM
fnp-5116	166	3	shows	show	VERB
fnp-5116	166	4	the	the	DET
fnp-5116	166	5	distribution	distribution	NOUN
fnp-5116	166	6	of	of	ADP
fnp-5116	166	7	mutations	mutation	NOUN
fnp-5116	166	8	across	across	ADP
fnp-5116	166	9	tumor	tumor	NOUN
fnp-5116	166	10	locations	location	NOUN
fnp-5116	166	11	.	.	PUNCT
fnp-5116	167	1	table	table	NOUN
fnp-5116	167	2	6	6	NUM
fnp-5116	167	3	.	.	PUNCT
fnp-5116	168	1	distribution	distribution	NOUN
fnp-5116	168	2	of	of	ADP
fnp-5116	168	3	specific	specific	ADJ
fnp-5116	168	4	mutations	mutation	NOUN
fnp-5116	168	5	across	across	ADP
fnp-5116	168	6	tumor	tumor	NOUN
fnp-5116	168	7	locations	location	NOUN
fnp-5116	168	8	mutation	mutation	NOUN
fnp-5116	168	9	type	type	NOUN
fnp-5116	168	10	tumor	tumor	NOUN
fnp-5116	168	11	location	location	NOUN
fnp-5116	168	12	  	  	SPACE
fnp-5116	168	13	supratentorial	supratentorial	ADJ
fnp-5116	168	14	infratentorial	infratentorial	ADJ
fnp-5116	168	15	spinal	spinal	ADJ
fnp-5116	168	16	total	total	ADJ
fnp-5116	168	17	braf	braf	NOUN
fnp-5116	168	18	alterations	alteration	NOUN
fnp-5116	168	19	59	59	NUM
fnp-5116	168	20	81	81	NUM
fnp-5116	168	21	9	9	NUM
fnp-5116	168	22	149	149	NUM
fnp-5116	168	23	fgfr1	fgfr1	NOUN
fnp-5116	168	24	alterations	alteration	NOUN
fnp-5116	168	25	7	7	NUM
fnp-5116	168	26	1	1	NUM
fnp-5116	168	27	0	0	NUM
fnp-5116	168	28	8	8	NUM
fnp-5116	168	29	nf1	nf1	NOUN
fnp-5116	168	30	alterations	alteration	NOUN
fnp-5116	168	31	(	(	PUNCT
fnp-5116	168	32	inc	inc	PROPN
fnp-5116	168	33	.	.	PROPN
fnp-5116	168	34	germline	germline	PROPN
fnp-5116	168	35	nf1	nf1	NOUN
fnp-5116	168	36	)	)	PUNCT
fnp-5116	168	37	10	10	NUM
fnp-5116	168	38	16	16	NUM
fnp-5116	168	39	3	3	NUM
fnp-5116	168	40	29	29	NUM
fnp-5116	168	41	other	other	ADJ
fnp-5116	168	42	mapk	mapk	NOUN
fnp-5116	168	43	alterations	alteration	NOUN
fnp-5116	168	44	7	7	NUM
fnp-5116	168	45	1	1	NUM
fnp-5116	168	46	0	0	NUM
fnp-5116	168	47	8	8	NUM
fnp-5116	168	48	no	no	DET
fnp-5116	168	49	abnormality	abnormality	NOUN
fnp-5116	168	50	found	find	VERB
fnp-5116	168	51	2	2	NUM
fnp-5116	168	52	1	1	NUM
fnp-5116	168	53	1	1	NUM
fnp-5116	168	54	4	4	NUM
fnp-5116	168	55	homozygous	homozygous	ADJ
fnp-5116	168	56	loss	loss	NOUN
fnp-5116	168	57	of	of	ADP
fnp-5116	168	58	cdkn2a	cdkn2a	PROPN
fnp-5116	168	59	has	have	AUX
fnp-5116	168	60	been	be	AUX
fnp-5116	168	61	reported	report	VERB
fnp-5116	168	62	as	as	ADP
fnp-5116	168	63	one	one	NUM
fnp-5116	168	64	of	of	ADP
fnp-5116	168	65	the	the	DET
fnp-5116	168	66	poor	poor	ADJ
fnp-5116	168	67	prognostic	prognostic	ADJ
fnp-5116	168	68	factors	factor	NOUN
fnp-5116	168	69	in	in	ADP
fnp-5116	168	70	the	the	DET
fnp-5116	168	71	literature	literature	NOUN
fnp-5116	168	72	[	[	X
fnp-5116	168	73	44	44	NUM
fnp-5116	168	74	]	]	PUNCT
fnp-5116	168	75	.	.	PUNCT
fnp-5116	169	1	among	among	ADP
fnp-5116	169	2	106	106	NUM
fnp-5116	169	3	patients	patient	NOUN
fnp-5116	169	4	where	where	SCONJ
fnp-5116	169	5	this	this	DET
fnp-5116	169	6	information	information	NOUN
fnp-5116	169	7	was	be	AUX
fnp-5116	169	8	available	available	ADJ
fnp-5116	169	9	,	,	PUNCT
fnp-5116	169	10	cdkn2a	cdkn2a	VERB
fnp-5116	169	11	homozygous	homozygous	ADJ
fnp-5116	169	12	loss	loss	NOUN
fnp-5116	169	13	occurred	occur	VERB
fnp-5116	169	14	in	in	ADP
fnp-5116	169	15	only	only	ADV
fnp-5116	169	16	4	4	NUM
fnp-5116	169	17	patients	patient	NOUN
fnp-5116	169	18	.	.	PUNCT
fnp-5116	170	1	histologically	histologically	ADV
fnp-5116	170	2	,	,	PUNCT
fnp-5116	170	3	all	all	DET
fnp-5116	170	4	four	four	NUM
fnp-5116	170	5	tumors	tumor	NOUN
fnp-5116	170	6	had	have	VERB
fnp-5116	170	7	anaplastic	anaplastic	ADJ
fnp-5116	170	8	histologic	histologic	ADJ
fnp-5116	170	9	features	feature	NOUN
fnp-5116	170	10	,	,	PUNCT
fnp-5116	170	11	typical	typical	ADJ
fnp-5116	170	12	mapk	mapk	NOUN
fnp-5116	170	13	driver	driver	NOUN
fnp-5116	170	14	mutations	mutation	NOUN
fnp-5116	170	15	(	(	PUNCT
fnp-5116	170	16	nf1	nf1	NOUN
fnp-5116	170	17	mutation	mutation	NOUN
fnp-5116	170	18	in	in	ADP
fnp-5116	170	19	two	two	NUM
fnp-5116	170	20	cases	case	NOUN
fnp-5116	170	21	;	;	PUNCT
fnp-5116	170	22	fgfr1	fgfr1	NOUN
fnp-5116	170	23	mutation	mutation	NOUN
fnp-5116	170	24	in	in	ADP
fnp-5116	170	25	,	,	PUNCT
fnp-5116	170	26	one	one	NUM
fnp-5116	170	27	case	case	NOUN
fnp-5116	170	28	;	;	PUNCT
fnp-5116	170	29	kiaa1549::braf	kiaa1549::braf	NOUN
fnp-5116	170	30	fusion	fusion	NOUN
fnp-5116	170	31	in	in	ADP
fnp-5116	170	32	one	one	NUM
fnp-5116	170	33	case	case	NOUN
fnp-5116	170	34	)	)	PUNCT
fnp-5116	170	35	,	,	PUNCT
fnp-5116	170	36	additional	additional	ADJ
fnp-5116	170	37	molecular	molecular	ADJ
fnp-5116	170	38	changes	change	NOUN
fnp-5116	170	39	(	(	PUNCT
fnp-5116	170	40	atrx	atrx	NOUN
fnp-5116	170	41	mutations	mutation	NOUN
fnp-5116	170	42	in	in	ADP
fnp-5116	170	43	three	three	NUM
fnp-5116	170	44	cases	case	NOUN
fnp-5116	170	45	)	)	PUNCT
fnp-5116	170	46	and	and	CCONJ
fnp-5116	170	47	multiple	multiple	ADJ
fnp-5116	170	48	chromosomal	chromosomal	ADJ
fnp-5116	170	49	gains	gain	NOUN
fnp-5116	170	50	and	and	CCONJ
fnp-5116	170	51	losses	loss	NOUN
fnp-5116	170	52	(	(	PUNCT
fnp-5116	170	53	see	see	VERB
fnp-5116	170	54	table	table	NOUN
fnp-5116	170	55	3	3	NUM
fnp-5116	170	56	)	)	PUNCT
fnp-5116	170	57	.	.	PUNCT
fnp-5116	171	1	all	all	DET
fnp-5116	171	2	four	four	NUM
fnp-5116	171	3	patients	patient	NOUN
fnp-5116	171	4	had	have	AUX
fnp-5116	171	5	suffered	suffer	VERB
fnp-5116	171	6	recurrences	recurrence	NOUN
fnp-5116	171	7	with	with	ADP
fnp-5116	171	8	a	a	DET
fnp-5116	171	9	median	median	ADJ
fnp-5116	171	10	time	time	NOUN
fnp-5116	171	11	to	to	PART
fnp-5116	171	12	recurrence	recurrence	NOUN
fnp-5116	171	13	of	of	ADP
fnp-5116	171	14	35.5	35.5	NUM
fnp-5116	171	15	months	month	NOUN
fnp-5116	171	16	(	(	PUNCT
fnp-5116	171	17	6	6	NUM
fnp-5116	171	18	,	,	PUNCT
fnp-5116	171	19	35	35	NUM
fnp-5116	171	20	,	,	PUNCT
fnp-5116	171	21	35	35	NUM
fnp-5116	171	22	,	,	PUNCT
fnp-5116	171	23	146	146	NUM
fnp-5116	171	24	months	month	NOUN
fnp-5116	171	25	)	)	PUNCT
fnp-5116	171	26	.	.	PUNCT
fnp-5116	172	1	in	in	ADP
fnp-5116	172	2	102	102	NUM
fnp-5116	172	3	tumors	tumor	NOUN
fnp-5116	172	4	without	without	ADP
fnp-5116	172	5	cdkn2a	cdkn2a	PROPN
fnp-5116	172	6	alterations	alteration	NOUN
fnp-5116	172	7	(	(	PUNCT
fnp-5116	172	8	102/106	102/106	NUM
fnp-5116	172	9	)	)	PUNCT
fnp-5116	172	10	,	,	PUNCT
fnp-5116	172	11	26	26	NUM
fnp-5116	172	12	of	of	ADP
fnp-5116	172	13	the	the	DET
fnp-5116	172	14	tumors	tumor	NOUN
fnp-5116	172	15	recurred	recur	VERB
fnp-5116	172	16	with	with	ADP
fnp-5116	172	17	a	a	DET
fnp-5116	172	18	median	median	ADJ
fnp-5116	172	19	rfs	rfs	NOUN
fnp-5116	172	20	of	of	ADP
fnp-5116	172	21	32	32	NUM
fnp-5116	172	22	months	month	NOUN
fnp-5116	172	23	(	(	PUNCT
fnp-5116	172	24	1	1	NUM
fnp-5116	172	25	269	269	NUM
fnp-5116	172	26	months	month	NOUN
fnp-5116	172	27	)	)	PUNCT
fnp-5116	172	28	.	.	PUNCT
fnp-5116	173	1	chromosomal	chromosomal	ADJ
fnp-5116	173	2	copy	copy	NOUN
fnp-5116	173	3	number	number	NOUN
fnp-5116	173	4	variation	variation	NOUN
fnp-5116	173	5	(	(	PUNCT
fnp-5116	173	6	cnv	cnv	NOUN
fnp-5116	173	7	)	)	PUNCT
fnp-5116	173	8	analysis	analysis	NOUN
fnp-5116	173	9	was	be	AUX
fnp-5116	173	10	done	do	VERB
fnp-5116	173	11	in	in	ADP
fnp-5116	173	12	106	106	NUM
fnp-5116	173	13	cases	case	NOUN
fnp-5116	173	14	and	and	CCONJ
fnp-5116	173	15	showed	show	VERB
fnp-5116	173	16	at	at	ADP
fnp-5116	173	17	least	least	ADV
fnp-5116	173	18	one	one	NUM
fnp-5116	173	19	cnv	cnv	NOUN
fnp-5116	173	20	in	in	ADP
fnp-5116	173	21	39	39	NUM
fnp-5116	173	22	tumors	tumor	NOUN
fnp-5116	173	23	(	(	PUNCT
fnp-5116	173	24	36.8	36.8	NUM
fnp-5116	173	25	%	%	NOUN
fnp-5116	173	26	)	)	PUNCT
fnp-5116	173	27	.	.	PUNCT
fnp-5116	174	1	nineteen	nineteen	NUM
fnp-5116	174	2	tumors	tumor	NOUN
fnp-5116	174	3	had	have	VERB
fnp-5116	174	4	whole	whole	ADJ
fnp-5116	174	5	chromosomal	chromosomal	ADJ
fnp-5116	174	6	gains	gain	NOUN
fnp-5116	174	7	only	only	ADV
fnp-5116	174	8	,	,	PUNCT
fnp-5116	174	9	while	while	SCONJ
fnp-5116	174	10	27	27	NUM
fnp-5116	174	11	tumors	tumor	NOUN
fnp-5116	174	12	had	have	VERB
fnp-5116	174	13	either	either	CCONJ
fnp-5116	174	14	gains	gain	NOUN
fnp-5116	174	15	or	or	CCONJ
fnp-5116	174	16	losses	loss	NOUN
fnp-5116	174	17	.	.	PUNCT
fnp-5116	175	1	in	in	ADP
fnp-5116	175	2	12	12	NUM
fnp-5116	175	3	tumors	tumor	NOUN
fnp-5116	175	4	,	,	PUNCT
fnp-5116	175	5	partial	partial	ADJ
fnp-5116	175	6	losses	loss	NOUN
fnp-5116	175	7	or	or	CCONJ
fnp-5116	175	8	gains	gain	NOUN
fnp-5116	175	9	were	be	AUX
fnp-5116	175	10	recorded	record	VERB
fnp-5116	175	11	.	.	PUNCT
fnp-5116	176	1	statistical	statistical	ADJ
fnp-5116	176	2	analysis	analysis	NOUN
fnp-5116	176	3	did	do	AUX
fnp-5116	176	4	not	not	PART
fnp-5116	176	5	show	show	VERB
fnp-5116	176	6	a	a	DET
fnp-5116	176	7	significant	significant	ADJ
fnp-5116	176	8	effect	effect	NOUN
fnp-5116	176	9	of	of	ADP
fnp-5116	176	10	the	the	DET
fnp-5116	176	11	presence	presence	NOUN
fnp-5116	176	12	of	of	ADP
fnp-5116	176	13	copy	copy	NOUN
fnp-5116	176	14	number	number	NOUN
fnp-5116	176	15	alteration	alteration	NOUN
fnp-5116	176	16	at	at	ADP
fnp-5116	176	17	any	any	DET
fnp-5116	176	18	degree	degree	NOUN
fnp-5116	176	19	on	on	ADP
fnp-5116	176	20	recurrence	recurrence	NOUN
fnp-5116	176	21	or	or	CCONJ
fnp-5116	176	22	rfs	rfs	X
fnp-5116	176	23	(	(	PUNCT
fnp-5116	176	24	p=0.816	p=0.816	PROPN
fnp-5116	176	25	,	,	PUNCT
fnp-5116	176	26	figure	figure	NOUN
fnp-5116	176	27	2	2	NUM
fnp-5116	176	28	)	)	PUNCT
fnp-5116	176	29	.	.	PUNCT
fnp-5116	177	1	there	there	PRON
fnp-5116	177	2	was	be	VERB
fnp-5116	177	3	no	no	DET
fnp-5116	177	4	association	association	NOUN
fnp-5116	177	5	between	between	ADP
fnp-5116	177	6	any	any	DET
fnp-5116	177	7	type	type	NOUN
fnp-5116	177	8	of	of	ADP
fnp-5116	177	9	genetic	genetic	ADJ
fnp-5116	177	10	alteration	alteration	NOUN
fnp-5116	177	11	(	(	PUNCT
fnp-5116	177	12	braf	braf	NOUN
fnp-5116	177	13	fusion	fusion	NOUN
fnp-5116	177	14	,	,	PUNCT
fnp-5116	177	15	fgfr1	fgfr1	PROPN
fnp-5116	177	16	alteration	alteration	NOUN
fnp-5116	177	17	,	,	PUNCT
fnp-5116	177	18	etc	etc	X
fnp-5116	177	19	.	.	X
fnp-5116	177	20	)	)	PUNCT
fnp-5116	177	21	with	with	ADP
fnp-5116	177	22	the	the	DET
fnp-5116	177	23	presence	presence	NOUN
fnp-5116	177	24	or	or	CCONJ
fnp-5116	177	25	extent	extent	NOUN
fnp-5116	177	26	of	of	ADP
fnp-5116	177	27	copy	copy	NOUN
fnp-5116	177	28	number	number	NOUN
fnp-5116	177	29	loss	loss	NOUN
fnp-5116	177	30	or	or	CCONJ
fnp-5116	177	31	gain	gain	NOUN
fnp-5116	177	32	.	.	PUNCT
fnp-5116	178	1	figure	figure	NOUN
fnp-5116	178	2	2	2	NUM
fnp-5116	178	3	.	.	PUNCT
fnp-5116	178	4	recurrence	recurrence	NOUN
fnp-5116	178	5	-	-	PUNCT
fnp-5116	178	6	free	free	ADJ
fnp-5116	178	7	survival	survival	NOUN
fnp-5116	178	8	in	in	ADP
fnp-5116	178	9	patients	patient	NOUN
fnp-5116	178	10	with	with	ADP
fnp-5116	178	11	pilocytic	pilocytic	ADJ
fnp-5116	178	12	astrocytoma	astrocytoma	NOUN
fnp-5116	178	13	,	,	PUNCT
fnp-5116	178	14	stratified	stratify	VERB
fnp-5116	178	15	by	by	ADP
fnp-5116	178	16	presence	presence	NOUN
fnp-5116	178	17	of	of	ADP
fnp-5116	178	18	copy	copy	NOUN
fnp-5116	178	19	number	number	NOUN
fnp-5116	178	20	variations	variation	NOUN
fnp-5116	178	21	(	(	PUNCT
fnp-5116	178	22	cnv	cnv	NOUN
fnp-5116	178	23	:	:	PUNCT
fnp-5116	178	24	copy	copy	NOUN
fnp-5116	178	25	number	number	NOUN
fnp-5116	178	26	variation	variation	NOUN
fnp-5116	178	27	)	)	PUNCT
fnp-5116	178	28	.	.	PUNCT
fnp-5116	179	1	we	we	PRON
fnp-5116	179	2	have	have	AUX
fnp-5116	179	3	also	also	ADV
fnp-5116	179	4	analyzed	analyze	VERB
fnp-5116	179	5	impact	impact	NOUN
fnp-5116	179	6	of	of	ADP
fnp-5116	179	7	chromosomal	chromosomal	ADJ
fnp-5116	179	8	losses	loss	NOUN
fnp-5116	179	9	and	and	CCONJ
fnp-5116	179	10	gains	gain	NOUN
fnp-5116	179	11	separately	separately	ADV
fnp-5116	179	12	.	.	PUNCT
fnp-5116	180	1	partial	partial	ADJ
fnp-5116	180	2	and/or	and/or	CCONJ
fnp-5116	180	3	whole	whole	ADJ
fnp-5116	180	4	chromosomal	chromosomal	ADJ
fnp-5116	180	5	loss	loss	NOUN
fnp-5116	180	6	was	be	AUX
fnp-5116	180	7	detected	detect	VERB
fnp-5116	180	8	in	in	ADP
fnp-5116	180	9	23	23	NUM
fnp-5116	180	10	patients	patient	NOUN
fnp-5116	180	11	;	;	PUNCT
fnp-5116	180	12	of	of	ADP
fnp-5116	180	13	which	which	PRON
fnp-5116	180	14	,	,	PUNCT
fnp-5116	180	15	8	8	NUM
fnp-5116	180	16	was	be	AUX
fnp-5116	180	17	whole	whole	ADJ
fnp-5116	180	18	chromosomal	chromosomal	ADJ
fnp-5116	180	19	loss	loss	NOUN
fnp-5116	180	20	.	.	PUNCT
fnp-5116	181	1	partial	partial	ADJ
fnp-5116	181	2	and/or	and/or	CCONJ
fnp-5116	181	3	whole	whole	ADJ
fnp-5116	181	4	chromosomal	chromosomal	ADJ
fnp-5116	181	5	gain	gain	NOUN
fnp-5116	181	6	was	be	AUX
fnp-5116	181	7	observed	observe	VERB
fnp-5116	181	8	in	in	ADP
fnp-5116	181	9	34	34	NUM
fnp-5116	181	10	patients	patient	NOUN
fnp-5116	181	11	;	;	PUNCT
fnp-5116	181	12	of	of	ADP
fnp-5116	181	13	which	which	PRON
fnp-5116	181	14	23	23	NUM
fnp-5116	181	15	was	be	AUX
fnp-5116	181	16	whole	whole	ADJ
fnp-5116	181	17	chromosomal	chromosomal	ADJ
fnp-5116	181	18	gains	gain	NOUN
fnp-5116	181	19	.	.	PUNCT
fnp-5116	182	1	cases	case	NOUN
fnp-5116	182	2	with	with	ADP
fnp-5116	182	3	any	any	DET
fnp-5116	182	4	degree	degree	NOUN
fnp-5116	182	5	of	of	ADP
fnp-5116	182	6	chromosomal	chromosomal	ADJ
fnp-5116	182	7	loss	loss	NOUN
fnp-5116	182	8	had	have	VERB
fnp-5116	182	9	a	a	DET
fnp-5116	182	10	median	median	ADJ
fnp-5116	182	11	rfs	rfs	NOUN
fnp-5116	182	12	of	of	ADP
fnp-5116	182	13	63	63	NUM
fnp-5116	182	14	months	month	NOUN
fnp-5116	182	15	whereas	whereas	SCONJ
fnp-5116	182	16	,	,	PUNCT
fnp-5116	182	17	it	it	PRON
fnp-5116	182	18	was	be	AUX
fnp-5116	182	19	54	54	NUM
fnp-5116	182	20	months	month	NOUN
fnp-5116	182	21	for	for	ADP
fnp-5116	182	22	cases	case	NOUN
fnp-5116	182	23	without	without	ADP
fnp-5116	182	24	any	any	DET
fnp-5116	182	25	chromosomal	chromosomal	ADJ
fnp-5116	182	26	losses	loss	NOUN
fnp-5116	182	27	.	.	PUNCT
fnp-5116	183	1	on	on	ADP
fnp-5116	183	2	the	the	DET
fnp-5116	183	3	other	other	ADJ
fnp-5116	183	4	hand	hand	NOUN
fnp-5116	183	5	,	,	PUNCT
fnp-5116	183	6	cases	case	NOUN
fnp-5116	183	7	with	with	ADP
fnp-5116	183	8	chromosomal	chromosomal	ADJ
fnp-5116	183	9	gain	gain	NOUN
fnp-5116	183	10	of	of	ADP
fnp-5116	183	11	any	any	DET
fnp-5116	183	12	size	size	NOUN
fnp-5116	183	13	had	have	VERB
fnp-5116	183	14	a	a	DET
fnp-5116	183	15	median	median	ADJ
fnp-5116	183	16	rfs	rfs	NOUN
fnp-5116	183	17	of	of	ADP
fnp-5116	183	18	63	63	NUM
fnp-5116	183	19	months	month	NOUN
fnp-5116	183	20	,	,	PUNCT
fnp-5116	183	21	whereas	whereas	SCONJ
fnp-5116	183	22	it	it	PRON
fnp-5116	183	23	was	be	AUX
fnp-5116	183	24	54	54	NUM
fnp-5116	183	25	months	month	NOUN
fnp-5116	183	26	for	for	ADP
fnp-5116	183	27	cases	case	NOUN
fnp-5116	183	28	without	without	ADP
fnp-5116	183	29	any	any	DET
fnp-5116	183	30	chromosomal	chromosomal	ADJ
fnp-5116	183	31	gains	gain	NOUN
fnp-5116	183	32	.	.	PUNCT
fnp-5116	184	1	no	no	DET
fnp-5116	184	2	significant	significant	ADJ
fnp-5116	184	3	influence	influence	NOUN
fnp-5116	184	4	of	of	ADP
fnp-5116	184	5	whole	whole	ADJ
fnp-5116	184	6	chromosomal	chromosomal	ADJ
fnp-5116	184	7	losses	loss	NOUN
fnp-5116	184	8	or	or	CCONJ
fnp-5116	184	9	gains	gain	NOUN
fnp-5116	184	10	was	be	AUX
fnp-5116	184	11	seen	see	VERB
fnp-5116	184	12	on	on	ADP
fnp-5116	184	13	recurrence	recurrence	NOUN
fnp-5116	184	14	,	,	PUNCT
fnp-5116	184	15	rfs	rfs	ADJ
fnp-5116	184	16	and	and	CCONJ
fnp-5116	184	17	underlying	underlying	ADJ
fnp-5116	184	18	molecular	molecular	ADJ
fnp-5116	184	19	features	feature	NOUN
fnp-5116	184	20	of	of	ADP
fnp-5116	184	21	the	the	DET
fnp-5116	184	22	tumor	tumor	NOUN
fnp-5116	184	23	as	as	ADV
fnp-5116	184	24	well	well	ADV
fnp-5116	184	25	.	.	PUNCT
fnp-5116	185	1	previous	previous	ADJ
fnp-5116	185	2	studies	study	NOUN
fnp-5116	185	3	proposed	propose	VERB
fnp-5116	185	4	whole	whole	ADJ
fnp-5116	185	5	chromosomal	chromosomal	ADJ
fnp-5116	185	6	gains	gain	NOUN
fnp-5116	185	7	as	as	ADP
fnp-5116	185	8	an	an	DET
fnp-5116	185	9	age	age	NOUN
fnp-5116	185	10	-	-	PUNCT
fnp-5116	185	11	associated	associate	VERB
fnp-5116	185	12	alteration	alteration	NOUN
fnp-5116	185	13	without	without	ADP
fnp-5116	185	14	an	an	DET
fnp-5116	185	15	impact	impact	NOUN
fnp-5116	185	16	on	on	ADP
fnp-5116	185	17	outcome	outcome	NOUN
fnp-5116	185	18	[	[	X
fnp-5116	185	19	45	45	NUM
fnp-5116	185	20	]	]	PUNCT
fnp-5116	185	21	.	.	PUNCT
fnp-5116	186	1	there	there	PRON
fnp-5116	186	2	were	be	VERB
fnp-5116	186	3	14	14	NUM
fnp-5116	186	4	cases	case	NOUN
fnp-5116	186	5	with	with	ADP
fnp-5116	186	6	whole	whole	ADJ
fnp-5116	186	7	chromosomal	chromosomal	ADJ
fnp-5116	186	8	gains	gain	NOUN
fnp-5116	186	9	with	with	ADP
fnp-5116	186	10	no	no	DET
fnp-5116	186	11	other	other	ADJ
fnp-5116	186	12	cnv	cnv	PROPN
fnp-5116	186	13	.	.	PUNCT
fnp-5116	187	1	thus	thus	ADV
fnp-5116	187	2	,	,	PUNCT
fnp-5116	187	3	we	we	PRON
fnp-5116	187	4	excluded	exclude	VERB
fnp-5116	187	5	these	these	DET
fnp-5116	187	6	cases	case	NOUN
fnp-5116	187	7	and	and	CCONJ
fnp-5116	187	8	conducted	conduct	VERB
fnp-5116	187	9	the	the	DET
fnp-5116	187	10	analysis	analysis	NOUN
fnp-5116	187	11	on	on	ADP
fnp-5116	187	12	the	the	DET
fnp-5116	187	13	remaining	remain	VERB
fnp-5116	187	14	25	25	NUM
fnp-5116	187	15	.	.	PUNCT
fnp-5116	188	1	the	the	DET
fnp-5116	188	2	results	result	NOUN
fnp-5116	188	3	showed	show	VERB
fnp-5116	188	4	no	no	DET
fnp-5116	188	5	statistically	statistically	ADV
fnp-5116	188	6	significant	significant	ADJ
fnp-5116	188	7	difference	difference	NOUN
fnp-5116	188	8	between	between	ADP
fnp-5116	188	9	cases	case	NOUN
fnp-5116	188	10	with	with	ADP
fnp-5116	188	11	or	or	CCONJ
fnp-5116	188	12	without	without	ADP
fnp-5116	188	13	cnv	cnv	PROPN
fnp-5116	188	14	(	(	PUNCT
fnp-5116	188	15	excluding	exclude	VERB
fnp-5116	188	16	whole	whole	ADJ
fnp-5116	188	17	chromosomal	chromosomal	ADJ
fnp-5116	188	18	gains	gain	NOUN
fnp-5116	188	19	)	)	PUNCT
fnp-5116	188	20	.	.	PUNCT
fnp-5116	189	1	impact	impact	NOUN
fnp-5116	189	2	of	of	ADP
fnp-5116	189	3	age	age	NOUN
fnp-5116	189	4	on	on	ADP
fnp-5116	189	5	recurrence	recurrence	NOUN
fnp-5116	189	6	-	-	PUNCT
fnp-5116	189	7	free	free	ADJ
fnp-5116	189	8	survival	survival	NOUN
fnp-5116	189	9	the	the	DET
fnp-5116	189	10	recurrence	recurrence	NOUN
fnp-5116	189	11	rates	rate	NOUN
fnp-5116	189	12	for	for	ADP
fnp-5116	189	13	patients	patient	NOUN
fnp-5116	189	14	younger	young	ADJ
fnp-5116	189	15	than	than	ADP
fnp-5116	189	16	14	14	NUM
fnp-5116	189	17	years	year	NOUN
fnp-5116	189	18	,	,	PUNCT
fnp-5116	189	19	between	between	ADP
fnp-5116	189	20	14	14	NUM
fnp-5116	189	21	and	and	CCONJ
fnp-5116	189	22	21	21	NUM
fnp-5116	189	23	years	year	NOUN
fnp-5116	189	24	,	,	PUNCT
fnp-5116	189	25	and	and	CCONJ
fnp-5116	189	26	21	21	NUM
fnp-5116	189	27	years	year	NOUN
fnp-5116	189	28	and	and	CCONJ
fnp-5116	189	29	over	over	ADV
fnp-5116	189	30	were	be	AUX
fnp-5116	189	31	40.9	40.9	NUM
fnp-5116	189	32	%	%	NOUN
fnp-5116	189	33	,	,	PUNCT
fnp-5116	189	34	34.6	34.6	NUM
fnp-5116	189	35	%	%	NOUN
fnp-5116	189	36	,	,	PUNCT
fnp-5116	189	37	and	and	CCONJ
fnp-5116	189	38	20.4	20.4	NUM
fnp-5116	189	39	%	%	NOUN
fnp-5116	189	40	,	,	PUNCT
fnp-5116	189	41	respectively	respectively	ADV
fnp-5116	189	42	.	.	PUNCT
fnp-5116	190	1	although	although	SCONJ
fnp-5116	190	2	the	the	DET
fnp-5116	190	3	recurrence	recurrence	NOUN
fnp-5116	190	4	rates	rate	NOUN
fnp-5116	190	5	are	be	AUX
fnp-5116	190	6	higher	high	ADJ
fnp-5116	190	7	in	in	ADP
fnp-5116	190	8	the	the	DET
fnp-5116	190	9	youngest	young	ADJ
fnp-5116	190	10	age	age	NOUN
fnp-5116	190	11	group	group	NOUN
fnp-5116	190	12	,	,	PUNCT
fnp-5116	190	13	this	this	DET
fnp-5116	190	14	difference	difference	NOUN
fnp-5116	190	15	was	be	AUX
fnp-5116	190	16	not	not	PART
fnp-5116	190	17	statistically	statistically	ADV
fnp-5116	190	18	significant	significant	ADJ
fnp-5116	190	19	.	.	PUNCT
fnp-5116	191	1	(	(	PUNCT
fnp-5116	191	2	p=0.003	p=0.003	NOUN
fnp-5116	191	3	)	)	PUNCT
fnp-5116	191	4	.	.	PUNCT
fnp-5116	192	1	among	among	ADP
fnp-5116	192	2	patients	patient	NOUN
fnp-5116	192	3	who	who	PRON
fnp-5116	192	4	underwent	undergo	VERB
fnp-5116	192	5	subtotal	subtotal	ADJ
fnp-5116	192	6	resection	resection	NOUN
fnp-5116	192	7	,	,	PUNCT
fnp-5116	192	8	patients	patient	NOUN
fnp-5116	192	9	older	old	ADJ
fnp-5116	192	10	than	than	ADP
fnp-5116	192	11	21	21	NUM
fnp-5116	192	12	years	year	NOUN
fnp-5116	192	13	at	at	ADP
fnp-5116	192	14	diagnosis	diagnosis	NOUN
fnp-5116	192	15	showed	show	VERB
fnp-5116	192	16	higher	high	ADJ
fnp-5116	192	17	recurrence	recurrence	NOUN
fnp-5116	192	18	rates	rate	NOUN
fnp-5116	192	19	(	(	PUNCT
fnp-5116	192	20	p<0.001	p<0.001	PROPN
fnp-5116	192	21	)	)	PUNCT
fnp-5116	192	22	,	,	PUNCT
fnp-5116	192	23	while	while	SCONJ
fnp-5116	192	24	there	there	PRON
fnp-5116	192	25	was	be	VERB
fnp-5116	192	26	no	no	DET
fnp-5116	192	27	difference	difference	NOUN
fnp-5116	192	28	between	between	ADP
fnp-5116	192	29	age	age	NOUN
fnp-5116	192	30	groups	group	NOUN
fnp-5116	192	31	among	among	ADP
fnp-5116	192	32	patients	patient	NOUN
fnp-5116	192	33	who	who	PRON
fnp-5116	192	34	underwent	undergo	VERB
fnp-5116	192	35	gtr	gtr	NOUN
fnp-5116	192	36	.	.	PUNCT
fnp-5116	193	1	we	we	PRON
fnp-5116	193	2	further	far	ADV
fnp-5116	193	3	investigated	investigate	VERB
fnp-5116	193	4	the	the	DET
fnp-5116	193	5	confounding	confound	VERB
fnp-5116	193	6	factors	factor	NOUN
fnp-5116	193	7	on	on	ADP
fnp-5116	193	8	the	the	DET
fnp-5116	193	9	difference	difference	NOUN
fnp-5116	193	10	in	in	ADP
fnp-5116	193	11	str	str	NOUN
fnp-5116	193	12	group	group	NOUN
fnp-5116	193	13	and	and	CCONJ
fnp-5116	193	14	included	include	VERB
fnp-5116	193	15	tumor	tumor	NOUN
fnp-5116	193	16	location	location	NOUN
fnp-5116	193	17	;	;	PUNCT
fnp-5116	193	18	even	even	ADV
fnp-5116	193	19	after	after	ADP
fnp-5116	193	20	including	include	VERB
fnp-5116	193	21	tumor	tumor	NOUN
fnp-5116	193	22	location	location	NOUN
fnp-5116	193	23	as	as	ADP
fnp-5116	193	24	a	a	DET
fnp-5116	193	25	variable	variable	NOUN
fnp-5116	193	26	,	,	PUNCT
fnp-5116	193	27	patients	patient	NOUN
fnp-5116	193	28	>	>	X
fnp-5116	193	29	21	21	NUM
fnp-5116	193	30	years	year	NOUN
fnp-5116	193	31	of	of	ADP
fnp-5116	193	32	age	age	NOUN
fnp-5116	193	33	showed	show	VERB
fnp-5116	193	34	a	a	DET
fnp-5116	193	35	significantly	significantly	ADV
fnp-5116	193	36	higher	high	ADJ
fnp-5116	193	37	recurrence	recurrence	NOUN
fnp-5116	193	38	rate	rate	NOUN
fnp-5116	193	39	(	(	PUNCT
fnp-5116	193	40	p<0.001	p<0.001	PROPN
fnp-5116	193	41	)	)	PUNCT
fnp-5116	193	42	.	.	PUNCT
fnp-5116	194	1	impact	impact	NOUN
fnp-5116	194	2	of	of	ADP
fnp-5116	194	3	extent	extent	NOUN
fnp-5116	194	4	of	of	ADP
fnp-5116	194	5	resection	resection	NOUN
fnp-5116	194	6	on	on	ADP
fnp-5116	194	7	recurrence	recurrence	NOUN
fnp-5116	194	8	-	-	PUNCT
fnp-5116	194	9	free	free	ADJ
fnp-5116	194	10	survival	survival	NOUN
fnp-5116	194	11	one	one	NUM
fnp-5116	194	12	-	-	PUNCT
fnp-5116	194	13	hundred	hundred	NUM
fnp-5116	194	14	-	-	PUNCT
fnp-5116	194	15	sixty	sixty	NUM
fnp-5116	194	16	-	-	PUNCT
fnp-5116	194	17	nine	nine	NUM
fnp-5116	194	18	(	(	PUNCT
fnp-5116	194	19	33.9	33.9	NUM
fnp-5116	194	20	%	%	NOUN
fnp-5116	194	21	)	)	PUNCT
fnp-5116	194	22	patients	patient	NOUN
fnp-5116	194	23	underwent	undergo	VERB
fnp-5116	194	24	gtr	gtr	NOUN
fnp-5116	194	25	and	and	CCONJ
fnp-5116	194	26	235	235	NUM
fnp-5116	194	27	(	(	PUNCT
fnp-5116	194	28	47.1	47.1	NUM
fnp-5116	194	29	%	%	NOUN
fnp-5116	194	30	)	)	PUNCT
fnp-5116	194	31	had	have	VERB
fnp-5116	194	32	str	str	NOUN
fnp-5116	194	33	.	.	PUNCT
fnp-5116	195	1	the	the	DET
fnp-5116	195	2	data	datum	NOUN
fnp-5116	195	3	on	on	ADP
fnp-5116	195	4	the	the	DET
fnp-5116	195	5	extent	extent	NOUN
fnp-5116	195	6	of	of	ADP
fnp-5116	195	7	surgery	surgery	NOUN
fnp-5116	195	8	was	be	AUX
fnp-5116	195	9	missing	miss	VERB
fnp-5116	195	10	in	in	ADP
fnp-5116	195	11	95	95	NUM
fnp-5116	195	12	(	(	PUNCT
fnp-5116	195	13	19.0	19.0	NUM
fnp-5116	195	14	%	%	NOUN
fnp-5116	195	15	)	)	PUNCT
fnp-5116	195	16	cases	case	NOUN
fnp-5116	195	17	.	.	PUNCT
fnp-5116	196	1	recurrence	recurrence	NOUN
fnp-5116	196	2	rates	rate	NOUN
fnp-5116	196	3	were	be	AUX
fnp-5116	196	4	8.5	8.5	NUM
fnp-5116	196	5	%	%	NOUN
fnp-5116	196	6	and	and	CCONJ
fnp-5116	196	7	20	20	NUM
fnp-5116	196	8	%	%	NOUN
fnp-5116	196	9	for	for	ADP
fnp-5116	196	10	patients	patient	NOUN
fnp-5116	196	11	who	who	PRON
fnp-5116	196	12	underwent	undergo	VERB
fnp-5116	196	13	gtr	gtr	NOUN
fnp-5116	196	14	and	and	CCONJ
fnp-5116	196	15	str	str	NOUN
fnp-5116	196	16	,	,	PUNCT
fnp-5116	196	17	respectively	respectively	ADV
fnp-5116	196	18	.	.	PUNCT
fnp-5116	197	1	the	the	DET
fnp-5116	197	2	mean	mean	ADJ
fnp-5116	197	3	rfs	rfs	PROPN
fnp-5116	197	4	was	be	AUX
fnp-5116	197	5	321	321	NUM
fnp-5116	197	6	months	month	NOUN
fnp-5116	197	7	for	for	ADP
fnp-5116	197	8	patients	patient	NOUN
fnp-5116	197	9	who	who	PRON
fnp-5116	197	10	underwent	undergo	VERB
fnp-5116	197	11	gtr	gtr	NOUN
fnp-5116	197	12	(	(	PUNCT
fnp-5116	197	13	ci	ci	NOUN
fnp-5116	197	14	:	:	PUNCT
fnp-5116	197	15	292.3	292.3	NUM
fnp-5116	197	16	–	–	PUNCT
fnp-5116	197	17	350.1	350.1	NUM
fnp-5116	197	18	)	)	PUNCT
fnp-5116	197	19	,	,	PUNCT
fnp-5116	197	20	and	and	CCONJ
fnp-5116	197	21	160.9	160.9	NUM
fnp-5116	197	22	months	month	NOUN
fnp-5116	197	23	(	(	PUNCT
fnp-5116	197	24	ci:124.5	ci:124.5	NUM
fnp-5116	197	25	–	–	PUNCT
fnp-5116	197	26	197.4	197.4	NUM
fnp-5116	197	27	)	)	PUNCT
fnp-5116	197	28	for	for	ADP
fnp-5116	197	29	patients	patient	NOUN
fnp-5116	197	30	who	who	PRON
fnp-5116	197	31	underwent	undergo	VERB
fnp-5116	197	32	str	str	NOUN
fnp-5116	197	33	.	.	PUNCT
fnp-5116	198	1	the	the	DET
fnp-5116	198	2	patients	patient	NOUN
fnp-5116	198	3	with	with	ADP
fnp-5116	198	4	gtr	gtr	NOUN
fnp-5116	198	5	have	have	VERB
fnp-5116	198	6	a	a	DET
fnp-5116	198	7	significantly	significantly	ADV
fnp-5116	198	8	longer	long	ADJ
fnp-5116	198	9	recurrence	recurrence	NOUN
fnp-5116	198	10	-	-	PUNCT
fnp-5116	198	11	free	free	ADJ
fnp-5116	198	12	survival	survival	NOUN
fnp-5116	198	13	(	(	PUNCT
fnp-5116	198	14	rfs	rfs	PROPN
fnp-5116	198	15	)	)	PUNCT
fnp-5116	198	16	compared	compare	VERB
fnp-5116	198	17	to	to	ADP
fnp-5116	198	18	those	those	PRON
fnp-5116	198	19	with	with	ADP
fnp-5116	198	20	str	str	NOUN
fnp-5116	198	21	(	(	PUNCT
fnp-5116	198	22	log	log	PROPN
fnp-5116	198	23	rank	rank	NOUN
fnp-5116	198	24	p	p	NOUN
fnp-5116	198	25	<	<	NOUN
fnp-5116	198	26	0.001	0.001	NUM
fnp-5116	198	27	,	,	PUNCT
fnp-5116	198	28	figure	figure	NOUN
fnp-5116	198	29	3	3	NUM
fnp-5116	198	30	)	)	PUNCT
fnp-5116	198	31	.	.	PUNCT
fnp-5116	199	1	the	the	DET
fnp-5116	199	2	median	median	ADJ
fnp-5116	199	3	survival	survival	NOUN
fnp-5116	199	4	probability	probability	NOUN
fnp-5116	199	5	for	for	ADP
fnp-5116	199	6	overall	overall	ADJ
fnp-5116	199	7	survival	survival	NOUN
fnp-5116	199	8	could	could	AUX
fnp-5116	199	9	not	not	PART
fnp-5116	199	10	be	be	AUX
fnp-5116	199	11	calculated	calculate	VERB
fnp-5116	199	12	due	due	ADJ
fnp-5116	199	13	to	to	ADP
fnp-5116	199	14	absence	absence	NOUN
fnp-5116	199	15	of	of	ADP
fnp-5116	199	16	effect	effect	NOUN
fnp-5116	199	17	of	of	ADP
fnp-5116	199	18	extension	extension	NOUN
fnp-5116	199	19	of	of	ADP
fnp-5116	199	20	surgery	surgery	NOUN
fnp-5116	199	21	on	on	ADP
fnp-5116	199	22	overall	overall	ADJ
fnp-5116	199	23	survival	survival	NOUN
fnp-5116	199	24	.	.	PUNCT
fnp-5116	200	1	figure	figure	VERB
fnp-5116	200	2	3	3	NUM
fnp-5116	200	3	.	.	PUNCT
fnp-5116	200	4	recurrence	recurrence	NOUN
fnp-5116	200	5	-	-	PUNCT
fnp-5116	200	6	free	free	ADJ
fnp-5116	200	7	survival	survival	NOUN
fnp-5116	200	8	in	in	ADP
fnp-5116	200	9	patients	patient	NOUN
fnp-5116	200	10	with	with	ADP
fnp-5116	200	11	pilocytic	pilocytic	ADJ
fnp-5116	200	12	astrocytoma	astrocytoma	NOUN
fnp-5116	200	13	,	,	PUNCT
fnp-5116	200	14	stratified	stratify	VERB
fnp-5116	200	15	by	by	ADP
fnp-5116	200	16	the	the	DET
fnp-5116	200	17	extent	extent	NOUN
fnp-5116	200	18	of	of	ADP
fnp-5116	200	19	surgical	surgical	ADJ
fnp-5116	200	20	resection	resection	NOUN
fnp-5116	200	21	(	(	PUNCT
fnp-5116	200	22	gtr	gtr	NOUN
fnp-5116	200	23	:	:	PUNCT
fnp-5116	200	24	gross	gross	ADJ
fnp-5116	200	25	total	total	ADJ
fnp-5116	200	26	resection	resection	NOUN
fnp-5116	200	27	,	,	PUNCT
fnp-5116	200	28	str	str	PRON
fnp-5116	200	29	:	:	PUNCT
fnp-5116	200	30	subtotal	subtotal	ADJ
fnp-5116	200	31	resection	resection	NOUN
fnp-5116	200	32	)	)	PUNCT
fnp-5116	200	33	.	.	PUNCT
fnp-5116	201	1	impact	impact	NOUN
fnp-5116	201	2	of	of	ADP
fnp-5116	201	3	chemotherapy	chemotherapy	NOUN
fnp-5116	201	4	and/or	and/or	CCONJ
fnp-5116	201	5	radiotherapy	radiotherapy	NOUN
fnp-5116	201	6	on	on	ADP
fnp-5116	201	7	recurrence	recurrence	NOUN
fnp-5116	201	8	-	-	PUNCT
fnp-5116	201	9	free	free	ADJ
fnp-5116	201	10	survival	survival	NOUN
fnp-5116	201	11	among	among	ADP
fnp-5116	201	12	81	81	NUM
fnp-5116	201	13	patients	patient	NOUN
fnp-5116	201	14	who	who	PRON
fnp-5116	201	15	received	receive	VERB
fnp-5116	201	16	chemotherapy	chemotherapy	NOUN
fnp-5116	201	17	,	,	PUNCT
fnp-5116	201	18	77	77	NUM
fnp-5116	201	19	had	have	VERB
fnp-5116	201	20	a	a	DET
fnp-5116	201	21	prior	prior	ADJ
fnp-5116	201	22	str	str	NOUN
fnp-5116	201	23	.	.	PUNCT
fnp-5116	202	1	patients	patient	NOUN
fnp-5116	202	2	who	who	PRON
fnp-5116	202	3	received	receive	VERB
fnp-5116	202	4	chemotherapy	chemotherapy	NOUN
fnp-5116	202	5	demonstrated	demonstrate	VERB
fnp-5116	202	6	a	a	DET
fnp-5116	202	7	shorter	short	ADJ
fnp-5116	202	8	median	median	ADJ
fnp-5116	202	9	rfs	rfs	NOUN
fnp-5116	202	10	(	(	PUNCT
fnp-5116	202	11	141	141	NUM
fnp-5116	202	12	vs	vs	ADP
fnp-5116	202	13	253	253	NUM
fnp-5116	202	14	months	month	NOUN
fnp-5116	202	15	)	)	PUNCT
fnp-5116	202	16	.	.	PUNCT
fnp-5116	203	1	however	however	ADV
fnp-5116	203	2	,	,	PUNCT
fnp-5116	203	3	we	we	PRON
fnp-5116	203	4	think	think	VERB
fnp-5116	203	5	that	that	SCONJ
fnp-5116	203	6	this	this	DET
fnp-5116	203	7	finding	finding	NOUN
fnp-5116	203	8	could	could	AUX
fnp-5116	203	9	be	be	AUX
fnp-5116	203	10	potentially	potentially	ADV
fnp-5116	203	11	skewed	skewed	ADJ
fnp-5116	203	12	due	due	ADP
fnp-5116	203	13	to	to	ADP
fnp-5116	203	14	selection	selection	NOUN
fnp-5116	203	15	bias	bias	NOUN
fnp-5116	203	16	,	,	PUNCT
fnp-5116	203	17	as	as	SCONJ
fnp-5116	203	18	the	the	DET
fnp-5116	203	19	patients	patient	NOUN
fnp-5116	203	20	with	with	ADP
fnp-5116	203	21	clinically	clinically	ADV
fnp-5116	203	22	more	more	ADV
fnp-5116	203	23	aggressive	aggressive	ADJ
fnp-5116	203	24	appearing	appearing	ADJ
fnp-5116	203	25	tumors	tumor	NOUN
fnp-5116	203	26	are	be	AUX
fnp-5116	203	27	more	more	ADV
fnp-5116	203	28	likely	likely	ADJ
fnp-5116	203	29	to	to	PART
fnp-5116	203	30	receive	receive	VERB
fnp-5116	203	31	chemotherapy	chemotherapy	NOUN
fnp-5116	203	32	.	.	PUNCT
fnp-5116	204	1	a	a	DET
fnp-5116	204	2	great	great	ADJ
fnp-5116	204	3	majority	majority	NOUN
fnp-5116	204	4	of	of	ADP
fnp-5116	204	5	cases	case	NOUN
fnp-5116	204	6	(	(	PUNCT
fnp-5116	204	7	97.5	97.5	NUM
fnp-5116	204	8	%	%	NOUN
fnp-5116	204	9	)	)	PUNCT
fnp-5116	204	10	received	receive	VERB
fnp-5116	204	11	chemotherapy	chemotherapy	NOUN
fnp-5116	204	12	had	have	VERB
fnp-5116	204	13	subtotal	subtotal	ADJ
fnp-5116	204	14	resections	resection	NOUN
fnp-5116	204	15	,	,	PUNCT
fnp-5116	204	16	which	which	PRON
fnp-5116	204	17	strongly	strongly	ADV
fnp-5116	204	18	supports	support	VERB
fnp-5116	204	19	our	our	PRON
fnp-5116	204	20	hypothesis	hypothesis	NOUN
fnp-5116	204	21	on	on	ADP
fnp-5116	204	22	selection	selection	NOUN
fnp-5116	204	23	bias	bias	NOUN
fnp-5116	204	24	.	.	PUNCT
fnp-5116	205	1	thus	thus	ADV
fnp-5116	205	2	,	,	PUNCT
fnp-5116	205	3	the	the	DET
fnp-5116	205	4	observed	observe	VERB
fnp-5116	205	5	difference	difference	NOUN
fnp-5116	205	6	in	in	ADP
fnp-5116	205	7	rfs	rfs	PROPN
fnp-5116	205	8	may	may	AUX
fnp-5116	205	9	not	not	PART
fnp-5116	205	10	be	be	AUX
fnp-5116	205	11	entirely	entirely	ADV
fnp-5116	205	12	surprising	surprising	ADJ
fnp-5116	205	13	.	.	PUNCT
fnp-5116	206	1	a	a	DET
fnp-5116	206	2	similar	similar	ADJ
fnp-5116	206	3	pattern	pattern	NOUN
fnp-5116	206	4	was	be	AUX
fnp-5116	206	5	also	also	ADV
fnp-5116	206	6	observed	observe	VERB
fnp-5116	206	7	among	among	ADP
fnp-5116	206	8	patients	patient	NOUN
fnp-5116	206	9	treated	treat	VERB
fnp-5116	206	10	with	with	ADP
fnp-5116	206	11	radiotherapy	radiotherapy	NOUN
fnp-5116	206	12	(	(	PUNCT
fnp-5116	206	13	151	151	NUM
fnp-5116	206	14	vs	vs	ADP
fnp-5116	206	15	243	243	NUM
fnp-5116	206	16	months	month	NOUN
fnp-5116	206	17	)	)	PUNCT
fnp-5116	206	18	.	.	PUNCT
fnp-5116	207	1	review	review	NOUN
fnp-5116	207	2	of	of	ADP
fnp-5116	207	3	patients	patient	NOUN
fnp-5116	207	4	with	with	ADP
fnp-5116	207	5	neurofibromatosis	neurofibromatosis	NOUN
fnp-5116	207	6	1	1	NUM
fnp-5116	207	7	there	there	PRON
fnp-5116	207	8	were	be	VERB
fnp-5116	207	9	24	24	NUM
fnp-5116	207	10	confirmed	confirm	VERB
fnp-5116	207	11	neurofibromatosis	neurofibromatosis	NOUN
fnp-5116	207	12	type	type	NOUN
fnp-5116	207	13	1	1	NUM
fnp-5116	207	14	patients	patient	NOUN
fnp-5116	207	15	(	(	PUNCT
fnp-5116	207	16	11	11	NUM
fnp-5116	207	17	female	female	ADJ
fnp-5116	207	18	and	and	CCONJ
fnp-5116	207	19	13	13	NUM
fnp-5116	207	20	male	male	NOUN
fnp-5116	207	21	)	)	PUNCT
fnp-5116	207	22	,	,	PUNCT
fnp-5116	207	23	which	which	PRON
fnp-5116	207	24	comprise	comprise	VERB
fnp-5116	207	25	4.8	4.8	NUM
fnp-5116	207	26	%	%	NOUN
fnp-5116	207	27	of	of	ADP
fnp-5116	207	28	the	the	DET
fnp-5116	207	29	entire	entire	ADJ
fnp-5116	207	30	cohort	cohort	NOUN
fnp-5116	207	31	.	.	PUNCT
fnp-5116	208	1	mean	mean	VERB
fnp-5116	208	2	age	age	NOUN
fnp-5116	208	3	at	at	ADP
fnp-5116	208	4	diagnosis	diagnosis	NOUN
fnp-5116	208	5	was	be	AUX
fnp-5116	208	6	19.5	19.5	NUM
fnp-5116	208	7	years	year	NOUN
fnp-5116	208	8	(	(	PUNCT
fnp-5116	208	9	3.1	3.1	NUM
fnp-5116	208	10	–	–	SYM
fnp-5116	208	11	42.7	42.7	NUM
fnp-5116	208	12	)	)	PUNCT
fnp-5116	208	13	.	.	PUNCT
fnp-5116	209	1	majority	majority	NOUN
fnp-5116	209	2	of	of	ADP
fnp-5116	209	3	the	the	DET
fnp-5116	209	4	tumors	tumor	NOUN
fnp-5116	209	5	(	(	PUNCT
fnp-5116	209	6	n=16	n=16	NOUN
fnp-5116	209	7	)	)	PUNCT
fnp-5116	209	8	were	be	AUX
fnp-5116	209	9	in	in	ADP
fnp-5116	209	10	the	the	DET
fnp-5116	209	11	posterior	posterior	ADJ
fnp-5116	209	12	fossa	fossa	NOUN
fnp-5116	209	13	,	,	PUNCT
fnp-5116	209	14	and	and	CCONJ
fnp-5116	209	15	four	four	NUM
fnp-5116	209	16	tumors	tumor	NOUN
fnp-5116	209	17	were	be	AUX
fnp-5116	209	18	in	in	ADP
fnp-5116	209	19	the	the	DET
fnp-5116	209	20	hypothalamic	hypothalamic	ADJ
fnp-5116	209	21	-	-	PUNCT
fnp-5116	209	22	suprachiasmatic	suprachiasmatic	ADJ
fnp-5116	209	23	region	region	NOUN
fnp-5116	209	24	.	.	PUNCT
fnp-5116	210	1	out	out	ADP
fnp-5116	210	2	of	of	ADP
fnp-5116	210	3	15	15	NUM
fnp-5116	210	4	patients	patient	NOUN
fnp-5116	210	5	with	with	ADP
fnp-5116	210	6	sufficient	sufficient	ADJ
fnp-5116	210	7	clinical	clinical	ADJ
fnp-5116	210	8	data	datum	NOUN
fnp-5116	210	9	,	,	PUNCT
fnp-5116	210	10	three	three	NUM
fnp-5116	210	11	experienced	experienced	ADJ
fnp-5116	210	12	recurrences	recurrence	NOUN
fnp-5116	210	13	.	.	PUNCT
fnp-5116	211	1	one	one	NUM
fnp-5116	211	2	patient	patient	NOUN
fnp-5116	211	3	died	die	VERB
fnp-5116	211	4	during	during	ADP
fnp-5116	211	5	follow	follow	NOUN
fnp-5116	211	6	-	-	PUNCT
fnp-5116	211	7	up	up	NOUN
fnp-5116	211	8	period	period	NOUN
fnp-5116	211	9	due	due	ADP
fnp-5116	211	10	to	to	ADP
fnp-5116	211	11	other	other	ADJ
fnp-5116	211	12	causes	cause	NOUN
fnp-5116	211	13	(	(	PUNCT
fnp-5116	211	14	for	for	SCONJ
fnp-5116	211	15	details	detail	NOUN
fnp-5116	211	16	see	see	VERB
fnp-5116	211	17	table	table	NOUN
fnp-5116	211	18	1	1	NUM
fnp-5116	211	19	,	,	PUNCT
fnp-5116	211	20	case#454	case#454	NOUN
fnp-5116	211	21	)	)	PUNCT
fnp-5116	211	22	.	.	PUNCT
fnp-5116	212	1	two	two	NUM
fnp-5116	212	2	cases	case	NOUN
fnp-5116	212	3	had	have	VERB
fnp-5116	212	4	anaplastic	anaplastic	ADJ
fnp-5116	212	5	features	feature	NOUN
fnp-5116	212	6	on	on	ADP
fnp-5116	212	7	histology	histology	NOUN
fnp-5116	212	8	,	,	PUNCT
fnp-5116	212	9	and	and	CCONJ
fnp-5116	212	10	the	the	DET
fnp-5116	212	11	remaining	remain	VERB
fnp-5116	212	12	22	22	NUM
fnp-5116	212	13	had	have	VERB
fnp-5116	212	14	classical	classical	ADJ
fnp-5116	212	15	pa	pa	PROPN
fnp-5116	212	16	morphology	morphology	NOUN
fnp-5116	212	17	.	.	PUNCT
fnp-5116	213	1	none	none	NOUN
fnp-5116	213	2	of	of	ADP
fnp-5116	213	3	the	the	DET
fnp-5116	213	4	nf1	nf1	NOUN
fnp-5116	213	5	-	-	PUNCT
fnp-5116	213	6	associated	associate	VERB
fnp-5116	213	7	cases	case	NOUN
fnp-5116	213	8	had	have	VERB
fnp-5116	213	9	mutations	mutation	NOUN
fnp-5116	213	10	in	in	ADP
fnp-5116	213	11	other	other	ADJ
fnp-5116	213	12	genes	gene	NOUN
fnp-5116	213	13	activating	activate	VERB
fnp-5116	213	14	mapk	mapk	NOUN
fnp-5116	213	15	pathway	pathway	NOUN
fnp-5116	213	16	(	(	PUNCT
fnp-5116	213	17	braf	braf	NOUN
fnp-5116	213	18	,	,	PUNCT
fnp-5116	213	19	fgfr1	fgfr1	PROPN
fnp-5116	213	20	,	,	PUNCT
fnp-5116	213	21	etc	etc	X
fnp-5116	213	22	.	.	X
fnp-5116	213	23	)	)	PUNCT
fnp-5116	213	24	.	.	PUNCT
fnp-5116	214	1	review	review	NOUN
fnp-5116	214	2	of	of	ADP
fnp-5116	214	3	patients	patient	NOUN
fnp-5116	214	4	with	with	ADP
fnp-5116	214	5	>	>	SYM
fnp-5116	214	6	5	5	NUM
fnp-5116	214	7	-	-	PUNCT
fnp-5116	214	8	year	year	NOUN
fnp-5116	214	9	follow	follow	NOUN
fnp-5116	214	10	-	-	PUNCT
fnp-5116	214	11	up	up	NOUN
fnp-5116	214	12	given	give	VERB
fnp-5116	214	13	pas	pas	NOUN
fnp-5116	214	14	grow	grow	VERB
fnp-5116	214	15	slowly	slowly	ADV
fnp-5116	214	16	and	and	CCONJ
fnp-5116	214	17	sufficiently	sufficiently	ADV
fnp-5116	214	18	long	long	ADJ
fnp-5116	214	19	follow	follow	NOUN
fnp-5116	214	20	-	-	PUNCT
fnp-5116	214	21	up	up	ADP
fnp-5116	214	22	times	time	NOUN
fnp-5116	214	23	are	be	AUX
fnp-5116	214	24	crucial	crucial	ADJ
fnp-5116	214	25	for	for	ADP
fnp-5116	214	26	a	a	DET
fnp-5116	214	27	realistic	realistic	ADJ
fnp-5116	214	28	assessment	assessment	NOUN
fnp-5116	214	29	of	of	ADP
fnp-5116	214	30	outcome	outcome	NOUN
fnp-5116	214	31	,	,	PUNCT
fnp-5116	214	32	we	we	PRON
fnp-5116	214	33	performed	perform	VERB
fnp-5116	214	34	a	a	DET
fnp-5116	214	35	subgroup	subgroup	NOUN
fnp-5116	214	36	analysis	analysis	NOUN
fnp-5116	214	37	of	of	ADP
fnp-5116	214	38	the	the	DET
fnp-5116	214	39	patients	patient	NOUN
fnp-5116	214	40	who	who	PRON
fnp-5116	214	41	have	have	VERB
fnp-5116	214	42	more	more	ADJ
fnp-5116	214	43	than	than	ADP
fnp-5116	214	44	5	5	NUM
fnp-5116	214	45	years	year	NOUN
fnp-5116	214	46	of	of	ADP
fnp-5116	214	47	follow	follow	NOUN
fnp-5116	214	48	-	-	PUNCT
fnp-5116	214	49	up	up	NOUN
fnp-5116	214	50	(	(	PUNCT
fnp-5116	214	51	n=178	n=178	NOUN
fnp-5116	214	52	)	)	PUNCT
fnp-5116	214	53	.	.	PUNCT
fnp-5116	215	1	mean	mean	VERB
fnp-5116	215	2	follow	follow	VERB
fnp-5116	215	3	up	up	ADP
fnp-5116	215	4	time	time	NOUN
fnp-5116	215	5	in	in	ADP
fnp-5116	215	6	this	this	DET
fnp-5116	215	7	subgroup	subgroup	NOUN
fnp-5116	215	8	was	be	AUX
fnp-5116	215	9	263.3	263.3	NUM
fnp-5116	215	10	months	month	NOUN
fnp-5116	215	11	;	;	PUNCT
fnp-5116	215	12	median	median	NOUN
fnp-5116	215	13	follow	follow	VERB
fnp-5116	215	14	up	up	ADP
fnp-5116	215	15	time	time	NOUN
fnp-5116	215	16	was	be	AUX
fnp-5116	215	17	252	252	NUM
fnp-5116	215	18	months	month	NOUN
fnp-5116	215	19	.	.	PUNCT
fnp-5116	216	1	out	out	ADP
fnp-5116	216	2	of	of	ADP
fnp-5116	216	3	the	the	DET
fnp-5116	216	4	164	164	NUM
fnp-5116	216	5	patients	patient	NOUN
fnp-5116	216	6	in	in	ADP
fnp-5116	216	7	this	this	DET
fnp-5116	216	8	group	group	NOUN
fnp-5116	216	9	for	for	ADP
fnp-5116	216	10	whom	whom	PRON
fnp-5116	216	11	we	we	PRON
fnp-5116	216	12	had	have	VERB
fnp-5116	216	13	adequate	adequate	ADJ
fnp-5116	216	14	recurrence	recurrence	NOUN
fnp-5116	216	15	data	datum	NOUN
fnp-5116	216	16	,	,	PUNCT
fnp-5116	216	17	68	68	NUM
fnp-5116	216	18	experienced	experience	VERB
fnp-5116	216	19	a	a	DET
fnp-5116	216	20	recurrence	recurrence	NOUN
fnp-5116	216	21	.	.	PUNCT
fnp-5116	217	1	the	the	DET
fnp-5116	217	2	type	type	NOUN
fnp-5116	217	3	of	of	ADP
fnp-5116	217	4	surgery	surgery	NOUN
fnp-5116	217	5	remained	remain	VERB
fnp-5116	217	6	one	one	NUM
fnp-5116	217	7	of	of	ADP
fnp-5116	217	8	the	the	DET
fnp-5116	217	9	strongest	strong	ADJ
fnp-5116	217	10	factors	factor	NOUN
fnp-5116	217	11	that	that	PRON
fnp-5116	217	12	determined	determine	VERB
fnp-5116	217	13	the	the	DET
fnp-5116	217	14	rate	rate	NOUN
fnp-5116	217	15	of	of	ADP
fnp-5116	217	16	recurrence	recurrence	NOUN
fnp-5116	217	17	and	and	CCONJ
fnp-5116	217	18	rfs	rf	NOUN
fnp-5116	217	19	,	,	PUNCT
fnp-5116	217	20	as	as	SCONJ
fnp-5116	217	21	cases	case	NOUN
fnp-5116	217	22	with	with	ADP
fnp-5116	217	23	str	str	NOUN
fnp-5116	217	24	recurred	recur	VERB
fnp-5116	217	25	more	more	ADV
fnp-5116	217	26	often	often	ADV
fnp-5116	217	27	and	and	CCONJ
fnp-5116	217	28	earlier	early	ADV
fnp-5116	217	29	(	(	PUNCT
fnp-5116	217	30	figure	figure	NOUN
fnp-5116	217	31	4	4	NUM
fnp-5116	217	32	)	)	PUNCT
fnp-5116	217	33	.	.	PUNCT
fnp-5116	218	1	sixty	sixty	NUM
fnp-5116	218	2	-	-	PUNCT
fnp-5116	218	3	one	one	NUM
fnp-5116	218	4	percent	percent	NOUN
fnp-5116	218	5	of	of	ADP
fnp-5116	218	6	the	the	DET
fnp-5116	218	7	patients	patient	NOUN
fnp-5116	218	8	with	with	ADP
fnp-5116	218	9	str	str	NOUN
fnp-5116	218	10	experienced	experienced	ADJ
fnp-5116	218	11	recurrence	recurrence	NOUN
fnp-5116	218	12	at	at	ADV
fnp-5116	218	13	least	least	ADJ
fnp-5116	218	14	once	once	ADV
fnp-5116	218	15	whereas	whereas	SCONJ
fnp-5116	218	16	the	the	DET
fnp-5116	218	17	recurrence	recurrence	NOUN
fnp-5116	218	18	rate	rate	NOUN
fnp-5116	218	19	was	be	AUX
fnp-5116	218	20	11	11	NUM
fnp-5116	218	21	%	%	NOUN
fnp-5116	218	22	for	for	ADP
fnp-5116	218	23	patients	patient	NOUN
fnp-5116	218	24	with	with	ADP
fnp-5116	218	25	gtr	gtr	NOUN
fnp-5116	218	26	(	(	PUNCT
fnp-5116	218	27	p<0.001	p<0.001	PROPN
fnp-5116	218	28	)	)	PUNCT
fnp-5116	218	29	.	.	PUNCT
fnp-5116	219	1	we	we	PRON
fnp-5116	219	2	were	be	AUX
fnp-5116	219	3	not	not	PART
fnp-5116	219	4	able	able	ADJ
fnp-5116	219	5	to	to	PART
fnp-5116	219	6	show	show	VERB
fnp-5116	219	7	an	an	DET
fnp-5116	219	8	association	association	NOUN
fnp-5116	219	9	between	between	ADP
fnp-5116	219	10	the	the	DET
fnp-5116	219	11	underlying	underlying	ADJ
fnp-5116	219	12	genetic	genetic	ADJ
fnp-5116	219	13	alterations	alteration	NOUN
fnp-5116	219	14	or	or	CCONJ
fnp-5116	219	15	tumor	tumor	NOUN
fnp-5116	219	16	location	location	NOUN
fnp-5116	219	17	and	and	CCONJ
fnp-5116	219	18	recurrence	recurrence	NOUN
fnp-5116	219	19	rate	rate	NOUN
fnp-5116	219	20	or	or	CCONJ
fnp-5116	219	21	rfs	rfs	PROPN
fnp-5116	219	22	.	.	PUNCT
fnp-5116	220	1	the	the	DET
fnp-5116	220	2	number	number	NOUN
fnp-5116	220	3	of	of	ADP
fnp-5116	220	4	cases	case	NOUN
fnp-5116	220	5	in	in	ADP
fnp-5116	220	6	each	each	DET
fnp-5116	220	7	group	group	NOUN
fnp-5116	220	8	was	be	AUX
fnp-5116	220	9	not	not	PART
fnp-5116	220	10	sufficient	sufficient	ADJ
fnp-5116	220	11	to	to	PART
fnp-5116	220	12	perform	perform	VERB
fnp-5116	220	13	an	an	DET
fnp-5116	220	14	analysis	analysis	NOUN
fnp-5116	220	15	of	of	ADP
fnp-5116	220	16	rfs	rfs	NOUN
fnp-5116	220	17	for	for	ADP
fnp-5116	220	18	cases	case	NOUN
fnp-5116	220	19	with	with	ADP
fnp-5116	220	20	and	and	CCONJ
fnp-5116	220	21	without	without	ADP
fnp-5116	220	22	cnv	cnv	PROPN
fnp-5116	220	23	.	.	PROPN
fnp-5116	220	24	figure	figure	NOUN
fnp-5116	220	25	4	4	NUM
fnp-5116	220	26	.	.	PUNCT
fnp-5116	220	27	subgroup	subgroup	NOUN
fnp-5116	220	28	analysis	analysis	NOUN
fnp-5116	220	29	of	of	ADP
fnp-5116	220	30	recurrence	recurrence	NOUN
fnp-5116	220	31	-	-	PUNCT
fnp-5116	220	32	free	free	ADJ
fnp-5116	220	33	survival	survival	NOUN
fnp-5116	220	34	in	in	ADP
fnp-5116	220	35	patients	patient	NOUN
fnp-5116	220	36	with	with	ADP
fnp-5116	220	37	pilocytic	pilocytic	ADJ
fnp-5116	220	38	astrocytoma	astrocytoma	NOUN
fnp-5116	220	39	followed	follow	VERB
fnp-5116	220	40	for	for	ADP
fnp-5116	220	41	>	>	X
fnp-5116	220	42	60	60	NUM
fnp-5116	220	43	months	month	NOUN
fnp-5116	220	44	,	,	PUNCT
fnp-5116	220	45	stratified	stratify	VERB
fnp-5116	220	46	by	by	ADP
fnp-5116	220	47	the	the	DET
fnp-5116	220	48	extent	extent	NOUN
fnp-5116	220	49	of	of	ADP
fnp-5116	220	50	surgical	surgical	ADJ
fnp-5116	220	51	resection	resection	NOUN
fnp-5116	220	52	(	(	PUNCT
fnp-5116	220	53	gtr	gtr	NOUN
fnp-5116	220	54	:	:	PUNCT
fnp-5116	220	55	gross	gross	ADJ
fnp-5116	220	56	total	total	ADJ
fnp-5116	220	57	resection	resection	NOUN
fnp-5116	220	58	,	,	PUNCT
fnp-5116	220	59	str	str	PRON
fnp-5116	220	60	:	:	PUNCT
fnp-5116	220	61	subtotal	subtotal	ADJ
fnp-5116	220	62	resection	resection	NOUN
fnp-5116	220	63	)	)	PUNCT
fnp-5116	220	64	.	.	PUNCT
fnp-5116	221	1	after	after	ADP
fnp-5116	221	2	conducting	conduct	VERB
fnp-5116	221	3	a	a	DET
fnp-5116	221	4	multivariate	multivariate	NOUN
fnp-5116	221	5	analysis	analysis	NOUN
fnp-5116	221	6	of	of	ADP
fnp-5116	221	7	rfs	rfs	NOUN
fnp-5116	221	8	considering	consider	VERB
fnp-5116	221	9	the	the	DET
fnp-5116	221	10	age	age	NOUN
fnp-5116	221	11	groups	group	NOUN
fnp-5116	221	12	,	,	PUNCT
fnp-5116	221	13	extent	extent	NOUN
fnp-5116	221	14	of	of	ADP
fnp-5116	221	15	resection	resection	NOUN
fnp-5116	221	16	,	,	PUNCT
fnp-5116	221	17	tumor	tumor	NOUN
fnp-5116	221	18	location	location	NOUN
fnp-5116	221	19	,	,	PUNCT
fnp-5116	221	20	nf1	nf1	NOUN
fnp-5116	221	21	status	status	NOUN
fnp-5116	221	22	,	,	PUNCT
fnp-5116	221	23	and	and	CCONJ
fnp-5116	221	24	treatment	treatment	NOUN
fnp-5116	221	25	modalities	modality	NOUN
fnp-5116	221	26	,	,	PUNCT
fnp-5116	221	27	we	we	PRON
fnp-5116	221	28	found	find	VERB
fnp-5116	221	29	that	that	SCONJ
fnp-5116	221	30	only	only	ADV
fnp-5116	221	31	the	the	DET
fnp-5116	221	32	extent	extent	NOUN
fnp-5116	221	33	of	of	ADP
fnp-5116	221	34	resection	resection	NOUN
fnp-5116	221	35	had	have	VERB
fnp-5116	221	36	a	a	DET
fnp-5116	221	37	statistically	statistically	ADV
fnp-5116	221	38	significant	significant	ADJ
fnp-5116	221	39	association	association	NOUN
fnp-5116	221	40	with	with	ADP
fnp-5116	221	41	rfs	rfs	PROPN
fnp-5116	221	42	(	(	PUNCT
fnp-5116	221	43	table	table	NOUN
fnp-5116	221	44	7	7	NUM
fnp-5116	221	45	)	)	PUNCT
fnp-5116	221	46	.	.	PUNCT
fnp-5116	222	1	table	table	NOUN
fnp-5116	222	2	7	7	NUM
fnp-5116	222	3	.	.	PUNCT
fnp-5116	222	4	multivariate	multivariate	NOUN
fnp-5116	222	5	analysis	analysis	NOUN
fnp-5116	222	6	of	of	ADP
fnp-5116	222	7	factors	factor	NOUN
fnp-5116	222	8	for	for	ADP
fnp-5116	222	9	recurrence	recurrence	NOUN
fnp-5116	222	10	free	free	ADJ
fnp-5116	222	11	survival	survival	PROPN
fnp-5116	222	12	probability	probability	NOUN
fnp-5116	222	13	  	  	SPACE
fnp-5116	222	14	univariate	univariate	ADJ
fnp-5116	222	15	multivariate	multivariate	NOUN
fnp-5116	222	16	variable	variable	ADJ
fnp-5116	222	17	significance	significance	NOUN
fnp-5116	222	18	hr	hr	NOUN
fnp-5116	222	19	%	%	NOUN
fnp-5116	222	20	95	95	NUM
fnp-5116	222	21	ci	ci	NOUN
fnp-5116	222	22	significance	significance	NOUN
fnp-5116	222	23	hr	hr	PROPN
fnp-5116	222	24	%	%	INTJ
fnp-5116	222	25	95	95	NUM
fnp-5116	222	26	ci	ci	NOUN
fnp-5116	222	27	type	type	NOUN
fnp-5116	222	28	of	of	ADP
fnp-5116	222	29	surgery	surgery	NOUN
fnp-5116	222	30	   	   	SPACE
fnp-5116	222	31	gtr	gtr	NOUN
fnp-5116	222	32	vs	vs	ADP
fnp-5116	222	33	str	str	NOUN
fnp-5116	222	34	  	  	SPACE
fnp-5116	222	35	<	<	X
fnp-5116	222	36	0.001	0.001	NUM
fnp-5116	222	37	  	  	SPACE
fnp-5116	222	38	6.28	6.28	NUM
fnp-5116	222	39	  	  	SPACE
fnp-5116	222	40	3.35	3.35	NUM
fnp-5116	222	41	–	–	PUNCT
fnp-5116	222	42	11.77	11.77	NUM
fnp-5116	222	43	  	  	SPACE
fnp-5116	222	44	<	<	X
fnp-5116	222	45	0.001	0.001	NUM
fnp-5116	222	46	  	  	SPACE
fnp-5116	222	47	6.23	6.23	NUM
fnp-5116	222	48	  	  	SPACE
fnp-5116	222	49	3.23	3.23	NUM
fnp-5116	222	50	–	–	PUNCT
fnp-5116	222	51	11.99	11.99	NUM
fnp-5116	222	52	  	  	SPACE
fnp-5116	222	53	location	location	NOUN
fnp-5116	222	54	   	   	SPACE
fnp-5116	222	55	infratentorial	infratentorial	ADJ
fnp-5116	222	56	vs	vs	ADP
fnp-5116	222	57	supratentorial	supratentorial	ADJ
fnp-5116	222	58	   	   	SPACE
fnp-5116	222	59	infratentorial	infratentorial	NOUN
fnp-5116	222	60	vs	vs	ADP
fnp-5116	222	61	spinal	spinal	NOUN
fnp-5116	222	62	0.049	0.049	NUM
fnp-5116	222	63	0.027	0.027	NUM
fnp-5116	222	64	0.097	0.097	NUM
fnp-5116	222	65	  	  	SPACE
fnp-5116	222	66	1.58	1.58	NUM
fnp-5116	222	67	1.97	1.97	NUM
fnp-5116	222	68	  	  	SPACE
fnp-5116	222	69	1.05	1.05	NUM
fnp-5116	222	70	–	–	PUNCT
fnp-5116	222	71	2.36	2.36	NUM
fnp-5116	222	72	0.88	0.88	NUM
fnp-5116	222	73	–	–	PUNCT
fnp-5116	222	74	4.40	4.40	NUM
fnp-5116	222	75	0.957	0.957	NUM
fnp-5116	222	76	0.925	0.925	NUM
fnp-5116	222	77	0.811	0.811	NUM
fnp-5116	222	78	  	  	SPACE
fnp-5116	222	79	0.98	0.98	NUM
fnp-5116	222	80	1.11	1.11	NUM
fnp-5116	222	81	  	  	SPACE
fnp-5116	222	82	0.63	0.63	NUM
fnp-5116	222	83	–	–	PUNCT
fnp-5116	222	84	1.51	1.51	NUM
fnp-5116	222	85	0.46	0.46	NUM
fnp-5116	222	86	–	–	PUNCT
fnp-5116	222	87	2.67	2.67	NUM
fnp-5116	222	88	  	  	SPACE
fnp-5116	222	89	age	age	NOUN
fnp-5116	222	90	   	   	SPACE
fnp-5116	222	91	0	0	NUM
fnp-5116	222	92	-	-	SYM
fnp-5116	222	93	14	14	NUM
fnp-5116	222	94	vs	vs	ADP
fnp-5116	222	95	14	14	NUM
fnp-5116	222	96	-	-	SYM
fnp-5116	222	97	21	21	NUM
fnp-5116	222	98	   	   	SPACE
fnp-5116	222	99	0	0	NUM
fnp-5116	222	100	-	-	SYM
fnp-5116	222	101	14	14	NUM
fnp-5116	222	102	vs	vs	ADP
fnp-5116	222	103	>	>	X
fnp-5116	222	104	21	21	NUM
fnp-5116	222	105	0.082	0.082	NUM
fnp-5116	222	106	0.564	0.564	NUM
fnp-5116	222	107	0.026	0.026	NUM
fnp-5116	222	108	  	  	SPACE
fnp-5116	222	109	0.855	0.855	NUM
fnp-5116	222	110	0.554	0.554	NUM
fnp-5116	222	111	  	  	SPACE
fnp-5116	222	112	0.50	0.50	NUM
fnp-5116	222	113	–	–	PUNCT
fnp-5116	222	114	1.46	1.46	NUM
fnp-5116	222	115	0.33	0.33	NUM
fnp-5116	222	116	–	–	PUNCT
fnp-5116	222	117	0.93	0.93	NUM
fnp-5116	222	118	0.094	0.094	NUM
fnp-5116	222	119	0.337	0.337	NUM
fnp-5116	222	120	0.036	0.036	NUM
fnp-5116	222	121	  	  	SPACE
fnp-5116	222	122	0.76	0.76	NUM
fnp-5116	222	123	0.56	0.56	NUM
fnp-5116	222	124	  	  	SPACE
fnp-5116	222	125	0.44	0.44	NUM
fnp-5116	222	126	–	–	PUNCT
fnp-5116	222	127	1.33	1.33	NUM
fnp-5116	222	128	0.33	0.33	NUM
fnp-5116	222	129	–	–	PUNCT
fnp-5116	222	130	0.96	0.96	NUM
fnp-5116	222	131	  	  	SPACE
fnp-5116	222	132	sex	sex	NOUN
fnp-5116	222	133	0.266	0.266	NUM
fnp-5116	222	134	1.25	1.25	NUM
fnp-5116	222	135	0.85	0.85	NUM
fnp-5116	222	136	–	–	PUNCT
fnp-5116	222	137	1.83	1.83	NUM
fnp-5116	222	138	      	      	SPACE
fnp-5116	222	139	discussion	discussion	NOUN
fnp-5116	222	140	multivariate	multivariate	NOUN
fnp-5116	222	141	analysis	analysis	NOUN
fnp-5116	222	142	of	of	ADP
fnp-5116	222	143	outcome	outcome	NOUN
fnp-5116	222	144	did	do	AUX
fnp-5116	222	145	not	not	PART
fnp-5116	222	146	reveal	reveal	VERB
fnp-5116	222	147	any	any	DET
fnp-5116	222	148	significant	significant	ADJ
fnp-5116	222	149	association	association	NOUN
fnp-5116	222	150	with	with	ADP
fnp-5116	222	151	clinical	clinical	ADJ
fnp-5116	222	152	and	and	CCONJ
fnp-5116	222	153	pathological	pathological	ADJ
fnp-5116	222	154	variables	variable	NOUN
fnp-5116	222	155	except	except	SCONJ
fnp-5116	222	156	for	for	ADP
fnp-5116	222	157	extent	extent	NOUN
fnp-5116	222	158	of	of	ADP
fnp-5116	222	159	resection	resection	NOUN
fnp-5116	222	160	.	.	PUNCT
fnp-5116	223	1	despite	despite	SCONJ
fnp-5116	223	2	the	the	DET
fnp-5116	223	3	large	large	ADJ
fnp-5116	223	4	number	number	NOUN
fnp-5116	223	5	of	of	ADP
fnp-5116	223	6	patients	patient	NOUN
fnp-5116	223	7	and	and	CCONJ
fnp-5116	223	8	follow	follow	VERB
fnp-5116	223	9	-	-	PUNCT
fnp-5116	223	10	up	up	ADP
fnp-5116	223	11	time	time	NOUN
fnp-5116	223	12	that	that	PRON
fnp-5116	223	13	is	be	AUX
fnp-5116	223	14	considerably	considerably	ADV
fnp-5116	223	15	longer	long	ADJ
fnp-5116	223	16	than	than	ADP
fnp-5116	223	17	most	most	ADJ
fnp-5116	223	18	studies	study	NOUN
fnp-5116	223	19	in	in	ADP
fnp-5116	223	20	the	the	DET
fnp-5116	223	21	literature	literature	NOUN
fnp-5116	223	22	,	,	PUNCT
fnp-5116	223	23	age	age	NOUN
fnp-5116	223	24	,	,	PUNCT
fnp-5116	223	25	nf1	nf1	NOUN
fnp-5116	223	26	status	status	NOUN
fnp-5116	223	27	,	,	PUNCT
fnp-5116	223	28	tumor	tumor	NOUN
fnp-5116	223	29	location	location	NOUN
fnp-5116	223	30	,	,	PUNCT
fnp-5116	223	31	adjuvant	adjuvant	ADJ
fnp-5116	223	32	treatment	treatment	NOUN
fnp-5116	223	33	and	and	CCONJ
fnp-5116	223	34	molecular	molecular	ADJ
fnp-5116	223	35	alterations	alteration	NOUN
fnp-5116	223	36	did	do	AUX
fnp-5116	223	37	not	not	PART
fnp-5116	223	38	significantly	significantly	ADV
fnp-5116	223	39	influence	influence	VERB
fnp-5116	223	40	rfs	rfs	PROPN
fnp-5116	223	41	.	.	PUNCT
fnp-5116	224	1	these	these	DET
fnp-5116	224	2	findings	finding	NOUN
fnp-5116	224	3	are	be	AUX
fnp-5116	224	4	at	at	ADP
fnp-5116	224	5	odds	odd	NOUN
fnp-5116	224	6	with	with	ADP
fnp-5116	224	7	some	some	PRON
fnp-5116	224	8	of	of	ADP
fnp-5116	224	9	the	the	DET
fnp-5116	224	10	studies	study	NOUN
fnp-5116	224	11	that	that	PRON
fnp-5116	224	12	suggest	suggest	VERB
fnp-5116	224	13	differences	difference	NOUN
fnp-5116	224	14	in	in	ADP
fnp-5116	224	15	outcome	outcome	NOUN
fnp-5116	224	16	between	between	ADP
fnp-5116	224	17	adult	adult	NOUN
fnp-5116	224	18	and	and	CCONJ
fnp-5116	224	19	pediatric	pediatric	ADJ
fnp-5116	224	20	patients	patient	NOUN
fnp-5116	224	21	or	or	CCONJ
fnp-5116	224	22	between	between	ADP
fnp-5116	224	23	germline	germline	NOUN
fnp-5116	224	24	nf1	nf1	NOUN
fnp-5116	224	25	and	and	CCONJ
fnp-5116	224	26	wildtype	wildtype	NOUN
fnp-5116	224	27	tumors	tumor	NOUN
fnp-5116	225	1	[	[	X
fnp-5116	225	2	46	46	NUM
fnp-5116	225	3	-	-	SYM
fnp-5116	225	4	48	48	NUM
fnp-5116	225	5	]	]	PUNCT
fnp-5116	225	6	.	.	PUNCT
fnp-5116	226	1	some	some	PRON
fnp-5116	226	2	suggested	suggest	VERB
fnp-5116	226	3	that	that	SCONJ
fnp-5116	226	4	adult	adult	NOUN
fnp-5116	226	5	cases	case	NOUN
fnp-5116	226	6	have	have	VERB
fnp-5116	226	7	a	a	DET
fnp-5116	226	8	worse	bad	ADJ
fnp-5116	226	9	prognosis	prognosis	NOUN
fnp-5116	226	10	than	than	ADP
fnp-5116	226	11	pediatric	pediatric	ADJ
fnp-5116	226	12	counterparts	counterpart	NOUN
fnp-5116	226	13	[	[	X
fnp-5116	226	14	18	18	NUM
fnp-5116	226	15	-	-	SYM
fnp-5116	226	16	21	21	NUM
fnp-5116	226	17	]	]	PUNCT
fnp-5116	226	18	while	while	SCONJ
fnp-5116	226	19	others	other	NOUN
fnp-5116	226	20	demonstrated	demonstrate	VERB
fnp-5116	226	21	a	a	DET
fnp-5116	226	22	very	very	ADV
fnp-5116	226	23	favorable	favorable	ADJ
fnp-5116	226	24	prognosis	prognosis	NOUN
fnp-5116	226	25	regardless	regardless	ADV
fnp-5116	226	26	of	of	ADP
fnp-5116	226	27	age	age	NOUN
fnp-5116	226	28	[	[	X
fnp-5116	226	29	18	18	NUM
fnp-5116	226	30	,	,	PUNCT
fnp-5116	226	31	49	49	NUM
fnp-5116	226	32	]	]	PUNCT
fnp-5116	226	33	.	.	PUNCT
fnp-5116	227	1	it	it	PRON
fnp-5116	227	2	is	be	AUX
fnp-5116	227	3	well	well	ADV
fnp-5116	227	4	recognized	recognize	VERB
fnp-5116	227	5	that	that	SCONJ
fnp-5116	227	6	older	old	ADJ
fnp-5116	227	7	age	age	NOUN
fnp-5116	227	8	is	be	AUX
fnp-5116	227	9	associated	associate	VERB
fnp-5116	227	10	with	with	ADP
fnp-5116	227	11	a	a	DET
fnp-5116	227	12	higher	high	ADJ
fnp-5116	227	13	incidence	incidence	NOUN
fnp-5116	227	14	of	of	ADP
fnp-5116	227	15	deaths	death	NOUN
fnp-5116	227	16	compared	compare	VERB
fnp-5116	227	17	to	to	ADP
fnp-5116	227	18	younger	young	ADJ
fnp-5116	227	19	populations	population	NOUN
fnp-5116	227	20	in	in	ADP
fnp-5116	227	21	patients	patient	NOUN
fnp-5116	227	22	with	with	ADP
fnp-5116	227	23	tumors	tumor	NOUN
fnp-5116	227	24	.	.	PUNCT
fnp-5116	228	1	this	this	PRON
fnp-5116	228	2	is	be	AUX
fnp-5116	228	3	often	often	ADV
fnp-5116	228	4	attributed	attribute	VERB
fnp-5116	228	5	to	to	ADP
fnp-5116	228	6	accelerated	accelerate	VERB
fnp-5116	228	7	epigenetic	epigenetic	ADJ
fnp-5116	228	8	age	age	NOUN
fnp-5116	228	9	and	and	CCONJ
fnp-5116	228	10	the	the	DET
fnp-5116	228	11	simple	simple	ADJ
fnp-5116	228	12	effect	effect	NOUN
fnp-5116	228	13	on	on	ADP
fnp-5116	228	14	age	age	NOUN
fnp-5116	228	15	on	on	ADP
fnp-5116	228	16	overall	overall	ADJ
fnp-5116	228	17	survival	survival	NOUN
fnp-5116	228	18	as	as	SCONJ
fnp-5116	228	19	opposed	oppose	VERB
fnp-5116	228	20	to	to	ADP
fnp-5116	228	21	factors	factor	NOUN
fnp-5116	228	22	directly	directly	ADV
fnp-5116	228	23	associated	associate	VERB
fnp-5116	228	24	with	with	ADP
fnp-5116	228	25	tumor	tumor	NOUN
fnp-5116	228	26	progression	progression	NOUN
fnp-5116	228	27	[	[	X
fnp-5116	228	28	50	50	NUM
fnp-5116	228	29	,	,	PUNCT
fnp-5116	228	30	51	51	NUM
fnp-5116	228	31	]	]	PUNCT
fnp-5116	228	32	.	.	PUNCT
fnp-5116	229	1	in	in	ADP
fnp-5116	229	2	our	our	PRON
fnp-5116	229	3	series	series	NOUN
fnp-5116	229	4	,	,	PUNCT
fnp-5116	229	5	we	we	PRON
fnp-5116	229	6	have	have	AUX
fnp-5116	229	7	separated	separate	VERB
fnp-5116	229	8	cases	case	NOUN
fnp-5116	229	9	into	into	ADP
fnp-5116	229	10	three	three	NUM
fnp-5116	229	11	age	age	NOUN
fnp-5116	229	12	groups	group	NOUN
fnp-5116	229	13	and	and	CCONJ
fnp-5116	229	14	although	although	SCONJ
fnp-5116	229	15	recurrence	recurrence	NOUN
fnp-5116	229	16	rates	rate	NOUN
fnp-5116	229	17	increased	increase	VERB
fnp-5116	229	18	with	with	ADP
fnp-5116	229	19	age	age	NOUN
fnp-5116	229	20	,	,	PUNCT
fnp-5116	229	21	this	this	DET
fnp-5116	229	22	difference	difference	NOUN
fnp-5116	229	23	was	be	AUX
fnp-5116	229	24	not	not	PART
fnp-5116	229	25	significant	significant	ADJ
fnp-5116	229	26	.	.	PUNCT
fnp-5116	230	1	even	even	ADV
fnp-5116	230	2	in	in	ADP
fnp-5116	230	3	subgroup	subgroup	ADJ
fnp-5116	230	4	analysis	analysis	NOUN
fnp-5116	230	5	of	of	ADP
fnp-5116	230	6	cases	case	NOUN
fnp-5116	230	7	with	with	ADP
fnp-5116	230	8	gtr	gtr	NOUN
fnp-5116	230	9	and	and	CCONJ
fnp-5116	230	10	str	str	NOUN
fnp-5116	230	11	,	,	PUNCT
fnp-5116	230	12	age	age	NOUN
fnp-5116	230	13	did	do	AUX
fnp-5116	230	14	not	not	PART
fnp-5116	230	15	stand	stand	VERB
fnp-5116	230	16	up	up	ADP
fnp-5116	230	17	as	as	ADP
fnp-5116	230	18	a	a	DET
fnp-5116	230	19	significant	significant	ADJ
fnp-5116	230	20	factor	factor	NOUN
fnp-5116	230	21	.	.	PUNCT
fnp-5116	231	1	we	we	PRON
fnp-5116	231	2	were	be	AUX
fnp-5116	231	3	not	not	PART
fnp-5116	231	4	able	able	ADJ
fnp-5116	231	5	to	to	PART
fnp-5116	231	6	assess	assess	VERB
fnp-5116	231	7	pa	pa	PROPN
fnp-5116	231	8	specific	specific	ADJ
fnp-5116	231	9	overall	overall	ADJ
fnp-5116	231	10	survival	survival	NOUN
fnp-5116	231	11	because	because	SCONJ
fnp-5116	231	12	we	we	PRON
fnp-5116	231	13	observed	observe	VERB
fnp-5116	231	14	no	no	DET
fnp-5116	231	15	pa	pa	NOUN
fnp-5116	231	16	-	-	PUNCT
fnp-5116	231	17	related	relate	VERB
fnp-5116	231	18	fatality	fatality	NOUN
fnp-5116	231	19	.	.	PUNCT
fnp-5116	232	1	it	it	PRON
fnp-5116	232	2	has	have	AUX
fnp-5116	232	3	been	be	AUX
fnp-5116	232	4	noted	note	VERB
fnp-5116	232	5	that	that	SCONJ
fnp-5116	232	6	location	location	NOUN
fnp-5116	232	7	could	could	AUX
fnp-5116	232	8	be	be	AUX
fnp-5116	232	9	an	an	DET
fnp-5116	232	10	independent	independent	ADJ
fnp-5116	232	11	prognostic	prognostic	ADJ
fnp-5116	232	12	variable	variable	NOUN
fnp-5116	232	13	and	and	CCONJ
fnp-5116	232	14	tumors	tumor	NOUN
fnp-5116	232	15	located	locate	VERB
fnp-5116	232	16	in	in	ADP
fnp-5116	232	17	the	the	DET
fnp-5116	232	18	posterior	posterior	ADJ
fnp-5116	232	19	fossa	fossa	NOUN
fnp-5116	232	20	generally	generally	ADV
fnp-5116	232	21	have	have	VERB
fnp-5116	232	22	more	more	ADV
fnp-5116	232	23	favorable	favorable	ADJ
fnp-5116	232	24	outcomes	outcome	NOUN
fnp-5116	232	25	[	[	X
fnp-5116	232	26	26	26	NUM
fnp-5116	232	27	,	,	PUNCT
fnp-5116	232	28	52	52	NUM
fnp-5116	232	29	,	,	PUNCT
fnp-5116	232	30	53	53	NUM
fnp-5116	232	31	]	]	PUNCT
fnp-5116	232	32	.	.	PUNCT
fnp-5116	233	1	this	this	PRON
fnp-5116	233	2	was	be	AUX
fnp-5116	233	3	presumed	presume	VERB
fnp-5116	233	4	to	to	PART
fnp-5116	233	5	be	be	AUX
fnp-5116	233	6	associated	associate	VERB
fnp-5116	233	7	with	with	ADP
fnp-5116	233	8	surgical	surgical	ADJ
fnp-5116	233	9	access	access	NOUN
fnp-5116	233	10	to	to	ADP
fnp-5116	233	11	tumor	tumor	NOUN
fnp-5116	233	12	and	and	CCONJ
fnp-5116	233	13	ability	ability	NOUN
fnp-5116	233	14	to	to	PART
fnp-5116	233	15	remove	remove	VERB
fnp-5116	233	16	completely	completely	ADV
fnp-5116	233	17	,	,	PUNCT
fnp-5116	233	18	and	and	CCONJ
fnp-5116	233	19	therefore	therefore	ADV
fnp-5116	233	20	tumors	tumor	NOUN
fnp-5116	233	21	located	locate	VERB
fnp-5116	233	22	in	in	ADP
fnp-5116	233	23	regions	region	NOUN
fnp-5116	233	24	difficult	difficult	ADJ
fnp-5116	233	25	to	to	PART
fnp-5116	233	26	access	access	VERB
fnp-5116	233	27	specifically	specifically	ADV
fnp-5116	233	28	the	the	DET
fnp-5116	233	29	brain	brain	NOUN
fnp-5116	233	30	stem	stem	NOUN
fnp-5116	233	31	and	and	CCONJ
fnp-5116	233	32	hypothalamo	hypothalamo	NOUN
fnp-5116	233	33	-	-	PUNCT
fnp-5116	233	34	suprachiasmatic	suprachiasmatic	ADJ
fnp-5116	233	35	region	region	NOUN
fnp-5116	233	36	were	be	AUX
fnp-5116	233	37	associated	associate	VERB
fnp-5116	233	38	with	with	ADP
fnp-5116	233	39	worse	bad	ADJ
fnp-5116	233	40	outcomes	outcome	NOUN
fnp-5116	233	41	[	[	X
fnp-5116	233	42	20	20	NUM
fnp-5116	233	43	,	,	PUNCT
fnp-5116	233	44	54	54	NUM
fnp-5116	233	45	]	]	PUNCT
fnp-5116	233	46	.	.	PUNCT
fnp-5116	234	1	one	one	NUM
fnp-5116	234	2	particular	particular	ADJ
fnp-5116	234	3	study	study	NOUN
fnp-5116	234	4	shows	show	VERB
fnp-5116	234	5	that	that	SCONJ
fnp-5116	234	6	while	while	SCONJ
fnp-5116	234	7	tumor	tumor	NOUN
fnp-5116	234	8	location	location	NOUN
fnp-5116	234	9	initially	initially	ADV
fnp-5116	234	10	appears	appear	VERB
fnp-5116	234	11	to	to	PART
fnp-5116	234	12	be	be	AUX
fnp-5116	234	13	a	a	DET
fnp-5116	234	14	strong	strong	ADJ
fnp-5116	234	15	prognosticator	prognosticator	NOUN
fnp-5116	234	16	,	,	PUNCT
fnp-5116	234	17	its	its	PRON
fnp-5116	234	18	significance	significance	NOUN
fnp-5116	234	19	diminishes	diminish	VERB
fnp-5116	234	20	when	when	SCONJ
fnp-5116	234	21	considering	consider	VERB
fnp-5116	234	22	the	the	DET
fnp-5116	234	23	extent	extent	NOUN
fnp-5116	234	24	of	of	ADP
fnp-5116	234	25	the	the	DET
fnp-5116	234	26	resection	resection	NOUN
fnp-5116	234	27	[	[	X
fnp-5116	234	28	55	55	NUM
fnp-5116	234	29	]	]	PUNCT
fnp-5116	234	30	.	.	PUNCT
fnp-5116	235	1	our	our	PRON
fnp-5116	235	2	analysis	analysis	NOUN
fnp-5116	235	3	failed	fail	VERB
fnp-5116	235	4	to	to	PART
fnp-5116	235	5	reveal	reveal	VERB
fnp-5116	235	6	a	a	DET
fnp-5116	235	7	statistically	statistically	ADV
fnp-5116	235	8	significant	significant	ADJ
fnp-5116	235	9	relationship	relationship	NOUN
fnp-5116	235	10	between	between	ADP
fnp-5116	235	11	location	location	NOUN
fnp-5116	235	12	and	and	CCONJ
fnp-5116	235	13	recurrence	recurrence	NOUN
fnp-5116	235	14	rate	rate	NOUN
fnp-5116	235	15	or	or	CCONJ
fnp-5116	235	16	rfs	rf	NOUN
fnp-5116	235	17	,	,	PUNCT
fnp-5116	235	18	despite	despite	SCONJ
fnp-5116	235	19	re	re	VERB
fnp-5116	235	20	-	-	ADJ
fnp-5116	235	21	categorizing	categorizing	ADJ
fnp-5116	235	22	cases	case	NOUN
fnp-5116	235	23	into	into	ADP
fnp-5116	235	24	narrower	narrow	ADJ
fnp-5116	235	25	,	,	PUNCT
fnp-5116	235	26	and	and	CCONJ
fnp-5116	235	27	later	later	ADV
fnp-5116	235	28	,	,	PUNCT
fnp-5116	235	29	two	two	NUM
fnp-5116	235	30	broad	broad	ADJ
fnp-5116	235	31	groups	group	NOUN
fnp-5116	235	32	"	"	PUNCT
fnp-5116	235	33	hypothalamo	hypothalamo	NOUN
fnp-5116	235	34	-	-	PUNCT
fnp-5116	235	35	suprachiasmatic	suprachiasmatic	ADJ
fnp-5116	235	36	+	+	CCONJ
fnp-5116	235	37	brainstem	brainstem	NOUN
fnp-5116	235	38	"	"	PUNCT
fnp-5116	235	39	and	and	CCONJ
fnp-5116	235	40	"	"	PUNCT
fnp-5116	235	41	other	other	ADJ
fnp-5116	235	42	locations	location	NOUN
fnp-5116	235	43	"	"	PUNCT
fnp-5116	235	44	.	.	PUNCT
fnp-5116	236	1	the	the	DET
fnp-5116	236	2	discrepancies	discrepancy	NOUN
fnp-5116	236	3	between	between	ADP
fnp-5116	236	4	our	our	PRON
fnp-5116	236	5	findings	finding	NOUN
fnp-5116	236	6	and	and	CCONJ
fnp-5116	236	7	those	those	PRON
fnp-5116	236	8	in	in	ADP
fnp-5116	236	9	other	other	ADJ
fnp-5116	236	10	studies	study	NOUN
fnp-5116	236	11	may	may	AUX
fnp-5116	236	12	be	be	AUX
fnp-5116	236	13	due	due	ADJ
fnp-5116	236	14	to	to	ADP
fnp-5116	236	15	the	the	DET
fnp-5116	236	16	acceptance	acceptance	NOUN
fnp-5116	236	17	of	of	ADP
fnp-5116	236	18	univariate	univariate	ADJ
fnp-5116	236	19	calculations	calculation	NOUN
fnp-5116	236	20	as	as	ADP
fnp-5116	236	21	significant	significant	ADJ
fnp-5116	236	22	,	,	PUNCT
fnp-5116	236	23	even	even	ADV
fnp-5116	236	24	though	though	SCONJ
fnp-5116	236	25	they	they	PRON
fnp-5116	236	26	may	may	AUX
fnp-5116	236	27	not	not	PART
fnp-5116	236	28	hold	hold	VERB
fnp-5116	236	29	up	up	ADP
fnp-5116	236	30	on	on	ADP
fnp-5116	236	31	multivariate	multivariate	NOUN
fnp-5116	236	32	analyses	analysis	NOUN
fnp-5116	236	33	when	when	SCONJ
fnp-5116	236	34	all	all	DET
fnp-5116	236	35	pertinent	pertinent	ADJ
fnp-5116	236	36	variables	variable	NOUN
fnp-5116	236	37	,	,	PUNCT
fnp-5116	236	38	especially	especially	ADV
fnp-5116	236	39	extent	extent	NOUN
fnp-5116	236	40	of	of	ADP
fnp-5116	236	41	resection	resection	NOUN
fnp-5116	236	42	,	,	PUNCT
fnp-5116	236	43	are	be	AUX
fnp-5116	236	44	considered	consider	VERB
fnp-5116	236	45	.	.	PUNCT
fnp-5116	237	1	another	another	DET
fnp-5116	237	2	problem	problem	NOUN
fnp-5116	237	3	is	be	AUX
fnp-5116	237	4	the	the	DET
fnp-5116	237	5	immediate	immediate	ADJ
fnp-5116	237	6	acceptance	acceptance	NOUN
fnp-5116	237	7	of	of	ADP
fnp-5116	237	8	p<0.05	p<0.05	NOUN
fnp-5116	237	9	as	as	ADP
fnp-5116	237	10	a	a	DET
fnp-5116	237	11	significant	significant	ADJ
fnp-5116	237	12	cut	cut	NOUN
fnp-5116	237	13	-	-	PUNCT
fnp-5116	237	14	off	off	NOUN
fnp-5116	237	15	to	to	PART
fnp-5116	237	16	determine	determine	VERB
fnp-5116	237	17	biologically	biologically	ADV
fnp-5116	237	18	meaningful	meaningful	ADJ
fnp-5116	237	19	differences	difference	NOUN
fnp-5116	237	20	[	[	X
fnp-5116	237	21	56	56	NUM
fnp-5116	237	22	-	-	SYM
fnp-5116	237	23	58	58	NUM
fnp-5116	237	24	]	]	PUNCT
fnp-5116	237	25	.	.	PUNCT
fnp-5116	238	1	yet	yet	ADV
fnp-5116	238	2	,	,	PUNCT
fnp-5116	238	3	a	a	DET
fnp-5116	238	4	series	series	NOUN
fnp-5116	238	5	of	of	ADP
fnp-5116	238	6	499	499	NUM
fnp-5116	238	7	patients	patient	NOUN
fnp-5116	238	8	may	may	AUX
fnp-5116	238	9	still	still	ADV
fnp-5116	238	10	be	be	AUX
fnp-5116	238	11	insufficient	insufficient	ADJ
fnp-5116	238	12	to	to	PART
fnp-5116	238	13	accurately	accurately	ADV
fnp-5116	238	14	determine	determine	VERB
fnp-5116	238	15	the	the	DET
fnp-5116	238	16	small	small	ADJ
fnp-5116	238	17	but	but	CCONJ
fnp-5116	238	18	significant	significant	ADJ
fnp-5116	238	19	effect	effect	NOUN
fnp-5116	238	20	of	of	ADP
fnp-5116	238	21	some	some	DET
fnp-5116	238	22	variables	variable	NOUN
fnp-5116	238	23	on	on	ADP
fnp-5116	238	24	outcome	outcome	NOUN
fnp-5116	238	25	.	.	PUNCT
fnp-5116	239	1	one	one	NUM
fnp-5116	239	2	critical	critical	ADJ
fnp-5116	239	3	issue	issue	NOUN
fnp-5116	239	4	in	in	ADP
fnp-5116	239	5	our	our	PRON
fnp-5116	239	6	study	study	NOUN
fnp-5116	239	7	is	be	AUX
fnp-5116	239	8	the	the	DET
fnp-5116	239	9	absence	absence	NOUN
fnp-5116	239	10	of	of	ADP
fnp-5116	239	11	patients	patient	NOUN
fnp-5116	239	12	who	who	PRON
fnp-5116	239	13	died	die	VERB
fnp-5116	239	14	due	due	ADP
fnp-5116	239	15	to	to	ADP
fnp-5116	239	16	their	their	PRON
fnp-5116	239	17	disease	disease	NOUN
fnp-5116	239	18	progression	progression	NOUN
fnp-5116	239	19	and	and	CCONJ
fnp-5116	239	20	presence	presence	NOUN
fnp-5116	239	21	of	of	ADP
fnp-5116	239	22	rare	rare	ADJ
fnp-5116	239	23	deaths	death	NOUN
fnp-5116	239	24	due	due	ADJ
fnp-5116	239	25	to	to	ADP
fnp-5116	239	26	other	other	ADJ
fnp-5116	239	27	factors	factor	NOUN
fnp-5116	239	28	.	.	PUNCT
fnp-5116	240	1	this	this	PRON
fnp-5116	240	2	could	could	AUX
fnp-5116	240	3	still	still	ADV
fnp-5116	240	4	reflect	reflect	VERB
fnp-5116	240	5	a	a	DET
fnp-5116	240	6	limitation	limitation	NOUN
fnp-5116	240	7	of	of	ADP
fnp-5116	240	8	sampling	sampling	NOUN
fnp-5116	240	9	,	,	PUNCT
fnp-5116	240	10	since	since	SCONJ
fnp-5116	240	11	earlier	early	ADJ
fnp-5116	240	12	studies	study	NOUN
fnp-5116	240	13	reported	report	VERB
fnp-5116	240	14	occasional	occasional	ADJ
fnp-5116	240	15	deaths	death	NOUN
fnp-5116	240	16	due	due	ADJ
fnp-5116	240	17	to	to	ADP
fnp-5116	240	18	disease	disease	NOUN
fnp-5116	240	19	progression	progression	NOUN
fnp-5116	240	20	in	in	ADP
fnp-5116	240	21	pa	pa	PROPN
fnp-5116	240	22	[	[	X
fnp-5116	240	23	59	59	NUM
fnp-5116	240	24	,	,	PUNCT
fnp-5116	240	25	60	60	NUM
fnp-5116	240	26	]	]	PUNCT
fnp-5116	240	27	.	.	PUNCT
fnp-5116	241	1	the	the	DET
fnp-5116	241	2	reported	report	VERB
fnp-5116	241	3	deaths	death	NOUN
fnp-5116	241	4	may	may	AUX
fnp-5116	241	5	obviously	obviously	ADV
fnp-5116	241	6	be	be	AUX
fnp-5116	241	7	associated	associate	VERB
fnp-5116	241	8	with	with	ADP
fnp-5116	241	9	confounding	confound	VERB
fnp-5116	241	10	factors	factor	NOUN
fnp-5116	241	11	(	(	PUNCT
fnp-5116	241	12	such	such	ADJ
fnp-5116	241	13	as	as	ADP
fnp-5116	241	14	radiation	radiation	NOUN
fnp-5116	241	15	treatment	treatment	NOUN
fnp-5116	241	16	or	or	CCONJ
fnp-5116	241	17	pathological	pathological	ADJ
fnp-5116	241	18	misclassification	misclassification	NOUN
fnp-5116	241	19	)	)	PUNCT
fnp-5116	241	20	or	or	CCONJ
fnp-5116	241	21	with	with	ADP
fnp-5116	241	22	the	the	DET
fnp-5116	241	23	assumption	assumption	NOUN
fnp-5116	241	24	that	that	SCONJ
fnp-5116	241	25	the	the	DET
fnp-5116	241	26	death	death	NOUN
fnp-5116	241	27	of	of	ADP
fnp-5116	241	28	a	a	DET
fnp-5116	241	29	patient	patient	NOUN
fnp-5116	241	30	is	be	AUX
fnp-5116	241	31	always	always	ADV
fnp-5116	241	32	a	a	DET
fnp-5116	241	33	consequence	consequence	NOUN
fnp-5116	241	34	of	of	ADP
fnp-5116	241	35	disease	disease	NOUN
fnp-5116	241	36	progression	progression	NOUN
fnp-5116	241	37	.	.	PUNCT
fnp-5116	242	1	our	our	PRON
fnp-5116	242	2	data	datum	NOUN
fnp-5116	242	3	is	be	AUX
fnp-5116	242	4	sourced	source	VERB
fnp-5116	242	5	from	from	ADP
fnp-5116	242	6	a	a	DET
fnp-5116	242	7	single	single	ADJ
fnp-5116	242	8	referral	referral	ADJ
fnp-5116	242	9	center	center	NOUN
fnp-5116	242	10	which	which	PRON
fnp-5116	242	11	minimizes	minimize	VERB
fnp-5116	242	12	certain	certain	ADJ
fnp-5116	242	13	confounding	confound	VERB
fnp-5116	242	14	factors	factor	NOUN
fnp-5116	242	15	,	,	PUNCT
fnp-5116	242	16	allowing	allow	VERB
fnp-5116	242	17	for	for	ADP
fnp-5116	242	18	a	a	DET
fnp-5116	242	19	more	more	ADV
fnp-5116	242	20	streamlined	streamlined	ADJ
fnp-5116	242	21	analysis	analysis	NOUN
fnp-5116	242	22	.	.	PUNCT
fnp-5116	243	1	however	however	ADV
fnp-5116	243	2	,	,	PUNCT
fnp-5116	243	3	the	the	DET
fnp-5116	243	4	data	datum	NOUN
fnp-5116	243	5	are	be	AUX
fnp-5116	243	6	not	not	PART
fnp-5116	243	7	associated	associate	VERB
fnp-5116	243	8	with	with	ADP
fnp-5116	243	9	an	an	DET
fnp-5116	243	10	epidemiologically	epidemiologically	ADV
fnp-5116	243	11	relevant	relevant	ADJ
fnp-5116	243	12	catchment	catchment	NOUN
fnp-5116	243	13	area	area	NOUN
fnp-5116	243	14	and	and	CCONJ
fnp-5116	243	15	may	may	AUX
fnp-5116	243	16	have	have	VERB
fnp-5116	243	17	selection	selection	NOUN
fnp-5116	243	18	bias	bias	NOUN
fnp-5116	243	19	due	due	ADP
fnp-5116	243	20	to	to	ADP
fnp-5116	243	21	the	the	DET
fnp-5116	243	22	fact	fact	NOUN
fnp-5116	243	23	that	that	SCONJ
fnp-5116	243	24	our	our	PRON
fnp-5116	243	25	institution	institution	NOUN
fnp-5116	243	26	is	be	AUX
fnp-5116	243	27	a	a	DET
fnp-5116	243	28	major	major	ADJ
fnp-5116	243	29	national	national	ADJ
fnp-5116	243	30	and	and	CCONJ
fnp-5116	243	31	international	international	ADJ
fnp-5116	243	32	referral	referral	ADJ
fnp-5116	243	33	center	center	NOUN
fnp-5116	243	34	.	.	PUNCT
fnp-5116	244	1	therefore	therefore	ADV
fnp-5116	244	2	,	,	PUNCT
fnp-5116	244	3	our	our	PRON
fnp-5116	244	4	findings	finding	NOUN
fnp-5116	244	5	need	need	VERB
fnp-5116	244	6	further	further	ADJ
fnp-5116	244	7	validation	validation	NOUN
fnp-5116	244	8	by	by	ADP
fnp-5116	244	9	large	large	ADJ
fnp-5116	244	10	,	,	PUNCT
fnp-5116	244	11	and	and	CCONJ
fnp-5116	244	12	multi	multi	ADJ
fnp-5116	244	13	-	-	ADJ
fnp-5116	244	14	institutional	institutional	ADJ
fnp-5116	244	15	and	and	CCONJ
fnp-5116	244	16	epidemiologically	epidemiologically	ADJ
fnp-5116	244	17	relevant	relevant	ADJ
fnp-5116	244	18	studies	study	NOUN
fnp-5116	244	19	.	.	PUNCT
fnp-5116	245	1	influence	influence	NOUN
fnp-5116	245	2	of	of	ADP
fnp-5116	245	3	histological	histological	ADJ
fnp-5116	245	4	features	feature	NOUN
fnp-5116	245	5	on	on	ADP
fnp-5116	245	6	the	the	DET
fnp-5116	245	7	course	course	NOUN
fnp-5116	245	8	of	of	ADP
fnp-5116	245	9	the	the	DET
fnp-5116	245	10	disease	disease	NOUN
fnp-5116	245	11	has	have	AUX
fnp-5116	245	12	always	always	ADV
fnp-5116	245	13	been	be	AUX
fnp-5116	245	14	a	a	DET
fnp-5116	245	15	debate	debate	NOUN
fnp-5116	245	16	in	in	ADP
fnp-5116	245	17	the	the	DET
fnp-5116	245	18	literature	literature	NOUN
fnp-5116	245	19	as	as	ADV
fnp-5116	245	20	well	well	ADV
fnp-5116	245	21	as	as	ADP
fnp-5116	245	22	the	the	DET
fnp-5116	245	23	criteria	criterion	NOUN
fnp-5116	245	24	for	for	ADP
fnp-5116	245	25	histological	histological	ADJ
fnp-5116	245	26	anaplasia	anaplasia	PROPN
fnp-5116	245	27	.	.	PUNCT
fnp-5116	246	1	who	who	PRON
fnp-5116	246	2	defines	define	VERB
fnp-5116	246	3	pa	pa	PROPN
fnp-5116	246	4	with	with	ADP
fnp-5116	246	5	histologic	histologic	ADJ
fnp-5116	246	6	features	feature	NOUN
fnp-5116	246	7	of	of	ADP
fnp-5116	246	8	anaplasia	anaplasia	NOUN
fnp-5116	246	9	as	as	ADP
fnp-5116	246	10	pa	pa	PROPN
fnp-5116	246	11	with	with	ADP
fnp-5116	246	12	brisk	brisk	ADJ
fnp-5116	246	13	mitotic	mitotic	ADJ
fnp-5116	246	14	activity	activity	NOUN
fnp-5116	246	15	with	with	ADP
fnp-5116	246	16	or	or	CCONJ
fnp-5116	246	17	without	without	ADP
fnp-5116	246	18	necrosis	necrosis	NOUN
fnp-5116	246	19	.	.	PUNCT
fnp-5116	247	1	while	while	SCONJ
fnp-5116	247	2	there	there	PRON
fnp-5116	247	3	exist	exist	VERB
fnp-5116	247	4	a	a	DET
fnp-5116	247	5	handful	handful	NOUN
fnp-5116	247	6	of	of	ADP
fnp-5116	247	7	studies	study	NOUN
fnp-5116	247	8	suggesting	suggest	VERB
fnp-5116	247	9	an	an	DET
fnp-5116	247	10	association	association	NOUN
fnp-5116	247	11	between	between	ADP
fnp-5116	247	12	histological	histological	ADJ
fnp-5116	247	13	anaplasia	anaplasia	PROPN
fnp-5116	247	14	in	in	ADP
fnp-5116	247	15	pa	pa	PROPN
fnp-5116	247	16	and	and	CCONJ
fnp-5116	247	17	unfavorable	unfavorable	ADJ
fnp-5116	247	18	outcome	outcome	NOUN
fnp-5116	247	19	[	[	X
fnp-5116	247	20	61	61	NUM
fnp-5116	247	21	,	,	PUNCT
fnp-5116	247	22	62	62	NUM
fnp-5116	247	23	]	]	PUNCT
fnp-5116	247	24	,	,	PUNCT
fnp-5116	247	25	our	our	PRON
fnp-5116	247	26	findings	finding	NOUN
fnp-5116	247	27	failed	fail	VERB
fnp-5116	247	28	to	to	PART
fnp-5116	247	29	provide	provide	VERB
fnp-5116	247	30	substantial	substantial	ADJ
fnp-5116	247	31	evidence	evidence	NOUN
fnp-5116	247	32	to	to	PART
fnp-5116	247	33	support	support	VERB
fnp-5116	247	34	or	or	CCONJ
fnp-5116	247	35	refute	refute	VERB
fnp-5116	247	36	these	these	DET
fnp-5116	247	37	claims	claim	NOUN
fnp-5116	247	38	.	.	PUNCT
fnp-5116	248	1	in	in	ADP
fnp-5116	248	2	our	our	PRON
fnp-5116	248	3	series	series	NOUN
fnp-5116	248	4	,	,	PUNCT
fnp-5116	248	5	we	we	PRON
fnp-5116	248	6	had	have	VERB
fnp-5116	248	7	only	only	ADV
fnp-5116	248	8	6	6	NUM
fnp-5116	248	9	cases	case	NOUN
fnp-5116	248	10	(	(	PUNCT
fnp-5116	248	11	among	among	ADP
fnp-5116	248	12	499	499	NUM
fnp-5116	248	13	)	)	PUNCT
fnp-5116	248	14	with	with	ADP
fnp-5116	248	15	histologic	histologic	ADJ
fnp-5116	248	16	features	feature	NOUN
fnp-5116	248	17	of	of	ADP
fnp-5116	248	18	anaplasia	anaplasia	NOUN
fnp-5116	248	19	,	,	PUNCT
fnp-5116	248	20	a	a	DET
fnp-5116	248	21	sample	sample	NOUN
fnp-5116	248	22	size	size	NOUN
fnp-5116	248	23	insufficient	insufficient	ADJ
fnp-5116	248	24	for	for	ADP
fnp-5116	248	25	meaningful	meaningful	ADJ
fnp-5116	248	26	comparison	comparison	NOUN
fnp-5116	248	27	.	.	PUNCT
fnp-5116	249	1	these	these	DET
fnp-5116	249	2	six	six	NUM
fnp-5116	249	3	patients	patient	NOUN
fnp-5116	249	4	were	be	AUX
fnp-5116	249	5	adults	adult	NOUN
fnp-5116	249	6	,	,	PUNCT
fnp-5116	249	7	with	with	ADP
fnp-5116	249	8	a	a	DET
fnp-5116	249	9	mean	mean	ADJ
fnp-5116	249	10	age	age	NOUN
fnp-5116	249	11	of	of	ADP
fnp-5116	249	12	46.2	46.2	NUM
fnp-5116	249	13	,	,	PUNCT
fnp-5116	249	14	ranging	range	VERB
fnp-5116	249	15	from	from	ADP
fnp-5116	249	16	27	27	NUM
fnp-5116	249	17	to	to	PART
fnp-5116	249	18	72	72	NUM
fnp-5116	249	19	years	year	NOUN
fnp-5116	249	20	old	old	ADJ
fnp-5116	249	21	.	.	PUNCT
fnp-5116	250	1	four	four	NUM
fnp-5116	250	2	tumors	tumor	NOUN
fnp-5116	250	3	were	be	AUX
fnp-5116	250	4	located	locate	VERB
fnp-5116	250	5	in	in	ADP
fnp-5116	250	6	posterior	posterior	ADJ
fnp-5116	250	7	fossa	fossa	NOUN
fnp-5116	250	8	whereas	whereas	SCONJ
fnp-5116	250	9	two	two	NUM
fnp-5116	250	10	were	be	AUX
fnp-5116	250	11	hemispheric	hemispheric	ADJ
fnp-5116	250	12	.	.	PUNCT
fnp-5116	251	1	of	of	ADP
fnp-5116	251	2	these	these	DET
fnp-5116	251	3	cases	case	NOUN
fnp-5116	251	4	,	,	PUNCT
fnp-5116	251	5	five	five	NUM
fnp-5116	251	6	tumors	tumor	NOUN
fnp-5116	251	7	were	be	AUX
fnp-5116	251	8	analyzed	analyze	VERB
fnp-5116	251	9	by	by	ADP
fnp-5116	251	10	ucsf500	ucsf500	PROPN
fnp-5116	251	11	ngs	ng	NOUN
fnp-5116	251	12	platform	platform	NOUN
fnp-5116	251	13	and	and	CCONJ
fnp-5116	251	14	four	four	NUM
fnp-5116	251	15	of	of	ADP
fnp-5116	251	16	them	they	PRON
fnp-5116	251	17	revealed	reveal	VERB
fnp-5116	251	18	a	a	DET
fnp-5116	251	19	cdkn2a	cdkn2a	ADJ
fnp-5116	251	20	loss	loss	NOUN
fnp-5116	251	21	.	.	PUNCT
fnp-5116	252	1	as	as	SCONJ
fnp-5116	252	2	stated	state	VERB
fnp-5116	252	3	in	in	ADP
fnp-5116	252	4	the	the	DET
fnp-5116	252	5	result	result	NOUN
fnp-5116	252	6	section	section	NOUN
fnp-5116	252	7	,	,	PUNCT
fnp-5116	252	8	all	all	DET
fnp-5116	252	9	four	four	NUM
fnp-5116	252	10	cases	case	NOUN
fnp-5116	252	11	with	with	ADP
fnp-5116	252	12	cdkn2a	cdkn2a	ADJ
fnp-5116	252	13	loss	loss	NOUN
fnp-5116	252	14	had	have	VERB
fnp-5116	252	15	histological	histological	ADJ
fnp-5116	252	16	features	feature	NOUN
fnp-5116	252	17	of	of	ADP
fnp-5116	252	18	anaplasia	anaplasia	PROPN
fnp-5116	252	19	.	.	PUNCT
fnp-5116	253	1	although	although	SCONJ
fnp-5116	253	2	there	there	PRON
fnp-5116	253	3	seems	seem	VERB
fnp-5116	253	4	to	to	PART
fnp-5116	253	5	be	be	AUX
fnp-5116	253	6	an	an	DET
fnp-5116	253	7	association	association	NOUN
fnp-5116	253	8	between	between	ADP
fnp-5116	253	9	cdkn2a	cdkn2a	PROPN
fnp-5116	253	10	loss	loss	NOUN
fnp-5116	253	11	and	and	CCONJ
fnp-5116	253	12	histological	histological	ADJ
fnp-5116	253	13	features	feature	NOUN
fnp-5116	253	14	of	of	ADP
fnp-5116	253	15	anaplasia	anaplasia	NOUN
fnp-5116	253	16	,	,	PUNCT
fnp-5116	253	17	small	small	ADJ
fnp-5116	253	18	number	number	NOUN
fnp-5116	253	19	of	of	ADP
fnp-5116	253	20	cases	case	NOUN
fnp-5116	253	21	prevent	prevent	VERB
fnp-5116	253	22	a	a	DET
fnp-5116	253	23	meaningful	meaningful	ADJ
fnp-5116	253	24	and	and	CCONJ
fnp-5116	253	25	statistically	statistically	ADV
fnp-5116	253	26	significant	significant	ADJ
fnp-5116	253	27	conclusion	conclusion	NOUN
fnp-5116	253	28	.	.	PUNCT
fnp-5116	254	1	in	in	ADP
fnp-5116	254	2	our	our	PRON
fnp-5116	254	3	series	series	NOUN
fnp-5116	254	4	,	,	PUNCT
fnp-5116	254	5	we	we	PRON
fnp-5116	254	6	identified	identify	VERB
fnp-5116	254	7	6	6	NUM
fnp-5116	254	8	cases	case	NOUN
fnp-5116	254	9	of	of	ADP
fnp-5116	254	10	pma	pma	NOUN
fnp-5116	254	11	,	,	PUNCT
fnp-5116	254	12	which	which	PRON
fnp-5116	254	13	suggests	suggest	VERB
fnp-5116	254	14	that	that	SCONJ
fnp-5116	254	15	the	the	DET
fnp-5116	254	16	prevalence	prevalence	NOUN
fnp-5116	254	17	of	of	ADP
fnp-5116	254	18	pma	pma	NOUN
fnp-5116	254	19	among	among	ADP
fnp-5116	254	20	pilocytic	pilocytic	ADJ
fnp-5116	254	21	tumors	tumor	NOUN
fnp-5116	254	22	is	be	AUX
fnp-5116	254	23	only	only	ADV
fnp-5116	254	24	around	around	ADV
fnp-5116	254	25	1	1	NUM
fnp-5116	254	26	%	%	NOUN
fnp-5116	254	27	,	,	PUNCT
fnp-5116	254	28	also	also	ADV
fnp-5116	254	29	supported	support	VERB
fnp-5116	254	30	by	by	ADP
fnp-5116	254	31	earlier	early	ADJ
fnp-5116	254	32	studies	study	NOUN
fnp-5116	254	33	[	[	X
fnp-5116	254	34	29	29	NUM
fnp-5116	254	35	,	,	PUNCT
fnp-5116	254	36	63	63	NUM
fnp-5116	254	37	]	]	PUNCT
fnp-5116	254	38	.	.	PUNCT
fnp-5116	255	1	the	the	DET
fnp-5116	255	2	overall	overall	ADJ
fnp-5116	255	3	ratio	ratio	NOUN
fnp-5116	255	4	and	and	CCONJ
fnp-5116	255	5	diagnostic	diagnostic	ADJ
fnp-5116	255	6	criteria	criterion	NOUN
fnp-5116	255	7	of	of	ADP
fnp-5116	255	8	pma	pma	NOUN
fnp-5116	255	9	and	and	CCONJ
fnp-5116	255	10	pa	pa	PROPN
fnp-5116	255	11	with	with	ADP
fnp-5116	255	12	anaplastic	anaplastic	ADJ
fnp-5116	255	13	features	feature	NOUN
fnp-5116	255	14	have	have	AUX
fnp-5116	255	15	been	be	AUX
fnp-5116	255	16	quite	quite	ADV
fnp-5116	255	17	variable	variable	ADJ
fnp-5116	255	18	,	,	PUNCT
fnp-5116	255	19	and	and	CCONJ
fnp-5116	255	20	some	some	DET
fnp-5116	255	21	published	publish	VERB
fnp-5116	255	22	studies	study	NOUN
fnp-5116	255	23	reported	report	VERB
fnp-5116	255	24	a	a	DET
fnp-5116	255	25	rate	rate	NOUN
fnp-5116	255	26	of	of	ADP
fnp-5116	255	27	8	8	NUM
fnp-5116	255	28	-	-	SYM
fnp-5116	255	29	20	20	NUM
fnp-5116	255	30	%	%	NOUN
fnp-5116	255	31	of	of	ADP
fnp-5116	255	32	pma	pma	NOUN
fnp-5116	255	33	among	among	ADP
fnp-5116	255	34	their	their	PRON
fnp-5116	255	35	pa	pa	PROPN
fnp-5116	255	36	cases	case	NOUN
fnp-5116	255	37	[	[	X
fnp-5116	255	38	63	63	NUM
fnp-5116	255	39	-	-	SYM
fnp-5116	255	40	65	65	NUM
fnp-5116	255	41	]	]	PUNCT
fnp-5116	255	42	.	.	PUNCT
fnp-5116	256	1	this	this	PRON
fnp-5116	256	2	may	may	AUX
fnp-5116	256	3	reflect	reflect	VERB
fnp-5116	256	4	the	the	DET
fnp-5116	256	5	challenges	challenge	NOUN
fnp-5116	256	6	of	of	ADP
fnp-5116	256	7	making	make	VERB
fnp-5116	256	8	the	the	DET
fnp-5116	256	9	diagnosis	diagnosis	NOUN
fnp-5116	256	10	or	or	CCONJ
fnp-5116	256	11	the	the	DET
fnp-5116	256	12	variations	variation	NOUN
fnp-5116	256	13	in	in	ADP
fnp-5116	256	14	histological	histological	ADJ
fnp-5116	256	15	criteria	criterion	NOUN
fnp-5116	256	16	for	for	ADP
fnp-5116	256	17	pma	pma	NOUN
fnp-5116	256	18	.	.	PUNCT
fnp-5116	257	1	we	we	PRON
fnp-5116	257	2	believe	believe	VERB
fnp-5116	257	3	that	that	SCONJ
fnp-5116	257	4	pma	pma	PROPN
fnp-5116	257	5	is	be	AUX
fnp-5116	257	6	typically	typically	ADV
fnp-5116	257	7	a	a	DET
fnp-5116	257	8	tumor	tumor	NOUN
fnp-5116	257	9	of	of	ADP
fnp-5116	257	10	young	young	ADJ
fnp-5116	257	11	age	age	NOUN
fnp-5116	257	12	and	and	CCONJ
fnp-5116	257	13	hypothalamic	hypothalamic	ADJ
fnp-5116	257	14	/	/	SYM
fnp-5116	257	15	chiasmatic	chiasmatic	ADJ
fnp-5116	257	16	location	location	NOUN
fnp-5116	257	17	with	with	ADP
fnp-5116	257	18	monomorphous	monomorphous	ADJ
fnp-5116	257	19	histological	histological	ADJ
fnp-5116	257	20	features	feature	NOUN
fnp-5116	257	21	and	and	CCONJ
fnp-5116	257	22	deviations	deviation	NOUN
fnp-5116	257	23	from	from	ADP
fnp-5116	257	24	this	this	DET
fnp-5116	257	25	typical	typical	ADJ
fnp-5116	257	26	spectrum	spectrum	NOUN
fnp-5116	257	27	should	should	AUX
fnp-5116	257	28	be	be	AUX
fnp-5116	257	29	interpreted	interpret	VERB
fnp-5116	257	30	with	with	ADP
fnp-5116	257	31	caution	caution	NOUN
fnp-5116	257	32	[	[	X
fnp-5116	257	33	63	63	NUM
fnp-5116	257	34	,	,	PUNCT
fnp-5116	257	35	65	65	NUM
fnp-5116	257	36	]	]	PUNCT
fnp-5116	257	37	.	.	PUNCT
fnp-5116	258	1	this	this	PRON
fnp-5116	258	2	could	could	AUX
fnp-5116	258	3	be	be	AUX
fnp-5116	258	4	the	the	DET
fnp-5116	258	5	reason	reason	NOUN
fnp-5116	258	6	some	some	DET
fnp-5116	258	7	studies	study	NOUN
fnp-5116	258	8	did	do	AUX
fnp-5116	258	9	not	not	PART
fnp-5116	258	10	identify	identify	VERB
fnp-5116	258	11	significant	significant	ADJ
fnp-5116	258	12	prognostic	prognostic	ADJ
fnp-5116	258	13	differences	difference	NOUN
fnp-5116	258	14	between	between	ADP
fnp-5116	258	15	tumors	tumor	NOUN
fnp-5116	258	16	designated	designate	VERB
fnp-5116	258	17	as	as	ADP
fnp-5116	258	18	pma	pma	NOUN
fnp-5116	258	19	and	and	CCONJ
fnp-5116	258	20	pa	pa	PROPN
fnp-5116	259	1	[	[	X
fnp-5116	259	2	64	64	NUM
fnp-5116	259	3	,	,	PUNCT
fnp-5116	259	4	66	66	NUM
fnp-5116	259	5	]	]	PUNCT
fnp-5116	259	6	.	.	PUNCT
fnp-5116	260	1	molecular	molecular	ADJ
fnp-5116	260	2	studies	study	NOUN
fnp-5116	260	3	have	have	AUX
fnp-5116	260	4	consistently	consistently	ADV
fnp-5116	260	5	demonstrated	demonstrate	VERB
fnp-5116	260	6	activation	activation	NOUN
fnp-5116	260	7	of	of	ADP
fnp-5116	260	8	the	the	DET
fnp-5116	260	9	mapk	mapk	NOUN
fnp-5116	260	10	pathway	pathway	NOUN
fnp-5116	260	11	in	in	ADP
fnp-5116	260	12	all	all	DET
fnp-5116	260	13	cases	case	NOUN
fnp-5116	260	14	of	of	ADP
fnp-5116	260	15	pa	pa	PROPN
fnp-5116	260	16	.	.	PUNCT
fnp-5116	261	1	the	the	DET
fnp-5116	261	2	most	most	ADV
fnp-5116	261	3	prevalent	prevalent	ADJ
fnp-5116	261	4	genetic	genetic	ADJ
fnp-5116	261	5	alteration	alteration	NOUN
fnp-5116	261	6	involves	involve	VERB
fnp-5116	261	7	kinase	kinase	PROPN
fnp-5116	261	8	domain	domain	NOUN
fnp-5116	261	9	duplication	duplication	NOUN
fnp-5116	261	10	and	and	CCONJ
fnp-5116	261	11	fusion	fusion	NOUN
fnp-5116	261	12	of	of	ADP
fnp-5116	261	13	the	the	DET
fnp-5116	261	14	braf	braf	NOUN
fnp-5116	261	15	gene	gene	NOUN
fnp-5116	261	16	with	with	ADP
fnp-5116	261	17	kiaa1549	kiaa1549	PROPN
fnp-5116	261	18	.	.	PUNCT
fnp-5116	262	1	other	other	ADJ
fnp-5116	262	2	alterations	alteration	NOUN
fnp-5116	262	3	seen	see	VERB
fnp-5116	262	4	in	in	ADP
fnp-5116	262	5	pa	pa	PROPN
fnp-5116	262	6	are	be	AUX
fnp-5116	262	7	brafv600e	brafv600e	VERB
fnp-5116	262	8	mutations	mutation	NOUN
fnp-5116	262	9	,	,	PUNCT
fnp-5116	262	10	fgfr1	fgfr1	NOUN
fnp-5116	262	11	alterations	alteration	NOUN
fnp-5116	262	12	,	,	PUNCT
fnp-5116	262	13	nf1	nf1	NOUN
fnp-5116	262	14	alterations	alteration	NOUN
fnp-5116	262	15	and	and	CCONJ
fnp-5116	262	16	also	also	ADV
fnp-5116	262	17	rare	rare	ADJ
fnp-5116	262	18	alterations	alteration	NOUN
fnp-5116	262	19	in	in	ADP
fnp-5116	262	20	other	other	ADJ
fnp-5116	262	21	components	component	NOUN
fnp-5116	262	22	of	of	ADP
fnp-5116	262	23	mapk	mapk	NOUN
fnp-5116	262	24	pathway	pathway	NOUN
fnp-5116	262	25	.	.	PUNCT
fnp-5116	263	1	fgfr1	fgfr1	NOUN
fnp-5116	263	2	alterations	alteration	NOUN
fnp-5116	263	3	are	be	AUX
fnp-5116	263	4	highly	highly	ADV
fnp-5116	263	5	enriched	enriched	ADJ
fnp-5116	263	6	in	in	ADP
fnp-5116	263	7	supratentorial	supratentorial	ADJ
fnp-5116	263	8	tumors	tumor	NOUN
fnp-5116	263	9	,	,	PUNCT
fnp-5116	263	10	but	but	CCONJ
fnp-5116	263	11	spinal	spinal	NOUN
fnp-5116	263	12	and	and	CCONJ
fnp-5116	263	13	cerebellar	cerebellar	ADJ
fnp-5116	263	14	tumors	tumor	NOUN
fnp-5116	263	15	also	also	ADV
fnp-5116	263	16	showed	show	VERB
fnp-5116	263	17	this	this	DET
fnp-5116	263	18	molecular	molecular	ADJ
fnp-5116	263	19	alteration	alteration	NOUN
fnp-5116	263	20	,	,	PUNCT
fnp-5116	263	21	as	as	SCONJ
fnp-5116	263	22	observed	observe	VERB
fnp-5116	263	23	in	in	ADP
fnp-5116	263	24	previous	previous	ADJ
fnp-5116	263	25	series	series	NOUN
fnp-5116	263	26	[	[	X
fnp-5116	263	27	33	33	NUM
fnp-5116	263	28	,	,	PUNCT
fnp-5116	263	29	67	67	NUM
fnp-5116	263	30	]	]	PUNCT
fnp-5116	263	31	.	.	PUNCT
fnp-5116	264	1	many	many	ADJ
fnp-5116	264	2	reports	report	NOUN
fnp-5116	264	3	showed	show	VERB
fnp-5116	264	4	evidence	evidence	NOUN
fnp-5116	264	5	that	that	SCONJ
fnp-5116	264	6	molecular	molecular	ADJ
fnp-5116	264	7	features	feature	NOUN
fnp-5116	264	8	such	such	ADJ
fnp-5116	264	9	as	as	ADP
fnp-5116	264	10	tert	tert	NOUN
fnp-5116	264	11	promoter	promoter	NOUN
fnp-5116	264	12	mutation	mutation	NOUN
fnp-5116	264	13	,	,	PUNCT
fnp-5116	264	14	cdkn2a	cdkn2a	PROPN
fnp-5116	264	15	loss	loss	NOUN
fnp-5116	264	16	,	,	PUNCT
fnp-5116	264	17	tp53	tp53	PROPN
fnp-5116	264	18	mutation	mutation	NOUN
fnp-5116	264	19	,	,	PUNCT
fnp-5116	264	20	or	or	CCONJ
fnp-5116	264	21	chromosomal	chromosomal	ADJ
fnp-5116	264	22	copy	copy	NOUN
fnp-5116	264	23	number	number	NOUN
fnp-5116	264	24	alterations	alteration	NOUN
fnp-5116	264	25	may	may	AUX
fnp-5116	264	26	be	be	AUX
fnp-5116	264	27	associated	associate	VERB
fnp-5116	264	28	with	with	ADP
fnp-5116	264	29	adverse	adverse	ADJ
fnp-5116	264	30	clinical	clinical	ADJ
fnp-5116	264	31	outcome	outcome	NOUN
fnp-5116	264	32	[	[	X
fnp-5116	264	33	68	68	NUM
fnp-5116	264	34	-	-	SYM
fnp-5116	264	35	71	71	NUM
fnp-5116	264	36	]	]	PUNCT
fnp-5116	264	37	.	.	PUNCT
fnp-5116	265	1	in	in	ADP
fnp-5116	265	2	our	our	PRON
fnp-5116	265	3	series	series	NOUN
fnp-5116	265	4	,	,	PUNCT
fnp-5116	265	5	we	we	PRON
fnp-5116	265	6	were	be	AUX
fnp-5116	265	7	unable	unable	ADJ
fnp-5116	265	8	to	to	PART
fnp-5116	265	9	identify	identify	VERB
fnp-5116	265	10	a	a	DET
fnp-5116	265	11	meaningful	meaningful	ADJ
fnp-5116	265	12	association	association	NOUN
fnp-5116	265	13	between	between	ADP
fnp-5116	265	14	molecular	molecular	ADJ
fnp-5116	265	15	alterations	alteration	NOUN
fnp-5116	265	16	and	and	CCONJ
fnp-5116	265	17	rfs	rfs	PROPN
fnp-5116	265	18	.	.	PROPN
fnp-5116	265	19	whole	whole	ADJ
fnp-5116	265	20	or	or	CCONJ
fnp-5116	265	21	partial	partial	ADJ
fnp-5116	265	22	chromosome	chromosome	NOUN
fnp-5116	265	23	copy	copy	NOUN
fnp-5116	265	24	number	number	NOUN
fnp-5116	265	25	alterations	alteration	NOUN
fnp-5116	265	26	could	could	AUX
fnp-5116	265	27	not	not	PART
fnp-5116	265	28	be	be	AUX
fnp-5116	265	29	correlated	correlate	VERB
fnp-5116	265	30	with	with	ADP
fnp-5116	265	31	outcome	outcome	NOUN
fnp-5116	265	32	either	either	ADV
fnp-5116	265	33	.	.	PUNCT
fnp-5116	266	1	this	this	PRON
fnp-5116	266	2	was	be	AUX
fnp-5116	266	3	partially	partially	ADV
fnp-5116	266	4	due	due	ADJ
fnp-5116	266	5	to	to	ADP
fnp-5116	266	6	small	small	ADJ
fnp-5116	266	7	numbers	number	NOUN
fnp-5116	266	8	and	and	CCONJ
fnp-5116	266	9	partly	partly	ADV
fnp-5116	266	10	due	due	ADJ
fnp-5116	266	11	to	to	ADP
fnp-5116	266	12	short	short	ADJ
fnp-5116	266	13	follow	follow	NOUN
fnp-5116	266	14	-	-	PUNCT
fnp-5116	266	15	up	up	NOUN
fnp-5116	266	16	times	time	NOUN
fnp-5116	266	17	for	for	ADP
fnp-5116	266	18	tumors	tumor	NOUN
fnp-5116	266	19	with	with	ADP
fnp-5116	266	20	comprehensive	comprehensive	ADJ
fnp-5116	266	21	molecular	molecular	ADJ
fnp-5116	266	22	analysis	analysis	NOUN
fnp-5116	266	23	since	since	SCONJ
fnp-5116	266	24	such	such	ADJ
fnp-5116	266	25	analyses	analysis	NOUN
fnp-5116	266	26	began	begin	VERB
fnp-5116	266	27	only	only	ADV
fnp-5116	266	28	in	in	ADP
fnp-5116	266	29	recent	recent	ADJ
fnp-5116	266	30	years	year	NOUN
fnp-5116	266	31	.	.	PUNCT
fnp-5116	267	1	analysis	analysis	NOUN
fnp-5116	267	2	of	of	ADP
fnp-5116	267	3	impact	impact	NOUN
fnp-5116	267	4	of	of	ADP
fnp-5116	267	5	molecular	molecular	ADJ
fnp-5116	267	6	alterations	alteration	NOUN
fnp-5116	267	7	including	include	VERB
fnp-5116	267	8	copy	copy	NOUN
fnp-5116	267	9	number	number	NOUN
fnp-5116	267	10	variations	variation	NOUN
fnp-5116	267	11	are	be	AUX
fnp-5116	267	12	more	more	ADV
fnp-5116	267	13	likely	likely	ADJ
fnp-5116	267	14	to	to	PART
fnp-5116	267	15	provide	provide	VERB
fnp-5116	267	16	meaningful	meaningful	ADJ
fnp-5116	267	17	results	result	NOUN
fnp-5116	267	18	in	in	ADP
fnp-5116	267	19	future	future	ADJ
fnp-5116	267	20	studies	study	NOUN
fnp-5116	267	21	with	with	ADP
fnp-5116	267	22	longer	long	ADJ
fnp-5116	267	23	follow	follow	VERB
fnp-5116	267	24	-	-	PUNCT
fnp-5116	267	25	up	up	ADP
fnp-5116	267	26	terms	term	NOUN
fnp-5116	267	27	and	and	CCONJ
fnp-5116	267	28	larger	large	ADJ
fnp-5116	267	29	number	number	NOUN
fnp-5116	267	30	of	of	ADP
fnp-5116	267	31	patients	patient	NOUN
fnp-5116	267	32	.	.	PUNCT
fnp-5116	268	1	while	while	SCONJ
fnp-5116	268	2	molecular	molecular	ADJ
fnp-5116	268	3	alterations	alteration	NOUN
fnp-5116	268	4	help	help	VERB
fnp-5116	268	5	in	in	ADP
fnp-5116	268	6	establishing	establish	VERB
fnp-5116	268	7	the	the	DET
fnp-5116	268	8	diagnosis	diagnosis	NOUN
fnp-5116	268	9	in	in	ADP
fnp-5116	268	10	pa	pa	PROPN
fnp-5116	268	11	,	,	PUNCT
fnp-5116	268	12	their	their	PRON
fnp-5116	268	13	association	association	NOUN
fnp-5116	268	14	with	with	ADP
fnp-5116	268	15	location	location	NOUN
fnp-5116	268	16	and	and	CCONJ
fnp-5116	268	17	outcome	outcome	NOUN
fnp-5116	268	18	remain	remain	VERB
fnp-5116	268	19	tenuous	tenuous	ADJ
fnp-5116	268	20	and	and	CCONJ
fnp-5116	268	21	require	require	VERB
fnp-5116	268	22	larger	large	ADJ
fnp-5116	268	23	and	and	CCONJ
fnp-5116	268	24	prospective	prospective	ADJ
fnp-5116	268	25	studies	study	NOUN
fnp-5116	268	26	for	for	ADP
fnp-5116	268	27	definitive	definitive	ADJ
fnp-5116	268	28	conclusions	conclusion	NOUN
fnp-5116	268	29	.	.	PUNCT
fnp-5116	269	1	one	one	NUM
fnp-5116	269	2	other	other	ADJ
fnp-5116	269	3	point	point	NOUN
fnp-5116	269	4	of	of	ADP
fnp-5116	269	5	discussion	discussion	NOUN
fnp-5116	269	6	that	that	PRON
fnp-5116	269	7	has	have	AUX
fnp-5116	269	8	been	be	AUX
fnp-5116	269	9	a	a	DET
fnp-5116	269	10	matter	matter	NOUN
fnp-5116	269	11	of	of	ADP
fnp-5116	269	12	contention	contention	NOUN
fnp-5116	269	13	is	be	AUX
fnp-5116	269	14	the	the	DET
fnp-5116	269	15	decision	decision	NOUN
fnp-5116	269	16	to	to	PART
fnp-5116	269	17	use	use	VERB
fnp-5116	269	18	the	the	DET
fnp-5116	269	19	term	term	NOUN
fnp-5116	269	20	“	"	PUNCT
fnp-5116	269	21	tumor	tumor	NOUN
fnp-5116	269	22	type	type	NOUN
fnp-5116	269	23	”	"	PUNCT
fnp-5116	269	24	instead	instead	ADV
fnp-5116	269	25	of	of	ADP
fnp-5116	269	26	“	"	PUNCT
fnp-5116	269	27	tumor	tumor	NOUN
fnp-5116	269	28	entity	entity	NOUN
fnp-5116	269	29	”	"	PUNCT
fnp-5116	269	30	by	by	ADP
fnp-5116	269	31	who	who	PRON
fnp-5116	269	32	2021	2021	NUM
fnp-5116	269	33	classification	classification	NOUN
fnp-5116	269	34	.	.	PUNCT
fnp-5116	270	1	while	while	SCONJ
fnp-5116	270	2	this	this	PRON
fnp-5116	270	3	seems	seem	VERB
fnp-5116	270	4	like	like	ADP
fnp-5116	270	5	a	a	DET
fnp-5116	270	6	reasonable	reasonable	ADJ
fnp-5116	270	7	change	change	NOUN
fnp-5116	270	8	prima	prima	NOUN
fnp-5116	270	9	facia	facia	PROPN
fnp-5116	270	10	due	due	ADP
fnp-5116	270	11	to	to	ADP
fnp-5116	270	12	the	the	DET
fnp-5116	270	13	desire	desire	NOUN
fnp-5116	270	14	to	to	PART
fnp-5116	270	15	classify	classify	VERB
fnp-5116	270	16	tumors	tumor	NOUN
fnp-5116	270	17	similar	similar	ADJ
fnp-5116	270	18	to	to	ADP
fnp-5116	270	19	animal	animal	NOUN
fnp-5116	270	20	and	and	CCONJ
fnp-5116	270	21	plant	plant	NOUN
fnp-5116	270	22	kingdom	kingdom	NOUN
fnp-5116	270	23	taxonomy	taxonomy	NOUN
fnp-5116	270	24	,	,	PUNCT
fnp-5116	270	25	this	this	DET
fnp-5116	270	26	approach	approach	NOUN
fnp-5116	270	27	entirely	entirely	ADV
fnp-5116	270	28	misses	miss	VERB
fnp-5116	270	29	the	the	DET
fnp-5116	270	30	point	point	NOUN
fnp-5116	270	31	that	that	PRON
fnp-5116	270	32	tumors	tumor	NOUN
fnp-5116	270	33	do	do	AUX
fnp-5116	270	34	not	not	PART
fnp-5116	270	35	fit	fit	VERB
fnp-5116	270	36	into	into	ADP
fnp-5116	270	37	neat	neat	ADJ
fnp-5116	270	38	categories	category	NOUN
fnp-5116	270	39	of	of	ADP
fnp-5116	270	40	species	specie	NOUN
fnp-5116	270	41	and	and	CCONJ
fnp-5116	270	42	genera	genera	NOUN
fnp-5116	270	43	that	that	PRON
fnp-5116	270	44	could	could	AUX
fnp-5116	270	45	be	be	AUX
fnp-5116	270	46	easily	easily	ADV
fnp-5116	270	47	placed	place	VERB
fnp-5116	270	48	in	in	ADP
fnp-5116	270	49	a	a	DET
fnp-5116	270	50	taxonomical	taxonomical	ADJ
fnp-5116	270	51	framework	framework	NOUN
fnp-5116	270	52	similar	similar	ADJ
fnp-5116	270	53	to	to	ADP
fnp-5116	270	54	animals	animal	NOUN
fnp-5116	270	55	and	and	CCONJ
fnp-5116	270	56	plants	plant	NOUN
fnp-5116	270	57	.	.	PUNCT
fnp-5116	271	1	the	the	DET
fnp-5116	271	2	major	major	ADJ
fnp-5116	271	3	objection	objection	NOUN
fnp-5116	271	4	to	to	ADP
fnp-5116	271	5	the	the	DET
fnp-5116	271	6	use	use	NOUN
fnp-5116	271	7	of	of	ADP
fnp-5116	271	8	tumor	tumor	NOUN
fnp-5116	271	9	“	"	PUNCT
fnp-5116	271	10	type	type	NOUN
fnp-5116	271	11	”	"	PUNCT
fnp-5116	271	12	is	be	AUX
fnp-5116	271	13	that	that	SCONJ
fnp-5116	271	14	a	a	DET
fnp-5116	271	15	diagnostic	diagnostic	ADJ
fnp-5116	271	16	entity	entity	NOUN
fnp-5116	271	17	such	such	ADJ
fnp-5116	271	18	as	as	ADP
fnp-5116	271	19	pa	pa	PROPN
fnp-5116	271	20	may	may	AUX
fnp-5116	271	21	not	not	PART
fnp-5116	271	22	be	be	AUX
fnp-5116	271	23	composed	compose	VERB
fnp-5116	271	24	of	of	ADP
fnp-5116	271	25	a	a	DET
fnp-5116	271	26	single	single	ADJ
fnp-5116	271	27	tumor	tumor	NOUN
fnp-5116	271	28	“	"	PUNCT
fnp-5116	271	29	type	type	NOUN
fnp-5116	271	30	”	"	PUNCT
fnp-5116	271	31	but	but	CCONJ
fnp-5116	271	32	rather	rather	ADV
fnp-5116	271	33	is	be	AUX
fnp-5116	271	34	a	a	DET
fnp-5116	271	35	group	group	NOUN
fnp-5116	271	36	of	of	ADP
fnp-5116	271	37	tumors	tumor	NOUN
fnp-5116	271	38	that	that	PRON
fnp-5116	271	39	have	have	VERB
fnp-5116	271	40	sufficiently	sufficiently	ADV
fnp-5116	271	41	similar	similar	ADJ
fnp-5116	271	42	clinicopathological	clinicopathological	ADJ
fnp-5116	271	43	(	(	PUNCT
fnp-5116	271	44	including	include	VERB
fnp-5116	271	45	genetic	genetic	NOUN
fnp-5116	271	46	)	)	PUNCT
fnp-5116	271	47	features	feature	NOUN
fnp-5116	271	48	to	to	PART
fnp-5116	271	49	constitute	constitute	VERB
fnp-5116	271	50	a	a	DET
fnp-5116	271	51	meaningful	meaningful	ADJ
fnp-5116	271	52	group	group	NOUN
fnp-5116	271	53	of	of	ADP
fnp-5116	271	54	disorders	disorder	NOUN
fnp-5116	271	55	from	from	ADP
fnp-5116	271	56	the	the	DET
fnp-5116	271	57	perspective	perspective	NOUN
fnp-5116	271	58	of	of	ADP
fnp-5116	271	59	the	the	DET
fnp-5116	271	60	treating	treat	VERB
fnp-5116	271	61	physician	physician	NOUN
fnp-5116	271	62	.	.	PUNCT
fnp-5116	272	1	attempting	attempt	VERB
fnp-5116	272	2	to	to	PART
fnp-5116	272	3	create	create	VERB
fnp-5116	272	4	“	"	PUNCT
fnp-5116	272	5	types	type	NOUN
fnp-5116	272	6	”	"	PUNCT
fnp-5116	272	7	with	with	ADP
fnp-5116	272	8	every	every	DET
fnp-5116	272	9	advancing	advance	VERB
fnp-5116	272	10	bit	bit	NOUN
fnp-5116	272	11	of	of	ADP
fnp-5116	272	12	information	information	NOUN
fnp-5116	272	13	would	would	AUX
fnp-5116	272	14	not	not	PART
fnp-5116	272	15	result	result	VERB
fnp-5116	272	16	in	in	ADP
fnp-5116	272	17	the	the	DET
fnp-5116	272	18	same	same	ADJ
fnp-5116	272	19	clinically	clinically	ADV
fnp-5116	272	20	meaningful	meaningful	ADJ
fnp-5116	272	21	group	group	NOUN
fnp-5116	272	22	of	of	ADP
fnp-5116	272	23	diseases	disease	NOUN
fnp-5116	272	24	.	.	PUNCT
fnp-5116	273	1	this	this	PRON
fnp-5116	273	2	is	be	AUX
fnp-5116	273	3	demonstrated	demonstrate	VERB
fnp-5116	273	4	in	in	ADP
fnp-5116	273	5	our	our	PRON
fnp-5116	273	6	study	study	NOUN
fnp-5116	273	7	that	that	SCONJ
fnp-5116	273	8	despite	despite	SCONJ
fnp-5116	273	9	their	their	PRON
fnp-5116	273	10	excellent	excellent	ADJ
fnp-5116	273	11	outcome	outcome	NOUN
fnp-5116	273	12	,	,	PUNCT
fnp-5116	273	13	tumors	tumor	NOUN
fnp-5116	273	14	classified	classify	VERB
fnp-5116	273	15	as	as	SCONJ
fnp-5116	273	16	pa	pa	PROPN
fnp-5116	273	17	harbor	harbor	VERB
fnp-5116	273	18	sufficiently	sufficiently	ADV
fnp-5116	273	19	different	different	ADJ
fnp-5116	273	20	genetic	genetic	ADJ
fnp-5116	273	21	alterations	alteration	NOUN
fnp-5116	273	22	,	,	PUNCT
fnp-5116	273	23	radiological	radiological	ADJ
fnp-5116	273	24	and	and	CCONJ
fnp-5116	273	25	pathological	pathological	ADJ
fnp-5116	273	26	features	feature	NOUN
fnp-5116	273	27	that	that	PRON
fnp-5116	273	28	are	be	AUX
fnp-5116	273	29	not	not	PART
fnp-5116	273	30	sufficient	sufficient	ADJ
fnp-5116	273	31	enough	enough	ADV
fnp-5116	273	32	to	to	PART
fnp-5116	273	33	consider	consider	VERB
fnp-5116	273	34	them	they	PRON
fnp-5116	273	35	as	as	ADP
fnp-5116	273	36	belonging	belong	VERB
fnp-5116	273	37	to	to	ADP
fnp-5116	273	38	a	a	DET
fnp-5116	273	39	different	different	ADJ
fnp-5116	273	40	entity	entity	NOUN
fnp-5116	273	41	but	but	CCONJ
fnp-5116	273	42	may	may	AUX
fnp-5116	273	43	arguably	arguably	ADV
fnp-5116	273	44	imply	imply	VERB
fnp-5116	273	45	different	different	ADJ
fnp-5116	273	46	tumor	tumor	NOUN
fnp-5116	273	47	“	"	PUNCT
fnp-5116	273	48	types	type	NOUN
fnp-5116	273	49	”	"	PUNCT
fnp-5116	273	50	or	or	CCONJ
fnp-5116	273	51	“	"	PUNCT
fnp-5116	273	52	subtypes	subtype	NOUN
fnp-5116	273	53	”	"	PUNCT
fnp-5116	273	54	.	.	PUNCT
fnp-5116	274	1	in	in	ADP
fnp-5116	274	2	the	the	DET
fnp-5116	274	3	opinion	opinion	NOUN
fnp-5116	274	4	of	of	ADP
fnp-5116	274	5	the	the	DET
fnp-5116	274	6	authors	author	NOUN
fnp-5116	274	7	,	,	PUNCT
fnp-5116	274	8	attempting	attempt	VERB
fnp-5116	274	9	to	to	PART
fnp-5116	274	10	classify	classify	VERB
fnp-5116	274	11	tumors	tumor	NOUN
fnp-5116	274	12	by	by	ADP
fnp-5116	274	13	placing	place	VERB
fnp-5116	274	14	rigid	rigid	ADJ
fnp-5116	274	15	types	type	NOUN
fnp-5116	274	16	and	and	CCONJ
fnp-5116	274	17	subtypes	subtype	NOUN
fnp-5116	274	18	akin	akin	ADJ
fnp-5116	274	19	to	to	ADP
fnp-5116	274	20	genera	genera	NOUN
fnp-5116	274	21	,	,	PUNCT
fnp-5116	274	22	and	and	CCONJ
fnp-5116	274	23	species	specie	NOUN
fnp-5116	274	24	designations	designation	NOUN
fnp-5116	274	25	for	for	ADP
fnp-5116	274	26	animal	animal	NOUN
fnp-5116	274	27	and	and	CCONJ
fnp-5116	274	28	plant	plant	NOUN
fnp-5116	274	29	kingdoms	kingdom	NOUN
fnp-5116	274	30	may	may	AUX
fnp-5116	274	31	underestimate	underestimate	VERB
fnp-5116	274	32	the	the	DET
fnp-5116	274	33	biological	biological	ADJ
fnp-5116	274	34	diversity	diversity	NOUN
fnp-5116	274	35	of	of	ADP
fnp-5116	274	36	pathological	pathological	ADJ
fnp-5116	274	37	processes	process	NOUN
fnp-5116	274	38	as	as	SCONJ
fnp-5116	274	39	opposed	oppose	VERB
fnp-5116	274	40	to	to	ADP
fnp-5116	274	41	evolutionary	evolutionary	ADJ
fnp-5116	274	42	biology	biology	NOUN
fnp-5116	274	43	.	.	PUNCT
fnp-5116	275	1	this	this	DET
fnp-5116	275	2	approach	approach	NOUN
fnp-5116	275	3	also	also	ADV
fnp-5116	275	4	ignores	ignore	VERB
fnp-5116	275	5	the	the	DET
fnp-5116	275	6	principal	principal	ADJ
fnp-5116	275	7	necessity	necessity	NOUN
fnp-5116	275	8	of	of	ADP
fnp-5116	275	9	trying	try	VERB
fnp-5116	275	10	to	to	PART
fnp-5116	275	11	classify	classify	VERB
fnp-5116	275	12	tumors	tumor	NOUN
fnp-5116	275	13	to	to	PART
fnp-5116	275	14	be	be	AUX
fnp-5116	275	15	able	able	ADJ
fnp-5116	275	16	to	to	PART
fnp-5116	275	17	manage	manage	VERB
fnp-5116	275	18	the	the	DET
fnp-5116	275	19	patients	patient	NOUN
fnp-5116	275	20	successfully	successfully	ADV
fnp-5116	275	21	.	.	PUNCT
fnp-5116	276	1	from	from	ADP
fnp-5116	276	2	that	that	DET
fnp-5116	276	3	perspective	perspective	NOUN
fnp-5116	276	4	,	,	PUNCT
fnp-5116	276	5	the	the	DET
fnp-5116	276	6	tumors	tumor	NOUN
fnp-5116	276	7	in	in	ADP
fnp-5116	276	8	this	this	DET
fnp-5116	276	9	series	series	NOUN
fnp-5116	276	10	that	that	PRON
fnp-5116	276	11	we	we	PRON
fnp-5116	276	12	believe	believe	VERB
fnp-5116	276	13	belong	belong	VERB
fnp-5116	276	14	to	to	ADP
fnp-5116	276	15	pa	pa	PROPN
fnp-5116	276	16	as	as	ADP
fnp-5116	276	17	an	an	DET
fnp-5116	276	18	entity	entity	NOUN
fnp-5116	276	19	,	,	PUNCT
fnp-5116	276	20	have	have	VERB
fnp-5116	276	21	excellent	excellent	ADJ
fnp-5116	276	22	long	long	ADJ
fnp-5116	276	23	-	-	PUNCT
fnp-5116	276	24	term	term	NOUN
fnp-5116	276	25	survival	survival	NOUN
fnp-5116	276	26	and	and	CCONJ
fnp-5116	276	27	may	may	AUX
fnp-5116	276	28	be	be	AUX
fnp-5116	276	29	considered	consider	VERB
fnp-5116	276	30	“	"	PUNCT
fnp-5116	276	31	chronic	chronic	ADJ
fnp-5116	276	32	diseases	disease	NOUN
fnp-5116	276	33	”	"	PUNCT
fnp-5116	276	34	and	and	CCONJ
fnp-5116	276	35	managed	manage	VERB
fnp-5116	276	36	accordingly	accordingly	ADV
fnp-5116	276	37	[	[	X
fnp-5116	276	38	72	72	NUM
fnp-5116	276	39	,	,	PUNCT
fnp-5116	276	40	73	73	NUM
fnp-5116	276	41	]	]	PUNCT
fnp-5116	276	42	.	.	PUNCT
fnp-5116	277	1	our	our	PRON
fnp-5116	277	2	study	study	NOUN
fnp-5116	277	3	is	be	AUX
fnp-5116	277	4	in	in	ADP
fnp-5116	277	5	agreement	agreement	NOUN
fnp-5116	277	6	with	with	ADP
fnp-5116	277	7	many	many	ADJ
fnp-5116	277	8	of	of	ADP
fnp-5116	277	9	the	the	DET
fnp-5116	277	10	prior	prior	ADJ
fnp-5116	277	11	studies	study	NOUN
fnp-5116	277	12	highlighting	highlight	VERB
fnp-5116	277	13	the	the	DET
fnp-5116	277	14	extent	extent	NOUN
fnp-5116	277	15	of	of	ADP
fnp-5116	277	16	resection	resection	NOUN
fnp-5116	277	17	as	as	ADP
fnp-5116	277	18	the	the	DET
fnp-5116	277	19	key	key	ADJ
fnp-5116	277	20	determinant	determinant	NOUN
fnp-5116	277	21	of	of	ADP
fnp-5116	277	22	recurrence	recurrence	NOUN
fnp-5116	277	23	in	in	ADP
fnp-5116	277	24	pa	pa	PROPN
fnp-5116	278	1	[	[	X
fnp-5116	278	2	16	16	NUM
fnp-5116	278	3	,	,	PUNCT
fnp-5116	278	4	53	53	NUM
fnp-5116	278	5	,	,	PUNCT
fnp-5116	278	6	55	55	NUM
fnp-5116	278	7	,	,	PUNCT
fnp-5116	278	8	74	74	NUM
fnp-5116	278	9	-	-	SYM
fnp-5116	278	10	76	76	NUM
fnp-5116	278	11	]	]	PUNCT
fnp-5116	278	12	.	.	PUNCT
fnp-5116	279	1	pa	pa	PROPN
fnp-5116	279	2	still	still	ADV
fnp-5116	279	3	remains	remain	VERB
fnp-5116	279	4	a	a	DET
fnp-5116	279	5	predominantly	predominantly	ADV
fnp-5116	279	6	surgical	surgical	ADJ
fnp-5116	279	7	disease	disease	NOUN
fnp-5116	279	8	due	due	ADP
fnp-5116	279	9	to	to	ADP
fnp-5116	279	10	the	the	DET
fnp-5116	279	11	importance	importance	NOUN
fnp-5116	279	12	of	of	ADP
fnp-5116	279	13	extent	extent	NOUN
fnp-5116	279	14	of	of	ADP
fnp-5116	279	15	resection	resection	NOUN
fnp-5116	279	16	and	and	CCONJ
fnp-5116	279	17	every	every	DET
fnp-5116	279	18	attempt	attempt	NOUN
fnp-5116	279	19	should	should	AUX
fnp-5116	279	20	be	be	AUX
fnp-5116	279	21	made	make	VERB
fnp-5116	279	22	to	to	PART
fnp-5116	279	23	achieve	achieve	VERB
fnp-5116	279	24	gtr	gtr	NOUN
fnp-5116	279	25	for	for	ADP
fnp-5116	279	26	maximum	maximum	ADJ
fnp-5116	279	27	benefit	benefit	NOUN
fnp-5116	279	28	[	[	X
fnp-5116	279	29	77	77	NUM
fnp-5116	279	30	,	,	PUNCT
fnp-5116	279	31	78	78	NUM
fnp-5116	279	32	]	]	PUNCT
fnp-5116	279	33	.	.	PUNCT
fnp-5116	280	1	but	but	CCONJ
fnp-5116	280	2	,	,	PUNCT
fnp-5116	280	3	there	there	PRON
fnp-5116	280	4	is	be	VERB
fnp-5116	280	5	yet	yet	ADV
fnp-5116	280	6	much	much	ADJ
fnp-5116	280	7	to	to	PART
fnp-5116	280	8	be	be	AUX
fnp-5116	280	9	learned	learn	VERB
fnp-5116	280	10	about	about	ADP
fnp-5116	280	11	pa	pa	PROPN
fnp-5116	280	12	,	,	PUNCT
fnp-5116	280	13	especially	especially	ADV
fnp-5116	280	14	the	the	DET
fnp-5116	280	15	biological	biological	ADJ
fnp-5116	280	16	implication	implication	NOUN
fnp-5116	280	17	of	of	ADP
fnp-5116	280	18	the	the	DET
fnp-5116	280	19	histological	histological	ADJ
fnp-5116	280	20	features	feature	NOUN
fnp-5116	280	21	of	of	ADP
fnp-5116	280	22	anaplasia	anaplasia	NOUN
fnp-5116	280	23	and	and	CCONJ
fnp-5116	280	24	additional	additional	ADJ
fnp-5116	280	25	molecular	molecular	ADJ
fnp-5116	280	26	abnormalities	abnormality	NOUN
fnp-5116	280	27	.	.	PUNCT
fnp-5116	281	1	we	we	PRON
fnp-5116	281	2	were	be	AUX
fnp-5116	281	3	unable	unable	ADJ
fnp-5116	281	4	to	to	PART
fnp-5116	281	5	identify	identify	VERB
fnp-5116	281	6	any	any	DET
fnp-5116	281	7	association	association	NOUN
fnp-5116	281	8	between	between	ADP
fnp-5116	281	9	these	these	DET
fnp-5116	281	10	variables	variable	NOUN
fnp-5116	281	11	and	and	CCONJ
fnp-5116	281	12	outcome	outcome	NOUN
fnp-5116	281	13	,	,	PUNCT
fnp-5116	281	14	most	most	ADV
fnp-5116	281	15	likely	likely	ADJ
fnp-5116	281	16	because	because	SCONJ
fnp-5116	281	17	we	we	PRON
fnp-5116	281	18	began	begin	VERB
fnp-5116	281	19	analyzing	analyze	VERB
fnp-5116	281	20	some	some	PRON
fnp-5116	281	21	of	of	ADP
fnp-5116	281	22	these	these	DET
fnp-5116	281	23	molecular	molecular	ADJ
fnp-5116	281	24	alterations	alteration	NOUN
fnp-5116	281	25	only	only	ADV
fnp-5116	281	26	recently	recently	ADV
fnp-5116	281	27	and	and	CCONJ
fnp-5116	281	28	sufficient	sufficient	ADJ
fnp-5116	281	29	time	time	NOUN
fnp-5116	281	30	has	have	AUX
fnp-5116	281	31	not	not	PART
fnp-5116	281	32	passed	pass	VERB
fnp-5116	281	33	to	to	PART
fnp-5116	281	34	see	see	VERB
fnp-5116	281	35	their	their	PRON
fnp-5116	281	36	effect	effect	NOUN
fnp-5116	281	37	on	on	ADP
fnp-5116	281	38	outcome	outcome	NOUN
fnp-5116	281	39	.	.	PUNCT
fnp-5116	282	1	prospective	prospective	ADJ
fnp-5116	282	2	studies	study	NOUN
fnp-5116	282	3	with	with	ADP
fnp-5116	282	4	follow	follow	VERB
fnp-5116	282	5	up	up	ADP
fnp-5116	282	6	times	time	NOUN
fnp-5116	282	7	longer	long	ADJ
fnp-5116	282	8	than	than	ADP
fnp-5116	282	9	10	10	NUM
fnp-5116	282	10	years	year	NOUN
fnp-5116	282	11	will	will	AUX
fnp-5116	282	12	be	be	AUX
fnp-5116	282	13	necessary	necessary	ADJ
fnp-5116	282	14	to	to	PART
fnp-5116	282	15	accurately	accurately	ADV
fnp-5116	282	16	determine	determine	VERB
fnp-5116	282	17	the	the	DET
fnp-5116	282	18	significance	significance	NOUN
fnp-5116	282	19	of	of	ADP
fnp-5116	282	20	molecular	molecular	ADJ
fnp-5116	282	21	alterations	alteration	NOUN
fnp-5116	282	22	or	or	CCONJ
fnp-5116	282	23	other	other	ADJ
fnp-5116	282	24	variables	variable	NOUN
fnp-5116	282	25	.	.	PUNCT
fnp-5116	283	1	this	this	PRON
fnp-5116	283	2	will	will	AUX
fnp-5116	283	3	require	require	VERB
fnp-5116	283	4	collaborative	collaborative	ADJ
fnp-5116	283	5	efforts	effort	NOUN
fnp-5116	283	6	and	and	CCONJ
fnp-5116	283	7	creating	create	VERB
fnp-5116	283	8	tumor	tumor	NOUN
fnp-5116	283	9	registries	registry	NOUN
fnp-5116	283	10	that	that	PRON
fnp-5116	283	11	provide	provide	VERB
fnp-5116	283	12	platforms	platform	NOUN
fnp-5116	283	13	for	for	ADP
fnp-5116	283	14	longitudinal	longitudinal	ADJ
fnp-5116	283	15	studies	study	NOUN
fnp-5116	283	16	.	.	PUNCT
fnp-5116	284	1	references	reference	NOUN
fnp-5116	284	2	1	1	NUM
fnp-5116	284	3	.	.	PUNCT
fnp-5116	285	1	p.	p.	NOUN
fnp-5116	285	2	kleihues	kleihues	PROPN
fnp-5116	285	3	,	,	PUNCT
fnp-5116	285	4	f.	f.	PROPN
fnp-5116	285	5	soylemezoglu	soylemezoglu	PROPN
fnp-5116	285	6	,	,	PUNCT
fnp-5116	285	7	b.	b.	PROPN
fnp-5116	285	8	schauble	schauble	PROPN
fnp-5116	285	9	,	,	PUNCT
fnp-5116	285	10	b.	b.	PROPN
fnp-5116	285	11	w.	w.	PROPN
fnp-5116	285	12	scheithauer	scheithauer	PROPN
fnp-5116	285	13	,	,	PUNCT
fnp-5116	285	14	and	and	CCONJ
fnp-5116	285	15	p.	p.	PROPN
fnp-5116	285	16	c.	c.	PROPN
fnp-5116	285	17	burger	burger	NOUN
fnp-5116	285	18	,	,	PUNCT
fnp-5116	285	19	"	"	PUNCT
fnp-5116	285	20	histopathology	histopathology	NOUN
fnp-5116	285	21	,	,	PUNCT
fnp-5116	285	22	classification	classification	NOUN
fnp-5116	285	23	,	,	PUNCT
fnp-5116	285	24	and	and	CCONJ
fnp-5116	285	25	grading	grade	VERB
fnp-5116	285	26	of	of	ADP
fnp-5116	285	27	gliomas	glioma	NOUN
fnp-5116	285	28	"	"	PUNCT
fnp-5116	285	29	,	,	PUNCT
fnp-5116	285	30	glia	glia	PROPN
fnp-5116	285	31	,	,	PUNCT
fnp-5116	285	32	vol	vol	NOUN
fnp-5116	285	33	.	.	PROPN
fnp-5116	285	34	15	15	NUM
fnp-5116	285	35	,	,	PUNCT
fnp-5116	285	36	no	no	INTJ
fnp-5116	285	37	.	.	NOUN
fnp-5116	285	38	3	3	NUM
fnp-5116	285	39	,	,	PUNCT
fnp-5116	285	40	pp	pp	ADJ
fnp-5116	285	41	.	.	PUNCT
fnp-5116	286	1	211	211	NUM
fnp-5116	286	2	-	-	SYM
fnp-5116	286	3	21	21	NUM
fnp-5116	286	4	,	,	PUNCT
fnp-5116	286	5	nov	nov	PROPN
fnp-5116	286	6	1995	1995	NUM
fnp-5116	286	7	,	,	PUNCT
fnp-5116	286	8	https://doi.org/10.1002/glia.440150303	https://doi.org/10.1002/glia.440150303	NOUN
fnp-5116	286	9	.	.	PROPN
fnp-5116	286	10	2	2	X
fnp-5116	286	11	.	.	X
fnp-5116	286	12	e.	e.	PROPN
fnp-5116	286	13	e.	e.	PROPN
fnp-5116	286	14	bar	bar	PROPN
fnp-5116	286	15	,	,	PUNCT
fnp-5116	286	16	a.	a.	NOUN
fnp-5116	286	17	lin	lin	PROPN
fnp-5116	286	18	,	,	PUNCT
fnp-5116	286	19	t.	t.	PROPN
fnp-5116	286	20	tihan	tihan	PROPN
fnp-5116	286	21	,	,	PUNCT
fnp-5116	286	22	p.	p.	PROPN
fnp-5116	286	23	c.	c.	PROPN
fnp-5116	286	24	burger	burger	NOUN
fnp-5116	286	25	,	,	PUNCT
fnp-5116	286	26	and	and	CCONJ
fnp-5116	286	27	c.	c.	PROPN
fnp-5116	286	28	g.	g.	PROPN
fnp-5116	286	29	eberhart	eberhart	PROPN
fnp-5116	286	30	,	,	PUNCT
fnp-5116	286	31	"	"	PUNCT
fnp-5116	286	32	frequent	frequent	ADJ
fnp-5116	286	33	gains	gain	NOUN
fnp-5116	286	34	at	at	ADP
fnp-5116	286	35	chromosome	chromosome	NOUN
fnp-5116	286	36	7q34	7q34	NUM
fnp-5116	286	37	involving	involve	VERB
fnp-5116	286	38	braf	braf	NOUN
fnp-5116	286	39	in	in	ADP
fnp-5116	286	40	pilocytic	pilocytic	ADJ
fnp-5116	286	41	astrocytoma	astrocytoma	NOUN
fnp-5116	286	42	"	"	PUNCT
fnp-5116	286	43	,	,	PUNCT
fnp-5116	286	44	j	j	PROPN
fnp-5116	286	45	neuropathol	neuropathol	PROPN
fnp-5116	286	46	exp	exp	NOUN
fnp-5116	286	47	neurol	neurol	PROPN
fnp-5116	286	48	,	,	PUNCT
fnp-5116	286	49	vol	vol	NOUN
fnp-5116	286	50	.	.	PROPN
fnp-5116	286	51	67	67	NUM
fnp-5116	286	52	,	,	PUNCT
fnp-5116	286	53	no	no	INTJ
fnp-5116	286	54	.	.	NOUN
fnp-5116	286	55	9	9	NUM
fnp-5116	286	56	,	,	PUNCT
fnp-5116	286	57	pp	pp	ADJ
fnp-5116	286	58	.	.	PUNCT
fnp-5116	287	1	878	878	NUM
fnp-5116	287	2	-	-	SYM
fnp-5116	287	3	87	87	NUM
fnp-5116	287	4	,	,	PUNCT
fnp-5116	287	5	sep	sep	PROPN
fnp-5116	287	6	2008	2008	NUM
fnp-5116	287	7	,	,	PUNCT
fnp-5116	287	8	https://doi.org/10.1097/nen.0b013e3181845622	https://doi.org/10.1097/nen.0b013e3181845622	NUM
fnp-5116	287	9	.	.	PUNCT
fnp-5116	288	1	3	3	X
fnp-5116	288	2	.	.	PUNCT
fnp-5116	288	3	a.	a.	PROPN
fnp-5116	288	4	r.	r.	PROPN
fnp-5116	288	5	elvidge	elvidge	PROPN
fnp-5116	288	6	,	,	PUNCT
fnp-5116	288	7	w.	w.	PROPN
fnp-5116	288	8	penfield	penfield	PROPN
fnp-5116	288	9	,	,	PUNCT
fnp-5116	288	10	and	and	CCONJ
fnp-5116	288	11	w.	w.	PROPN
fnp-5116	288	12	cone	cone	PROPN
fnp-5116	288	13	,	,	PUNCT
fnp-5116	288	14	"	"	PUNCT
fnp-5116	288	15	the	the	DET
fnp-5116	288	16	gliomas	glioma	NOUN
fnp-5116	288	17	of	of	ADP
fnp-5116	288	18	the	the	DET
fnp-5116	288	19	central	central	ADJ
fnp-5116	288	20	nervous	nervous	ADJ
fnp-5116	288	21	system	system	NOUN
fnp-5116	288	22	.	.	PUNCT
fnp-5116	289	1	a	a	DET
fnp-5116	289	2	study	study	NOUN
fnp-5116	289	3	of	of	ADP
fnp-5116	289	4	210	210	NUM
fnp-5116	289	5	verified	verified	ADJ
fnp-5116	289	6	cases	case	NOUN
fnp-5116	289	7	"	"	PUNCT
fnp-5116	289	8	,	,	PUNCT
fnp-5116	289	9	research	research	NOUN
fnp-5116	289	10	publications	publication	NOUN
fnp-5116	289	11	association	association	NOUN
fnp-5116	289	12	for	for	ADP
fnp-5116	289	13	research	research	NOUN
fnp-5116	289	14	in	in	ADP
fnp-5116	289	15	nervous	nervous	ADJ
fnp-5116	289	16	and	and	CCONJ
fnp-5116	289	17	mental	mental	ADJ
fnp-5116	289	18	disease	disease	NOUN
fnp-5116	289	19	,	,	PUNCT
fnp-5116	289	20	vol	vol	NOUN
fnp-5116	289	21	.	.	PROPN
fnp-5116	289	22	16	16	NUM
fnp-5116	289	23	,	,	PUNCT
fnp-5116	289	24	pp	pp	ADJ
fnp-5116	289	25	.	.	PUNCT
fnp-5116	290	1	107	107	NUM
fnp-5116	290	2	-	-	SYM
fnp-5116	290	3	181	181	NUM
fnp-5116	290	4	,	,	PUNCT
fnp-5116	290	5	1937	1937	NUM
fnp-5116	290	6	.	.	PUNCT
fnp-5116	291	1	4	4	X
fnp-5116	291	2	.	.	X
fnp-5116	291	3	h.	h.	PROPN
fnp-5116	291	4	ohgaki	ohgaki	PROPN
fnp-5116	291	5	and	and	CCONJ
fnp-5116	291	6	p.	p.	PROPN
fnp-5116	291	7	kleihues	kleihue	NOUN
fnp-5116	291	8	,	,	PUNCT
fnp-5116	291	9	"	"	PUNCT
fnp-5116	291	10	population	population	NOUN
fnp-5116	291	11	-	-	PUNCT
fnp-5116	291	12	based	base	VERB
fnp-5116	291	13	studies	study	NOUN
fnp-5116	291	14	on	on	ADP
fnp-5116	291	15	incidence	incidence	NOUN
fnp-5116	291	16	,	,	PUNCT
fnp-5116	291	17	survival	survival	NOUN
fnp-5116	291	18	rates	rate	NOUN
fnp-5116	291	19	,	,	PUNCT
fnp-5116	291	20	and	and	CCONJ
fnp-5116	291	21	genetic	genetic	ADJ
fnp-5116	291	22	alterations	alteration	NOUN
fnp-5116	291	23	in	in	ADP
fnp-5116	291	24	astrocytic	astrocytic	ADJ
fnp-5116	291	25	and	and	CCONJ
fnp-5116	291	26	oligodendroglial	oligodendroglial	ADJ
fnp-5116	291	27	gliomas	glioma	NOUN
fnp-5116	291	28	"	"	PUNCT
fnp-5116	291	29	,	,	PUNCT
fnp-5116	291	30	j	j	PROPN
fnp-5116	291	31	neuropathol	neuropathol	PROPN
fnp-5116	291	32	exp	exp	NOUN
fnp-5116	291	33	neurol	neurol	PROPN
fnp-5116	291	34	,	,	PUNCT
fnp-5116	291	35	vol	vol	NOUN
fnp-5116	291	36	.	.	PROPN
fnp-5116	291	37	64	64	NUM
fnp-5116	291	38	,	,	PUNCT
fnp-5116	291	39	no	no	INTJ
fnp-5116	291	40	.	.	NOUN
fnp-5116	291	41	6	6	NUM
fnp-5116	291	42	,	,	PUNCT
fnp-5116	291	43	pp	pp	ADJ
fnp-5116	291	44	.	.	PUNCT
fnp-5116	292	1	479	479	NUM
fnp-5116	292	2	-	-	SYM
fnp-5116	292	3	89	89	NUM
fnp-5116	292	4	,	,	PUNCT
fnp-5116	292	5	jun	jun	PROPN
fnp-5116	292	6	2005	2005	NUM
fnp-5116	292	7	,	,	PUNCT
fnp-5116	292	8	https://doi.org/10.1093/jnen/64.6.479	https://doi.org/10.1093/jnen/64.6.479	NUM
fnp-5116	292	9	.	.	X
fnp-5116	293	1	5	5	NUM
fnp-5116	293	2	.	.	PUNCT
fnp-5116	293	3	c.	c.	PROPN
fnp-5116	293	4	burkhard	burkhard	PROPN
fnp-5116	293	5	et	et	PROPN
fnp-5116	293	6	al	al	PROPN
fnp-5116	293	7	.	.	PROPN
fnp-5116	293	8	,	,	PUNCT
fnp-5116	293	9	"	"	PUNCT
fnp-5116	293	10	a	a	DET
fnp-5116	293	11	population	population	NOUN
fnp-5116	293	12	-	-	PUNCT
fnp-5116	293	13	based	base	VERB
fnp-5116	293	14	study	study	NOUN
fnp-5116	293	15	of	of	ADP
fnp-5116	293	16	the	the	DET
fnp-5116	293	17	incidence	incidence	NOUN
fnp-5116	293	18	and	and	CCONJ
fnp-5116	293	19	survival	survival	NOUN
fnp-5116	293	20	rates	rate	NOUN
fnp-5116	293	21	in	in	ADP
fnp-5116	293	22	patients	patient	NOUN
fnp-5116	293	23	with	with	ADP
fnp-5116	293	24	pilocytic	pilocytic	ADJ
fnp-5116	293	25	astrocytoma	astrocytoma	NOUN
fnp-5116	293	26	"	"	PUNCT
fnp-5116	293	27	,	,	PUNCT
fnp-5116	293	28	j	j	PROPN
fnp-5116	293	29	neurosurg	neurosurg	PROPN
fnp-5116	293	30	,	,	PUNCT
fnp-5116	293	31	vol	vol	NOUN
fnp-5116	293	32	.	.	PROPN
fnp-5116	293	33	98	98	NUM
fnp-5116	293	34	,	,	PUNCT
fnp-5116	293	35	no	no	INTJ
fnp-5116	293	36	.	.	NOUN
fnp-5116	293	37	6	6	NUM
fnp-5116	293	38	,	,	PUNCT
fnp-5116	293	39	pp	pp	ADJ
fnp-5116	293	40	.	.	PUNCT
fnp-5116	294	1	1170	1170	NUM
fnp-5116	294	2	-	-	SYM
fnp-5116	294	3	4	4	NUM
fnp-5116	294	4	,	,	PUNCT
fnp-5116	294	5	jun	jun	PROPN
fnp-5116	294	6	2003	2003	NUM
fnp-5116	294	7	,	,	PUNCT
fnp-5116	294	8	https://doi.org/10.3171/jns.2003.98.6.1170	https://doi.org/10.3171/jns.2003.98.6.1170	PROPN
fnp-5116	294	9	.	.	PUNCT
fnp-5116	295	1	6	6	NUM
fnp-5116	295	2	.	.	PUNCT
fnp-5116	295	3	q.	q.	PROPN
fnp-5116	295	4	t.	t.	PROPN
fnp-5116	295	5	ostrom	ostrom	PROPN
fnp-5116	295	6	et	et	PROPN
fnp-5116	295	7	al	al	PROPN
fnp-5116	295	8	.	.	PROPN
fnp-5116	295	9	,	,	PUNCT
fnp-5116	295	10	"	"	PUNCT
fnp-5116	295	11	cbtrus	cbtrus	NOUN
fnp-5116	295	12	statistical	statistical	ADJ
fnp-5116	295	13	report	report	NOUN
fnp-5116	295	14	:	:	PUNCT
fnp-5116	295	15	primary	primary	ADJ
fnp-5116	295	16	brain	brain	NOUN
fnp-5116	295	17	and	and	CCONJ
fnp-5116	295	18	central	central	ADJ
fnp-5116	295	19	nervous	nervous	ADJ
fnp-5116	295	20	system	system	NOUN
fnp-5116	295	21	tumors	tumor	NOUN
fnp-5116	295	22	diagnosed	diagnose	VERB
fnp-5116	295	23	in	in	ADP
fnp-5116	295	24	the	the	DET
fnp-5116	295	25	united	united	PROPN
fnp-5116	295	26	states	states	PROPN
fnp-5116	295	27	in	in	ADP
fnp-5116	295	28	2007	2007	NUM
fnp-5116	295	29	-	-	SYM
fnp-5116	295	30	2011	2011	NUM
fnp-5116	295	31	"	"	PUNCT
fnp-5116	295	32	,	,	PUNCT
fnp-5116	295	33	neuro	neuro	PROPN
fnp-5116	295	34	oncol	oncol	PROPN
fnp-5116	295	35	,	,	PUNCT
fnp-5116	295	36	vol	vol	NOUN
fnp-5116	295	37	.	.	PUNCT
fnp-5116	296	1	16	16	NUM
fnp-5116	296	2	suppl	suppl	ADJ
fnp-5116	296	3	4	4	NUM
fnp-5116	296	4	,	,	PUNCT
fnp-5116	296	5	no	no	INTJ
fnp-5116	296	6	.	.	PUNCT
fnp-5116	297	1	suppl	suppl	PROPN
fnp-5116	297	2	4	4	NUM
fnp-5116	297	3	,	,	PUNCT
fnp-5116	297	4	pp	pp	ADJ
fnp-5116	297	5	.	.	PUNCT
fnp-5116	298	1	iv1	iv1	PROPN
fnp-5116	298	2	-	-	PUNCT
fnp-5116	298	3	63	63	NUM
fnp-5116	298	4	,	,	PUNCT
fnp-5116	298	5	oct	oct	PROPN
fnp-5116	298	6	2014	2014	NUM
fnp-5116	298	7	,	,	PUNCT
fnp-5116	298	8	https://doi.org/10.1093/neuonc/nou223	https://doi.org/10.1093/neuonc/nou223	NOUN
fnp-5116	298	9	.	.	PUNCT
fnp-5116	299	1	7	7	X
fnp-5116	299	2	.	.	X
fnp-5116	299	3	r.	r.	PROPN
fnp-5116	299	4	j.	j.	PROPN
fnp-5116	299	5	packer	packer	PROPN
fnp-5116	299	6	et	et	PROPN
fnp-5116	299	7	al	al	PROPN
fnp-5116	299	8	.	.	PROPN
fnp-5116	299	9	,	,	PUNCT
fnp-5116	299	10	"	"	PUNCT
fnp-5116	299	11	pediatric	pediatric	ADJ
fnp-5116	299	12	low	low	ADJ
fnp-5116	299	13	-	-	PUNCT
fnp-5116	299	14	grade	grade	NOUN
fnp-5116	299	15	gliomas	glioma	NOUN
fnp-5116	299	16	:	:	PUNCT
fnp-5116	299	17	implications	implication	NOUN
fnp-5116	299	18	of	of	ADP
fnp-5116	299	19	the	the	DET
fnp-5116	299	20	biologic	biologic	ADJ
fnp-5116	299	21	era	era	NOUN
fnp-5116	299	22	"	"	PUNCT
fnp-5116	299	23	,	,	PUNCT
fnp-5116	299	24	neuro	neuro	PROPN
fnp-5116	299	25	oncol	oncol	PROPN
fnp-5116	299	26	,	,	PUNCT
fnp-5116	299	27	vol	vol	NOUN
fnp-5116	299	28	.	.	PROPN
fnp-5116	300	1	19	19	NUM
fnp-5116	300	2	,	,	PUNCT
fnp-5116	300	3	no	no	INTJ
fnp-5116	300	4	.	.	NOUN
fnp-5116	300	5	6	6	NUM
fnp-5116	300	6	,	,	PUNCT
fnp-5116	300	7	pp	pp	ADJ
fnp-5116	300	8	.	.	PUNCT
fnp-5116	301	1	750	750	NUM
fnp-5116	301	2	-	-	SYM
fnp-5116	301	3	761	761	NUM
fnp-5116	301	4	,	,	PUNCT
fnp-5116	301	5	jun	jun	PROPN
fnp-5116	301	6	1	1	NUM
fnp-5116	301	7	2017	2017	NUM
fnp-5116	301	8	,	,	PUNCT
fnp-5116	301	9	https://doi.org/10.1093/neuonc/now209	https://doi.org/10.1093/neuonc/now209	ADJ
fnp-5116	301	10	.	.	NOUN
fnp-5116	301	11	8	8	NUM
fnp-5116	301	12	.	.	PUNCT
fnp-5116	301	13	i.	i.	PROPN
fnp-5116	301	14	fried	fried	PROPN
fnp-5116	301	15	,	,	PUNCT
fnp-5116	301	16	u.	u.	NOUN
fnp-5116	301	17	tabori	tabori	NOUN
fnp-5116	301	18	,	,	PUNCT
fnp-5116	301	19	t.	t.	PROPN
fnp-5116	301	20	tihan	tihan	PROPN
fnp-5116	301	21	,	,	PUNCT
fnp-5116	301	22	a.	a.	NOUN
fnp-5116	301	23	reginald	reginald	PROPN
fnp-5116	301	24	,	,	PUNCT
fnp-5116	301	25	and	and	CCONJ
fnp-5116	301	26	e.	e.	PROPN
fnp-5116	301	27	bouffet	bouffet	PROPN
fnp-5116	301	28	,	,	PUNCT
fnp-5116	301	29	"	"	PUNCT
fnp-5116	301	30	optic	optic	ADJ
fnp-5116	301	31	pathway	pathway	NOUN
fnp-5116	301	32	gliomas	glioma	NOUN
fnp-5116	301	33	:	:	PUNCT
fnp-5116	301	34	a	a	DET
fnp-5116	301	35	review	review	NOUN
fnp-5116	301	36	"	"	PUNCT
fnp-5116	301	37	,	,	PUNCT
fnp-5116	301	38	cns	cns	PROPN
fnp-5116	301	39	oncol	oncol	ADJ
fnp-5116	301	40	,	,	PUNCT
fnp-5116	301	41	vol	vol	NOUN
fnp-5116	301	42	.	.	PROPN
fnp-5116	302	1	2	2	NUM
fnp-5116	302	2	,	,	PUNCT
fnp-5116	302	3	no	no	INTJ
fnp-5116	302	4	.	.	NOUN
fnp-5116	302	5	2	2	NUM
fnp-5116	302	6	,	,	PUNCT
fnp-5116	302	7	pp	pp	ADJ
fnp-5116	302	8	.	.	PUNCT
fnp-5116	303	1	143	143	NUM
fnp-5116	303	2	-	-	SYM
fnp-5116	303	3	59	59	NUM
fnp-5116	303	4	,	,	PUNCT
fnp-5116	303	5	mar	mar	PROPN
fnp-5116	303	6	2013	2013	NUM
fnp-5116	303	7	,	,	PUNCT
fnp-5116	303	8	https://doi.org/10.2217/cns.12.47	https://doi.org/10.2217/cns.12.47	NOUN
fnp-5116	303	9	.	.	NOUN
fnp-5116	303	10	9	9	NUM
fnp-5116	303	11	.	.	PUNCT
fnp-5116	304	1	q.	q.	PROPN
fnp-5116	304	2	t.	t.	PROPN
fnp-5116	304	3	ostrom	ostrom	PROPN
fnp-5116	304	4	et	et	PROPN
fnp-5116	304	5	al	al	PROPN
fnp-5116	304	6	.	.	PROPN
fnp-5116	304	7	,	,	PUNCT
fnp-5116	304	8	"	"	PUNCT
fnp-5116	304	9	cbtrus	cbtrus	NOUN
fnp-5116	304	10	statistical	statistical	ADJ
fnp-5116	304	11	report	report	NOUN
fnp-5116	304	12	:	:	PUNCT
fnp-5116	304	13	primary	primary	ADJ
fnp-5116	304	14	brain	brain	NOUN
fnp-5116	304	15	and	and	CCONJ
fnp-5116	304	16	other	other	ADJ
fnp-5116	304	17	central	central	ADJ
fnp-5116	304	18	nervous	nervous	ADJ
fnp-5116	304	19	system	system	NOUN
fnp-5116	304	20	tumors	tumor	NOUN
fnp-5116	304	21	diagnosed	diagnose	VERB
fnp-5116	304	22	in	in	ADP
fnp-5116	304	23	the	the	DET
fnp-5116	304	24	united	united	PROPN
fnp-5116	304	25	states	states	PROPN
fnp-5116	304	26	in	in	ADP
fnp-5116	304	27	2012	2012	NUM
fnp-5116	304	28	-	-	SYM
fnp-5116	304	29	2016	2016	NUM
fnp-5116	304	30	"	"	PUNCT
fnp-5116	304	31	,	,	PUNCT
fnp-5116	304	32	neuro	neuro	PROPN
fnp-5116	304	33	oncol	oncol	PROPN
fnp-5116	304	34	,	,	PUNCT
fnp-5116	304	35	vol	vol	NOUN
fnp-5116	304	36	.	.	PROPN
fnp-5116	304	37	21	21	NUM
fnp-5116	304	38	,	,	PUNCT
fnp-5116	304	39	no	no	INTJ
fnp-5116	304	40	.	.	PUNCT
fnp-5116	305	1	suppl	suppl	PROPN
fnp-5116	305	2	5	5	NUM
fnp-5116	305	3	,	,	PUNCT
fnp-5116	305	4	pp	pp	PROPN
fnp-5116	305	5	.	.	PUNCT
fnp-5116	306	1	v1	v1	PROPN
fnp-5116	306	2	-	-	PUNCT
fnp-5116	306	3	v100	v100	PROPN
fnp-5116	306	4	,	,	PUNCT
fnp-5116	306	5	nov	nov	PROPN
fnp-5116	306	6	1	1	NUM
fnp-5116	306	7	2019	2019	NUM
fnp-5116	306	8	,	,	PUNCT
fnp-5116	306	9	https://doi.org/10.1093/neuonc/noz150	https://doi.org/10.1093/neuonc/noz150	NOUN
fnp-5116	306	10	.	.	PUNCT
fnp-5116	307	1	10	10	NUM
fnp-5116	307	2	.	.	PUNCT
fnp-5116	308	1	p.	p.	NOUN
fnp-5116	308	2	d.	d.	PROPN
fnp-5116	308	3	brown	brown	PROPN
fnp-5116	308	4	et	et	PROPN
fnp-5116	308	5	al	al	PROPN
fnp-5116	308	6	.	.	PROPN
fnp-5116	308	7	,	,	PUNCT
fnp-5116	308	8	"	"	PUNCT
fnp-5116	308	9	adult	adult	NOUN
fnp-5116	308	10	patients	patient	NOUN
fnp-5116	308	11	with	with	ADP
fnp-5116	308	12	supratentorial	supratentorial	ADJ
fnp-5116	308	13	pilocytic	pilocytic	ADJ
fnp-5116	308	14	astrocytoma	astrocytoma	NOUN
fnp-5116	308	15	:	:	PUNCT
fnp-5116	308	16	long	long	ADJ
fnp-5116	308	17	-	-	PUNCT
fnp-5116	308	18	term	term	NOUN
fnp-5116	308	19	follow	follow	NOUN
fnp-5116	308	20	-	-	PUNCT
fnp-5116	308	21	up	up	NOUN
fnp-5116	308	22	of	of	ADP
fnp-5116	308	23	prospective	prospective	ADJ
fnp-5116	308	24	multicenter	multicenter	ADJ
fnp-5116	308	25	clinical	clinical	ADJ
fnp-5116	308	26	trial	trial	NOUN
fnp-5116	308	27	ncctg-867251	ncctg-867251	NOUN
fnp-5116	308	28	(	(	PUNCT
fnp-5116	308	29	alliance	alliance	NOUN
fnp-5116	308	30	)	)	PUNCT
fnp-5116	308	31	"	"	PUNCT
fnp-5116	308	32	,	,	PUNCT
fnp-5116	308	33	neurooncol	neurooncol	ADJ
fnp-5116	308	34	pract	pract	NOUN
fnp-5116	308	35	,	,	PUNCT
fnp-5116	308	36	vol	vol	NOUN
fnp-5116	308	37	.	.	PROPN
fnp-5116	308	38	2	2	NUM
fnp-5116	308	39	,	,	PUNCT
fnp-5116	308	40	no	no	INTJ
fnp-5116	308	41	.	.	NOUN
fnp-5116	308	42	4	4	NUM
fnp-5116	308	43	,	,	PUNCT
fnp-5116	308	44	pp	pp	ADJ
fnp-5116	308	45	.	.	PUNCT
fnp-5116	309	1	199	199	NUM
fnp-5116	309	2	-	-	SYM
fnp-5116	309	3	204	204	NUM
fnp-5116	309	4	,	,	PUNCT
fnp-5116	309	5	dec	dec	PROPN
fnp-5116	309	6	2015	2015	NUM
fnp-5116	309	7	,	,	PUNCT
fnp-5116	309	8	https://doi.org/10.1093/nop/npv031	https://doi.org/10.1093/nop/npv031	PROPN
fnp-5116	309	9	.	.	PROPN
fnp-5116	309	10	11	11	NUM
fnp-5116	309	11	.	.	PUNCT
fnp-5116	310	1	p.	p.	NOUN
fnp-5116	310	2	d.	d.	PROPN
fnp-5116	310	3	brown	brown	PROPN
fnp-5116	310	4	et	et	PROPN
fnp-5116	310	5	al	al	PROPN
fnp-5116	310	6	.	.	PROPN
fnp-5116	310	7	,	,	PUNCT
fnp-5116	310	8	"	"	PUNCT
fnp-5116	310	9	adult	adult	NOUN
fnp-5116	310	10	patients	patient	NOUN
fnp-5116	310	11	with	with	ADP
fnp-5116	310	12	supratentorial	supratentorial	ADJ
fnp-5116	310	13	pilocytic	pilocytic	ADJ
fnp-5116	310	14	astrocytomas	astrocytoma	NOUN
fnp-5116	310	15	:	:	PUNCT
fnp-5116	310	16	a	a	DET
fnp-5116	310	17	prospective	prospective	ADJ
fnp-5116	310	18	multicenter	multicenter	ADJ
fnp-5116	310	19	clinical	clinical	ADJ
fnp-5116	310	20	trial	trial	NOUN
fnp-5116	310	21	"	"	PUNCT
fnp-5116	310	22	,	,	PUNCT
fnp-5116	310	23	int	int	PROPN
fnp-5116	310	24	j	j	PROPN
fnp-5116	310	25	radiat	radiat	PROPN
fnp-5116	310	26	oncol	oncol	ADJ
fnp-5116	310	27	biol	biol	PROPN
fnp-5116	310	28	phys	phy	NOUN
fnp-5116	310	29	,	,	PUNCT
fnp-5116	310	30	vol	vol	NOUN
fnp-5116	310	31	.	.	PROPN
fnp-5116	311	1	58	58	NUM
fnp-5116	311	2	,	,	PUNCT
fnp-5116	311	3	no	no	INTJ
fnp-5116	311	4	.	.	NOUN
fnp-5116	311	5	4	4	NUM
fnp-5116	311	6	,	,	PUNCT
fnp-5116	311	7	pp	pp	ADJ
fnp-5116	311	8	.	.	PUNCT
fnp-5116	312	1	1153	1153	NUM
fnp-5116	312	2	-	-	SYM
fnp-5116	312	3	60	60	NUM
fnp-5116	312	4	,	,	PUNCT
fnp-5116	312	5	mar	mar	PROPN
fnp-5116	312	6	15	15	NUM
fnp-5116	312	7	2004	2004	NUM
fnp-5116	312	8	,	,	PUNCT
fnp-5116	312	9	https://doi.org/10.1016/j.ijrobp.2003.09.020	https://doi.org/10.1016/j.ijrobp.2003.09.020	PROPN
fnp-5116	312	10	.	.	PUNCT
fnp-5116	312	11	12	12	NUM
fnp-5116	312	12	.	.	PUNCT
fnp-5116	313	1	q.	q.	PROPN
fnp-5116	313	2	t.	t.	PROPN
fnp-5116	313	3	ostrom	ostrom	PROPN
fnp-5116	313	4	,	,	PUNCT
fnp-5116	313	5	n.	n.	PROPN
fnp-5116	313	6	patil	patil	PROPN
fnp-5116	313	7	,	,	PUNCT
fnp-5116	313	8	g.	g.	PROPN
fnp-5116	313	9	cioffi	cioffi	PROPN
fnp-5116	313	10	,	,	PUNCT
fnp-5116	313	11	k.	k.	PROPN
fnp-5116	313	12	waite	waite	PROPN
fnp-5116	313	13	,	,	PUNCT
fnp-5116	313	14	c.	c.	PROPN
fnp-5116	313	15	kruchko	kruchko	PROPN
fnp-5116	313	16	,	,	PUNCT
fnp-5116	313	17	and	and	CCONJ
fnp-5116	313	18	j.	j.	PROPN
fnp-5116	313	19	s.	s.	PROPN
fnp-5116	313	20	barnholtz	barnholtz	PROPN
fnp-5116	313	21	-	-	PUNCT
fnp-5116	313	22	sloan	sloan	NOUN
fnp-5116	313	23	,	,	PUNCT
fnp-5116	313	24	"	"	PUNCT
fnp-5116	313	25	cbtrus	cbtrus	NOUN
fnp-5116	313	26	statistical	statistical	ADJ
fnp-5116	313	27	report	report	NOUN
fnp-5116	313	28	:	:	PUNCT
fnp-5116	313	29	primary	primary	ADJ
fnp-5116	313	30	brain	brain	NOUN
fnp-5116	313	31	and	and	CCONJ
fnp-5116	313	32	other	other	ADJ
fnp-5116	313	33	central	central	ADJ
fnp-5116	313	34	nervous	nervous	ADJ
fnp-5116	313	35	system	system	NOUN
fnp-5116	313	36	tumors	tumor	NOUN
fnp-5116	313	37	diagnosed	diagnose	VERB
fnp-5116	313	38	in	in	ADP
fnp-5116	313	39	the	the	DET
fnp-5116	313	40	united	united	PROPN
fnp-5116	313	41	states	states	PROPN
fnp-5116	313	42	in	in	ADP
fnp-5116	313	43	2013	2013	NUM
fnp-5116	313	44	-	-	SYM
fnp-5116	313	45	2017	2017	NUM
fnp-5116	313	46	"	"	PUNCT
fnp-5116	313	47	,	,	PUNCT
fnp-5116	313	48	neuro	neuro	PROPN
fnp-5116	313	49	oncol	oncol	PROPN
fnp-5116	313	50	,	,	PUNCT
fnp-5116	313	51	vol	vol	NOUN
fnp-5116	313	52	.	.	PROPN
fnp-5116	314	1	22	22	NUM
fnp-5116	314	2	,	,	PUNCT
fnp-5116	314	3	no	no	INTJ
fnp-5116	314	4	.	.	NOUN
fnp-5116	314	5	12	12	NUM
fnp-5116	315	1	suppl	suppl	ADJ
fnp-5116	315	2	2	2	NUM
fnp-5116	315	3	,	,	PUNCT
fnp-5116	315	4	pp	pp	PROPN
fnp-5116	315	5	.	.	PUNCT
fnp-5116	316	1	iv1	iv1	PROPN
fnp-5116	316	2	-	-	PROPN
fnp-5116	316	3	iv96	iv96	PROPN
fnp-5116	316	4	,	,	PUNCT
fnp-5116	316	5	oct	oct	NOUN
fnp-5116	316	6	30	30	NUM
fnp-5116	316	7	2020	2020	NUM
fnp-5116	316	8	,	,	PUNCT
fnp-5116	316	9	https://doi.org/10.1093/neuonc/noaa200	https://doi.org/10.1093/neuonc/noaa200	PROPN
fnp-5116	316	10	.	.	PUNCT
fnp-5116	317	1	13	13	NUM
fnp-5116	317	2	.	.	PUNCT
fnp-5116	317	3	q.	q.	PROPN
fnp-5116	317	4	t.	t.	PROPN
fnp-5116	317	5	ostrom	ostrom	PROPN
fnp-5116	317	6	,	,	PUNCT
fnp-5116	317	7	g.	g.	PROPN
fnp-5116	317	8	cioffi	cioffi	PROPN
fnp-5116	317	9	,	,	PUNCT
fnp-5116	317	10	k.	k.	PROPN
fnp-5116	317	11	waite	waite	PROPN
fnp-5116	317	12	,	,	PUNCT
fnp-5116	317	13	c.	c.	PROPN
fnp-5116	317	14	kruchko	kruchko	PROPN
fnp-5116	317	15	,	,	PUNCT
fnp-5116	317	16	and	and	CCONJ
fnp-5116	317	17	j.	j.	PROPN
fnp-5116	317	18	s.	s.	PROPN
fnp-5116	317	19	barnholtz	barnholtz	PROPN
fnp-5116	317	20	-	-	PUNCT
fnp-5116	317	21	sloan	sloan	NOUN
fnp-5116	317	22	,	,	PUNCT
fnp-5116	317	23	"	"	PUNCT
fnp-5116	317	24	cbtrus	cbtrus	NOUN
fnp-5116	317	25	statistical	statistical	ADJ
fnp-5116	317	26	report	report	NOUN
fnp-5116	317	27	:	:	PUNCT
fnp-5116	317	28	primary	primary	ADJ
fnp-5116	317	29	brain	brain	NOUN
fnp-5116	317	30	and	and	CCONJ
fnp-5116	317	31	other	other	ADJ
fnp-5116	317	32	central	central	ADJ
fnp-5116	317	33	nervous	nervous	ADJ
fnp-5116	317	34	system	system	NOUN
fnp-5116	317	35	tumors	tumor	NOUN
fnp-5116	317	36	diagnosed	diagnose	VERB
fnp-5116	317	37	in	in	ADP
fnp-5116	317	38	the	the	DET
fnp-5116	317	39	united	united	PROPN
fnp-5116	317	40	states	states	PROPN
fnp-5116	317	41	in	in	ADP
fnp-5116	317	42	2014	2014	NUM
fnp-5116	317	43	-	-	SYM
fnp-5116	317	44	2018	2018	NUM
fnp-5116	317	45	"	"	PUNCT
fnp-5116	317	46	,	,	PUNCT
fnp-5116	317	47	neuro	neuro	PROPN
fnp-5116	317	48	oncol	oncol	PROPN
fnp-5116	317	49	,	,	PUNCT
fnp-5116	317	50	vol	vol	NOUN
fnp-5116	317	51	.	.	PROPN
fnp-5116	318	1	23	23	NUM
fnp-5116	318	2	,	,	PUNCT
fnp-5116	319	1	no	no	INTJ
fnp-5116	319	2	.	.	NOUN
fnp-5116	319	3	12	12	NUM
fnp-5116	319	4	suppl	suppl	ADJ
fnp-5116	319	5	2	2	NUM
fnp-5116	319	6	,	,	PUNCT
fnp-5116	319	7	pp	pp	PROPN
fnp-5116	319	8	.	.	PUNCT
fnp-5116	320	1	iii1	iii1	PROPN
fnp-5116	320	2	-	-	PUNCT
fnp-5116	320	3	iii105	iii105	PROPN
fnp-5116	320	4	,	,	PUNCT
fnp-5116	320	5	oct	oct	NOUN
fnp-5116	320	6	5	5	NUM
fnp-5116	320	7	2021	2021	NUM
fnp-5116	320	8	,	,	PUNCT
fnp-5116	320	9	https://doi.org/10.1093/neuonc/noab200	https://doi.org/10.1093/neuonc/noab200	PROPN
fnp-5116	320	10	.	.	PUNCT
fnp-5116	321	1	14	14	NUM
fnp-5116	321	2	.	.	PUNCT
fnp-5116	322	1	j.	j.	PROPN
fnp-5116	322	2	s.	s.	PROPN
fnp-5116	322	3	nix	nix	PROPN
fnp-5116	322	4	,	,	PUNCT
fnp-5116	322	5	j.	j.	PROPN
fnp-5116	322	6	blakeley	blakeley	PROPN
fnp-5116	322	7	,	,	PUNCT
fnp-5116	322	8	and	and	CCONJ
fnp-5116	322	9	f.	f.	PROPN
fnp-5116	322	10	j.	j.	PROPN
fnp-5116	322	11	rodriguez	rodriguez	PROPN
fnp-5116	322	12	,	,	PUNCT
fnp-5116	322	13	"	"	PUNCT
fnp-5116	322	14	an	an	DET
fnp-5116	322	15	update	update	NOUN
fnp-5116	322	16	on	on	ADP
fnp-5116	322	17	the	the	DET
fnp-5116	322	18	central	central	ADJ
fnp-5116	322	19	nervous	nervous	ADJ
fnp-5116	322	20	system	system	NOUN
fnp-5116	322	21	manifestations	manifestation	NOUN
fnp-5116	322	22	of	of	ADP
fnp-5116	322	23	neurofibromatosis	neurofibromatosis	NOUN
fnp-5116	322	24	type	type	NOUN
fnp-5116	322	25	1	1	NUM
fnp-5116	322	26	"	"	PUNCT
fnp-5116	322	27	,	,	PUNCT
fnp-5116	322	28	acta	acta	PROPN
fnp-5116	322	29	neuropathol	neuropathol	PROPN
fnp-5116	322	30	,	,	PUNCT
fnp-5116	322	31	vol	vol	NOUN
fnp-5116	322	32	.	.	PROPN
fnp-5116	322	33	139	139	NUM
fnp-5116	322	34	,	,	PUNCT
fnp-5116	322	35	no	no	INTJ
fnp-5116	322	36	.	.	NOUN
fnp-5116	322	37	4	4	NUM
fnp-5116	322	38	,	,	PUNCT
fnp-5116	322	39	pp	pp	ADJ
fnp-5116	322	40	.	.	PUNCT
fnp-5116	322	41	625	625	NUM
fnp-5116	322	42	-	-	SYM
fnp-5116	322	43	641	641	NUM
fnp-5116	322	44	,	,	PUNCT
fnp-5116	322	45	apr	apr	NOUN
fnp-5116	322	46	2020	2020	NUM
fnp-5116	322	47	,	,	PUNCT
fnp-5116	322	48	https://doi.org/10.1007/s00401-019-02002-2	https://doi.org/10.1007/s00401-019-02002-2	X
fnp-5116	322	49	.	.	PUNCT
fnp-5116	323	1	15	15	NUM
fnp-5116	323	2	.	.	PUNCT
fnp-5116	323	3	c.	c.	PROPN
fnp-5116	323	4	fernandez	fernandez	PROPN
fnp-5116	323	5	et	et	PROPN
fnp-5116	323	6	al	al	PROPN
fnp-5116	323	7	.	.	PROPN
fnp-5116	323	8	,	,	PUNCT
fnp-5116	323	9	"	"	PUNCT
fnp-5116	323	10	pilocytic	pilocytic	ADJ
fnp-5116	323	11	astrocytomas	astrocytoma	NOUN
fnp-5116	323	12	in	in	ADP
fnp-5116	323	13	children	child	NOUN
fnp-5116	323	14	:	:	PUNCT
fnp-5116	323	15	prognostic	prognostic	ADJ
fnp-5116	323	16	factors	factor	NOUN
fnp-5116	323	17	--	--	PUNCT
fnp-5116	323	18	a	a	DET
fnp-5116	323	19	retrospective	retrospective	ADJ
fnp-5116	323	20	study	study	NOUN
fnp-5116	323	21	of	of	ADP
fnp-5116	323	22	80	80	NUM
fnp-5116	323	23	cases	case	NOUN
fnp-5116	323	24	"	"	PUNCT
fnp-5116	323	25	,	,	PUNCT
fnp-5116	323	26	neurosurgery	neurosurgery	NOUN
fnp-5116	323	27	,	,	PUNCT
fnp-5116	323	28	vol	vol	NOUN
fnp-5116	323	29	.	.	PROPN
fnp-5116	324	1	53	53	NUM
fnp-5116	324	2	,	,	PUNCT
fnp-5116	324	3	no	no	INTJ
fnp-5116	324	4	.	.	NOUN
fnp-5116	324	5	3	3	NUM
fnp-5116	324	6	,	,	PUNCT
fnp-5116	324	7	pp	pp	ADJ
fnp-5116	324	8	.	.	PUNCT
fnp-5116	325	1	544	544	NUM
fnp-5116	325	2	-	-	SYM
fnp-5116	325	3	53	53	NUM
fnp-5116	325	4	;	;	PUNCT
fnp-5116	325	5	discussion	discussion	NOUN
fnp-5116	325	6	554	554	NUM
fnp-5116	325	7	-	-	SYM
fnp-5116	325	8	5	5	NUM
fnp-5116	325	9	,	,	PUNCT
fnp-5116	325	10	sep	sep	NOUN
fnp-5116	325	11	2003	2003	NUM
fnp-5116	325	12	,	,	PUNCT
fnp-5116	325	13	https://doi.org/10.1227/01.neu.0000079330.01541.6e	https://doi.org/10.1227/01.neu.0000079330.01541.6e	NUM
fnp-5116	325	14	.	.	PUNCT
fnp-5116	326	1	16	16	NUM
fnp-5116	326	2	.	.	PUNCT
fnp-5116	327	1	c.	c.	PROPN
fnp-5116	327	2	jungk	jungk	PROPN
fnp-5116	327	3	et	et	PROPN
fnp-5116	327	4	al	al	PROPN
fnp-5116	327	5	.	.	PROPN
fnp-5116	327	6	,	,	PUNCT
fnp-5116	327	7	"	"	PUNCT
fnp-5116	327	8	extent	extent	NOUN
fnp-5116	327	9	of	of	ADP
fnp-5116	327	10	resection	resection	NOUN
fnp-5116	327	11	,	,	PUNCT
fnp-5116	327	12	mgmt	mgmt	PROPN
fnp-5116	327	13	promoter	promoter	NOUN
fnp-5116	327	14	methylation	methylation	NOUN
fnp-5116	327	15	status	status	NOUN
fnp-5116	327	16	and	and	CCONJ
fnp-5116	327	17	tumor	tumor	NOUN
fnp-5116	327	18	location	location	NOUN
fnp-5116	327	19	independently	independently	ADV
fnp-5116	327	20	predict	predict	VERB
fnp-5116	327	21	progression	progression	NOUN
fnp-5116	327	22	-	-	PUNCT
fnp-5116	327	23	free	free	ADJ
fnp-5116	327	24	survival	survival	NOUN
fnp-5116	327	25	in	in	ADP
fnp-5116	327	26	adult	adult	NOUN
fnp-5116	327	27	sporadic	sporadic	ADJ
fnp-5116	327	28	pilocytic	pilocytic	ADJ
fnp-5116	327	29	astrocytoma	astrocytoma	NOUN
fnp-5116	327	30	"	"	PUNCT
fnp-5116	327	31	,	,	PUNCT
fnp-5116	327	32	cancers	cancer	NOUN
fnp-5116	327	33	(	(	PUNCT
fnp-5116	327	34	basel	basel	PROPN
fnp-5116	327	35	)	)	PUNCT
fnp-5116	327	36	,	,	PUNCT
fnp-5116	327	37	vol	vol	NOUN
fnp-5116	327	38	.	.	PROPN
fnp-5116	327	39	11	11	NUM
fnp-5116	327	40	,	,	PUNCT
fnp-5116	327	41	no	no	INTJ
fnp-5116	327	42	.	.	NOUN
fnp-5116	327	43	8	8	NUM
fnp-5116	327	44	,	,	PUNCT
fnp-5116	327	45	jul	jul	PROPN
fnp-5116	327	46	29	29	NUM
fnp-5116	327	47	2019	2019	NUM
fnp-5116	327	48	,	,	PUNCT
fnp-5116	327	49	https://doi.org/10.3390/cancers11081072	https://doi.org/10.3390/cancers11081072	NOUN
fnp-5116	327	50	.	.	PUNCT
fnp-5116	328	1	17	17	NUM
fnp-5116	328	2	.	.	PUNCT
fnp-5116	329	1	c.	c.	PROPN
fnp-5116	329	2	colin	colin	PROPN
fnp-5116	329	3	et	et	PROPN
fnp-5116	329	4	al	al	PROPN
fnp-5116	329	5	.	.	PROPN
fnp-5116	329	6	,	,	PUNCT
fnp-5116	329	7	"	"	PUNCT
fnp-5116	329	8	outcome	outcome	VERB
fnp-5116	329	9	analysis	analysis	NOUN
fnp-5116	329	10	of	of	ADP
fnp-5116	329	11	childhood	childhood	NOUN
fnp-5116	329	12	pilocytic	pilocytic	ADJ
fnp-5116	329	13	astrocytomas	astrocytoma	NOUN
fnp-5116	329	14	:	:	PUNCT
fnp-5116	329	15	a	a	DET
fnp-5116	329	16	retrospective	retrospective	ADJ
fnp-5116	329	17	study	study	NOUN
fnp-5116	329	18	of	of	ADP
fnp-5116	329	19	148	148	NUM
fnp-5116	329	20	cases	case	NOUN
fnp-5116	329	21	at	at	ADP
fnp-5116	329	22	a	a	DET
fnp-5116	329	23	single	single	ADJ
fnp-5116	329	24	institution	institution	NOUN
fnp-5116	329	25	"	"	PUNCT
fnp-5116	329	26	,	,	PUNCT
fnp-5116	329	27	neuropathol	neuropathol	NOUN
fnp-5116	329	28	appl	appl	PROPN
fnp-5116	329	29	neurobiol	neurobiol	PROPN
fnp-5116	329	30	,	,	PUNCT
fnp-5116	329	31	vol	vol	NOUN
fnp-5116	329	32	.	.	PROPN
fnp-5116	329	33	39	39	NUM
fnp-5116	329	34	,	,	PUNCT
fnp-5116	329	35	no	no	INTJ
fnp-5116	329	36	.	.	NOUN
fnp-5116	329	37	6	6	NUM
fnp-5116	329	38	,	,	PUNCT
fnp-5116	329	39	pp	pp	ADJ
fnp-5116	329	40	.	.	PUNCT
fnp-5116	330	1	693	693	NUM
fnp-5116	330	2	-	-	SYM
fnp-5116	330	3	705	705	NUM
fnp-5116	330	4	,	,	PUNCT
fnp-5116	330	5	oct	oct	PROPN
fnp-5116	330	6	2013	2013	NUM
fnp-5116	330	7	,	,	PUNCT
fnp-5116	330	8	https://doi.org/10.1111/nan.12013	https://doi.org/10.1111/nan.12013	PROPN
fnp-5116	330	9	.	.	PROPN
fnp-5116	330	10	18	18	NUM
fnp-5116	330	11	.	.	PUNCT
fnp-5116	331	1	y.	y.	PROPN
fnp-5116	331	2	tomita	tomita	PROPN
fnp-5116	331	3	et	et	PROPN
fnp-5116	331	4	al	al	PROPN
fnp-5116	331	5	.	.	PROPN
fnp-5116	331	6	,	,	PUNCT
fnp-5116	331	7	"	"	PUNCT
fnp-5116	331	8	age	age	NOUN
fnp-5116	331	9	is	be	AUX
fnp-5116	331	10	a	a	DET
fnp-5116	331	11	major	major	ADJ
fnp-5116	331	12	determinant	determinant	ADJ
fnp-5116	331	13	for	for	ADP
fnp-5116	331	14	poor	poor	ADJ
fnp-5116	331	15	prognosis	prognosis	NOUN
fnp-5116	331	16	in	in	ADP
fnp-5116	331	17	patients	patient	NOUN
fnp-5116	331	18	with	with	ADP
fnp-5116	331	19	pilocytic	pilocytic	ADJ
fnp-5116	331	20	astrocytoma	astrocytoma	NOUN
fnp-5116	331	21	:	:	PUNCT
fnp-5116	331	22	a	a	DET
fnp-5116	331	23	seer	seer	NOUN
fnp-5116	331	24	population	population	NOUN
fnp-5116	331	25	study	study	NOUN
fnp-5116	331	26	"	"	PUNCT
fnp-5116	331	27	,	,	PUNCT
fnp-5116	331	28	clin	clin	PROPN
fnp-5116	331	29	exp	exp	PROPN
fnp-5116	331	30	med	med	PROPN
fnp-5116	331	31	,	,	PUNCT
fnp-5116	331	32	2023	2023	NUM
fnp-5116	331	33	oct;23(6):2301	oct;23(6):2301	PROPN
fnp-5116	331	34	-	-	PUNCT
fnp-5116	331	35	2309	2309	NUM
fnp-5116	331	36	.	.	PUNCT
fnp-5116	331	37	,	,	PUNCT
fnp-5116	331	38	https://doi.org/10.1007/s10238-022-00882-5	https://doi.org/10.1007/s10238-022-00882-5	NUM
fnp-5116	331	39	.	.	PUNCT
fnp-5116	332	1	19	19	NUM
fnp-5116	332	2	.	.	PUNCT
fnp-5116	333	1	k.	k.	PROPN
fnp-5116	333	2	j.	j.	PROPN
fnp-5116	333	3	lee	lee	PROPN
fnp-5116	333	4	et	et	PROPN
fnp-5116	333	5	al	al	PROPN
fnp-5116	333	6	.	.	PROPN
fnp-5116	333	7	,	,	PUNCT
fnp-5116	333	8	"	"	PUNCT
fnp-5116	333	9	management	management	NOUN
fnp-5116	333	10	and	and	CCONJ
fnp-5116	333	11	survival	survival	NOUN
fnp-5116	333	12	of	of	ADP
fnp-5116	333	13	adult	adult	NOUN
fnp-5116	333	14	patients	patient	NOUN
fnp-5116	333	15	with	with	ADP
fnp-5116	333	16	pilocytic	pilocytic	ADJ
fnp-5116	333	17	astrocytoma	astrocytoma	NOUN
fnp-5116	333	18	in	in	ADP
fnp-5116	333	19	the	the	DET
fnp-5116	333	20	national	national	ADJ
fnp-5116	333	21	cancer	cancer	NOUN
fnp-5116	333	22	database	database	NOUN
fnp-5116	333	23	"	"	PUNCT
fnp-5116	333	24	,	,	PUNCT
fnp-5116	333	25	world	world	NOUN
fnp-5116	333	26	neurosurg	neurosurg	PROPN
fnp-5116	333	27	,	,	PUNCT
fnp-5116	333	28	vol	vol	NOUN
fnp-5116	333	29	.	.	PROPN
fnp-5116	334	1	112	112	NUM
fnp-5116	334	2	,	,	PUNCT
fnp-5116	334	3	pp	pp	ADJ
fnp-5116	334	4	.	.	PUNCT
fnp-5116	335	1	e881	e881	PROPN
fnp-5116	335	2	-	-	PUNCT
fnp-5116	335	3	e887	e887	PROPN
fnp-5116	335	4	,	,	PUNCT
fnp-5116	335	5	apr	apr	NOUN
fnp-5116	335	6	2018	2018	NUM
fnp-5116	335	7	,	,	PUNCT
fnp-5116	335	8	https://doi.org/10.1016/j.wneu.2018.01.208	https://doi.org/10.1016/j.wneu.2018.01.208	NOUN
fnp-5116	335	9	.	.	NOUN
fnp-5116	335	10	20	20	NUM
fnp-5116	335	11	.	.	PUNCT
fnp-5116	336	1	w.	w.	PROPN
fnp-5116	336	2	yang	yang	PROPN
fnp-5116	336	3	,	,	PUNCT
fnp-5116	336	4	j.	j.	PROPN
fnp-5116	336	5	l.	l.	PROPN
fnp-5116	336	6	porras	porras	PROPN
fnp-5116	336	7	,	,	PUNCT
fnp-5116	336	8	a.	a.	PROPN
fnp-5116	336	9	m.	m.	PROPN
fnp-5116	336	10	khalafallah	khalafallah	PROPN
fnp-5116	336	11	,	,	PUNCT
fnp-5116	336	12	y.	y.	PROPN
fnp-5116	336	13	sun	sun	PROPN
fnp-5116	336	14	,	,	PUNCT
fnp-5116	336	15	a.	a.	NOUN
fnp-5116	336	16	bettegowda	bettegowda	NOUN
fnp-5116	336	17	,	,	PUNCT
fnp-5116	336	18	and	and	CCONJ
fnp-5116	336	19	d.	d.	PROPN
fnp-5116	336	20	mukherjee	mukherjee	PROPN
fnp-5116	336	21	,	,	PUNCT
fnp-5116	336	22	"	"	PUNCT
fnp-5116	336	23	comparison	comparison	NOUN
fnp-5116	336	24	of	of	ADP
fnp-5116	336	25	adult	adult	NOUN
fnp-5116	336	26	and	and	CCONJ
fnp-5116	336	27	pediatric	pediatric	ADJ
fnp-5116	336	28	pilocytic	pilocytic	ADJ
fnp-5116	336	29	astrocytomas	astrocytoma	NOUN
fnp-5116	336	30	using	use	VERB
fnp-5116	336	31	competing	compete	VERB
fnp-5116	336	32	risk	risk	NOUN
fnp-5116	336	33	analysis	analysis	NOUN
fnp-5116	336	34	:	:	PUNCT
fnp-5116	336	35	a	a	DET
fnp-5116	336	36	population	population	NOUN
fnp-5116	336	37	-	-	PUNCT
fnp-5116	336	38	based	base	VERB
fnp-5116	336	39	study	study	NOUN
fnp-5116	336	40	"	"	PUNCT
fnp-5116	336	41	,	,	PUNCT
fnp-5116	336	42	clin	clin	PROPN
fnp-5116	336	43	neurol	neurol	PROPN
fnp-5116	336	44	neurosurg	neurosurg	PROPN
fnp-5116	336	45	,	,	PUNCT
fnp-5116	336	46	vol	vol	NOUN
fnp-5116	336	47	.	.	PROPN
fnp-5116	336	48	212	212	NUM
fnp-5116	336	49	,	,	PUNCT
fnp-5116	336	50	p.	p.	NOUN
fnp-5116	336	51	107084	107084	NUM
fnp-5116	336	52	,	,	PUNCT
fnp-5116	336	53	jan	jan	PROPN
fnp-5116	336	54	2022	2022	NUM
fnp-5116	336	55	,	,	PUNCT
fnp-5116	336	56	https://doi.org/10.1016/j.clineuro.2021.107084	https://doi.org/10.1016/j.clineuro.2021.107084	PROPN
fnp-5116	336	57	.	.	PUNCT
fnp-5116	337	1	21	21	NUM
fnp-5116	337	2	.	.	PUNCT
fnp-5116	337	3	i.	i.	PROPN
fnp-5116	337	4	shin	shin	PROPN
fnp-5116	337	5	et	et	PROPN
fnp-5116	337	6	al	al	PROPN
fnp-5116	337	7	.	.	PROPN
fnp-5116	337	8	,	,	PUNCT
fnp-5116	337	9	"	"	PUNCT
fnp-5116	337	10	clinical	clinical	ADJ
fnp-5116	337	11	factors	factor	NOUN
fnp-5116	337	12	and	and	CCONJ
fnp-5116	337	13	conventional	conventional	ADJ
fnp-5116	337	14	mri	mri	NOUN
fnp-5116	337	15	may	may	AUX
fnp-5116	337	16	independently	independently	ADV
fnp-5116	337	17	predict	predict	VERB
fnp-5116	337	18	progression	progression	NOUN
fnp-5116	337	19	-	-	PUNCT
fnp-5116	337	20	free	free	ADJ
fnp-5116	337	21	survival	survival	NOUN
fnp-5116	337	22	and	and	CCONJ
fnp-5116	337	23	overall	overall	ADJ
fnp-5116	337	24	survival	survival	NOUN
fnp-5116	337	25	in	in	ADP
fnp-5116	337	26	adult	adult	NOUN
fnp-5116	337	27	pilocytic	pilocytic	ADJ
fnp-5116	337	28	astrocytomas	astrocytoma	NOUN
fnp-5116	337	29	"	"	PUNCT
fnp-5116	337	30	,	,	PUNCT
fnp-5116	337	31	neuroradiology	neuroradiology	NOUN
fnp-5116	337	32	,	,	PUNCT
fnp-5116	337	33	vol	vol	NOUN
fnp-5116	337	34	.	.	PROPN
fnp-5116	338	1	64	64	NUM
fnp-5116	338	2	,	,	PUNCT
fnp-5116	338	3	no	no	INTJ
fnp-5116	338	4	.	.	NOUN
fnp-5116	338	5	8	8	NUM
fnp-5116	338	6	,	,	PUNCT
fnp-5116	338	7	pp	pp	ADJ
fnp-5116	338	8	.	.	PUNCT
fnp-5116	339	1	1529	1529	NUM
fnp-5116	339	2	-	-	SYM
fnp-5116	339	3	1537	1537	NUM
fnp-5116	339	4	,	,	PUNCT
fnp-5116	339	5	aug	aug	PROPN
fnp-5116	339	6	2022	2022	NUM
fnp-5116	339	7	,	,	PUNCT
fnp-5116	339	8	https://doi.org/10.1007/s00234-021-02872-y	https://doi.org/10.1007/s00234-021-02872-y	NOUN
fnp-5116	339	9	.	.	PUNCT
fnp-5116	340	1	22	22	NUM
fnp-5116	340	2	.	.	PUNCT
fnp-5116	341	1	k.	k.	PROPN
fnp-5116	341	2	j.	j.	PROPN
fnp-5116	341	3	coakley	coakley	PROPN
fnp-5116	341	4	,	,	PUNCT
fnp-5116	341	5	j.	j.	PROPN
fnp-5116	341	6	huston	huston	PROPN
fnp-5116	341	7	,	,	PUNCT
fnp-5116	341	8	3rd	3rd	PROPN
fnp-5116	341	9	,	,	PUNCT
fnp-5116	341	10	b.	b.	PROPN
fnp-5116	341	11	w.	w.	PROPN
fnp-5116	341	12	scheithauer	scheithauer	PROPN
fnp-5116	341	13	,	,	PUNCT
fnp-5116	341	14	g.	g.	PROPN
fnp-5116	341	15	forbes	forbes	PROPN
fnp-5116	341	16	,	,	PUNCT
fnp-5116	341	17	and	and	CCONJ
fnp-5116	341	18	p.	p.	PROPN
fnp-5116	341	19	j.	j.	PROPN
fnp-5116	341	20	kelly	kelly	PROPN
fnp-5116	341	21	,	,	PUNCT
fnp-5116	341	22	"	"	PUNCT
fnp-5116	341	23	pilocytic	pilocytic	ADJ
fnp-5116	341	24	astrocytomas	astrocytoma	NOUN
fnp-5116	341	25	:	:	PUNCT
fnp-5116	341	26	well	well	ADV
fnp-5116	341	27	-	-	PUNCT
fnp-5116	341	28	demarcated	demarcate	VERB
fnp-5116	341	29	magnetic	magnetic	ADJ
fnp-5116	341	30	resonance	resonance	NOUN
fnp-5116	341	31	appearance	appearance	NOUN
fnp-5116	341	32	despite	despite	SCONJ
fnp-5116	341	33	frequent	frequent	ADJ
fnp-5116	341	34	infiltration	infiltration	NOUN
fnp-5116	341	35	histologically	histologically	NOUN
fnp-5116	341	36	"	"	PUNCT
fnp-5116	341	37	,	,	PUNCT
fnp-5116	341	38	mayo	mayo	PROPN
fnp-5116	341	39	clin	clin	PROPN
fnp-5116	341	40	proc	proc	PROPN
fnp-5116	341	41	,	,	PUNCT
fnp-5116	341	42	vol	vol	NOUN
fnp-5116	341	43	.	.	PROPN
fnp-5116	341	44	70	70	NUM
fnp-5116	341	45	,	,	PUNCT
fnp-5116	341	46	no	no	INTJ
fnp-5116	341	47	.	.	NOUN
fnp-5116	341	48	8	8	NUM
fnp-5116	341	49	,	,	PUNCT
fnp-5116	341	50	pp	pp	ADJ
fnp-5116	341	51	.	.	PUNCT
fnp-5116	342	1	747	747	NUM
fnp-5116	342	2	-	-	SYM
fnp-5116	342	3	51	51	NUM
fnp-5116	342	4	,	,	PUNCT
fnp-5116	342	5	aug	aug	PROPN
fnp-5116	342	6	1995	1995	NUM
fnp-5116	342	7	,	,	PUNCT
fnp-5116	342	8	https://doi.org/10.4065/70.8.747	https://doi.org/10.4065/70.8.747	PROPN
fnp-5116	342	9	.	.	PUNCT
fnp-5116	343	1	23	23	NUM
fnp-5116	343	2	.	.	PUNCT
fnp-5116	343	3	a.	a.	PROPN
fnp-5116	343	4	palpan	palpan	PROPN
fnp-5116	343	5	flores	flores	PROPN
fnp-5116	343	6	,	,	PUNCT
fnp-5116	343	7	v.	v.	PROPN
fnp-5116	343	8	rodriguez	rodriguez	PROPN
fnp-5116	343	9	dominguez	dominguez	PROPN
fnp-5116	343	10	,	,	PUNCT
fnp-5116	343	11	i.	i.	PROPN
fnp-5116	343	12	esteban	esteban	PROPN
fnp-5116	343	13	rodriguez	rodriguez	PROPN
fnp-5116	343	14	,	,	PUNCT
fnp-5116	343	15	m.	m.	NOUN
fnp-5116	343	16	roman	roman	PROPN
fnp-5116	343	17	de	de	PROPN
fnp-5116	343	18	aragon	aragon	PROPN
fnp-5116	343	19	,	,	PUNCT
fnp-5116	343	20	and	and	CCONJ
fnp-5116	343	21	a.	a.	PROPN
fnp-5116	343	22	zamarron	zamarron	PROPN
fnp-5116	343	23	perez	perez	PROPN
fnp-5116	343	24	,	,	PUNCT
fnp-5116	343	25	"	"	PUNCT
fnp-5116	343	26	h3k27m	h3k27m	ADJ
fnp-5116	343	27	-	-	ADJ
fnp-5116	343	28	mutant	mutant	ADJ
fnp-5116	343	29	glioma	glioma	NOUN
fnp-5116	343	30	in	in	ADP
fnp-5116	343	31	thoracic	thoracic	NOUN
fnp-5116	343	32	spinal	spinal	NOUN
fnp-5116	343	33	cord	cord	NOUN
fnp-5116	343	34	and	and	CCONJ
fnp-5116	343	35	conus	conus	NOUN
fnp-5116	343	36	medullaris	medullaris	NOUN
fnp-5116	343	37	with	with	ADP
fnp-5116	343	38	pilocytic	pilocytic	ADJ
fnp-5116	343	39	astrocytoma	astrocytoma	PROPN
fnp-5116	343	40	morphology	morphology	NOUN
fnp-5116	343	41	:	:	PUNCT
fnp-5116	343	42	case	case	NOUN
fnp-5116	343	43	report	report	NOUN
fnp-5116	343	44	and	and	CCONJ
fnp-5116	343	45	review	review	NOUN
fnp-5116	343	46	of	of	ADP
fnp-5116	343	47	the	the	DET
fnp-5116	343	48	literature	literature	NOUN
fnp-5116	343	49	"	"	PUNCT
fnp-5116	343	50	,	,	PUNCT
fnp-5116	343	51	br	br	PROPN
fnp-5116	343	52	j	j	PROPN
fnp-5116	343	53	neurosurg	neurosurg	PROPN
fnp-5116	343	54	,	,	PUNCT
fnp-5116	343	55	pp	pp	ADJ
fnp-5116	343	56	.	.	PUNCT
fnp-5116	344	1	1	1	NUM
fnp-5116	344	2	-	-	SYM
fnp-5116	344	3	7	7	NUM
fnp-5116	344	4	,	,	PUNCT
fnp-5116	344	5	oct	oct	PROPN
fnp-5116	344	6	7	7	NUM
fnp-5116	344	7	2021	2021	NUM
fnp-5116	344	8	,	,	PUNCT
fnp-5116	344	9	https://doi.org/10.1080/02688697.2021.1988054	https://doi.org/10.1080/02688697.2021.1988054	PROPN
fnp-5116	344	10	.	.	PROPN
fnp-5116	345	1	24	24	NUM
fnp-5116	345	2	.	.	PUNCT
fnp-5116	346	1	d.	d.	PROPN
fnp-5116	346	2	brat	brat	PROPN
fnp-5116	346	3	et	et	PROPN
fnp-5116	346	4	al	al	PROPN
fnp-5116	346	5	.	.	PROPN
fnp-5116	346	6	,	,	PUNCT
fnp-5116	346	7	who	who	PRON
fnp-5116	346	8	classification	classification	NOUN
fnp-5116	346	9	of	of	ADP
fnp-5116	346	10	tumours	tumour	NOUN
fnp-5116	346	11	of	of	ADP
fnp-5116	346	12	the	the	DET
fnp-5116	346	13	central	central	ADJ
fnp-5116	346	14	nervous	nervous	ADJ
fnp-5116	346	15	system	system	NOUN
fnp-5116	346	16	,	,	PUNCT
fnp-5116	346	17	5th	5th	ADJ
fnp-5116	346	18	ed	ed	NOUN
fnp-5116	346	19	.	.	PUNCT
fnp-5116	347	1	(	(	PUNCT
fnp-5116	347	2	who	who	PRON
fnp-5116	347	3	classification	classification	NOUN
fnp-5116	347	4	of	of	ADP
fnp-5116	347	5	tumours	tumours	PROPN
fnp-5116	347	6	,	,	PUNCT
fnp-5116	347	7	no	no	INTJ
fnp-5116	347	8	.	.	NOUN
fnp-5116	347	9	6	6	NUM
fnp-5116	347	10	)	)	PUNCT
fnp-5116	347	11	.	.	PUNCT
fnp-5116	348	1	lyon	lyon	PROPN
fnp-5116	348	2	:	:	PUNCT
fnp-5116	348	3	international	international	ADJ
fnp-5116	348	4	agency	agency	NOUN
fnp-5116	348	5	for	for	ADP
fnp-5116	348	6	research	research	NOUN
fnp-5116	348	7	on	on	ADP
fnp-5116	348	8	cancer	cancer	NOUN
fnp-5116	348	9	,	,	PUNCT
fnp-5116	348	10	2021	2021	NUM
fnp-5116	348	11	.	.	PUNCT
fnp-5116	349	1	25	25	NUM
fnp-5116	349	2	.	.	PUNCT
fnp-5116	350	1	f.	f.	PROPN
fnp-5116	350	2	j.	j.	PROPN
fnp-5116	350	3	rodriguez	rodriguez	PROPN
fnp-5116	350	4	,	,	PUNCT
fnp-5116	350	5	b.	b.	PROPN
fnp-5116	350	6	w.	w.	PROPN
fnp-5116	350	7	scheithauer	scheithauer	PROPN
fnp-5116	350	8	,	,	PUNCT
fnp-5116	350	9	p.	p.	PROPN
fnp-5116	350	10	c.	c.	PROPN
fnp-5116	350	11	burger	burger	PROPN
fnp-5116	350	12	,	,	PUNCT
fnp-5116	350	13	s.	s.	PROPN
fnp-5116	350	14	jenkins	jenkins	PROPN
fnp-5116	350	15	,	,	PUNCT
fnp-5116	350	16	and	and	CCONJ
fnp-5116	350	17	c.	c.	PROPN
fnp-5116	350	18	giannini	giannini	PROPN
fnp-5116	350	19	,	,	PUNCT
fnp-5116	350	20	"	"	PUNCT
fnp-5116	350	21	anaplasia	anaplasia	NOUN
fnp-5116	350	22	in	in	ADP
fnp-5116	350	23	pilocytic	pilocytic	ADJ
fnp-5116	350	24	astrocytoma	astrocytoma	NOUN
fnp-5116	350	25	predicts	predict	VERB
fnp-5116	350	26	aggressive	aggressive	ADJ
fnp-5116	350	27	behavior	behavior	NOUN
fnp-5116	350	28	"	"	PUNCT
fnp-5116	350	29	,	,	PUNCT
fnp-5116	350	30	am	be	AUX
fnp-5116	350	31	j	j	PROPN
fnp-5116	350	32	surg	surg	PROPN
fnp-5116	350	33	pathol	pathol	PROPN
fnp-5116	350	34	,	,	PUNCT
fnp-5116	350	35	vol	vol	NOUN
fnp-5116	350	36	.	.	PROPN
fnp-5116	351	1	34	34	NUM
fnp-5116	351	2	,	,	PUNCT
fnp-5116	351	3	no	no	INTJ
fnp-5116	351	4	.	.	NOUN
fnp-5116	351	5	2	2	NUM
fnp-5116	351	6	,	,	PUNCT
fnp-5116	351	7	pp	pp	ADJ
fnp-5116	351	8	.	.	PUNCT
fnp-5116	352	1	147	147	NUM
fnp-5116	352	2	-	-	SYM
fnp-5116	352	3	60	60	NUM
fnp-5116	352	4	,	,	PUNCT
fnp-5116	352	5	feb	feb	NOUN
fnp-5116	352	6	2010	2010	NUM
fnp-5116	352	7	,	,	PUNCT
fnp-5116	352	8	https://doi.org/10.1097/pas.0b013e3181c75238	https://doi.org/10.1097/pas.0b013e3181c75238	PROPN
fnp-5116	352	9	.	.	PROPN
fnp-5116	353	1	26	26	NUM
fnp-5116	353	2	.	.	PUNCT
fnp-5116	354	1	p.	p.	NOUN
fnp-5116	354	2	a.	a.	NOUN
fnp-5116	354	3	forsyth	forsyth	PROPN
fnp-5116	354	4	,	,	PUNCT
fnp-5116	354	5	e.	e.	PROPN
fnp-5116	354	6	g.	g.	PROPN
fnp-5116	354	7	shaw	shaw	PROPN
fnp-5116	354	8	,	,	PUNCT
fnp-5116	354	9	b.	b.	PROPN
fnp-5116	354	10	w.	w.	PROPN
fnp-5116	354	11	scheithauer	scheithauer	PROPN
fnp-5116	354	12	,	,	PUNCT
fnp-5116	354	13	j.	j.	PROPN
fnp-5116	354	14	r.	r.	PROPN
fnp-5116	354	15	o'fallon	o'fallon	PROPN
fnp-5116	354	16	,	,	PUNCT
fnp-5116	354	17	d.	d.	PROPN
fnp-5116	354	18	d.	d.	PROPN
fnp-5116	354	19	layton	layton	PROPN
fnp-5116	354	20	,	,	PUNCT
fnp-5116	354	21	jr	jr	PROPN
fnp-5116	354	22	.	.	PROPN
fnp-5116	354	23	,	,	PUNCT
fnp-5116	354	24	and	and	CCONJ
fnp-5116	354	25	j.	j.	PROPN
fnp-5116	354	26	a.	a.	PROPN
fnp-5116	354	27	katzmann	katzmann	PROPN
fnp-5116	354	28	,	,	PUNCT
fnp-5116	354	29	"	"	PUNCT
fnp-5116	354	30	supratentorial	supratentorial	ADJ
fnp-5116	354	31	pilocytic	pilocytic	ADJ
fnp-5116	354	32	astrocytomas	astrocytoma	NOUN
fnp-5116	354	33	.	.	PUNCT
fnp-5116	355	1	a	a	DET
fnp-5116	355	2	clinicopathologic	clinicopathologic	ADJ
fnp-5116	355	3	,	,	PUNCT
fnp-5116	355	4	prognostic	prognostic	NOUN
fnp-5116	355	5	,	,	PUNCT
fnp-5116	355	6	and	and	CCONJ
fnp-5116	355	7	flow	flow	VERB
fnp-5116	355	8	cytometric	cytometric	ADJ
fnp-5116	355	9	study	study	NOUN
fnp-5116	355	10	of	of	ADP
fnp-5116	355	11	51	51	NUM
fnp-5116	355	12	patients	patient	NOUN
fnp-5116	355	13	"	"	PUNCT
fnp-5116	355	14	,	,	PUNCT
fnp-5116	355	15	cancer	cancer	NOUN
fnp-5116	355	16	,	,	PUNCT
fnp-5116	355	17	vol	vol	NOUN
fnp-5116	355	18	.	.	PROPN
fnp-5116	355	19	72	72	NUM
fnp-5116	355	20	,	,	PUNCT
fnp-5116	355	21	no	no	INTJ
fnp-5116	355	22	.	.	NOUN
fnp-5116	355	23	4	4	NUM
fnp-5116	355	24	,	,	PUNCT
fnp-5116	355	25	pp	pp	ADJ
fnp-5116	355	26	.	.	PUNCT
fnp-5116	356	1	1335	1335	NUM
fnp-5116	356	2	-	-	SYM
fnp-5116	356	3	42	42	NUM
fnp-5116	356	4	,	,	PUNCT
fnp-5116	356	5	aug	aug	PROPN
fnp-5116	356	6	15	15	NUM
fnp-5116	356	7	1993	1993	NUM
fnp-5116	356	8	,	,	PUNCT
fnp-5116	356	9	https://doi.org/10.1002/1097-0142(19930815)72:4<1335::aid-cncr2820720431>3.0.co;2-e	https://doi.org/10.1002/1097-0142(19930815)72:4<1335::aid-cncr2820720431>3.0.co;2-e	PROPN
fnp-5116	356	10	.	.	PROPN
fnp-5116	356	11	27	27	NUM
fnp-5116	356	12	.	.	PUNCT
fnp-5116	356	13	a.	a.	PROPN
fnp-5116	356	14	wade	wade	PROPN
fnp-5116	356	15	,	,	PUNCT
fnp-5116	356	16	c.	c.	PROPN
fnp-5116	356	17	hayhurst	hayhurst	PROPN
fnp-5116	356	18	,	,	PUNCT
fnp-5116	356	19	a.	a.	PROPN
fnp-5116	356	20	amato	amato	PROPN
fnp-5116	356	21	-	-	PUNCT
fnp-5116	356	22	watkins	watkins	PROPN
fnp-5116	356	23	,	,	PUNCT
fnp-5116	356	24	a.	a.	NOUN
fnp-5116	356	25	lammie	lammie	PROPN
fnp-5116	356	26	,	,	PUNCT
fnp-5116	356	27	and	and	CCONJ
fnp-5116	356	28	p.	p.	NOUN
fnp-5116	356	29	leach	leach	NOUN
fnp-5116	356	30	,	,	PUNCT
fnp-5116	356	31	"	"	PUNCT
fnp-5116	356	32	cerebellar	cerebellar	ADJ
fnp-5116	356	33	pilocytic	pilocytic	ADJ
fnp-5116	356	34	astrocytoma	astrocytoma	NOUN
fnp-5116	356	35	in	in	ADP
fnp-5116	356	36	adults	adult	NOUN
fnp-5116	356	37	:	:	PUNCT
fnp-5116	356	38	a	a	DET
fnp-5116	356	39	management	management	NOUN
fnp-5116	356	40	paradigm	paradigm	NOUN
fnp-5116	356	41	for	for	ADP
fnp-5116	356	42	a	a	DET
fnp-5116	356	43	rare	rare	ADJ
fnp-5116	356	44	tumour	tumour	NOUN
fnp-5116	356	45	"	"	PUNCT
fnp-5116	356	46	,	,	PUNCT
fnp-5116	356	47	acta	acta	PROPN
fnp-5116	356	48	neurochir	neurochir	PROPN
fnp-5116	356	49	(	(	PUNCT
fnp-5116	356	50	wien	wien	PROPN
fnp-5116	356	51	)	)	PUNCT
fnp-5116	356	52	,	,	PUNCT
fnp-5116	356	53	vol	vol	NOUN
fnp-5116	356	54	.	.	PROPN
fnp-5116	356	55	155	155	NUM
fnp-5116	356	56	,	,	PUNCT
fnp-5116	356	57	no	no	INTJ
fnp-5116	356	58	.	.	NOUN
fnp-5116	356	59	8	8	NUM
fnp-5116	356	60	,	,	PUNCT
fnp-5116	356	61	pp	pp	ADJ
fnp-5116	356	62	.	.	PUNCT
fnp-5116	357	1	1431	1431	NUM
fnp-5116	357	2	-	-	SYM
fnp-5116	357	3	5	5	NUM
fnp-5116	357	4	,	,	PUNCT
fnp-5116	357	5	aug	aug	PROPN
fnp-5116	357	6	2013	2013	NUM
fnp-5116	357	7	,	,	PUNCT
fnp-5116	357	8	https://doi.org/10.1007/s00701-013-1790-1	https://doi.org/10.1007/s00701-013-1790-1	NUM
fnp-5116	357	9	.	.	PUNCT
fnp-5116	358	1	28	28	NUM
fnp-5116	358	2	.	.	PUNCT
fnp-5116	358	3	a.	a.	PROPN
fnp-5116	358	4	paixao	paixao	PROPN
fnp-5116	358	5	becker	becker	PROPN
fnp-5116	358	6	,	,	PUNCT
fnp-5116	358	7	r.	r.	PROPN
fnp-5116	358	8	s.	s.	PROPN
fnp-5116	358	9	de	de	PROPN
fnp-5116	358	10	oliveira	oliveira	PROPN
fnp-5116	358	11	,	,	PUNCT
fnp-5116	358	12	f.	f.	PROPN
fnp-5116	358	13	p.	p.	PROPN
fnp-5116	358	14	saggioro	saggioro	PROPN
fnp-5116	358	15	,	,	PUNCT
fnp-5116	358	16	l.	l.	PROPN
fnp-5116	358	17	neder	neder	PROPN
fnp-5116	358	18	,	,	PUNCT
fnp-5116	358	19	l.	l.	PROPN
fnp-5116	358	20	m.	m.	PROPN
fnp-5116	358	21	chimelli	chimelli	PROPN
fnp-5116	358	22	,	,	PUNCT
fnp-5116	358	23	and	and	CCONJ
fnp-5116	358	24	h.	h.	PROPN
fnp-5116	358	25	r.	r.	PROPN
fnp-5116	358	26	machado	machado	PROPN
fnp-5116	358	27	,	,	PUNCT
fnp-5116	358	28	"	"	PUNCT
fnp-5116	358	29	in	in	ADP
fnp-5116	358	30	pursuit	pursuit	NOUN
fnp-5116	358	31	of	of	ADP
fnp-5116	358	32	prognostic	prognostic	ADJ
fnp-5116	358	33	factors	factor	NOUN
fnp-5116	358	34	in	in	ADP
fnp-5116	358	35	children	child	NOUN
fnp-5116	358	36	with	with	ADP
fnp-5116	358	37	pilocytic	pilocytic	ADJ
fnp-5116	358	38	astrocytomas	astrocytoma	NOUN
fnp-5116	358	39	"	"	PUNCT
fnp-5116	358	40	,	,	PUNCT
fnp-5116	358	41	childs	child	VERB
fnp-5116	358	42	nerv	nerv	PROPN
fnp-5116	358	43	syst	syst	PROPN
fnp-5116	358	44	,	,	PUNCT
fnp-5116	358	45	vol	vol	NOUN
fnp-5116	358	46	.	.	PROPN
fnp-5116	358	47	26	26	NUM
fnp-5116	358	48	,	,	PUNCT
fnp-5116	358	49	no	no	INTJ
fnp-5116	358	50	.	.	NOUN
fnp-5116	358	51	1	1	NUM
fnp-5116	358	52	,	,	PUNCT
fnp-5116	358	53	pp	pp	ADJ
fnp-5116	358	54	.	.	PUNCT
fnp-5116	359	1	19	19	NUM
fnp-5116	359	2	-	-	SYM
fnp-5116	359	3	28	28	NUM
fnp-5116	359	4	,	,	PUNCT
fnp-5116	359	5	jan	jan	PROPN
fnp-5116	359	6	2010	2010	NUM
fnp-5116	359	7	,	,	PUNCT
fnp-5116	359	8	https://doi.org/10.1007/s00381-009-0990-8	https://doi.org/10.1007/s00381-009-0990-8	NUM
fnp-5116	359	9	.	.	PUNCT
fnp-5116	360	1	29	29	NUM
fnp-5116	360	2	.	.	PUNCT
fnp-5116	360	3	r.	r.	PROPN
fnp-5116	360	4	j.	j.	PROPN
fnp-5116	360	5	komotar	komotar	PROPN
fnp-5116	360	6	et	et	PROPN
fnp-5116	360	7	al	al	PROPN
fnp-5116	360	8	.	.	PROPN
fnp-5116	360	9	,	,	PUNCT
fnp-5116	360	10	"	"	PUNCT
fnp-5116	360	11	pilocytic	pilocytic	ADJ
fnp-5116	360	12	and	and	CCONJ
fnp-5116	360	13	pilomyxoid	pilomyxoid	VERB
fnp-5116	360	14	hypothalamic	hypothalamic	ADJ
fnp-5116	360	15	/	/	SYM
fnp-5116	360	16	chiasmatic	chiasmatic	ADJ
fnp-5116	360	17	astrocytomas	astrocytoma	NOUN
fnp-5116	360	18	"	"	PUNCT
fnp-5116	360	19	,	,	PUNCT
fnp-5116	360	20	neurosurgery	neurosurgery	NOUN
fnp-5116	360	21	,	,	PUNCT
fnp-5116	360	22	vol	vol	NOUN
fnp-5116	360	23	.	.	PROPN
fnp-5116	360	24	54	54	NUM
fnp-5116	360	25	,	,	PUNCT
fnp-5116	360	26	no	no	INTJ
fnp-5116	360	27	.	.	NOUN
fnp-5116	360	28	1	1	NUM
fnp-5116	360	29	,	,	PUNCT
fnp-5116	360	30	pp	pp	ADJ
fnp-5116	360	31	.	.	PUNCT
fnp-5116	360	32	72	72	NUM
fnp-5116	360	33	-	-	SYM
fnp-5116	360	34	9	9	NUM
fnp-5116	360	35	;	;	PUNCT
fnp-5116	360	36	discussion	discussion	NOUN
fnp-5116	360	37	79	79	NUM
fnp-5116	360	38	-	-	SYM
fnp-5116	360	39	80	80	NUM
fnp-5116	360	40	,	,	PUNCT
fnp-5116	360	41	jan	jan	PROPN
fnp-5116	360	42	2004	2004	NUM
fnp-5116	360	43	,	,	PUNCT
fnp-5116	360	44	https://doi.org/10.1227/01.neu.0000097266.89676.25	https://doi.org/10.1227/01.neu.0000097266.89676.25	PROPN
fnp-5116	360	45	.	.	PROPN
fnp-5116	360	46	30	30	NUM
fnp-5116	360	47	.	.	PUNCT
fnp-5116	361	1	e.	e.	PROPN
fnp-5116	361	2	t.	t.	PROPN
fnp-5116	361	3	hidalgo	hidalgo	PROPN
fnp-5116	361	4	et	et	PROPN
fnp-5116	361	5	al	al	PROPN
fnp-5116	361	6	.	.	PROPN
fnp-5116	361	7	,	,	PUNCT
fnp-5116	361	8	"	"	PUNCT
fnp-5116	361	9	long	long	ADJ
fnp-5116	361	10	-	-	PUNCT
fnp-5116	361	11	term	term	NOUN
fnp-5116	361	12	clinical	clinical	ADJ
fnp-5116	361	13	and	and	CCONJ
fnp-5116	361	14	visual	visual	ADJ
fnp-5116	361	15	outcomes	outcome	NOUN
fnp-5116	361	16	after	after	ADP
fnp-5116	361	17	surgical	surgical	ADJ
fnp-5116	361	18	resection	resection	NOUN
fnp-5116	361	19	of	of	ADP
fnp-5116	361	20	pediatric	pediatric	ADJ
fnp-5116	361	21	pilocytic	pilocytic	ADJ
fnp-5116	361	22	/	/	SYM
fnp-5116	361	23	pilomyxoid	pilomyxoid	NOUN
fnp-5116	361	24	optic	optic	ADJ
fnp-5116	361	25	pathway	pathway	NOUN
fnp-5116	361	26	gliomas	glioma	NOUN
fnp-5116	361	27	"	"	PUNCT
fnp-5116	361	28	,	,	PUNCT
fnp-5116	361	29	j	j	PROPN
fnp-5116	361	30	neurosurg	neurosurg	PROPN
fnp-5116	361	31	pediatr	pediatr	PROPN
fnp-5116	361	32	,	,	PUNCT
fnp-5116	361	33	vol	vol	NOUN
fnp-5116	361	34	.	.	PROPN
fnp-5116	361	35	24	24	NUM
fnp-5116	361	36	,	,	PUNCT
fnp-5116	361	37	no	no	INTJ
fnp-5116	361	38	.	.	NOUN
fnp-5116	361	39	2	2	NUM
fnp-5116	361	40	,	,	PUNCT
fnp-5116	361	41	pp	pp	ADJ
fnp-5116	361	42	.	.	PUNCT
fnp-5116	362	1	166	166	NUM
fnp-5116	362	2	-	-	SYM
fnp-5116	362	3	173	173	NUM
fnp-5116	362	4	,	,	PUNCT
fnp-5116	362	5	may	may	AUX
fnp-5116	362	6	17	17	NUM
fnp-5116	362	7	2019	2019	NUM
fnp-5116	362	8	,	,	PUNCT
fnp-5116	362	9	https://doi.org/10.3171/2019.2.peds18529	https://doi.org/10.3171/2019.2.peds18529	ADV
fnp-5116	362	10	.	.	PUNCT
fnp-5116	363	1	31	31	NUM
fnp-5116	363	2	.	.	PUNCT
fnp-5116	364	1	r.	r.	PROPN
fnp-5116	364	2	parisi	parisi	PROPN
fnp-5116	364	3	et	et	PROPN
fnp-5116	364	4	al	al	PROPN
fnp-5116	364	5	.	.	PROPN
fnp-5116	364	6	,	,	PUNCT
fnp-5116	364	7	"	"	PUNCT
fnp-5116	364	8	multi	multi	ADJ
fnp-5116	364	9	-	-	ADJ
fnp-5116	364	10	institution	institution	ADJ
fnp-5116	364	11	analysis	analysis	NOUN
fnp-5116	364	12	of	of	ADP
fnp-5116	364	13	tumor	tumor	NOUN
fnp-5116	364	14	mutational	mutational	ADJ
fnp-5116	364	15	burden	burden	NOUN
fnp-5116	364	16	and	and	CCONJ
fnp-5116	364	17	outcomes	outcome	NOUN
fnp-5116	364	18	in	in	ADP
fnp-5116	364	19	pediatric	pediatric	ADJ
fnp-5116	364	20	central	central	ADJ
fnp-5116	364	21	nervous	nervous	ADJ
fnp-5116	364	22	system	system	NOUN
fnp-5116	364	23	tumor	tumor	NOUN
fnp-5116	364	24	patients	patient	NOUN
fnp-5116	364	25	"	"	PUNCT
fnp-5116	364	26	,	,	PUNCT
fnp-5116	364	27	pediatr	pediatr	ADJ
fnp-5116	364	28	blood	blood	NOUN
fnp-5116	364	29	cancer	cancer	NOUN
fnp-5116	364	30	,	,	PUNCT
fnp-5116	364	31	vol	vol	NOUN
fnp-5116	364	32	.	.	PROPN
fnp-5116	365	1	70	70	NUM
fnp-5116	365	2	,	,	PUNCT
fnp-5116	365	3	no	no	INTJ
fnp-5116	365	4	.	.	NOUN
fnp-5116	365	5	3	3	NUM
fnp-5116	365	6	,	,	PUNCT
fnp-5116	365	7	p.	p.	NOUN
fnp-5116	365	8	e30139	e30139	PROPN
fnp-5116	365	9	,	,	PUNCT
fnp-5116	365	10	mar	mar	PROPN
fnp-5116	365	11	2023	2023	NUM
fnp-5116	365	12	,	,	PUNCT
fnp-5116	366	1	https://doi.org/10.1002/pbc.30139	https://doi.org/10.1002/pbc.30139	PROPN
fnp-5116	366	2	.	.	PUNCT
fnp-5116	367	1	32	32	NUM
fnp-5116	367	2	.	.	PUNCT
fnp-5116	368	1	v.	v.	ADP
fnp-5116	368	2	thatikonda	thatikonda	ADV
fnp-5116	368	3	et	et	PROPN
fnp-5116	368	4	al	al	PROPN
fnp-5116	368	5	.	.	PROPN
fnp-5116	368	6	,	,	PUNCT
fnp-5116	368	7	"	"	PUNCT
fnp-5116	368	8	comprehensive	comprehensive	ADJ
fnp-5116	368	9	analysis	analysis	NOUN
fnp-5116	368	10	of	of	ADP
fnp-5116	368	11	mutational	mutational	ADJ
fnp-5116	368	12	signatures	signature	NOUN
fnp-5116	368	13	reveals	reveal	VERB
fnp-5116	368	14	distinct	distinct	ADJ
fnp-5116	368	15	patterns	pattern	NOUN
fnp-5116	368	16	and	and	CCONJ
fnp-5116	368	17	molecular	molecular	ADJ
fnp-5116	368	18	processes	process	NOUN
fnp-5116	368	19	across	across	ADP
fnp-5116	368	20	27	27	NUM
fnp-5116	368	21	pediatric	pediatric	ADJ
fnp-5116	368	22	cancers	cancer	NOUN
fnp-5116	368	23	"	"	PUNCT
fnp-5116	368	24	,	,	PUNCT
fnp-5116	368	25	nat	nat	NOUN
fnp-5116	368	26	cancer	cancer	NOUN
fnp-5116	368	27	,	,	PUNCT
fnp-5116	368	28	vol	vol	NOUN
fnp-5116	368	29	.	.	PROPN
fnp-5116	368	30	4	4	NUM
fnp-5116	368	31	,	,	PUNCT
fnp-5116	368	32	no	no	INTJ
fnp-5116	368	33	.	.	NOUN
fnp-5116	368	34	2	2	NUM
fnp-5116	368	35	,	,	PUNCT
fnp-5116	368	36	pp	pp	ADJ
fnp-5116	368	37	.	.	PUNCT
fnp-5116	369	1	276	276	NUM
fnp-5116	369	2	-	-	SYM
fnp-5116	369	3	289	289	NUM
fnp-5116	369	4	,	,	PUNCT
fnp-5116	369	5	feb	feb	PROPN
fnp-5116	369	6	2023	2023	NUM
fnp-5116	369	7	,	,	PUNCT
fnp-5116	369	8	https://doi.org/10.1038/s43018-022-00509-4	https://doi.org/10.1038/s43018-022-00509-4	NUM
fnp-5116	369	9	.	.	PUNCT
fnp-5116	370	1	33	33	NUM
fnp-5116	370	2	.	.	PUNCT
fnp-5116	371	1	d.	d.	PROPN
fnp-5116	371	2	t.	t.	PROPN
fnp-5116	371	3	jones	jones	PROPN
fnp-5116	371	4	et	et	PROPN
fnp-5116	371	5	al	al	PROPN
fnp-5116	371	6	.	.	PROPN
fnp-5116	371	7	,	,	PUNCT
fnp-5116	371	8	"	"	PUNCT
fnp-5116	371	9	recurrent	recurrent	ADJ
fnp-5116	371	10	somatic	somatic	ADJ
fnp-5116	371	11	alterations	alteration	NOUN
fnp-5116	371	12	of	of	ADP
fnp-5116	371	13	fgfr1	fgfr1	NOUN
fnp-5116	371	14	and	and	CCONJ
fnp-5116	371	15	ntrk2	ntrk2	NOUN
fnp-5116	371	16	in	in	ADP
fnp-5116	371	17	pilocytic	pilocytic	ADJ
fnp-5116	371	18	astrocytoma	astrocytoma	PROPN
fnp-5116	371	19	"	"	PUNCT
fnp-5116	371	20	,	,	PUNCT
fnp-5116	371	21	nat	nat	PROPN
fnp-5116	371	22	genet	genet	NOUN
fnp-5116	371	23	,	,	PUNCT
fnp-5116	371	24	vol	vol	NOUN
fnp-5116	371	25	.	.	PROPN
fnp-5116	372	1	45	45	NUM
fnp-5116	372	2	,	,	PUNCT
fnp-5116	372	3	no	no	INTJ
fnp-5116	372	4	.	.	NOUN
fnp-5116	372	5	8	8	NUM
fnp-5116	372	6	,	,	PUNCT
fnp-5116	372	7	pp	pp	ADJ
fnp-5116	372	8	.	.	PUNCT
fnp-5116	373	1	927	927	NUM
fnp-5116	373	2	-	-	SYM
fnp-5116	373	3	32	32	NUM
fnp-5116	373	4	,	,	PUNCT
fnp-5116	373	5	aug	aug	PROPN
fnp-5116	373	6	2013	2013	NUM
fnp-5116	373	7	,	,	PUNCT
fnp-5116	373	8	https://doi.org/10.1038/ng.2682	https://doi.org/10.1038/ng.2682	PRON
fnp-5116	373	9	.	.	PROPN
fnp-5116	373	10	34	34	NUM
fnp-5116	373	11	.	.	PUNCT
fnp-5116	374	1	j.	j.	PROPN
fnp-5116	374	2	zhang	zhang	PROPN
fnp-5116	374	3	et	et	PROPN
fnp-5116	374	4	al	al	PROPN
fnp-5116	374	5	.	.	PROPN
fnp-5116	374	6	,	,	PUNCT
fnp-5116	374	7	"	"	PUNCT
fnp-5116	374	8	whole	whole	ADJ
fnp-5116	374	9	-	-	PUNCT
fnp-5116	374	10	genome	genome	NOUN
fnp-5116	374	11	sequencing	sequencing	NOUN
fnp-5116	374	12	identifies	identify	VERB
fnp-5116	374	13	genetic	genetic	ADJ
fnp-5116	374	14	alterations	alteration	NOUN
fnp-5116	374	15	in	in	ADP
fnp-5116	374	16	pediatric	pediatric	ADJ
fnp-5116	374	17	low	low	ADJ
fnp-5116	374	18	-	-	PUNCT
fnp-5116	374	19	grade	grade	NOUN
fnp-5116	374	20	gliomas	glioma	NOUN
fnp-5116	374	21	"	"	PUNCT
fnp-5116	374	22	,	,	PUNCT
fnp-5116	374	23	nat	nat	PROPN
fnp-5116	374	24	genet	genet	NOUN
fnp-5116	374	25	,	,	PUNCT
fnp-5116	374	26	vol	vol	NOUN
fnp-5116	374	27	.	.	PROPN
fnp-5116	375	1	45	45	NUM
fnp-5116	375	2	,	,	PUNCT
fnp-5116	375	3	no	no	INTJ
fnp-5116	375	4	.	.	NOUN
fnp-5116	375	5	6	6	NUM
fnp-5116	375	6	,	,	PUNCT
fnp-5116	375	7	pp	pp	ADJ
fnp-5116	375	8	.	.	PUNCT
fnp-5116	376	1	602	602	NUM
fnp-5116	376	2	-	-	SYM
fnp-5116	376	3	12	12	NUM
fnp-5116	376	4	,	,	PUNCT
fnp-5116	376	5	jun	jun	PROPN
fnp-5116	376	6	2013	2013	NUM
fnp-5116	376	7	,	,	PUNCT
fnp-5116	376	8	https://doi.org/10.1038/ng.2611	https://doi.org/10.1038/ng.2611	PROPN
fnp-5116	376	9	.	.	PROPN
fnp-5116	376	10	35	35	NUM
fnp-5116	376	11	.	.	PUNCT
fnp-5116	377	1	k.	k.	PROPN
fnp-5116	377	2	jacob	jacob	PROPN
fnp-5116	377	3	et	et	PROPN
fnp-5116	377	4	al	al	PROPN
fnp-5116	377	5	.	.	PROPN
fnp-5116	377	6	,	,	PUNCT
fnp-5116	377	7	"	"	PUNCT
fnp-5116	377	8	duplication	duplication	NOUN
fnp-5116	377	9	of	of	ADP
fnp-5116	377	10	7q34	7q34	NUM
fnp-5116	377	11	is	be	AUX
fnp-5116	377	12	specific	specific	ADJ
fnp-5116	377	13	to	to	AUX
fnp-5116	377	14	juvenile	juvenile	ADJ
fnp-5116	377	15	pilocytic	pilocytic	ADJ
fnp-5116	377	16	astrocytomas	astrocytoma	NOUN
fnp-5116	377	17	and	and	CCONJ
fnp-5116	377	18	a	a	DET
fnp-5116	377	19	hallmark	hallmark	NOUN
fnp-5116	377	20	of	of	ADP
fnp-5116	377	21	cerebellar	cerebellar	ADJ
fnp-5116	377	22	and	and	CCONJ
fnp-5116	377	23	optic	optic	ADJ
fnp-5116	377	24	pathway	pathway	NOUN
fnp-5116	377	25	tumours	tumours	PROPN
fnp-5116	377	26	"	"	PUNCT
fnp-5116	377	27	,	,	PUNCT
fnp-5116	377	28	br	br	PROPN
fnp-5116	377	29	j	j	PROPN
fnp-5116	377	30	cancer	cancer	NOUN
fnp-5116	377	31	,	,	PUNCT
fnp-5116	377	32	vol	vol	NOUN
fnp-5116	377	33	.	.	PROPN
fnp-5116	378	1	101	101	NUM
fnp-5116	378	2	,	,	PUNCT
fnp-5116	378	3	no	no	INTJ
fnp-5116	378	4	.	.	NOUN
fnp-5116	378	5	4	4	NUM
fnp-5116	378	6	,	,	PUNCT
fnp-5116	378	7	pp	pp	ADJ
fnp-5116	378	8	.	.	PUNCT
fnp-5116	379	1	722	722	NUM
fnp-5116	379	2	-	-	SYM
fnp-5116	379	3	33	33	NUM
fnp-5116	379	4	,	,	PUNCT
fnp-5116	379	5	aug	aug	PROPN
fnp-5116	379	6	18	18	NUM
fnp-5116	379	7	2009	2009	NUM
fnp-5116	379	8	,	,	PUNCT
fnp-5116	379	9	https://doi.org/10.1038/sj.bjc.6605179	https://doi.org/10.1038/sj.bjc.6605179	NOUN
fnp-5116	379	10	.	.	PUNCT
fnp-5116	380	1	36	36	NUM
fnp-5116	380	2	.	.	PUNCT
fnp-5116	381	1	t.	t.	PROPN
fnp-5116	381	2	forshew	forshew	PROPN
fnp-5116	381	3	et	et	PROPN
fnp-5116	381	4	al	al	PROPN
fnp-5116	381	5	.	.	PROPN
fnp-5116	381	6	,	,	PUNCT
fnp-5116	381	7	"	"	PUNCT
fnp-5116	381	8	activation	activation	NOUN
fnp-5116	381	9	of	of	ADP
fnp-5116	381	10	the	the	DET
fnp-5116	381	11	erk	erk	PROPN
fnp-5116	381	12	/	/	SYM
fnp-5116	381	13	mapk	mapk	NOUN
fnp-5116	381	14	pathway	pathway	NOUN
fnp-5116	381	15	:	:	PUNCT
fnp-5116	381	16	a	a	DET
fnp-5116	381	17	signature	signature	NOUN
fnp-5116	381	18	genetic	genetic	ADJ
fnp-5116	381	19	defect	defect	NOUN
fnp-5116	381	20	in	in	ADP
fnp-5116	381	21	posterior	posterior	ADJ
fnp-5116	381	22	fossa	fossa	ADJ
fnp-5116	381	23	pilocytic	pilocytic	ADJ
fnp-5116	381	24	astrocytomas	astrocytoma	NOUN
fnp-5116	381	25	"	"	PUNCT
fnp-5116	381	26	,	,	PUNCT
fnp-5116	381	27	j	j	PROPN
fnp-5116	381	28	pathol	pathol	NOUN
fnp-5116	381	29	,	,	PUNCT
fnp-5116	381	30	vol	vol	NOUN
fnp-5116	381	31	.	.	PROPN
fnp-5116	381	32	218	218	NUM
fnp-5116	381	33	,	,	PUNCT
fnp-5116	381	34	no	no	INTJ
fnp-5116	381	35	.	.	NOUN
fnp-5116	381	36	2	2	NUM
fnp-5116	381	37	,	,	PUNCT
fnp-5116	381	38	pp	pp	ADJ
fnp-5116	381	39	.	.	PUNCT
fnp-5116	382	1	172	172	NUM
fnp-5116	382	2	-	-	SYM
fnp-5116	382	3	81	81	NUM
fnp-5116	382	4	,	,	PUNCT
fnp-5116	382	5	jun	jun	PROPN
fnp-5116	382	6	2009	2009	NUM
fnp-5116	382	7	,	,	PUNCT
fnp-5116	382	8	https://doi.org/10.1002/path.2558	https://doi.org/10.1002/path.2558	NOUN
fnp-5116	382	9	.	.	PUNCT
fnp-5116	383	1	37	37	NUM
fnp-5116	383	2	.	.	PUNCT
fnp-5116	383	3	d.	d.	PROPN
fnp-5116	383	4	salles	salles	PROPN
fnp-5116	383	5	,	,	PUNCT
fnp-5116	383	6	g.	g.	PROPN
fnp-5116	383	7	laviola	laviola	PROPN
fnp-5116	383	8	,	,	PUNCT
fnp-5116	383	9	a.	a.	PROPN
fnp-5116	383	10	c.	c.	PROPN
fnp-5116	383	11	m.	m.	PROPN
fnp-5116	383	12	malinverni	malinverni	PROPN
fnp-5116	383	13	,	,	PUNCT
fnp-5116	383	14	and	and	CCONJ
fnp-5116	383	15	j.	j.	PROPN
fnp-5116	383	16	n.	n.	PROPN
fnp-5116	383	17	stavale	stavale	PROPN
fnp-5116	383	18	,	,	PUNCT
fnp-5116	383	19	"	"	PUNCT
fnp-5116	383	20	pilocytic	pilocytic	ADJ
fnp-5116	383	21	astrocytoma	astrocytoma	NOUN
fnp-5116	383	22	:	:	PUNCT
fnp-5116	383	23	a	a	DET
fnp-5116	383	24	review	review	NOUN
fnp-5116	383	25	of	of	ADP
fnp-5116	383	26	general	general	ADJ
fnp-5116	383	27	,	,	PUNCT
fnp-5116	383	28	clinical	clinical	ADJ
fnp-5116	383	29	,	,	PUNCT
fnp-5116	383	30	and	and	CCONJ
fnp-5116	383	31	molecular	molecular	ADJ
fnp-5116	383	32	characteristics	characteristic	NOUN
fnp-5116	383	33	"	"	PUNCT
fnp-5116	383	34	,	,	PUNCT
fnp-5116	383	35	j	j	PROPN
fnp-5116	383	36	child	child	NOUN
fnp-5116	383	37	neurol	neurol	NOUN
fnp-5116	383	38	,	,	PUNCT
fnp-5116	383	39	vol	vol	NOUN
fnp-5116	383	40	.	.	PROPN
fnp-5116	383	41	35	35	NUM
fnp-5116	383	42	,	,	PUNCT
fnp-5116	383	43	no	no	INTJ
fnp-5116	383	44	.	.	NOUN
fnp-5116	383	45	12	12	NUM
fnp-5116	383	46	,	,	PUNCT
fnp-5116	383	47	pp	pp	ADJ
fnp-5116	383	48	.	.	PUNCT
fnp-5116	384	1	852	852	NUM
fnp-5116	384	2	-	-	SYM
fnp-5116	384	3	858	858	NUM
fnp-5116	384	4	,	,	PUNCT
fnp-5116	384	5	oct	oct	PROPN
fnp-5116	384	6	2020	2020	NUM
fnp-5116	384	7	,	,	PUNCT
fnp-5116	384	8	https://doi.org/10.1177/0883073820937225	https://doi.org/10.1177/0883073820937225	X
fnp-5116	384	9	.	.	PUNCT
fnp-5116	385	1	38	38	NUM
fnp-5116	385	2	.	.	PUNCT
fnp-5116	386	1	y.	y.	PROPN
fnp-5116	386	2	h.	h.	PROPN
fnp-5116	386	3	chen	chen	PROPN
fnp-5116	386	4	and	and	CCONJ
fnp-5116	386	5	d.	d.	PROPN
fnp-5116	386	6	h.	h.	PROPN
fnp-5116	386	7	gutmann	gutmann	PROPN
fnp-5116	386	8	,	,	PUNCT
fnp-5116	386	9	"	"	PUNCT
fnp-5116	386	10	the	the	DET
fnp-5116	386	11	molecular	molecular	ADJ
fnp-5116	386	12	and	and	CCONJ
fnp-5116	386	13	cell	cell	NOUN
fnp-5116	386	14	biology	biology	NOUN
fnp-5116	386	15	of	of	ADP
fnp-5116	386	16	pediatric	pediatric	ADJ
fnp-5116	386	17	low	low	ADJ
fnp-5116	386	18	-	-	PUNCT
fnp-5116	386	19	grade	grade	NOUN
fnp-5116	386	20	gliomas	glioma	NOUN
fnp-5116	386	21	"	"	PUNCT
fnp-5116	386	22	,	,	PUNCT
fnp-5116	386	23	oncogene	oncogene	NOUN
fnp-5116	386	24	,	,	PUNCT
fnp-5116	386	25	vol	vol	NOUN
fnp-5116	386	26	.	.	PROPN
fnp-5116	386	27	33	33	NUM
fnp-5116	386	28	,	,	PUNCT
fnp-5116	386	29	no	no	INTJ
fnp-5116	386	30	.	.	NOUN
fnp-5116	386	31	16	16	NUM
fnp-5116	386	32	,	,	PUNCT
fnp-5116	386	33	pp	pp	ADJ
fnp-5116	386	34	.	.	PUNCT
fnp-5116	387	1	2019	2019	NUM
fnp-5116	387	2	-	-	SYM
fnp-5116	387	3	26	26	NUM
fnp-5116	387	4	,	,	PUNCT
fnp-5116	387	5	apr	apr	PROPN
fnp-5116	387	6	17	17	NUM
fnp-5116	387	7	2014	2014	NUM
fnp-5116	387	8	,	,	PUNCT
fnp-5116	387	9	https://doi.org/10.1038/onc.2013.148	https://doi.org/10.1038/onc.2013.148	PROPN
fnp-5116	387	10	.	.	PROPN
fnp-5116	387	11	39	39	NUM
fnp-5116	387	12	.	.	PUNCT
fnp-5116	388	1	t.	t.	PROPN
fnp-5116	388	2	t.	t.	PROPN
fnp-5116	388	3	tomic	tomic	PROPN
fnp-5116	388	4	et	et	PROPN
fnp-5116	388	5	al	al	PROPN
fnp-5116	388	6	.	.	PROPN
fnp-5116	388	7	,	,	PUNCT
fnp-5116	388	8	"	"	PUNCT
fnp-5116	388	9	a	a	DET
fnp-5116	388	10	new	new	ADJ
fnp-5116	388	11	gtf2i	gtf2i	NOUN
fnp-5116	388	12	-	-	PUNCT
fnp-5116	388	13	braf	braf	NOUN
fnp-5116	388	14	fusion	fusion	NOUN
fnp-5116	388	15	mediating	mediate	VERB
fnp-5116	388	16	mapk	mapk	NOUN
fnp-5116	388	17	pathway	pathway	NOUN
fnp-5116	388	18	activation	activation	NOUN
fnp-5116	388	19	in	in	ADP
fnp-5116	388	20	pilocytic	pilocytic	ADJ
fnp-5116	388	21	astrocytoma	astrocytoma	NOUN
fnp-5116	388	22	"	"	PUNCT
fnp-5116	388	23	,	,	PUNCT
fnp-5116	388	24	plos	plos	PROPN
fnp-5116	388	25	one	one	NUM
fnp-5116	388	26	,	,	PUNCT
fnp-5116	388	27	vol	vol	NOUN
fnp-5116	388	28	.	.	PROPN
fnp-5116	388	29	12	12	NUM
fnp-5116	388	30	,	,	PUNCT
fnp-5116	388	31	no	no	INTJ
fnp-5116	388	32	.	.	NOUN
fnp-5116	388	33	4	4	NUM
fnp-5116	388	34	,	,	PUNCT
fnp-5116	388	35	p.	p.	NOUN
fnp-5116	388	36	e0175638	e0175638	NOUN
fnp-5116	388	37	,	,	PUNCT
fnp-5116	388	38	2017	2017	NUM
fnp-5116	388	39	,	,	PUNCT
fnp-5116	388	40	https://doi.org/10.1371/journal.pone.0175638	https://doi.org/10.1371/journal.pone.0175638	NOUN
fnp-5116	388	41	.	.	NOUN
fnp-5116	388	42	40	40	NUM
fnp-5116	388	43	.	.	PUNCT
fnp-5116	388	44	a.	a.	PROPN
fnp-5116	388	45	p.	p.	PROPN
fnp-5116	388	46	becker	becker	PROPN
fnp-5116	388	47	et	et	PROPN
fnp-5116	388	48	al	al	PROPN
fnp-5116	388	49	.	.	PROPN
fnp-5116	388	50	,	,	PUNCT
fnp-5116	388	51	"	"	PUNCT
fnp-5116	388	52	kiaa1549	kiaa1549	PROPN
fnp-5116	388	53	:	:	PUNCT
fnp-5116	388	54	braf	braf	NOUN
fnp-5116	388	55	gene	gene	NOUN
fnp-5116	388	56	fusion	fusion	NOUN
fnp-5116	388	57	and	and	CCONJ
fnp-5116	388	58	fgfr1	fgfr1	NOUN
fnp-5116	388	59	hotspot	hotspot	NOUN
fnp-5116	388	60	mutations	mutation	NOUN
fnp-5116	388	61	are	be	AUX
fnp-5116	388	62	prognostic	prognostic	ADJ
fnp-5116	388	63	factors	factor	NOUN
fnp-5116	388	64	in	in	ADP
fnp-5116	388	65	pilocytic	pilocytic	ADJ
fnp-5116	388	66	astrocytomas	astrocytoma	NOUN
fnp-5116	388	67	"	"	PUNCT
fnp-5116	388	68	,	,	PUNCT
fnp-5116	388	69	j	j	PROPN
fnp-5116	388	70	neuropathol	neuropathol	PROPN
fnp-5116	388	71	exp	exp	NOUN
fnp-5116	388	72	neurol	neurol	PROPN
fnp-5116	388	73	,	,	PUNCT
fnp-5116	388	74	vol	vol	NOUN
fnp-5116	388	75	.	.	PROPN
fnp-5116	389	1	74	74	NUM
fnp-5116	389	2	,	,	PUNCT
fnp-5116	389	3	no	no	INTJ
fnp-5116	389	4	.	.	NOUN
fnp-5116	389	5	7	7	NUM
fnp-5116	389	6	,	,	PUNCT
fnp-5116	389	7	pp	pp	ADJ
fnp-5116	389	8	.	.	PUNCT
fnp-5116	390	1	743	743	NUM
fnp-5116	390	2	-	-	SYM
fnp-5116	390	3	54	54	NUM
fnp-5116	390	4	,	,	PUNCT
fnp-5116	390	5	jul	jul	PROPN
fnp-5116	390	6	2015	2015	NUM
fnp-5116	390	7	,	,	PUNCT
fnp-5116	390	8	https://doi.org/10.1097/nen.0000000000000213	https://doi.org/10.1097/nen.0000000000000213	NOUN
fnp-5116	390	9	.	.	NOUN
fnp-5116	390	10	41	41	NUM
fnp-5116	390	11	.	.	PUNCT
fnp-5116	391	1	c.	c.	PROPN
fnp-5116	391	2	stuer	stuer	PROPN
fnp-5116	391	3	,	,	PUNCT
fnp-5116	391	4	b.	b.	PROPN
fnp-5116	391	5	vilz	vilz	NOUN
fnp-5116	391	6	,	,	PUNCT
fnp-5116	391	7	m.	m.	NOUN
fnp-5116	391	8	majores	majore	NOUN
fnp-5116	391	9	,	,	PUNCT
fnp-5116	391	10	a.	a.	NOUN
fnp-5116	391	11	becker	becker	PROPN
fnp-5116	391	12	,	,	PUNCT
fnp-5116	391	13	j.	j.	PROPN
fnp-5116	391	14	schramm	schramm	PROPN
fnp-5116	391	15	,	,	PUNCT
fnp-5116	391	16	and	and	CCONJ
fnp-5116	391	17	m.	m.	PROPN
fnp-5116	391	18	simon	simon	PROPN
fnp-5116	391	19	,	,	PUNCT
fnp-5116	391	20	"	"	PUNCT
fnp-5116	391	21	frequent	frequent	ADJ
fnp-5116	391	22	recurrence	recurrence	NOUN
fnp-5116	391	23	and	and	CCONJ
fnp-5116	391	24	progression	progression	NOUN
fnp-5116	391	25	in	in	ADP
fnp-5116	391	26	pilocytic	pilocytic	ADJ
fnp-5116	391	27	astrocytoma	astrocytoma	NOUN
fnp-5116	391	28	in	in	ADP
fnp-5116	391	29	adults	adult	NOUN
fnp-5116	391	30	"	"	PUNCT
fnp-5116	391	31	,	,	PUNCT
fnp-5116	391	32	cancer	cancer	NOUN
fnp-5116	391	33	,	,	PUNCT
fnp-5116	391	34	vol	vol	NOUN
fnp-5116	391	35	.	.	PROPN
fnp-5116	392	1	110	110	NUM
fnp-5116	392	2	,	,	PUNCT
fnp-5116	392	3	no	no	INTJ
fnp-5116	392	4	.	.	NOUN
fnp-5116	392	5	12	12	NUM
fnp-5116	392	6	,	,	PUNCT
fnp-5116	392	7	pp	pp	ADJ
fnp-5116	392	8	.	.	PUNCT
fnp-5116	393	1	2799	2799	NUM
fnp-5116	393	2	-	-	SYM
fnp-5116	393	3	808	808	NUM
fnp-5116	393	4	,	,	PUNCT
fnp-5116	393	5	dec	dec	PROPN
fnp-5116	393	6	15	15	NUM
fnp-5116	393	7	2007	2007	NUM
fnp-5116	393	8	,	,	PUNCT
fnp-5116	393	9	https://doi.org/10.1002/cncr.23148	https://doi.org/10.1002/cncr.23148	NOUN
fnp-5116	393	10	.	.	PUNCT
fnp-5116	394	1	42	42	NUM
fnp-5116	394	2	.	.	PUNCT
fnp-5116	395	1	d.	d.	PROPN
fnp-5116	395	2	j.	j.	PROPN
fnp-5116	395	3	cote	cote	PROPN
fnp-5116	395	4	et	et	PROPN
fnp-5116	395	5	al	al	PROPN
fnp-5116	395	6	.	.	PROPN
fnp-5116	395	7	,	,	PUNCT
fnp-5116	395	8	"	"	PUNCT
fnp-5116	395	9	glioma	glioma	ADJ
fnp-5116	395	10	incidence	incidence	NOUN
fnp-5116	395	11	and	and	CCONJ
fnp-5116	395	12	survival	survival	NOUN
fnp-5116	395	13	variations	variation	NOUN
fnp-5116	395	14	by	by	ADP
fnp-5116	395	15	county	county	NOUN
fnp-5116	395	16	-	-	PUNCT
fnp-5116	395	17	level	level	NOUN
fnp-5116	395	18	socioeconomic	socioeconomic	ADJ
fnp-5116	395	19	measures	measure	NOUN
fnp-5116	395	20	"	"	PUNCT
fnp-5116	395	21	,	,	PUNCT
fnp-5116	395	22	cancer	cancer	NOUN
fnp-5116	395	23	,	,	PUNCT
fnp-5116	395	24	vol	vol	NOUN
fnp-5116	395	25	.	.	PROPN
fnp-5116	395	26	125	125	NUM
fnp-5116	395	27	,	,	PUNCT
fnp-5116	395	28	no	no	INTJ
fnp-5116	395	29	.	.	NOUN
fnp-5116	395	30	19	19	NUM
fnp-5116	395	31	,	,	PUNCT
fnp-5116	395	32	pp	pp	ADJ
fnp-5116	395	33	.	.	PUNCT
fnp-5116	395	34	3390	3390	NUM
fnp-5116	395	35	-	-	SYM
fnp-5116	395	36	3400	3400	NUM
fnp-5116	395	37	,	,	PUNCT
fnp-5116	395	38	oct	oct	PROPN
fnp-5116	395	39	1	1	NUM
fnp-5116	395	40	2019	2019	NUM
fnp-5116	395	41	,	,	PUNCT
fnp-5116	395	42	https://doi.org/10.1002/cncr.32328	https://doi.org/10.1002/cncr.32328	NOUN
fnp-5116	395	43	.	.	PUNCT
fnp-5116	396	1	43	43	NUM
fnp-5116	396	2	.	.	PUNCT
fnp-5116	397	1	c.	c.	PROPN
fnp-5116	397	2	n.	n.	PROPN
fnp-5116	397	3	kline	kline	PROPN
fnp-5116	397	4	et	et	PROPN
fnp-5116	397	5	al	al	PROPN
fnp-5116	397	6	.	.	PROPN
fnp-5116	397	7	,	,	PUNCT
fnp-5116	397	8	"	"	PUNCT
fnp-5116	397	9	targeted	target	VERB
fnp-5116	397	10	next	next	ADJ
fnp-5116	397	11	-	-	PUNCT
fnp-5116	397	12	generation	generation	NOUN
fnp-5116	397	13	sequencing	sequencing	NOUN
fnp-5116	397	14	of	of	ADP
fnp-5116	397	15	pediatric	pediatric	ADJ
fnp-5116	397	16	neuro	neuro	NOUN
fnp-5116	397	17	-	-	PUNCT
fnp-5116	397	18	oncology	oncology	NOUN
fnp-5116	397	19	patients	patient	NOUN
fnp-5116	397	20	improves	improve	VERB
fnp-5116	397	21	diagnosis	diagnosis	NOUN
fnp-5116	397	22	,	,	PUNCT
fnp-5116	397	23	identifies	identify	VERB
fnp-5116	397	24	pathogenic	pathogenic	ADJ
fnp-5116	397	25	germline	germline	NOUN
fnp-5116	397	26	mutations	mutation	NOUN
fnp-5116	397	27	,	,	PUNCT
fnp-5116	397	28	and	and	CCONJ
fnp-5116	397	29	directs	direct	VERB
fnp-5116	397	30	targeted	targeted	ADJ
fnp-5116	397	31	therapy	therapy	NOUN
fnp-5116	397	32	"	"	PUNCT
fnp-5116	397	33	,	,	PUNCT
fnp-5116	397	34	neuro	neuro	PROPN
fnp-5116	397	35	oncol	oncol	PROPN
fnp-5116	397	36	,	,	PUNCT
fnp-5116	397	37	vol	vol	NOUN
fnp-5116	397	38	.	.	PROPN
fnp-5116	397	39	19	19	NUM
fnp-5116	397	40	,	,	PUNCT
fnp-5116	397	41	no	no	INTJ
fnp-5116	397	42	.	.	NOUN
fnp-5116	397	43	5	5	NUM
fnp-5116	397	44	,	,	PUNCT
fnp-5116	397	45	pp	pp	ADJ
fnp-5116	397	46	.	.	PUNCT
fnp-5116	398	1	699	699	NUM
fnp-5116	398	2	-	-	SYM
fnp-5116	398	3	709	709	NUM
fnp-5116	398	4	,	,	PUNCT
fnp-5116	398	5	may	may	AUX
fnp-5116	398	6	1	1	NUM
fnp-5116	398	7	2017	2017	NUM
fnp-5116	398	8	,	,	PUNCT
fnp-5116	398	9	https://doi.org/10.1093/neuonc/now254	https://doi.org/10.1093/neuonc/now254	ADV
fnp-5116	398	10	.	.	PUNCT
fnp-5116	399	1	44	44	NUM
fnp-5116	399	2	.	.	PUNCT
fnp-5116	399	3	a.	a.	PROPN
fnp-5116	399	4	reinhardt	reinhardt	PROPN
fnp-5116	399	5	et	et	PROPN
fnp-5116	399	6	al	al	PROPN
fnp-5116	399	7	.	.	PROPN
fnp-5116	399	8	,	,	PUNCT
fnp-5116	399	9	"	"	PUNCT
fnp-5116	399	10	anaplastic	anaplastic	ADJ
fnp-5116	399	11	astrocytoma	astrocytoma	NOUN
fnp-5116	399	12	with	with	ADP
fnp-5116	399	13	piloid	piloid	PROPN
fnp-5116	399	14	features	feature	NOUN
fnp-5116	399	15	,	,	PUNCT
fnp-5116	399	16	a	a	DET
fnp-5116	399	17	novel	novel	ADJ
fnp-5116	399	18	molecular	molecular	ADJ
fnp-5116	399	19	class	class	NOUN
fnp-5116	399	20	of	of	ADP
fnp-5116	399	21	idh	idh	PROPN
fnp-5116	399	22	wildtype	wildtype	PROPN
fnp-5116	399	23	glioma	glioma	NOUN
fnp-5116	399	24	with	with	ADP
fnp-5116	399	25	recurrent	recurrent	ADJ
fnp-5116	399	26	mapk	mapk	NOUN
fnp-5116	399	27	pathway	pathway	NOUN
fnp-5116	399	28	,	,	PUNCT
fnp-5116	399	29	cdkn2a	cdkn2a	PROPN
fnp-5116	399	30	/	/	SYM
fnp-5116	399	31	b	b	PROPN
fnp-5116	399	32	and	and	CCONJ
fnp-5116	399	33	atrx	atrx	NOUN
fnp-5116	399	34	alterations	alteration	NOUN
fnp-5116	399	35	"	"	PUNCT
fnp-5116	399	36	,	,	PUNCT
fnp-5116	399	37	acta	acta	PROPN
fnp-5116	399	38	neuropathol	neuropathol	PROPN
fnp-5116	399	39	,	,	PUNCT
fnp-5116	399	40	vol	vol	NOUN
fnp-5116	399	41	.	.	PROPN
fnp-5116	399	42	136	136	NUM
fnp-5116	399	43	,	,	PUNCT
fnp-5116	399	44	no	no	INTJ
fnp-5116	399	45	.	.	NOUN
fnp-5116	399	46	2	2	NUM
fnp-5116	399	47	,	,	PUNCT
fnp-5116	399	48	pp	pp	ADJ
fnp-5116	399	49	.	.	PUNCT
fnp-5116	400	1	273	273	NUM
fnp-5116	400	2	-	-	SYM
fnp-5116	400	3	291	291	NUM
fnp-5116	400	4	,	,	PUNCT
fnp-5116	400	5	aug	aug	PROPN
fnp-5116	400	6	2018	2018	NUM
fnp-5116	400	7	,	,	PUNCT
fnp-5116	400	8	https://doi.org/10.1007/s00401-018-1837-8	https://doi.org/10.1007/s00401-018-1837-8	NUM
fnp-5116	400	9	.	.	PUNCT
fnp-5116	401	1	45	45	NUM
fnp-5116	401	2	.	.	PUNCT
fnp-5116	402	1	k.	k.	PROPN
fnp-5116	402	2	chatsirisupachai	chatsirisupachai	PROPN
fnp-5116	402	3	,	,	PUNCT
fnp-5116	402	4	t.	t.	PROPN
fnp-5116	402	5	lesluyes	lesluyes	PROPN
fnp-5116	402	6	,	,	PUNCT
fnp-5116	402	7	l.	l.	PROPN
fnp-5116	402	8	paraoan	paraoan	PROPN
fnp-5116	402	9	,	,	PUNCT
fnp-5116	402	10	p.	p.	PROPN
fnp-5116	402	11	van	van	PROPN
fnp-5116	402	12	loo	loo	PROPN
fnp-5116	402	13	,	,	PUNCT
fnp-5116	402	14	and	and	CCONJ
fnp-5116	402	15	j.	j.	PROPN
fnp-5116	402	16	p.	p.	PROPN
fnp-5116	402	17	de	de	PROPN
fnp-5116	402	18	magalhaes	magalhaes	PROPN
fnp-5116	402	19	,	,	PUNCT
fnp-5116	402	20	"	"	PUNCT
fnp-5116	402	21	an	an	DET
fnp-5116	402	22	integrative	integrative	ADJ
fnp-5116	402	23	analysis	analysis	NOUN
fnp-5116	402	24	of	of	ADP
fnp-5116	402	25	the	the	DET
fnp-5116	402	26	age	age	NOUN
fnp-5116	402	27	-	-	PUNCT
fnp-5116	402	28	associated	associate	VERB
fnp-5116	402	29	multi	multi	ADJ
fnp-5116	402	30	-	-	ADJ
fnp-5116	402	31	omic	omic	ADJ
fnp-5116	402	32	landscape	landscape	NOUN
fnp-5116	402	33	across	across	ADP
fnp-5116	402	34	cancers	cancer	NOUN
fnp-5116	402	35	"	"	PUNCT
fnp-5116	402	36	,	,	PUNCT
fnp-5116	402	37	nat	nat	PROPN
fnp-5116	402	38	commun	commun	PROPN
fnp-5116	402	39	,	,	PUNCT
fnp-5116	402	40	vol	vol	NOUN
fnp-5116	402	41	.	.	PROPN
fnp-5116	403	1	12	12	NUM
fnp-5116	403	2	,	,	PUNCT
fnp-5116	403	3	no	no	INTJ
fnp-5116	403	4	.	.	NOUN
fnp-5116	403	5	1	1	NUM
fnp-5116	403	6	,	,	PUNCT
fnp-5116	403	7	p.	p.	NOUN
fnp-5116	403	8	2345	2345	NUM
fnp-5116	403	9	,	,	PUNCT
fnp-5116	403	10	apr	apr	VERB
fnp-5116	403	11	20	20	NUM
fnp-5116	403	12	2021	2021	NUM
fnp-5116	403	13	,	,	PUNCT
fnp-5116	403	14	https://doi.org/10.1038/s41467-021-22560-y	https://doi.org/10.1038/s41467-021-22560-y	PROPN
fnp-5116	403	15	.	.	PUNCT
fnp-5116	404	1	46	46	NUM
fnp-5116	404	2	.	.	PUNCT
fnp-5116	404	3	r.	r.	PROPN
fnp-5116	404	4	e.	e.	PROPN
fnp-5116	404	5	strowd	strowd	PROPN
fnp-5116	404	6	,	,	PUNCT
fnp-5116	404	7	3rd	3rd	PROPN
fnp-5116	404	8	et	et	NOUN
fnp-5116	404	9	al	al	PROPN
fnp-5116	404	10	.	.	PROPN
fnp-5116	404	11	,	,	PUNCT
fnp-5116	404	12	"	"	PUNCT
fnp-5116	404	13	histologically	histologically	ADV
fnp-5116	404	14	benign	benign	NOUN
fnp-5116	404	15	,	,	PUNCT
fnp-5116	404	16	clinically	clinically	ADV
fnp-5116	404	17	aggressive	aggressive	ADJ
fnp-5116	404	18	:	:	PUNCT
fnp-5116	404	19	progressive	progressive	ADJ
fnp-5116	404	20	non	non	ADJ
fnp-5116	404	21	-	-	ADJ
fnp-5116	404	22	optic	optic	ADJ
fnp-5116	404	23	pathway	pathway	NOUN
fnp-5116	404	24	pilocytic	pilocytic	ADJ
fnp-5116	404	25	astrocytomas	astrocytoma	NOUN
fnp-5116	404	26	in	in	ADP
fnp-5116	404	27	adults	adult	NOUN
fnp-5116	404	28	with	with	ADP
fnp-5116	404	29	nf1	nf1	NOUN
fnp-5116	404	30	"	"	PUNCT
fnp-5116	404	31	,	,	PUNCT
fnp-5116	404	32	am	be	AUX
fnp-5116	404	33	j	j	PROPN
fnp-5116	404	34	med	med	PROPN
fnp-5116	404	35	genet	genet	PROPN
fnp-5116	404	36	a	a	DET
fnp-5116	404	37	,	,	PUNCT
fnp-5116	404	38	vol	vol	NOUN
fnp-5116	404	39	.	.	PROPN
fnp-5116	404	40	170	170	NUM
fnp-5116	404	41	,	,	PUNCT
fnp-5116	404	42	no	no	INTJ
fnp-5116	404	43	.	.	NOUN
fnp-5116	404	44	6	6	NUM
fnp-5116	404	45	,	,	PUNCT
fnp-5116	404	46	pp	pp	ADJ
fnp-5116	404	47	.	.	PUNCT
fnp-5116	405	1	1455	1455	NUM
fnp-5116	405	2	-	-	SYM
fnp-5116	405	3	61	61	NUM
fnp-5116	405	4	,	,	PUNCT
fnp-5116	405	5	jun	jun	PROPN
fnp-5116	405	6	2016	2016	NUM
fnp-5116	405	7	,	,	PUNCT
fnp-5116	405	8	https://doi.org/10.1002/ajmg.a.37622	https://doi.org/10.1002/ajmg.a.37622	X
fnp-5116	405	9	.	.	PUNCT
fnp-5116	406	1	47	47	NUM
fnp-5116	406	2	.	.	PUNCT
fnp-5116	407	1	j.	j.	PROPN
fnp-5116	407	2	helfferich	helfferich	PROPN
fnp-5116	407	3	et	et	PROPN
fnp-5116	407	4	al	al	PROPN
fnp-5116	407	5	.	.	PROPN
fnp-5116	407	6	,	,	PUNCT
fnp-5116	407	7	"	"	PUNCT
fnp-5116	407	8	neurofibromatosis	neurofibromatosis	NOUN
fnp-5116	407	9	type	type	NOUN
fnp-5116	407	10	1	1	NUM
fnp-5116	407	11	associated	associated	ADJ
fnp-5116	407	12	low	low	ADJ
fnp-5116	407	13	grade	grade	NOUN
fnp-5116	407	14	gliomas	glioma	NOUN
fnp-5116	407	15	:	:	PUNCT
fnp-5116	407	16	a	a	DET
fnp-5116	407	17	comparison	comparison	NOUN
fnp-5116	407	18	with	with	ADP
fnp-5116	407	19	sporadic	sporadic	ADJ
fnp-5116	407	20	low	low	ADJ
fnp-5116	407	21	grade	grade	NOUN
fnp-5116	407	22	gliomas	glioma	NOUN
fnp-5116	407	23	"	"	PUNCT
fnp-5116	407	24	,	,	PUNCT
fnp-5116	407	25	crit	crit	PROPN
fnp-5116	407	26	rev	rev	VERB
fnp-5116	407	27	oncol	oncol	ADJ
fnp-5116	407	28	hematol	hematol	NOUN
fnp-5116	407	29	,	,	PUNCT
fnp-5116	407	30	vol	vol	NOUN
fnp-5116	407	31	.	.	PROPN
fnp-5116	408	1	104	104	NUM
fnp-5116	408	2	,	,	PUNCT
fnp-5116	408	3	pp	pp	ADJ
fnp-5116	408	4	.	.	PUNCT
fnp-5116	409	1	30	30	NUM
fnp-5116	409	2	-	-	SYM
fnp-5116	409	3	41	41	NUM
fnp-5116	409	4	,	,	PUNCT
fnp-5116	409	5	aug	aug	PROPN
fnp-5116	409	6	2016	2016	NUM
fnp-5116	409	7	,	,	PUNCT
fnp-5116	409	8	https://doi.org/10.1016/j.critrevonc.2016.05.008	https://doi.org/10.1016/j.critrevonc.2016.05.008	PROPN
fnp-5116	409	9	.	.	PUNCT
fnp-5116	410	1	48	48	NUM
fnp-5116	410	2	.	.	PUNCT
fnp-5116	411	1	v.	v.	ADP
fnp-5116	411	2	laithier	laithier	NOUN
fnp-5116	411	3	et	et	PROPN
fnp-5116	411	4	al	al	PROPN
fnp-5116	411	5	.	.	PROPN
fnp-5116	411	6	,	,	PUNCT
fnp-5116	411	7	"	"	PUNCT
fnp-5116	411	8	progression	progression	NOUN
fnp-5116	411	9	-	-	PUNCT
fnp-5116	411	10	free	free	ADJ
fnp-5116	411	11	survival	survival	NOUN
fnp-5116	411	12	in	in	ADP
fnp-5116	411	13	children	child	NOUN
fnp-5116	411	14	with	with	ADP
fnp-5116	411	15	optic	optic	ADJ
fnp-5116	411	16	pathway	pathway	NOUN
fnp-5116	411	17	tumors	tumor	NOUN
fnp-5116	411	18	:	:	PUNCT
fnp-5116	411	19	dependence	dependence	NOUN
fnp-5116	411	20	on	on	ADP
fnp-5116	411	21	age	age	NOUN
fnp-5116	411	22	and	and	CCONJ
fnp-5116	411	23	the	the	DET
fnp-5116	411	24	quality	quality	NOUN
fnp-5116	411	25	of	of	ADP
fnp-5116	411	26	the	the	DET
fnp-5116	411	27	response	response	NOUN
fnp-5116	411	28	to	to	ADP
fnp-5116	411	29	chemotherapy	chemotherapy	NOUN
fnp-5116	411	30	--	--	PUNCT
fnp-5116	411	31	results	result	NOUN
fnp-5116	411	32	of	of	ADP
fnp-5116	411	33	the	the	DET
fnp-5116	411	34	first	first	ADJ
fnp-5116	411	35	french	french	ADJ
fnp-5116	411	36	prospective	prospective	ADJ
fnp-5116	411	37	study	study	NOUN
fnp-5116	411	38	for	for	ADP
fnp-5116	411	39	the	the	DET
fnp-5116	411	40	french	french	ADJ
fnp-5116	411	41	society	society	NOUN
fnp-5116	411	42	of	of	ADP
fnp-5116	411	43	pediatric	pediatric	ADJ
fnp-5116	411	44	oncology	oncology	NOUN
fnp-5116	411	45	"	"	PUNCT
fnp-5116	411	46	,	,	PUNCT
fnp-5116	411	47	j	j	PROPN
fnp-5116	411	48	clin	clin	PROPN
fnp-5116	411	49	oncol	oncol	PROPN
fnp-5116	411	50	,	,	PUNCT
fnp-5116	411	51	vol	vol	NOUN
fnp-5116	411	52	.	.	PROPN
fnp-5116	411	53	21	21	NUM
fnp-5116	411	54	,	,	PUNCT
fnp-5116	411	55	no	no	INTJ
fnp-5116	411	56	.	.	NOUN
fnp-5116	411	57	24	24	NUM
fnp-5116	411	58	,	,	PUNCT
fnp-5116	411	59	pp	pp	ADJ
fnp-5116	411	60	.	.	PUNCT
fnp-5116	412	1	4572	4572	NUM
fnp-5116	412	2	-	-	SYM
fnp-5116	412	3	8	8	NUM
fnp-5116	412	4	,	,	PUNCT
fnp-5116	412	5	dec	dec	PROPN
fnp-5116	412	6	15	15	NUM
fnp-5116	412	7	2003	2003	NUM
fnp-5116	412	8	,	,	PUNCT
fnp-5116	412	9	https://doi.org/10.1200/jco.2003.03.043	https://doi.org/10.1200/jco.2003.03.043	PROPN
fnp-5116	412	10	.	.	PROPN
fnp-5116	412	11	49	49	NUM
fnp-5116	412	12	.	.	PUNCT
fnp-5116	413	1	d.	d.	PROPN
fnp-5116	413	2	r.	r.	PROPN
fnp-5116	413	3	johnson	johnson	PROPN
fnp-5116	413	4	,	,	PUNCT
fnp-5116	413	5	p.	p.	PROPN
fnp-5116	413	6	d.	d.	PROPN
fnp-5116	413	7	brown	brown	PROPN
fnp-5116	413	8	,	,	PUNCT
fnp-5116	413	9	e.	e.	PROPN
fnp-5116	413	10	galanis	galanis	PROPN
fnp-5116	413	11	,	,	PUNCT
fnp-5116	413	12	and	and	CCONJ
fnp-5116	413	13	j.	j.	PROPN
fnp-5116	413	14	e.	e.	PROPN
fnp-5116	413	15	hammack	hammack	PROPN
fnp-5116	413	16	,	,	PUNCT
fnp-5116	413	17	"	"	PUNCT
fnp-5116	413	18	pilocytic	pilocytic	ADJ
fnp-5116	413	19	astrocytoma	astrocytoma	NOUN
fnp-5116	413	20	survival	survival	NOUN
fnp-5116	413	21	in	in	ADP
fnp-5116	413	22	adults	adult	NOUN
fnp-5116	413	23	:	:	PUNCT
fnp-5116	413	24	analysis	analysis	NOUN
fnp-5116	413	25	of	of	ADP
fnp-5116	413	26	the	the	DET
fnp-5116	413	27	surveillance	surveillance	NOUN
fnp-5116	413	28	,	,	PUNCT
fnp-5116	413	29	epidemiology	epidemiology	NOUN
fnp-5116	413	30	,	,	PUNCT
fnp-5116	413	31	and	and	CCONJ
fnp-5116	413	32	end	end	VERB
fnp-5116	413	33	results	result	NOUN
fnp-5116	413	34	program	program	NOUN
fnp-5116	413	35	of	of	ADP
fnp-5116	413	36	the	the	DET
fnp-5116	413	37	national	national	PROPN
fnp-5116	413	38	cancer	cancer	PROPN
fnp-5116	413	39	institute	institute	PROPN
fnp-5116	413	40	"	"	PUNCT
fnp-5116	413	41	,	,	PUNCT
fnp-5116	413	42	j	j	PROPN
fnp-5116	413	43	neurooncol	neurooncol	PROPN
fnp-5116	413	44	,	,	PUNCT
fnp-5116	413	45	vol	vol	NOUN
fnp-5116	413	46	.	.	PROPN
fnp-5116	413	47	108	108	NUM
fnp-5116	413	48	,	,	PUNCT
fnp-5116	413	49	no	no	INTJ
fnp-5116	413	50	.	.	NOUN
fnp-5116	413	51	1	1	NUM
fnp-5116	413	52	,	,	PUNCT
fnp-5116	413	53	pp	pp	ADJ
fnp-5116	413	54	.	.	PUNCT
fnp-5116	414	1	187	187	NUM
fnp-5116	414	2	-	-	SYM
fnp-5116	414	3	93	93	NUM
fnp-5116	414	4	,	,	PUNCT
fnp-5116	414	5	may	may	PROPN
fnp-5116	414	6	2012	2012	NUM
fnp-5116	414	7	,	,	PUNCT
fnp-5116	414	8	https://doi.org/10.1007/s11060-012-0829-0	https://doi.org/10.1007/s11060-012-0829-0	NUM
fnp-5116	414	9	.	.	PUNCT
fnp-5116	415	1	50	50	NUM
fnp-5116	415	2	.	.	PUNCT
fnp-5116	416	1	s.	s.	PROPN
fnp-5116	416	2	shafqat	shafqat	PROPN
fnp-5116	416	3	,	,	PUNCT
fnp-5116	416	4	e.	e.	PROPN
fnp-5116	416	5	arana	arana	PROPN
fnp-5116	416	6	chicas	chicas	PROPN
fnp-5116	416	7	,	,	PUNCT
fnp-5116	416	8	a.	a.	NOUN
fnp-5116	416	9	shafqat	shafqat	NOUN
fnp-5116	416	10	,	,	PUNCT
fnp-5116	416	11	and	and	CCONJ
fnp-5116	416	12	s.	s.	PROPN
fnp-5116	416	13	k.	k.	PROPN
fnp-5116	416	14	hashmi	hashmi	PROPN
fnp-5116	416	15	,	,	PUNCT
fnp-5116	416	16	"	"	PUNCT
fnp-5116	416	17	the	the	DET
fnp-5116	416	18	achilles	achille	NOUN
fnp-5116	416	19	'	'	PART
fnp-5116	416	20	heel	heel	NOUN
fnp-5116	416	21	of	of	ADP
fnp-5116	416	22	cancer	cancer	NOUN
fnp-5116	416	23	survivors	survivor	NOUN
fnp-5116	416	24	:	:	PUNCT
fnp-5116	416	25	fundamentals	fundamental	NOUN
fnp-5116	416	26	of	of	ADP
fnp-5116	416	27	accelerated	accelerate	VERB
fnp-5116	416	28	cellular	cellular	ADJ
fnp-5116	416	29	senescence	senescence	NOUN
fnp-5116	416	30	"	"	PUNCT
fnp-5116	416	31	,	,	PUNCT
fnp-5116	416	32	j	j	PROPN
fnp-5116	416	33	clin	clin	PROPN
fnp-5116	416	34	invest	invest	PROPN
fnp-5116	416	35	,	,	PUNCT
fnp-5116	416	36	vol	vol	NOUN
fnp-5116	416	37	.	.	PROPN
fnp-5116	417	1	132	132	NUM
fnp-5116	417	2	,	,	PUNCT
fnp-5116	417	3	no	no	INTJ
fnp-5116	417	4	.	.	NOUN
fnp-5116	417	5	13	13	NUM
fnp-5116	417	6	,	,	PUNCT
fnp-5116	417	7	jul	jul	PROPN
fnp-5116	417	8	1	1	NUM
fnp-5116	417	9	2022	2022	NUM
fnp-5116	417	10	,	,	PUNCT
fnp-5116	417	11	https://doi.org/10.1172/jci158452	https://doi.org/10.1172/jci158452	PROPN
fnp-5116	417	12	.	.	PUNCT
fnp-5116	417	13	51	51	NUM
fnp-5116	417	14	.	.	PUNCT
fnp-5116	417	15	a.	a.	NOUN
fnp-5116	417	16	m.	m.	NOUN
fnp-5116	417	17	molinaro	molinaro	PROPN
fnp-5116	417	18	et	et	PROPN
fnp-5116	417	19	al	al	PROPN
fnp-5116	417	20	.	.	PROPN
fnp-5116	417	21	,	,	PUNCT
fnp-5116	417	22	"	"	PUNCT
fnp-5116	417	23	interactions	interaction	NOUN
fnp-5116	417	24	of	of	ADP
fnp-5116	417	25	age	age	NOUN
fnp-5116	417	26	and	and	CCONJ
fnp-5116	417	27	blood	blood	NOUN
fnp-5116	417	28	immune	immune	ADJ
fnp-5116	417	29	factors	factor	NOUN
fnp-5116	417	30	and	and	CCONJ
fnp-5116	417	31	noninvasive	noninvasive	ADJ
fnp-5116	417	32	prediction	prediction	NOUN
fnp-5116	417	33	of	of	ADP
fnp-5116	417	34	glioma	glioma	NOUN
fnp-5116	417	35	survival	survival	NOUN
fnp-5116	417	36	"	"	PUNCT
fnp-5116	417	37	,	,	PUNCT
fnp-5116	417	38	j	j	PROPN
fnp-5116	417	39	natl	natl	PROPN
fnp-5116	417	40	cancer	cancer	PROPN
fnp-5116	417	41	inst	inst	PROPN
fnp-5116	417	42	,	,	PUNCT
fnp-5116	417	43	vol	vol	NOUN
fnp-5116	417	44	.	.	PROPN
fnp-5116	417	45	114	114	NUM
fnp-5116	417	46	,	,	PUNCT
fnp-5116	417	47	no	no	INTJ
fnp-5116	417	48	.	.	NOUN
fnp-5116	417	49	3	3	NUM
fnp-5116	417	50	,	,	PUNCT
fnp-5116	417	51	pp	pp	ADJ
fnp-5116	417	52	.	.	PUNCT
fnp-5116	418	1	446	446	NUM
fnp-5116	418	2	-	-	SYM
fnp-5116	418	3	457	457	NUM
fnp-5116	418	4	,	,	PUNCT
fnp-5116	418	5	mar	mar	PROPN
fnp-5116	418	6	8	8	NUM
fnp-5116	418	7	2022	2022	NUM
fnp-5116	418	8	,	,	PUNCT
fnp-5116	418	9	https://doi.org/10.1093/jnci/djab195	https://doi.org/10.1093/jnci/djab195	NOUN
fnp-5116	418	10	.	.	PROPN
fnp-5116	418	11	52	52	NUM
fnp-5116	418	12	.	.	PUNCT
fnp-5116	419	1	s.	s.	PROPN
fnp-5116	419	2	cyrine	cyrine	PROPN
fnp-5116	419	3	et	et	PROPN
fnp-5116	419	4	al	al	PROPN
fnp-5116	419	5	.	.	PROPN
fnp-5116	419	6	,	,	PUNCT
fnp-5116	419	7	"	"	PUNCT
fnp-5116	419	8	pilocytic	pilocytic	ADJ
fnp-5116	419	9	astrocytoma	astrocytoma	NOUN
fnp-5116	419	10	:	:	PUNCT
fnp-5116	419	11	a	a	DET
fnp-5116	419	12	retrospective	retrospective	ADJ
fnp-5116	419	13	study	study	NOUN
fnp-5116	419	14	of	of	ADP
fnp-5116	419	15	32	32	NUM
fnp-5116	419	16	cases	case	NOUN
fnp-5116	419	17	"	"	PUNCT
fnp-5116	419	18	,	,	PUNCT
fnp-5116	419	19	clin	clin	PROPN
fnp-5116	419	20	neurol	neurol	PROPN
fnp-5116	419	21	neurosurg	neurosurg	PROPN
fnp-5116	419	22	,	,	PUNCT
fnp-5116	419	23	vol	vol	NOUN
fnp-5116	419	24	.	.	PROPN
fnp-5116	419	25	115	115	NUM
fnp-5116	419	26	,	,	PUNCT
fnp-5116	419	27	no	no	INTJ
fnp-5116	419	28	.	.	NOUN
fnp-5116	419	29	8	8	NUM
fnp-5116	419	30	,	,	PUNCT
fnp-5116	419	31	pp	pp	ADJ
fnp-5116	419	32	.	.	PUNCT
fnp-5116	419	33	1220	1220	NUM
fnp-5116	419	34	-	-	SYM
fnp-5116	419	35	5	5	NUM
fnp-5116	419	36	,	,	PUNCT
fnp-5116	419	37	aug	aug	PROPN
fnp-5116	419	38	2013	2013	NUM
fnp-5116	419	39	,	,	PUNCT
fnp-5116	419	40	https://doi.org/10.1016/j.clineuro.2012.11.009	https://doi.org/10.1016/j.clineuro.2012.11.009	X
fnp-5116	419	41	.	.	PUNCT
fnp-5116	420	1	53	53	NUM
fnp-5116	420	2	.	.	PUNCT
fnp-5116	421	1	t.	t.	PROPN
fnp-5116	421	2	kayama	kayama	PROPN
fnp-5116	421	3	,	,	PUNCT
fnp-5116	421	4	t.	t.	NOUN
fnp-5116	421	5	tominaga	tominaga	NOUN
fnp-5116	421	6	,	,	PUNCT
fnp-5116	421	7	and	and	CCONJ
fnp-5116	421	8	t.	t.	PROPN
fnp-5116	421	9	yoshimoto	yoshimoto	NOUN
fnp-5116	421	10	,	,	PUNCT
fnp-5116	421	11	"	"	PUNCT
fnp-5116	421	12	management	management	NOUN
fnp-5116	421	13	of	of	ADP
fnp-5116	421	14	pilocytic	pilocytic	ADJ
fnp-5116	421	15	astrocytoma	astrocytoma	NOUN
fnp-5116	421	16	"	"	PUNCT
fnp-5116	421	17	,	,	PUNCT
fnp-5116	421	18	neurosurg	neurosurg	PROPN
fnp-5116	421	19	rev	rev	PROPN
fnp-5116	421	20	,	,	PUNCT
fnp-5116	421	21	vol	vol	NOUN
fnp-5116	421	22	.	.	PROPN
fnp-5116	421	23	19	19	NUM
fnp-5116	421	24	,	,	PUNCT
fnp-5116	421	25	no	no	INTJ
fnp-5116	421	26	.	.	NOUN
fnp-5116	421	27	4	4	NUM
fnp-5116	421	28	,	,	PUNCT
fnp-5116	421	29	pp	pp	ADJ
fnp-5116	421	30	.	.	PUNCT
fnp-5116	422	1	217	217	NUM
fnp-5116	422	2	-	-	SYM
fnp-5116	422	3	20	20	NUM
fnp-5116	422	4	,	,	PUNCT
fnp-5116	422	5	1996	1996	NUM
fnp-5116	422	6	,	,	PUNCT
fnp-5116	422	7	https://doi.org/10.1007/bf00314833	https://doi.org/10.1007/bf00314833	PROPN
fnp-5116	422	8	.	.	PROPN
fnp-5116	423	1	54	54	NUM
fnp-5116	423	2	.	.	PUNCT
fnp-5116	424	1	j.	j.	PROPN
fnp-5116	424	2	m.	m.	PROPN
fnp-5116	424	3	ye	ye	PROPN
fnp-5116	424	4	,	,	PUNCT
fnp-5116	424	5	m.	m.	NOUN
fnp-5116	424	6	j.	j.	PROPN
fnp-5116	424	7	ye	ye	PROPN
fnp-5116	424	8	,	,	PUNCT
fnp-5116	424	9	s.	s.	PROPN
fnp-5116	424	10	kranz	kranz	PROPN
fnp-5116	424	11	,	,	PUNCT
fnp-5116	424	12	and	and	CCONJ
fnp-5116	424	13	p.	p.	PROPN
fnp-5116	424	14	lo	lo	PROPN
fnp-5116	424	15	,	,	PUNCT
fnp-5116	424	16	"	"	PUNCT
fnp-5116	424	17	a	a	DET
fnp-5116	424	18	10	10	NUM
fnp-5116	424	19	year	year	NOUN
fnp-5116	424	20	retrospective	retrospective	ADJ
fnp-5116	424	21	study	study	NOUN
fnp-5116	424	22	of	of	ADP
fnp-5116	424	23	surgical	surgical	ADJ
fnp-5116	424	24	outcomes	outcome	NOUN
fnp-5116	424	25	of	of	ADP
fnp-5116	424	26	adult	adult	NOUN
fnp-5116	424	27	intracranial	intracranial	ADJ
fnp-5116	424	28	pilocytic	pilocytic	ADJ
fnp-5116	424	29	astrocytoma	astrocytoma	NOUN
fnp-5116	424	30	"	"	PUNCT
fnp-5116	424	31	,	,	PUNCT
fnp-5116	424	32	j	j	PROPN
fnp-5116	424	33	clin	clin	PROPN
fnp-5116	424	34	neurosci	neurosci	PROPN
fnp-5116	424	35	,	,	PUNCT
fnp-5116	424	36	vol	vol	NOUN
fnp-5116	424	37	.	.	PROPN
fnp-5116	424	38	21	21	NUM
fnp-5116	424	39	,	,	PUNCT
fnp-5116	424	40	no	no	INTJ
fnp-5116	424	41	.	.	NOUN
fnp-5116	424	42	12	12	NUM
fnp-5116	424	43	,	,	PUNCT
fnp-5116	424	44	pp	pp	ADJ
fnp-5116	424	45	.	.	PUNCT
fnp-5116	424	46	2160	2160	NUM
fnp-5116	424	47	-	-	SYM
fnp-5116	424	48	4	4	NUM
fnp-5116	424	49	,	,	PUNCT
fnp-5116	424	50	dec	dec	PROPN
fnp-5116	424	51	2014	2014	NUM
fnp-5116	424	52	,	,	PUNCT
fnp-5116	424	53	https://doi.org/10.1016/j.jocn.2014.04.015	https://doi.org/10.1016/j.jocn.2014.04.015	PROPN
fnp-5116	424	54	.	.	PUNCT
fnp-5116	425	1	55	55	NUM
fnp-5116	425	2	.	.	PUNCT
fnp-5116	426	1	j.	j.	PROPN
fnp-5116	426	2	w.	w.	PROPN
fnp-5116	426	3	kim	kim	PROPN
fnp-5116	426	4	et	et	PROPN
fnp-5116	426	5	al	al	PROPN
fnp-5116	426	6	.	.	PROPN
fnp-5116	426	7	,	,	PUNCT
fnp-5116	426	8	"	"	PUNCT
fnp-5116	426	9	comparison	comparison	NOUN
fnp-5116	426	10	of	of	ADP
fnp-5116	426	11	the	the	DET
fnp-5116	426	12	clinical	clinical	ADJ
fnp-5116	426	13	features	feature	NOUN
fnp-5116	426	14	and	and	CCONJ
fnp-5116	426	15	treatment	treatment	NOUN
fnp-5116	426	16	outcomes	outcome	NOUN
fnp-5116	426	17	of	of	ADP
fnp-5116	426	18	pilocytic	pilocytic	ADJ
fnp-5116	426	19	astrocytoma	astrocytoma	NOUN
fnp-5116	426	20	in	in	ADP
fnp-5116	426	21	pediatric	pediatric	ADJ
fnp-5116	426	22	and	and	CCONJ
fnp-5116	426	23	adult	adult	NOUN
fnp-5116	426	24	patients	patient	NOUN
fnp-5116	426	25	"	"	PUNCT
fnp-5116	426	26	,	,	PUNCT
fnp-5116	426	27	childs	child	VERB
fnp-5116	426	28	nerv	nerv	PROPN
fnp-5116	426	29	syst	syst	PROPN
fnp-5116	426	30	,	,	PUNCT
fnp-5116	426	31	vol	vol	NOUN
fnp-5116	426	32	.	.	PROPN
fnp-5116	426	33	39	39	NUM
fnp-5116	426	34	,	,	PUNCT
fnp-5116	426	35	no	no	INTJ
fnp-5116	426	36	.	.	NOUN
fnp-5116	426	37	3	3	NUM
fnp-5116	426	38	,	,	PUNCT
fnp-5116	426	39	pp	pp	ADJ
fnp-5116	426	40	.	.	PUNCT
fnp-5116	427	1	583	583	NUM
fnp-5116	427	2	-	-	SYM
fnp-5116	427	3	591	591	NUM
fnp-5116	427	4	,	,	PUNCT
fnp-5116	427	5	mar	mar	PROPN
fnp-5116	427	6	2023	2023	NUM
fnp-5116	427	7	,	,	PUNCT
fnp-5116	427	8	https://doi.org/10.1007/s00381-023-05839-x	https://doi.org/10.1007/s00381-023-05839-x	PROPN
fnp-5116	427	9	.	.	PUNCT
fnp-5116	428	1	56	56	NUM
fnp-5116	428	2	.	.	PUNCT
fnp-5116	428	3	r.	r.	PROPN
fnp-5116	428	4	jimenez	jimenez	PROPN
fnp-5116	428	5	-	-	PUNCT
fnp-5116	428	6	paneque	paneque	PROPN
fnp-5116	428	7	,	,	PUNCT
fnp-5116	428	8	"	"	PUNCT
fnp-5116	428	9	the	the	DET
fnp-5116	428	10	questioned	question	VERB
fnp-5116	428	11	p	p	NOUN
fnp-5116	428	12	value	value	NOUN
fnp-5116	428	13	:	:	PUNCT
fnp-5116	428	14	clinical	clinical	ADJ
fnp-5116	428	15	,	,	PUNCT
fnp-5116	428	16	practical	practical	ADJ
fnp-5116	428	17	and	and	CCONJ
fnp-5116	428	18	statistical	statistical	ADJ
fnp-5116	428	19	significance	significance	NOUN
fnp-5116	428	20	"	"	PUNCT
fnp-5116	428	21	,	,	PUNCT
fnp-5116	428	22	medwave	medwave	ADJ
fnp-5116	428	23	,	,	PUNCT
fnp-5116	428	24	vol	vol	NOUN
fnp-5116	428	25	.	.	PROPN
fnp-5116	428	26	16	16	NUM
fnp-5116	428	27	,	,	PUNCT
fnp-5116	428	28	no	no	INTJ
fnp-5116	428	29	.	.	NOUN
fnp-5116	428	30	8	8	NUM
fnp-5116	428	31	,	,	PUNCT
fnp-5116	428	32	p.	p.	NOUN
fnp-5116	429	1	e6534	e6534	PROPN
fnp-5116	429	2	,	,	PUNCT
fnp-5116	429	3	sep	sep	PROPN
fnp-5116	429	4	9	9	NUM
fnp-5116	429	5	2016	2016	NUM
fnp-5116	429	6	,	,	PUNCT
fnp-5116	429	7	https://doi.org/10.5867/medwave.2016.08.6534	https://doi.org/10.5867/medwave.2016.08.6534	X
fnp-5116	429	8	.	.	PUNCT
fnp-5116	429	9	el	el	PROPN
fnp-5116	429	10	valor	valor	PROPN
fnp-5116	429	11	de	de	PROPN
fnp-5116	429	12	p	p	PROPN
fnp-5116	429	13	en	en	ADP
fnp-5116	429	14	entredicho	entredicho	NOUN
fnp-5116	429	15	:	:	PUNCT
fnp-5116	429	16	significacion	significacion	PROPN
fnp-5116	429	17	estadistica	estadistica	PROPN
fnp-5116	429	18	,	,	PUNCT
fnp-5116	429	19	clinica	clinica	PROPN
fnp-5116	429	20	y	y	PROPN
fnp-5116	429	21	practica	practica	PROPN
fnp-5116	429	22	.	.	PUNCT
fnp-5116	430	1	57	57	NUM
fnp-5116	430	2	.	.	PUNCT
fnp-5116	431	1	p.	p.	PROPN
fnp-5116	431	2	r.	r.	PROPN
fnp-5116	431	3	burton	burton	PROPN
fnp-5116	431	4	,	,	PUNCT
fnp-5116	431	5	l.	l.	PROPN
fnp-5116	431	6	c.	c.	PROPN
fnp-5116	431	7	gurrin	gurrin	NOUN
fnp-5116	431	8	,	,	PUNCT
fnp-5116	431	9	and	and	CCONJ
fnp-5116	431	10	m.	m.	PROPN
fnp-5116	431	11	j.	j.	PROPN
fnp-5116	431	12	campbell	campbell	PROPN
fnp-5116	431	13	,	,	PUNCT
fnp-5116	431	14	"	"	PUNCT
fnp-5116	431	15	clinical	clinical	ADJ
fnp-5116	431	16	significance	significance	NOUN
fnp-5116	431	17	not	not	PART
fnp-5116	431	18	statistical	statistical	ADJ
fnp-5116	431	19	significance	significance	NOUN
fnp-5116	431	20	:	:	PUNCT
fnp-5116	431	21	a	a	DET
fnp-5116	431	22	simple	simple	ADJ
fnp-5116	431	23	bayesian	bayesian	NOUN
fnp-5116	431	24	alternative	alternative	NOUN
fnp-5116	431	25	to	to	ADP
fnp-5116	431	26	p	p	NOUN
fnp-5116	431	27	values	value	NOUN
fnp-5116	431	28	"	"	PUNCT
fnp-5116	431	29	,	,	PUNCT
fnp-5116	431	30	j	j	PROPN
fnp-5116	431	31	epidemiol	epidemiol	PROPN
fnp-5116	431	32	community	community	PROPN
fnp-5116	431	33	health	health	PROPN
fnp-5116	431	34	,	,	PUNCT
fnp-5116	431	35	vol	vol	NOUN
fnp-5116	431	36	.	.	PROPN
fnp-5116	431	37	52	52	NUM
fnp-5116	431	38	,	,	PUNCT
fnp-5116	431	39	no	no	INTJ
fnp-5116	431	40	.	.	NOUN
fnp-5116	431	41	5	5	NUM
fnp-5116	431	42	,	,	PUNCT
fnp-5116	431	43	pp	pp	ADJ
fnp-5116	431	44	.	.	PUNCT
fnp-5116	432	1	318	318	NUM
fnp-5116	432	2	-	-	SYM
fnp-5116	432	3	23	23	NUM
fnp-5116	432	4	,	,	PUNCT
fnp-5116	432	5	may	may	AUX
fnp-5116	432	6	1998	1998	NUM
fnp-5116	432	7	,	,	PUNCT
fnp-5116	432	8	https://doi.org/10.1136/jech.52.5.318	https://doi.org/10.1136/jech.52.5.318	PROPN
fnp-5116	432	9	.	.	PUNCT
fnp-5116	433	1	58	58	NUM
fnp-5116	433	2	.	.	PUNCT
fnp-5116	434	1	p.	p.	NOUN
fnp-5116	434	2	martinez	martinez	PROPN
fnp-5116	434	3	-	-	PUNCT
fnp-5116	434	4	camblor	camblor	PROPN
fnp-5116	434	5	,	,	PUNCT
fnp-5116	434	6	s.	s.	PROPN
fnp-5116	434	7	perez	perez	PROPN
fnp-5116	434	8	-	-	PUNCT
fnp-5116	434	9	fernandez	fernandez	PROPN
fnp-5116	434	10	,	,	PUNCT
fnp-5116	434	11	and	and	CCONJ
fnp-5116	434	12	s.	s.	PROPN
fnp-5116	434	13	diaz	diaz	PROPN
fnp-5116	434	14	-	-	PUNCT
fnp-5116	434	15	coto	coto	PROPN
fnp-5116	434	16	,	,	PUNCT
fnp-5116	434	17	"	"	PUNCT
fnp-5116	434	18	the	the	DET
fnp-5116	434	19	role	role	NOUN
fnp-5116	434	20	of	of	ADP
fnp-5116	434	21	the	the	DET
fnp-5116	434	22	p	p	NOUN
fnp-5116	434	23	-	-	PUNCT
fnp-5116	434	24	value	value	NOUN
fnp-5116	434	25	in	in	ADP
fnp-5116	434	26	the	the	DET
fnp-5116	434	27	multitesting	multitesting	NOUN
fnp-5116	434	28	problem	problem	NOUN
fnp-5116	434	29	"	"	PUNCT
fnp-5116	434	30	,	,	PUNCT
fnp-5116	434	31	j	j	PROPN
fnp-5116	434	32	appl	appl	PROPN
fnp-5116	434	33	stat	stat	PROPN
fnp-5116	434	34	,	,	PUNCT
fnp-5116	434	35	vol	vol	NOUN
fnp-5116	434	36	.	.	PROPN
fnp-5116	435	1	47	47	NUM
fnp-5116	435	2	,	,	PUNCT
fnp-5116	435	3	no	no	INTJ
fnp-5116	435	4	.	.	NOUN
fnp-5116	435	5	9	9	NUM
fnp-5116	435	6	,	,	PUNCT
fnp-5116	435	7	pp	pp	ADJ
fnp-5116	435	8	.	.	PUNCT
fnp-5116	436	1	1529	1529	NUM
fnp-5116	436	2	-	-	SYM
fnp-5116	436	3	1542	1542	NUM
fnp-5116	436	4	,	,	PUNCT
fnp-5116	436	5	2020	2020	NUM
fnp-5116	436	6	,	,	PUNCT
fnp-5116	436	7	https://doi.org/10.1080/02664763.2019.1682128	https://doi.org/10.1080/02664763.2019.1682128	PROPN
fnp-5116	436	8	.	.	PROPN
fnp-5116	436	9	59	59	NUM
fnp-5116	436	10	.	.	PUNCT
fnp-5116	436	11	j.	j.	PROPN
fnp-5116	436	12	coelho	coelho	PROPN
fnp-5116	436	13	,	,	PUNCT
fnp-5116	436	14	s.	s.	PROPN
fnp-5116	436	15	nunes	nunes	PROPN
fnp-5116	436	16	,	,	PUNCT
fnp-5116	436	17	and	and	CCONJ
fnp-5116	436	18	d.	d.	PROPN
fnp-5116	436	19	salgado	salgado	PROPN
fnp-5116	436	20	,	,	PUNCT
fnp-5116	436	21	"	"	PUNCT
fnp-5116	436	22	spontaneous	spontaneous	ADJ
fnp-5116	436	23	malignant	malignant	ADJ
fnp-5116	436	24	transformation	transformation	NOUN
fnp-5116	436	25	of	of	ADP
fnp-5116	436	26	a	a	DET
fnp-5116	436	27	pilocytic	pilocytic	ADJ
fnp-5116	436	28	astrocytoma	astrocytoma	NOUN
fnp-5116	436	29	of	of	ADP
fnp-5116	436	30	cerebellum	cerebellum	ADJ
fnp-5116	436	31	:	:	PUNCT
fnp-5116	436	32	case	case	NOUN
fnp-5116	436	33	report	report	NOUN
fnp-5116	436	34	"	"	PUNCT
fnp-5116	436	35	,	,	PUNCT
fnp-5116	436	36	child	child	NOUN
fnp-5116	436	37	neurol	neurol	NOUN
fnp-5116	436	38	open	open	VERB
fnp-5116	436	39	,	,	PUNCT
fnp-5116	436	40	vol	vol	NOUN
fnp-5116	436	41	.	.	PROPN
fnp-5116	437	1	2	2	NUM
fnp-5116	437	2	,	,	PUNCT
fnp-5116	437	3	no	no	INTJ
fnp-5116	437	4	.	.	NOUN
fnp-5116	437	5	1	1	NUM
fnp-5116	437	6	,	,	PUNCT
fnp-5116	437	7	p.	p.	NOUN
fnp-5116	437	8	2329048x14566813	2329048x14566813	NUM
fnp-5116	437	9	,	,	PUNCT
fnp-5116	437	10	jan	jan	PROPN
fnp-5116	437	11	-	-	PUNCT
fnp-5116	437	12	mar	mar	PROPN
fnp-5116	437	13	2015	2015	NUM
fnp-5116	437	14	,	,	PUNCT
fnp-5116	437	15	https://doi.org/10.1177/2329048x14566813	https://doi.org/10.1177/2329048x14566813	NOUN
fnp-5116	437	16	.	.	NOUN
fnp-5116	437	17	60	60	NUM
fnp-5116	437	18	.	.	PUNCT
fnp-5116	438	1	j.	j.	PROPN
fnp-5116	438	2	a.	a.	PROPN
fnp-5116	438	3	ellis	ellis	PROPN
fnp-5116	438	4	,	,	PUNCT
fnp-5116	438	5	a.	a.	PROPN
fnp-5116	438	6	waziri	waziri	PROPN
fnp-5116	438	7	,	,	PUNCT
fnp-5116	438	8	c.	c.	PROPN
fnp-5116	438	9	balmaceda	balmaceda	PROPN
fnp-5116	438	10	,	,	PUNCT
fnp-5116	438	11	p.	p.	PROPN
fnp-5116	438	12	canoll	canoll	PROPN
fnp-5116	438	13	,	,	PUNCT
fnp-5116	438	14	j.	j.	PROPN
fnp-5116	438	15	n.	n.	PROPN
fnp-5116	438	16	bruce	bruce	PROPN
fnp-5116	438	17	,	,	PUNCT
fnp-5116	438	18	and	and	CCONJ
fnp-5116	438	19	m.	m.	PROPN
fnp-5116	438	20	b.	b.	PROPN
fnp-5116	438	21	sisti	sisti	PROPN
fnp-5116	438	22	,	,	PUNCT
fnp-5116	438	23	"	"	PUNCT
fnp-5116	438	24	rapid	rapid	ADJ
fnp-5116	438	25	recurrence	recurrence	NOUN
fnp-5116	438	26	and	and	CCONJ
fnp-5116	438	27	malignant	malignant	ADJ
fnp-5116	438	28	transformation	transformation	NOUN
fnp-5116	438	29	of	of	ADP
fnp-5116	438	30	pilocytic	pilocytic	ADJ
fnp-5116	438	31	astrocytoma	astrocytoma	NOUN
fnp-5116	438	32	in	in	ADP
fnp-5116	438	33	adult	adult	NOUN
fnp-5116	438	34	patients	patient	NOUN
fnp-5116	438	35	"	"	PUNCT
fnp-5116	438	36	,	,	PUNCT
fnp-5116	438	37	j	j	PROPN
fnp-5116	438	38	neurooncol	neurooncol	PROPN
fnp-5116	438	39	,	,	PUNCT
fnp-5116	438	40	vol	vol	NOUN
fnp-5116	438	41	.	.	PROPN
fnp-5116	438	42	95	95	NUM
fnp-5116	438	43	,	,	PUNCT
fnp-5116	438	44	no	no	INTJ
fnp-5116	438	45	.	.	NOUN
fnp-5116	438	46	3	3	NUM
fnp-5116	438	47	,	,	PUNCT
fnp-5116	438	48	pp	pp	ADJ
fnp-5116	438	49	.	.	PUNCT
fnp-5116	439	1	377	377	NUM
fnp-5116	439	2	-	-	SYM
fnp-5116	439	3	382	382	NUM
fnp-5116	439	4	,	,	PUNCT
fnp-5116	439	5	dec	dec	PROPN
fnp-5116	439	6	2009	2009	NUM
fnp-5116	439	7	,	,	PUNCT
fnp-5116	439	8	https://doi.org/10.1007/s11060-009-9935-z	https://doi.org/10.1007/s11060-009-9935-z	PROPN
fnp-5116	439	9	.	.	PUNCT
fnp-5116	439	10	61	61	NUM
fnp-5116	439	11	.	.	PUNCT
fnp-5116	440	1	c.	c.	PROPN
fnp-5116	440	2	dix	dix	PROPN
fnp-5116	440	3	et	et	PROPN
fnp-5116	440	4	al	al	PROPN
fnp-5116	440	5	.	.	PROPN
fnp-5116	440	6	,	,	PUNCT
fnp-5116	440	7	"	"	PUNCT
fnp-5116	440	8	c	c	X
fnp-5116	440	9	-	-	ADJ
fnp-5116	440	10	reactive	reactive	ADJ
fnp-5116	440	11	protein	protein	NOUN
fnp-5116	440	12	,	,	PUNCT
fnp-5116	440	13	immunothrombosis	immunothrombosis	NOUN
fnp-5116	440	14	and	and	CCONJ
fnp-5116	440	15	venous	venous	ADJ
fnp-5116	440	16	thromboembolism	thromboembolism	NOUN
fnp-5116	440	17	"	"	PUNCT
fnp-5116	440	18	,	,	PUNCT
fnp-5116	440	19	front	front	ADJ
fnp-5116	440	20	immunol	immunol	NOUN
fnp-5116	440	21	,	,	PUNCT
fnp-5116	440	22	vol	vol	NOUN
fnp-5116	440	23	.	.	PROPN
fnp-5116	440	24	13	13	NUM
fnp-5116	440	25	,	,	PUNCT
fnp-5116	440	26	p.	p.	NOUN
fnp-5116	440	27	1002652	1002652	NUM
fnp-5116	440	28	,	,	PUNCT
fnp-5116	440	29	2022	2022	NUM
fnp-5116	440	30	,	,	PUNCT
fnp-5116	440	31	https://doi.org/10.3389/fimmu.2022.1002652	https://doi.org/10.3389/fimmu.2022.1002652	PROPN
fnp-5116	440	32	.	.	PUNCT
fnp-5116	441	1	62	62	NUM
fnp-5116	441	2	.	.	PUNCT
fnp-5116	442	1	f.	f.	PROPN
fnp-5116	442	2	j.	j.	PROPN
fnp-5116	442	3	rodriguez	rodriguez	PROPN
fnp-5116	442	4	et	et	PROPN
fnp-5116	442	5	al	al	PROPN
fnp-5116	442	6	.	.	PROPN
fnp-5116	442	7	,	,	PUNCT
fnp-5116	442	8	"	"	PUNCT
fnp-5116	442	9	alternative	alternative	ADJ
fnp-5116	442	10	lengthening	lengthening	NOUN
fnp-5116	442	11	of	of	ADP
fnp-5116	442	12	telomeres	telomere	NOUN
fnp-5116	442	13	,	,	PUNCT
fnp-5116	442	14	atrx	atrx	NOUN
fnp-5116	442	15	loss	loss	NOUN
fnp-5116	442	16	and	and	CCONJ
fnp-5116	442	17	h3	h3	NOUN
fnp-5116	442	18	-	-	PUNCT
fnp-5116	442	19	k27	k27	NOUN
fnp-5116	442	20	m	m	NOUN
fnp-5116	442	21	mutations	mutation	NOUN
fnp-5116	442	22	in	in	ADP
fnp-5116	442	23	histologically	histologically	ADV
fnp-5116	442	24	defined	define	VERB
fnp-5116	442	25	pilocytic	pilocytic	ADJ
fnp-5116	442	26	astrocytoma	astrocytoma	NOUN
fnp-5116	442	27	with	with	ADP
fnp-5116	442	28	anaplasia	anaplasia	PROPN
fnp-5116	442	29	"	"	PUNCT
fnp-5116	442	30	,	,	PUNCT
fnp-5116	442	31	brain	brain	NOUN
fnp-5116	442	32	pathol	pathol	NOUN
fnp-5116	442	33	,	,	PUNCT
fnp-5116	442	34	vol	vol	NOUN
fnp-5116	442	35	.	.	PROPN
fnp-5116	442	36	29	29	NUM
fnp-5116	442	37	,	,	PUNCT
fnp-5116	442	38	no	no	INTJ
fnp-5116	442	39	.	.	NOUN
fnp-5116	442	40	1	1	NUM
fnp-5116	442	41	,	,	PUNCT
fnp-5116	442	42	pp	pp	ADJ
fnp-5116	442	43	.	.	PUNCT
fnp-5116	443	1	126	126	NUM
fnp-5116	443	2	-	-	SYM
fnp-5116	443	3	140	140	NUM
fnp-5116	443	4	,	,	PUNCT
fnp-5116	443	5	jan	jan	PROPN
fnp-5116	443	6	2019	2019	NUM
fnp-5116	443	7	,	,	PUNCT
fnp-5116	443	8	https://doi.org/10.1111/bpa.12646	https://doi.org/10.1111/bpa.12646	PROPN
fnp-5116	443	9	.	.	PUNCT
fnp-5116	444	1	63	63	NUM
fnp-5116	444	2	.	.	PUNCT
fnp-5116	445	1	t.	t.	PROPN
fnp-5116	445	2	tihan	tihan	PROPN
fnp-5116	445	3	et	et	PROPN
fnp-5116	445	4	al	al	PROPN
fnp-5116	445	5	.	.	PROPN
fnp-5116	445	6	,	,	PUNCT
fnp-5116	445	7	"	"	PUNCT
fnp-5116	445	8	pediatric	pediatric	ADJ
fnp-5116	445	9	astrocytomas	astrocytoma	NOUN
fnp-5116	445	10	with	with	ADP
fnp-5116	445	11	monomorphous	monomorphous	ADJ
fnp-5116	445	12	pilomyxoid	pilomyxoid	NOUN
fnp-5116	445	13	features	feature	NOUN
fnp-5116	445	14	and	and	CCONJ
fnp-5116	445	15	a	a	DET
fnp-5116	445	16	less	less	ADV
fnp-5116	445	17	favorable	favorable	ADJ
fnp-5116	445	18	outcome	outcome	NOUN
fnp-5116	445	19	"	"	PUNCT
fnp-5116	445	20	,	,	PUNCT
fnp-5116	445	21	j	j	PROPN
fnp-5116	445	22	neuropathol	neuropathol	PROPN
fnp-5116	445	23	exp	exp	NOUN
fnp-5116	445	24	neurol	neurol	PROPN
fnp-5116	445	25	,	,	PUNCT
fnp-5116	445	26	vol	vol	NOUN
fnp-5116	445	27	.	.	PROPN
fnp-5116	445	28	58	58	NUM
fnp-5116	445	29	,	,	PUNCT
fnp-5116	445	30	no	no	INTJ
fnp-5116	445	31	.	.	NOUN
fnp-5116	445	32	10	10	NUM
fnp-5116	445	33	,	,	PUNCT
fnp-5116	445	34	pp	pp	ADJ
fnp-5116	445	35	.	.	PUNCT
fnp-5116	445	36	1061	1061	NUM
fnp-5116	445	37	-	-	SYM
fnp-5116	445	38	8	8	NUM
fnp-5116	445	39	,	,	PUNCT
fnp-5116	445	40	oct	oct	NOUN
fnp-5116	445	41	1999	1999	NUM
fnp-5116	445	42	,	,	PUNCT
fnp-5116	445	43	https://doi.org/10.1097/00005072-199910000-00004	https://doi.org/10.1097/00005072-199910000-00004	PROPN
fnp-5116	445	44	.	.	PUNCT
fnp-5116	446	1	64	64	NUM
fnp-5116	446	2	.	.	PUNCT
fnp-5116	447	1	d.	d.	PROPN
fnp-5116	447	2	bhargava	bhargava	PROPN
fnp-5116	447	3	et	et	PROPN
fnp-5116	447	4	al	al	PROPN
fnp-5116	447	5	.	.	PROPN
fnp-5116	447	6	,	,	PUNCT
fnp-5116	447	7	"	"	PUNCT
fnp-5116	447	8	occurrence	occurrence	NOUN
fnp-5116	447	9	and	and	CCONJ
fnp-5116	447	10	distribution	distribution	NOUN
fnp-5116	447	11	of	of	ADP
fnp-5116	447	12	pilomyxoid	pilomyxoid	NOUN
fnp-5116	447	13	astrocytoma	astrocytoma	PROPN
fnp-5116	447	14	"	"	PUNCT
fnp-5116	447	15	,	,	PUNCT
fnp-5116	447	16	br	br	PROPN
fnp-5116	447	17	j	j	PROPN
fnp-5116	447	18	neurosurg	neurosurg	PROPN
fnp-5116	447	19	,	,	PUNCT
fnp-5116	447	20	vol	vol	NOUN
fnp-5116	447	21	.	.	PROPN
fnp-5116	447	22	27	27	NUM
fnp-5116	447	23	,	,	PUNCT
fnp-5116	447	24	no	no	INTJ
fnp-5116	447	25	.	.	NOUN
fnp-5116	447	26	4	4	NUM
fnp-5116	447	27	,	,	PUNCT
fnp-5116	447	28	pp	pp	ADJ
fnp-5116	447	29	.	.	PUNCT
fnp-5116	448	1	413	413	NUM
fnp-5116	448	2	-	-	SYM
fnp-5116	448	3	8	8	NUM
fnp-5116	448	4	,	,	PUNCT
fnp-5116	448	5	aug	aug	PROPN
fnp-5116	448	6	2013	2013	NUM
fnp-5116	448	7	,	,	PUNCT
fnp-5116	448	8	https://doi.org/10.3109/02688697.2012.752430	https://doi.org/10.3109/02688697.2012.752430	PROPN
fnp-5116	448	9	.	.	PROPN
fnp-5116	448	10	65	65	NUM
fnp-5116	448	11	.	.	PUNCT
fnp-5116	449	1	k.	k.	PROPN
fnp-5116	449	2	chikai	chikai	PROPN
fnp-5116	449	3	et	et	PROPN
fnp-5116	449	4	al	al	PROPN
fnp-5116	449	5	.	.	PROPN
fnp-5116	449	6	,	,	PUNCT
fnp-5116	449	7	"	"	PUNCT
fnp-5116	449	8	clinico	clinico	ADJ
fnp-5116	449	9	-	-	PUNCT
fnp-5116	449	10	pathological	pathological	ADJ
fnp-5116	449	11	features	feature	NOUN
fnp-5116	449	12	of	of	ADP
fnp-5116	449	13	pilomyxoid	pilomyxoid	NOUN
fnp-5116	449	14	astrocytoma	astrocytoma	NOUN
fnp-5116	449	15	of	of	ADP
fnp-5116	449	16	the	the	DET
fnp-5116	449	17	optic	optic	ADJ
fnp-5116	449	18	pathway	pathway	NOUN
fnp-5116	449	19	"	"	PUNCT
fnp-5116	449	20	,	,	PUNCT
fnp-5116	449	21	acta	acta	PROPN
fnp-5116	449	22	neuropathol	neuropathol	PROPN
fnp-5116	449	23	,	,	PUNCT
fnp-5116	449	24	vol	vol	NOUN
fnp-5116	449	25	.	.	PROPN
fnp-5116	449	26	108	108	NUM
fnp-5116	449	27	,	,	PUNCT
fnp-5116	449	28	no	no	INTJ
fnp-5116	449	29	.	.	NOUN
fnp-5116	449	30	2	2	NUM
fnp-5116	449	31	,	,	PUNCT
fnp-5116	449	32	pp	pp	ADJ
fnp-5116	449	33	.	.	PUNCT
fnp-5116	450	1	109	109	NUM
fnp-5116	450	2	-	-	SYM
fnp-5116	450	3	14	14	NUM
fnp-5116	450	4	,	,	PUNCT
fnp-5116	450	5	aug	aug	PROPN
fnp-5116	450	6	2004	2004	NUM
fnp-5116	450	7	,	,	PUNCT
fnp-5116	450	8	https://doi.org/10.1007/s00401-004-0858-7	https://doi.org/10.1007/s00401-004-0858-7	NUM
fnp-5116	450	9	.	.	PUNCT
fnp-5116	451	1	66	66	NUM
fnp-5116	451	2	.	.	PUNCT
fnp-5116	452	1	e.	e.	PROPN
fnp-5116	452	2	alshail	alshail	PROPN
fnp-5116	452	3	et	et	PROPN
fnp-5116	452	4	al	al	PROPN
fnp-5116	452	5	.	.	PROPN
fnp-5116	452	6	,	,	PUNCT
fnp-5116	452	7	"	"	PUNCT
fnp-5116	452	8	a	a	DET
fnp-5116	452	9	molecular	molecular	ADJ
fnp-5116	452	10	study	study	NOUN
fnp-5116	452	11	of	of	ADP
fnp-5116	452	12	pediatric	pediatric	ADJ
fnp-5116	452	13	pilomyxoid	pilomyxoid	NOUN
fnp-5116	452	14	and	and	CCONJ
fnp-5116	452	15	pilocytic	pilocytic	ADJ
fnp-5116	452	16	astrocytomas	astrocytoma	NOUN
fnp-5116	452	17	:	:	PUNCT
fnp-5116	452	18	genome	genome	NOUN
fnp-5116	452	19	-	-	PUNCT
fnp-5116	452	20	wide	wide	ADJ
fnp-5116	452	21	copy	copy	NOUN
fnp-5116	452	22	number	number	NOUN
fnp-5116	452	23	screening	screening	NOUN
fnp-5116	452	24	,	,	PUNCT
fnp-5116	452	25	retrospective	retrospective	ADJ
fnp-5116	452	26	analysis	analysis	NOUN
fnp-5116	452	27	of	of	ADP
fnp-5116	452	28	clinicopathological	clinicopathological	ADJ
fnp-5116	452	29	features	feature	NOUN
fnp-5116	452	30	and	and	CCONJ
fnp-5116	452	31	long	long	ADJ
fnp-5116	452	32	-	-	PUNCT
fnp-5116	452	33	term	term	NOUN
fnp-5116	452	34	clinical	clinical	ADJ
fnp-5116	452	35	outcome	outcome	NOUN
fnp-5116	452	36	"	"	PUNCT
fnp-5116	452	37	,	,	PUNCT
fnp-5116	452	38	front	front	ADJ
fnp-5116	452	39	oncol	oncol	ADJ
fnp-5116	452	40	,	,	PUNCT
fnp-5116	452	41	vol	vol	NOUN
fnp-5116	452	42	.	.	PROPN
fnp-5116	452	43	13	13	NUM
fnp-5116	452	44	,	,	PUNCT
fnp-5116	452	45	p.	p.	NOUN
fnp-5116	452	46	1034292	1034292	NUM
fnp-5116	452	47	,	,	PUNCT
fnp-5116	452	48	2023	2023	NUM
fnp-5116	452	49	,	,	PUNCT
fnp-5116	452	50	https://doi.org/10.3389/fonc.2023.1034292	https://doi.org/10.3389/fonc.2023.1034292	PROPN
fnp-5116	452	51	.	.	PROPN
fnp-5116	452	52	67	67	NUM
fnp-5116	452	53	.	.	PUNCT
fnp-5116	453	1	c.	c.	PROPN
fnp-5116	453	2	g.	g.	PROPN
fnp-5116	453	3	lucas	lucas	PROPN
fnp-5116	453	4	et	et	PROPN
fnp-5116	453	5	al	al	PROPN
fnp-5116	453	6	.	.	PROPN
fnp-5116	453	7	,	,	PUNCT
fnp-5116	453	8	"	"	PUNCT
fnp-5116	453	9	comprehensive	comprehensive	ADJ
fnp-5116	453	10	analysis	analysis	NOUN
fnp-5116	453	11	of	of	ADP
fnp-5116	453	12	diverse	diverse	ADJ
fnp-5116	453	13	low	low	ADJ
fnp-5116	453	14	-	-	PUNCT
fnp-5116	453	15	grade	grade	NOUN
fnp-5116	453	16	neuroepithelial	neuroepithelial	ADJ
fnp-5116	453	17	tumors	tumor	NOUN
fnp-5116	453	18	with	with	ADP
fnp-5116	453	19	fgfr1	fgfr1	NOUN
fnp-5116	453	20	alterations	alteration	NOUN
fnp-5116	453	21	reveals	reveal	VERB
fnp-5116	453	22	a	a	DET
fnp-5116	453	23	distinct	distinct	ADJ
fnp-5116	453	24	molecular	molecular	ADJ
fnp-5116	453	25	signature	signature	NOUN
fnp-5116	453	26	of	of	ADP
fnp-5116	453	27	rosette	rosette	NOUN
fnp-5116	453	28	-	-	PUNCT
fnp-5116	453	29	forming	form	VERB
fnp-5116	453	30	glioneuronal	glioneuronal	ADJ
fnp-5116	453	31	tumor	tumor	NOUN
fnp-5116	453	32	"	"	PUNCT
fnp-5116	453	33	,	,	PUNCT
fnp-5116	453	34	acta	acta	PROPN
fnp-5116	453	35	neuropathol	neuropathol	PROPN
fnp-5116	453	36	commun	commun	PROPN
fnp-5116	453	37	,	,	PUNCT
fnp-5116	453	38	vol	vol	NOUN
fnp-5116	453	39	.	.	PROPN
fnp-5116	453	40	8	8	NUM
fnp-5116	453	41	,	,	PUNCT
fnp-5116	453	42	no	no	INTJ
fnp-5116	453	43	.	.	NOUN
fnp-5116	453	44	1	1	NUM
fnp-5116	453	45	,	,	PUNCT
fnp-5116	453	46	p.	p.	NOUN
fnp-5116	453	47	151	151	NUM
fnp-5116	453	48	,	,	PUNCT
fnp-5116	453	49	aug	aug	PROPN
fnp-5116	453	50	28	28	NUM
fnp-5116	453	51	2020	2020	NUM
fnp-5116	453	52	,	,	PUNCT
fnp-5116	453	53	https://doi.org/10.1186/s40478-020-01027-z	https://doi.org/10.1186/s40478-020-01027-z	PROPN
fnp-5116	453	54	.	.	PROPN
fnp-5116	453	55	68	68	NUM
fnp-5116	453	56	.	.	PUNCT
fnp-5116	454	1	r.	r.	PROPN
fnp-5116	454	2	tamura	tamura	PROPN
fnp-5116	454	3	et	et	PROPN
fnp-5116	454	4	al	al	PROPN
fnp-5116	454	5	.	.	PROPN
fnp-5116	454	6	,	,	PUNCT
fnp-5116	454	7	"	"	PUNCT
fnp-5116	454	8	clinical	clinical	ADJ
fnp-5116	454	9	,	,	PUNCT
fnp-5116	454	10	histopathological	histopathological	ADJ
fnp-5116	454	11	and	and	CCONJ
fnp-5116	454	12	molecular	molecular	ADJ
fnp-5116	454	13	risk	risk	NOUN
fnp-5116	454	14	factors	factor	NOUN
fnp-5116	454	15	for	for	ADP
fnp-5116	454	16	recurrence	recurrence	NOUN
fnp-5116	454	17	of	of	ADP
fnp-5116	454	18	pilocytic	pilocytic	ADJ
fnp-5116	454	19	astrocytomas	astrocytoma	NOUN
fnp-5116	454	20	:	:	PUNCT
fnp-5116	454	21	brainstem	brainstem	NOUN
fnp-5116	454	22	/	/	SYM
fnp-5116	454	23	spinal	spinal	NOUN
fnp-5116	454	24	location	location	NOUN
fnp-5116	454	25	,	,	PUNCT
fnp-5116	454	26	nestin	nestin	NOUN
fnp-5116	454	27	expression	expression	NOUN
fnp-5116	454	28	and	and	CCONJ
fnp-5116	454	29	gain	gain	NOUN
fnp-5116	454	30	of	of	ADP
fnp-5116	454	31	7q	7q	NOUN
fnp-5116	454	32	and	and	CCONJ
fnp-5116	454	33	19	19	NUM
fnp-5116	454	34	are	be	AUX
fnp-5116	454	35	associated	associate	VERB
fnp-5116	454	36	with	with	ADP
fnp-5116	454	37	early	early	ADJ
fnp-5116	454	38	tumor	tumor	NOUN
fnp-5116	454	39	recurrence	recurrence	NOUN
fnp-5116	454	40	"	"	PUNCT
fnp-5116	454	41	,	,	PUNCT
fnp-5116	454	42	brain	brain	NOUN
fnp-5116	454	43	tumor	tumor	NOUN
fnp-5116	454	44	pathol	pathol	NOUN
fnp-5116	454	45	,	,	PUNCT
fnp-5116	454	46	vol	vol	NOUN
fnp-5116	454	47	.	.	PROPN
fnp-5116	454	48	40	40	NUM
fnp-5116	454	49	,	,	PUNCT
fnp-5116	454	50	no	no	INTJ
fnp-5116	454	51	.	.	NOUN
fnp-5116	454	52	2	2	NUM
fnp-5116	454	53	,	,	PUNCT
fnp-5116	454	54	pp	pp	ADJ
fnp-5116	454	55	.	.	PUNCT
fnp-5116	455	1	109	109	NUM
fnp-5116	455	2	-	-	SYM
fnp-5116	455	3	123	123	NUM
fnp-5116	455	4	,	,	PUNCT
fnp-5116	455	5	apr	apr	NOUN
fnp-5116	455	6	2023	2023	NUM
fnp-5116	455	7	,	,	PUNCT
fnp-5116	455	8	https://doi.org/10.1007/s10014-023-00453-w	https://doi.org/10.1007/s10014-023-00453-w	PROPN
fnp-5116	455	9	.	.	PROPN
fnp-5116	455	10	69	69	NUM
fnp-5116	455	11	.	.	PUNCT
fnp-5116	456	1	j.	j.	PROPN
fnp-5116	456	2	v.	v.	PROPN
fnp-5116	456	3	francis	francis	PROPN
fnp-5116	456	4	,	,	PUNCT
fnp-5116	456	5	b.	b.	PROPN
fnp-5116	456	6	tanrikulu	tanrikulu	PROPN
fnp-5116	456	7	,	,	PUNCT
fnp-5116	456	8	a.	a.	PROPN
fnp-5116	456	9	e.	e.	PROPN
fnp-5116	456	10	danyeli	danyeli	PROPN
fnp-5116	456	11	,	,	PUNCT
fnp-5116	456	12	and	and	CCONJ
fnp-5116	456	13	m.	m.	NOUN
fnp-5116	456	14	m.	m.	NOUN
fnp-5116	456	15	ozek	ozek	PROPN
fnp-5116	456	16	,	,	PUNCT
fnp-5116	456	17	"	"	PUNCT
fnp-5116	456	18	is	be	AUX
fnp-5116	456	19	it	it	PRON
fnp-5116	456	20	a	a	DET
fnp-5116	456	21	new	new	ADJ
fnp-5116	456	22	culprit	culprit	NOUN
fnp-5116	456	23	?	?	PUNCT
fnp-5116	457	1	"	"	PUNCT
fnp-5116	457	2	tert	tert	NOUN
fnp-5116	457	3	promoter	promoter	NOUN
fnp-5116	457	4	mutation	mutation	NOUN
fnp-5116	457	5	"	"	PUNCT
fnp-5116	457	6	in	in	ADP
fnp-5116	457	7	an	an	DET
fnp-5116	457	8	aggressive	aggressive	ADJ
fnp-5116	457	9	pediatric	pediatric	ADJ
fnp-5116	457	10	pilocytic	pilocytic	ADJ
fnp-5116	457	11	astrocytoma	astrocytoma	NOUN
fnp-5116	457	12	"	"	PUNCT
fnp-5116	457	13	,	,	PUNCT
fnp-5116	457	14	childs	child	VERB
fnp-5116	457	15	nerv	nerv	PROPN
fnp-5116	457	16	syst	syst	PROPN
fnp-5116	457	17	,	,	PUNCT
fnp-5116	457	18	vol	vol	NOUN
fnp-5116	457	19	.	.	PROPN
fnp-5116	458	1	37	37	NUM
fnp-5116	458	2	,	,	PUNCT
fnp-5116	458	3	no	no	INTJ
fnp-5116	458	4	.	.	NOUN
fnp-5116	458	5	3	3	NUM
fnp-5116	458	6	,	,	PUNCT
fnp-5116	458	7	pp	pp	ADJ
fnp-5116	458	8	.	.	PUNCT
fnp-5116	459	1	1003	1003	NUM
fnp-5116	459	2	-	-	SYM
fnp-5116	459	3	1008	1008	NUM
fnp-5116	459	4	,	,	PUNCT
fnp-5116	459	5	mar	mar	PROPN
fnp-5116	459	6	2021	2021	NUM
fnp-5116	459	7	,	,	PUNCT
fnp-5116	459	8	https://doi.org/10.1007/s00381-020-04803-3	https://doi.org/10.1007/s00381-020-04803-3	NUM
fnp-5116	459	9	.	.	PUNCT
fnp-5116	460	1	70	70	NUM
fnp-5116	460	2	.	.	X
fnp-5116	460	3	d.	d.	PROPN
fnp-5116	460	4	n.	n.	PROPN
fnp-5116	460	5	cagney	cagney	PROPN
fnp-5116	460	6	et	et	PROPN
fnp-5116	460	7	al	al	PROPN
fnp-5116	460	8	.	.	PROPN
fnp-5116	460	9	,	,	PUNCT
fnp-5116	460	10	"	"	PUNCT
fnp-5116	460	11	clinical	clinical	ADJ
fnp-5116	460	12	importance	importance	NOUN
fnp-5116	460	13	of	of	ADP
fnp-5116	460	14	cdkn2a	cdkn2a	ADJ
fnp-5116	460	15	loss	loss	NOUN
fnp-5116	460	16	and	and	CCONJ
fnp-5116	460	17	monosomy	monosomy	NOUN
fnp-5116	460	18	10	10	NUM
fnp-5116	460	19	in	in	ADP
fnp-5116	460	20	pilocytic	pilocytic	ADJ
fnp-5116	460	21	astrocytoma	astrocytoma	NOUN
fnp-5116	460	22	"	"	PUNCT
fnp-5116	460	23	,	,	PUNCT
fnp-5116	460	24	cureus	cureus	NOUN
fnp-5116	460	25	,	,	PUNCT
fnp-5116	460	26	vol	vol	NOUN
fnp-5116	460	27	.	.	PROPN
fnp-5116	460	28	11	11	NUM
fnp-5116	460	29	,	,	PUNCT
fnp-5116	460	30	no	no	INTJ
fnp-5116	460	31	.	.	NOUN
fnp-5116	460	32	5	5	NUM
fnp-5116	460	33	,	,	PUNCT
fnp-5116	460	34	p.	p.	NOUN
fnp-5116	460	35	e4726	e4726	PROPN
fnp-5116	460	36	,	,	PUNCT
fnp-5116	460	37	may	may	AUX
fnp-5116	460	38	23	23	NUM
fnp-5116	460	39	2019	2019	NUM
fnp-5116	460	40	,	,	PUNCT
fnp-5116	460	41	https://doi.org/10.7759/cureus.4726	https://doi.org/10.7759/cureus.4726	X
fnp-5116	460	42	.	.	PUNCT
fnp-5116	461	1	71	71	NUM
fnp-5116	461	2	.	.	PUNCT
fnp-5116	462	1	e.	e.	PROPN
fnp-5116	462	2	f.	f.	PROPN
fnp-5116	462	3	rodriguez	rodriguez	PROPN
fnp-5116	462	4	et	et	PROPN
fnp-5116	462	5	al	al	PROPN
fnp-5116	462	6	.	.	PROPN
fnp-5116	462	7	,	,	PUNCT
fnp-5116	462	8	"	"	PUNCT
fnp-5116	462	9	pi3k	pi3k	NOUN
fnp-5116	462	10	/	/	SYM
fnp-5116	462	11	akt	akt	PROPN
fnp-5116	462	12	pathway	pathway	NOUN
fnp-5116	462	13	alterations	alteration	NOUN
fnp-5116	462	14	are	be	AUX
fnp-5116	462	15	associated	associate	VERB
fnp-5116	462	16	with	with	ADP
fnp-5116	462	17	clinically	clinically	ADV
fnp-5116	462	18	aggressive	aggressive	ADJ
fnp-5116	462	19	and	and	CCONJ
fnp-5116	462	20	histologically	histologically	ADV
fnp-5116	462	21	anaplastic	anaplastic	ADJ
fnp-5116	462	22	subsets	subset	NOUN
fnp-5116	462	23	of	of	ADP
fnp-5116	462	24	pilocytic	pilocytic	ADJ
fnp-5116	462	25	astrocytoma	astrocytoma	NOUN
fnp-5116	462	26	"	"	PUNCT
fnp-5116	462	27	,	,	PUNCT
fnp-5116	462	28	acta	acta	PROPN
fnp-5116	462	29	neuropathol	neuropathol	PROPN
fnp-5116	462	30	,	,	PUNCT
fnp-5116	462	31	vol	vol	NOUN
fnp-5116	462	32	.	.	PROPN
fnp-5116	462	33	121	121	NUM
fnp-5116	462	34	,	,	PUNCT
fnp-5116	462	35	no	no	INTJ
fnp-5116	462	36	.	.	NOUN
fnp-5116	462	37	3	3	NUM
fnp-5116	462	38	,	,	PUNCT
fnp-5116	462	39	pp	pp	ADJ
fnp-5116	462	40	.	.	PUNCT
fnp-5116	463	1	407	407	NUM
fnp-5116	463	2	-	-	SYM
fnp-5116	463	3	20	20	NUM
fnp-5116	463	4	,	,	PUNCT
fnp-5116	463	5	mar	mar	PROPN
fnp-5116	463	6	2011	2011	NUM
fnp-5116	463	7	,	,	PUNCT
fnp-5116	463	8	https://doi.org/10.1007/s00401-010-0784-9	https://doi.org/10.1007/s00401-010-0784-9	NUM
fnp-5116	463	9	.	.	PUNCT
fnp-5116	464	1	72	72	NUM
fnp-5116	464	2	.	.	PUNCT
fnp-5116	464	3	g.	g.	PROPN
fnp-5116	464	4	f.	f.	PROPN
fnp-5116	464	5	reis	reis	PROPN
fnp-5116	464	6	and	and	CCONJ
fnp-5116	464	7	t.	t.	PROPN
fnp-5116	464	8	tihan	tihan	PROPN
fnp-5116	464	9	,	,	PUNCT
fnp-5116	464	10	"	"	PUNCT
fnp-5116	464	11	practical	practical	ADJ
fnp-5116	464	12	molecular	molecular	ADJ
fnp-5116	464	13	pathologic	pathologic	ADJ
fnp-5116	464	14	diagnosis	diagnosis	NOUN
fnp-5116	464	15	of	of	ADP
fnp-5116	464	16	pilocytic	pilocytic	ADJ
fnp-5116	464	17	astrocytomas	astrocytoma	NOUN
fnp-5116	464	18	"	"	PUNCT
fnp-5116	464	19	,	,	PUNCT
fnp-5116	464	20	surg	surg	NOUN
fnp-5116	464	21	pathol	pathol	VERB
fnp-5116	464	22	clin	clin	PROPN
fnp-5116	464	23	,	,	PUNCT
fnp-5116	464	24	vol	vol	NOUN
fnp-5116	464	25	.	.	PROPN
fnp-5116	464	26	8	8	NUM
fnp-5116	464	27	,	,	PUNCT
fnp-5116	464	28	no	no	INTJ
fnp-5116	464	29	.	.	NOUN
fnp-5116	464	30	1	1	NUM
fnp-5116	464	31	,	,	PUNCT
fnp-5116	464	32	pp	pp	ADJ
fnp-5116	464	33	.	.	PUNCT
fnp-5116	465	1	63	63	NUM
fnp-5116	465	2	-	-	SYM
fnp-5116	465	3	71	71	NUM
fnp-5116	465	4	,	,	PUNCT
fnp-5116	465	5	mar	mar	PROPN
fnp-5116	465	6	2015	2015	NUM
fnp-5116	465	7	,	,	PUNCT
fnp-5116	465	8	https://doi.org/10.1016/j.path.2014.10.002	https://doi.org/10.1016/j.path.2014.10.002	NOUN
fnp-5116	465	9	.	.	PUNCT
fnp-5116	466	1	73	73	NUM
fnp-5116	466	2	.	.	PUNCT
fnp-5116	467	1	p.	p.	NOUN
fnp-5116	467	2	daszkiewicz	daszkiewicz	PROPN
fnp-5116	467	3	,	,	PUNCT
fnp-5116	467	4	a.	a.	NOUN
fnp-5116	467	5	maryniak	maryniak	PROPN
fnp-5116	467	6	,	,	PUNCT
fnp-5116	467	7	m.	m.	NOUN
fnp-5116	467	8	roszkowski	roszkowski	NOUN
fnp-5116	467	9	,	,	PUNCT
fnp-5116	467	10	and	and	CCONJ
fnp-5116	467	11	s.	s.	PROPN
fnp-5116	467	12	barszcz	barszcz	PROPN
fnp-5116	467	13	,	,	PUNCT
fnp-5116	467	14	"	"	PUNCT
fnp-5116	467	15	long	long	ADJ
fnp-5116	467	16	-	-	PUNCT
fnp-5116	467	17	term	term	NOUN
fnp-5116	467	18	functional	functional	ADJ
fnp-5116	467	19	outcome	outcome	NOUN
fnp-5116	467	20	of	of	ADP
fnp-5116	467	21	surgical	surgical	ADJ
fnp-5116	467	22	treatment	treatment	NOUN
fnp-5116	467	23	of	of	ADP
fnp-5116	467	24	juvenile	juvenile	ADJ
fnp-5116	467	25	pilocytic	pilocytic	ADJ
fnp-5116	467	26	astrocytoma	astrocytoma	NOUN
fnp-5116	467	27	of	of	ADP
fnp-5116	467	28	the	the	DET
fnp-5116	467	29	cerebellum	cerebellum	NOUN
fnp-5116	467	30	in	in	ADP
fnp-5116	467	31	children	child	NOUN
fnp-5116	467	32	"	"	PUNCT
fnp-5116	467	33	,	,	PUNCT
fnp-5116	467	34	childs	child	VERB
fnp-5116	467	35	nerv	nerv	PROPN
fnp-5116	467	36	syst	syst	PROPN
fnp-5116	467	37	,	,	PUNCT
fnp-5116	467	38	vol	vol	NOUN
fnp-5116	467	39	.	.	PROPN
fnp-5116	468	1	25	25	NUM
fnp-5116	468	2	,	,	PUNCT
fnp-5116	468	3	no	no	INTJ
fnp-5116	468	4	.	.	NOUN
fnp-5116	468	5	7	7	NUM
fnp-5116	468	6	,	,	PUNCT
fnp-5116	468	7	pp	pp	ADJ
fnp-5116	468	8	.	.	PUNCT
fnp-5116	469	1	855	855	NUM
fnp-5116	469	2	-	-	SYM
fnp-5116	469	3	60	60	NUM
fnp-5116	469	4	,	,	PUNCT
fnp-5116	469	5	jul	jul	PROPN
fnp-5116	469	6	2009	2009	NUM
fnp-5116	469	7	,	,	PUNCT
fnp-5116	469	8	https://doi.org/10.1007/s00381-009-0855-1	https://doi.org/10.1007/s00381-009-0855-1	PROPN
fnp-5116	469	9	.	.	PUNCT
fnp-5116	470	1	74	74	NUM
fnp-5116	470	2	.	.	PUNCT
fnp-5116	471	1	k.	k.	PROPN
fnp-5116	471	2	m.	m.	PROPN
fnp-5116	471	3	bond	bond	PROPN
fnp-5116	471	4	,	,	PUNCT
fnp-5116	471	5	j.	j.	PROPN
fnp-5116	471	6	d.	d.	PROPN
fnp-5116	471	7	hughes	hughes	PROPN
fnp-5116	471	8	,	,	PUNCT
fnp-5116	471	9	a.	a.	PROPN
fnp-5116	471	10	l.	l.	PROPN
fnp-5116	471	11	porter	porter	PROPN
fnp-5116	471	12	,	,	PUNCT
fnp-5116	471	13	j.	j.	PROPN
fnp-5116	471	14	orina	orina	PROPN
fnp-5116	471	15	,	,	PUNCT
fnp-5116	471	16	s.	s.	PROPN
fnp-5116	471	17	fang	fang	PROPN
fnp-5116	471	18	,	,	PUNCT
fnp-5116	471	19	and	and	CCONJ
fnp-5116	471	20	i.	i.	PROPN
fnp-5116	471	21	f.	f.	PROPN
fnp-5116	471	22	parney	parney	PROPN
fnp-5116	471	23	,	,	PUNCT
fnp-5116	471	24	"	"	PUNCT
fnp-5116	471	25	adult	adult	NOUN
fnp-5116	471	26	pilocytic	pilocytic	ADJ
fnp-5116	471	27	astrocytoma	astrocytoma	NOUN
fnp-5116	471	28	:	:	PUNCT
fnp-5116	471	29	an	an	DET
fnp-5116	471	30	institutional	institutional	ADJ
fnp-5116	471	31	series	series	NOUN
fnp-5116	471	32	and	and	CCONJ
fnp-5116	471	33	systematic	systematic	ADJ
fnp-5116	471	34	literature	literature	NOUN
fnp-5116	471	35	review	review	NOUN
fnp-5116	471	36	for	for	ADP
fnp-5116	471	37	extent	extent	NOUN
fnp-5116	471	38	of	of	ADP
fnp-5116	471	39	resection	resection	NOUN
fnp-5116	471	40	and	and	CCONJ
fnp-5116	471	41	recurrence	recurrence	NOUN
fnp-5116	471	42	"	"	PUNCT
fnp-5116	471	43	,	,	PUNCT
fnp-5116	471	44	world	world	NOUN
fnp-5116	471	45	neurosurg	neurosurg	PROPN
fnp-5116	471	46	,	,	PUNCT
fnp-5116	471	47	vol	vol	NOUN
fnp-5116	471	48	.	.	PROPN
fnp-5116	472	1	110	110	NUM
fnp-5116	472	2	,	,	PUNCT
fnp-5116	472	3	pp	pp	ADJ
fnp-5116	472	4	.	.	PUNCT
fnp-5116	473	1	276	276	NUM
fnp-5116	473	2	-	-	SYM
fnp-5116	473	3	283	283	NUM
fnp-5116	473	4	,	,	PUNCT
fnp-5116	473	5	feb	feb	PROPN
fnp-5116	473	6	2018	2018	NUM
fnp-5116	473	7	,	,	PUNCT
fnp-5116	473	8	https://doi.org/10.1016/j.wneu.2017.11.102	https://doi.org/10.1016/j.wneu.2017.11.102	NUM
fnp-5116	473	9	.	.	PUNCT
fnp-5116	474	1	75	75	NUM
fnp-5116	474	2	.	.	PUNCT
fnp-5116	474	3	a.	a.	PROPN
fnp-5116	474	4	n.	n.	PROPN
fnp-5116	474	5	santos	santos	PROPN
fnp-5116	474	6	et	et	PROPN
fnp-5116	474	7	al	al	PROPN
fnp-5116	474	8	.	.	PROPN
fnp-5116	474	9	,	,	PUNCT
fnp-5116	474	10	"	"	PUNCT
fnp-5116	474	11	long	long	ADJ
fnp-5116	474	12	-	-	PUNCT
fnp-5116	474	13	term	term	NOUN
fnp-5116	474	14	outcome	outcome	NOUN
fnp-5116	474	15	after	after	ADP
fnp-5116	474	16	management	management	NOUN
fnp-5116	474	17	of	of	ADP
fnp-5116	474	18	pilocytic	pilocytic	ADJ
fnp-5116	474	19	astrocytoma	astrocytoma	NOUN
fnp-5116	474	20	in	in	ADP
fnp-5116	474	21	the	the	DET
fnp-5116	474	22	posterior	posterior	ADJ
fnp-5116	474	23	fossa	fossa	NOUN
fnp-5116	474	24	in	in	ADP
fnp-5116	474	25	a	a	DET
fnp-5116	474	26	pediatric	pediatric	ADJ
fnp-5116	474	27	population	population	NOUN
fnp-5116	474	28	"	"	PUNCT
fnp-5116	474	29	,	,	PUNCT
fnp-5116	474	30	ibro	ibro	PROPN
fnp-5116	474	31	neurosci	neurosci	PROPN
fnp-5116	474	32	rep	rep	PROPN
fnp-5116	474	33	,	,	PUNCT
fnp-5116	474	34	vol	vol	NOUN
fnp-5116	474	35	.	.	PROPN
fnp-5116	474	36	13	13	NUM
fnp-5116	474	37	,	,	PUNCT
fnp-5116	474	38	pp	pp	ADJ
fnp-5116	474	39	.	.	PUNCT
fnp-5116	475	1	388	388	NUM
fnp-5116	475	2	-	-	SYM
fnp-5116	475	3	392	392	NUM
fnp-5116	475	4	,	,	PUNCT
fnp-5116	475	5	dec	dec	PROPN
fnp-5116	475	6	2022	2022	NUM
fnp-5116	475	7	,	,	PUNCT
fnp-5116	475	8	https://doi.org/10.1016/j.ibneur.2022.10.001	https://doi.org/10.1016/j.ibneur.2022.10.001	NOUN
fnp-5116	475	9	.	.	PUNCT
fnp-5116	476	1	76	76	NUM
fnp-5116	476	2	.	.	PUNCT
fnp-5116	476	3	b.	b.	PROPN
fnp-5116	476	4	a.	a.	PROPN
fnp-5116	476	5	muhsen	muhsen	PROPN
fnp-5116	476	6	,	,	PUNCT
fnp-5116	476	7	a.	a.	PROPN
fnp-5116	476	8	i.	i.	PROPN
fnp-5116	476	9	aljariri	aljariri	PROPN
fnp-5116	476	10	,	,	PUNCT
fnp-5116	476	11	m.	m.	NOUN
fnp-5116	476	12	elayyan	elayyan	PROPN
fnp-5116	476	13	,	,	PUNCT
fnp-5116	476	14	h.	h.	PROPN
fnp-5116	476	15	hirbawi	hirbawi	PROPN
fnp-5116	476	16	,	,	PUNCT
fnp-5116	476	17	and	and	CCONJ
fnp-5116	476	18	m.	m.	PROPN
fnp-5116	476	19	a.	a.	PROPN
fnp-5116	476	20	masri	masri	PROPN
fnp-5116	476	21	,	,	PUNCT
fnp-5116	476	22	"	"	PUNCT
fnp-5116	476	23	insight	insight	NOUN
fnp-5116	476	24	about	about	ADP
fnp-5116	476	25	the	the	DET
fnp-5116	476	26	characteristics	characteristic	NOUN
fnp-5116	476	27	and	and	CCONJ
fnp-5116	476	28	surgical	surgical	ADJ
fnp-5116	476	29	resectability	resectability	NOUN
fnp-5116	476	30	of	of	ADP
fnp-5116	476	31	adult	adult	NOUN
fnp-5116	476	32	pilocytic	pilocytic	ADJ
fnp-5116	476	33	astrocytoma	astrocytoma	NOUN
fnp-5116	476	34	:	:	PUNCT
fnp-5116	476	35	tertiary	tertiary	ADJ
fnp-5116	476	36	center	center	NOUN
fnp-5116	476	37	experience	experience	NOUN
fnp-5116	476	38	"	"	PUNCT
fnp-5116	476	39	,	,	PUNCT
fnp-5116	476	40	cns	cns	PROPN
fnp-5116	476	41	oncol	oncol	ADJ
fnp-5116	476	42	,	,	PUNCT
fnp-5116	476	43	vol	vol	NOUN
fnp-5116	476	44	.	.	PROPN
fnp-5116	476	45	11	11	NUM
fnp-5116	476	46	,	,	PUNCT
fnp-5116	476	47	no	no	INTJ
fnp-5116	476	48	.	.	NOUN
fnp-5116	476	49	1	1	NUM
fnp-5116	476	50	,	,	PUNCT
fnp-5116	476	51	p.	p.	PROPN
fnp-5116	476	52	cns81	cns81	PROPN
fnp-5116	476	53	,	,	PUNCT
fnp-5116	476	54	apr	apr	VERB
fnp-5116	476	55	6	6	NUM
fnp-5116	476	56	2022	2022	NUM
fnp-5116	476	57	,	,	PUNCT
fnp-5116	476	58	https://doi.org/10.2217/cns-2021-0014	https://doi.org/10.2217/cns-2021-0014	NOUN
fnp-5116	476	59	.	.	PUNCT
fnp-5116	477	1	77	77	NUM
fnp-5116	477	2	.	.	PUNCT
fnp-5116	478	1	l.	l.	PROPN
fnp-5116	478	2	y.	y.	PROPN
fnp-5116	478	3	wen	wen	PROPN
fnp-5116	478	4	et	et	PROPN
fnp-5116	478	5	al	al	PROPN
fnp-5116	478	6	.	.	PROPN
fnp-5116	478	7	,	,	PUNCT
fnp-5116	478	8	"	"	PUNCT
fnp-5116	478	9	associations	association	NOUN
fnp-5116	478	10	between	between	ADP
fnp-5116	478	11	chinese	chinese	ADJ
fnp-5116	478	12	college	college	PROPN
fnp-5116	478	13	students	student	NOUN
fnp-5116	478	14	'	'	PART
fnp-5116	478	15	anxiety	anxiety	NOUN
fnp-5116	478	16	and	and	CCONJ
fnp-5116	478	17	depression	depression	NOUN
fnp-5116	478	18	:	:	PUNCT
fnp-5116	478	19	a	a	DET
fnp-5116	478	20	chain	chain	NOUN
fnp-5116	478	21	mediation	mediation	NOUN
fnp-5116	478	22	analysis	analysis	NOUN
fnp-5116	478	23	"	"	PUNCT
fnp-5116	478	24	,	,	PUNCT
fnp-5116	478	25	plos	plos	PROPN
fnp-5116	478	26	one	one	NUM
fnp-5116	478	27	,	,	PUNCT
fnp-5116	478	28	vol	vol	NOUN
fnp-5116	478	29	.	.	PROPN
fnp-5116	478	30	17	17	NUM
fnp-5116	478	31	,	,	PUNCT
fnp-5116	478	32	no	no	INTJ
fnp-5116	478	33	.	.	NOUN
fnp-5116	478	34	6	6	NUM
fnp-5116	478	35	,	,	PUNCT
fnp-5116	478	36	p.	p.	PROPN
fnp-5116	478	37	e0268773	e0268773	PROPN
fnp-5116	478	38	,	,	PUNCT
fnp-5116	478	39	2022	2022	NUM
fnp-5116	478	40	,	,	PUNCT
fnp-5116	478	41	https://doi.org/10.1371/journal.pone.0268773	https://doi.org/10.1371/journal.pone.0268773	PROPN
fnp-5116	478	42	.	.	PROPN
fnp-5116	478	43	78	78	NUM
fnp-5116	478	44	.	.	PUNCT
fnp-5116	479	1	s.	s.	PROPN
fnp-5116	479	2	j.	j.	PROPN
fnp-5116	479	3	cler	cler	PROPN
fnp-5116	479	4	et	et	PROPN
fnp-5116	479	5	al	al	PROPN
fnp-5116	479	6	.	.	PROPN
fnp-5116	479	7	,	,	PUNCT
fnp-5116	479	8	"	"	PUNCT
fnp-5116	479	9	genetic	genetic	ADJ
fnp-5116	479	10	and	and	CCONJ
fnp-5116	479	11	histopathological	histopathological	ADJ
fnp-5116	479	12	associations	association	NOUN
fnp-5116	479	13	with	with	ADP
fnp-5116	479	14	outcome	outcome	NOUN
fnp-5116	479	15	in	in	ADP
fnp-5116	479	16	pediatric	pediatric	ADJ
fnp-5116	479	17	pilocytic	pilocytic	ADJ
fnp-5116	479	18	astrocytoma	astrocytoma	NOUN
fnp-5116	479	19	"	"	PUNCT
fnp-5116	479	20	,	,	PUNCT
fnp-5116	479	21	j	j	PROPN
fnp-5116	479	22	neurosurg	neurosurg	PROPN
fnp-5116	479	23	pediatr	pediatr	PROPN
fnp-5116	479	24	,	,	PUNCT
fnp-5116	479	25	vol	vol	NOUN
fnp-5116	479	26	.	.	PROPN
fnp-5116	479	27	29	29	NUM
fnp-5116	479	28	,	,	PUNCT
fnp-5116	479	29	no	no	INTJ
fnp-5116	479	30	.	.	NOUN
fnp-5116	479	31	5	5	NUM
fnp-5116	479	32	,	,	PUNCT
fnp-5116	479	33	pp	pp	ADJ
fnp-5116	479	34	.	.	PUNCT
fnp-5116	480	1	504	504	NUM
fnp-5116	480	2	-	-	SYM
fnp-5116	480	3	512	512	NUM
fnp-5116	480	4	,	,	PUNCT
fnp-5116	480	5	may	may	AUX
fnp-5116	480	6	1	1	NUM
fnp-5116	480	7	2022	2022	NUM
fnp-5116	480	8	,	,	PUNCT
fnp-5116	480	9	https://doi.org/10.3171/2021.9.peds21405	https://doi.org/10.3171/2021.9.peds21405	PROPN
fnp-5116	480	10	.	.	PUNCT
fnp-5116	481	1	copyright	copyright	NOUN
fnp-5116	481	2	:	:	PUNCT
fnp-5116	481	3	©	©	PROPN
fnp-5116	481	4	2023	2023	NUM
fnp-5116	481	5	the	the	DET
fnp-5116	481	6	author(s	author(s	NOUN
fnp-5116	481	7	)	)	PUNCT
fnp-5116	481	8	.	.	PUNCT
fnp-5116	482	1	this	this	PRON
fnp-5116	482	2	is	be	AUX
fnp-5116	482	3	an	an	DET
fnp-5116	482	4	open	open	ADJ
fnp-5116	482	5	access	access	NOUN
fnp-5116	482	6	article	article	NOUN
fnp-5116	482	7	distributed	distribute	VERB
fnp-5116	482	8	under	under	ADP
fnp-5116	482	9	the	the	DET
fnp-5116	482	10	terms	term	NOUN
fnp-5116	482	11	of	of	ADP
fnp-5116	482	12	the	the	DET
fnp-5116	482	13	creative	creative	ADJ
fnp-5116	482	14	commons	common	NOUN
fnp-5116	482	15	attribution	attribution	NOUN
fnp-5116	482	16	4.0	4.0	NUM
fnp-5116	482	17	international	international	ADJ
fnp-5116	482	18	license	license	NOUN
fnp-5116	482	19	(	(	PUNCT
fnp-5116	482	20	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
fnp-5116	482	21	)	)	PUNCT
fnp-5116	482	22	,	,	PUNCT
fnp-5116	482	23	which	which	PRON
fnp-5116	482	24	permits	permit	VERB
fnp-5116	482	25	unrestricted	unrestricted	ADJ
fnp-5116	482	26	use	use	NOUN
fnp-5116	482	27	,	,	PUNCT
fnp-5116	482	28	distribution	distribution	NOUN
fnp-5116	482	29	,	,	PUNCT
fnp-5116	482	30	and	and	CCONJ
fnp-5116	482	31	reproduction	reproduction	NOUN
fnp-5116	482	32	in	in	ADP
fnp-5116	482	33	any	any	DET
fnp-5116	482	34	medium	medium	NOUN
fnp-5116	482	35	,	,	PUNCT
fnp-5116	482	36	provided	provide	VERB
fnp-5116	482	37	the	the	DET
fnp-5116	482	38	original	original	ADJ
fnp-5116	482	39	author	author	NOUN
fnp-5116	482	40	and	and	CCONJ
fnp-5116	482	41	source	source	NOUN
fnp-5116	482	42	are	be	AUX
fnp-5116	482	43	credited	credit	VERB
fnp-5116	482	44	,	,	PUNCT
fnp-5116	482	45	a	a	DET
fnp-5116	482	46	link	link	NOUN
fnp-5116	482	47	to	to	ADP
fnp-5116	482	48	the	the	DET
fnp-5116	482	49	creative	creative	ADJ
fnp-5116	482	50	commons	common	NOUN
fnp-5116	482	51	license	license	NOUN
fnp-5116	482	52	is	be	AUX
fnp-5116	482	53	provided	provide	VERB
fnp-5116	482	54	,	,	PUNCT
fnp-5116	482	55	and	and	CCONJ
fnp-5116	482	56	any	any	DET
fnp-5116	482	57	changes	change	NOUN
fnp-5116	482	58	are	be	AUX
fnp-5116	482	59	indicated	indicate	VERB
fnp-5116	482	60	.	.	PUNCT
fnp-5116	483	1	the	the	DET
fnp-5116	483	2	creative	creative	ADJ
fnp-5116	483	3	commons	common	NOUN
fnp-5116	483	4	public	public	ADJ
fnp-5116	483	5	domain	domain	NOUN
fnp-5116	483	6	dedication	dedication	NOUN
fnp-5116	483	7	waiver	waiver	NOUN
fnp-5116	483	8	(	(	PUNCT
fnp-5116	483	9	https://creativecommons.org/publicdomain/zero/1.0/	https://creativecommons.org/publicdomain/zero/1.0/	PROPN
fnp-5116	483	10	)	)	PUNCT
fnp-5116	483	11	applies	apply	VERB
fnp-5116	483	12	to	to	ADP
fnp-5116	483	13	the	the	DET
fnp-5116	483	14	data	datum	NOUN
fnp-5116	483	15	made	make	VERB
fnp-5116	483	16	available	available	ADJ
fnp-5116	483	17	in	in	ADP
fnp-5116	483	18	this	this	DET
fnp-5116	483	19	article	article	NOUN
fnp-5116	483	20	,	,	PUNCT
fnp-5116	483	21	unless	unless	SCONJ
fnp-5116	483	22	otherwise	otherwise	ADV
fnp-5116	483	23	stated	state	VERB
fnp-5116	483	24	.	.	PUNCT